Molecular definition of group 1 innate lymphoid cells in the uterus by Filipovic, Iva
 Molecular definition of group 1 innate 
lymphoid cells in the uterus 
 
 
 
Iva Filipovic 
King’s College 
 
Submitted in December 2018 
 
This dissertation is submitted for the degree of Doctor of Philosophy at the 
University of Cambridge. 
  1 
Declaration of originality 
This dissertation is the result of my own work and includes nothing which is the outcome of 
work done in collaboration except as declared in the Preface and specified in the text. 
 
It is not substantially the same as any that I have submitted, or, is being concurrently 
submitted for a degree or diploma or other qualification at the University of Cambridge or 
any other University or similar institution except as declared in the Preface and specified in 
the text. I further state that no substantial part of my dissertation has already been submitted, 
or, is being concurrently submitted for any such degree, diploma or other qualification at the 
University of Cambridge or any other University of similar institution except as declared in 
the Preface and specified in the text. 
 
This thesis does not exceed the recommended word limit of 60,000 words set by the Degree 
Committee of Biology. 
 
 
 
 
 
 
 
  
  2 
Molecular definition of group 1 innate lymphoid cells in the uterus 
Iva Filipovic 
Summary  
Uterine NK cells (uNKs) are group 1 (g1) innate lymphoid cells (ILCs) that have been shown 
to regulate remodelling of uterine blood vessels, an event necessary to support fetal growth. 
Recently, other ILCs were identified in the mucosa and wall of the uterus of mice and 
women, pregnant or not. They may regulate important functions as they produce factors 
known to impact on uterine physiology and pathology. Unique to the mouse uterus is a 
population of CD49a+Eomes+ g1 ILCs (trNK), resembling human uNK cells. However, how 
they relate to uterine Eomes+CD49a- conventional NK cells (cNK) and CD49a+Eomes- ILC1 
has been unknown. Determining the function of uterine lymphocytes is challenging because 
of the rapidly changing nature of the organ in response to sex hormones and, during 
pregnancy, to the invading fetal trophoblast cells. In my work, I provide the first genome-
wide transcriptome atlas of mouse uterine g1 ILCs at mid-gestation. I show that the 
composition of g1 ILCs fluctuates throughout reproductive life, with CD49a+Eomes- ILC1s 
dominating before puberty and specifically expanding in second pregnancies, when the 
expression of CXCR6, a marker of memory NK cells, is upregulated. Tissue-resident 
CD49a+Eomes+ NK cells (trNK) are most abundant during early pregnancy, and showcase 
gene signatures of responsiveness to TGF-b. On the transcriptome level, they are also 
equipped with the machinery that may allow them to interact with majority of other cells at 
the maternal-fetal interface, as well as with the extracellular matrix. Conventional NK cells 
expand late in gestation and may interact with trNK cells through the production of IL-18 and 
IFN-g. These results identify trNK cells as the cellular hub of uterine g1 ILCs at mid-
gestation and mark CXCR6+ ILC1s as potential memory cells of pregnancy. I have also 
identified in the uterus an early developmental stage along the g1 ILC lineage. The 
identification of this stage of lymphoid development should facilitate the delineation of g1 
ILC differentiation in the uterus. This study represents the first report of the uterine g1 ILC 
transcriptome and it will be an essential resource for designing future studies in the field of 
reproductive immunology. Determining the molecular identity and function of mouse uterine 
g1 ILCs as demonstrated here will be instrumental to guide further work with human uNKs.  
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Foreword 
Despite my general lack of appreciation for motivational quotes, I came across several over 
the course of last three years that I found captivating. The reason why they have remained so 
ingrained in my mind is because they summarised some of the main lessons I learnt during 
my PhD. Nevertheless, not all of these quotes came from scientists, which, for me, was 
another important lesson during the time that it took to get here: skills one needs in order to 
be a competent scientist are not unique. They are skills essential for anyone in position where 
leadership, resourcefulness and creativity are required to bring change. I will cite them here, 
each one with my own reflections and advice for scientists who may find themselves reading 
this dissertation. 
 
‘Do what you can, with what you have, where you are’ – Squire Bill Widener, from chapter 
IX of Theodore Roosevelt: An Autobiography (1913). 
There is a common misconception that this quote originated from Theodore Roosevelt 
himself, the 26th President of the United States, but looking back at the original 
autobiography, a reader can discover that Roosevelt himself attributed the quote to the person 
above. Similarly, scientific reviews can often leave a reader convinced in a piece of evidence 
that may have been unintentionally misinterpreted and cited by the review authors. Whenever 
possible, look at the original research paper. And in relation to the quote, it is important to 
remember that science is a critical thinking process. As scientists, we often depend on a 
limited supply of tissue samples and, occasionally, we may find ourselves constrained by the 
resources or infrastructure available. Critical thinking and asking simple, yet insightful 
questions can overcome such limitations. Resourcefulness is the key. 
 
 
  4 
‘Discovery is seeing what everybody else has seen, and thinking what nobody else has 
thought’ – Albert Szent-Györgyi von Nagyrápolt, a Hungarian biochemist and a winner of 
the Nobel Prize in Physiology or Medicine (1937) for the isolation of vitamin C and his work 
which laid the foundations for the discovery of the citric acid (Krebs) cycle.   
I find this quote highly relatable to the work in the field of reproductive immunology. As 
explained in the Introduction to this dissertation (sections 1.2.2.2 and 1.2.2.9 and represented 
in Fig. 1.7), although uterine Natural Killer cells were not truly known as Natural Killer cells, 
they have been observed by researchers of various backgrounds since the end of the 19th 
century, long before conventional Natural Killer cells were discovered almost a full century 
later. As we move forward in science, it will become increasingly important to address long-
standing questions using novel technologies and interdisciplinary approaches. This will offer 
new insights that will allow for a deeper understanding of potentially misunderstood and/or 
underappreciated knowledge that we had available for centuries. 
 
‘The only way to get ahead is to find errors in conventional wisdom’ – Larry Ellison, the 
founder of the Oracle (a database used by The Central Intelligence Agency). 
This quote is somewhat related to the previous one. There are numerous landmark studies 
without which it would be impossible to get to where we are today in science. Historical 
papers are among the most valuable resources available to young scientists today and there is 
nothing wrong with the ‘conventional wisdom’. However, by using technologies mentioned 
above, new discoveries make it a challenge to update the textbooks with new data generated 
almost daily. In 2018, we are overwhelmed with the data originating from the technological 
advances and we must be thorough in further exploration of the findings that will lead to 
understanding, and possibly revisiting, the basic physiological mechanisms. Ultimately, this 
will benefit the medical advances and human health.  
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‘But I am very poorly today and very stupid and hate everybody and everything’ – Charles 
Darwin 
Even the most famous scientists had rough weeks. This, however, never made me doubt my 
academic goals. As long as I am able to navigate my way through academia, I will remain a 
scientist, because I could never imagine myself doing anything else. Every project is a puzzle 
where I have to both (1) come up with the pieces and (2) put them together. For me, to be 
able to do this every day for the rest of my life, is a great privilege. 
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1. Introduction 
1.1 Reproduction 
1.1.1 A brief guide to the tree of life: focus on modes of reproduction 
Recent technological advances in the field of genomics have allowed sequencing of the 
genomes of many novel organisms, particularly of the ones living in the extreme habitats. 
Genetic information obtained from the sequencing of over 1,000 new genomes has led to a 
reconstruction of the molecular tree of life. However, the new data reveals diversification 
principally in the domain Bacteria, while Eukarya exhibits much less phylogenetic diversity 
due to a more recent evolution (Hug et al., 2016). One of the most important traits that 
differentiates multicellular eukaryotic animals (biological kingdom Animalia in the scientific 
classification) from the rest of the living organisms is the ability to reproduce sexually, via 
fusion of the two gametes created by meiosis. Despite the lower level of diversity in Eukarya 
and consequently in its kingdom Animalia, there is still a very poor understanding of the 
events post-fertilisation at the molecular level. Of particular importance in the evolutionary 
history of life is the phylum Chordata of the animal kingdom, also known as chordates. These 
are deuterostomes that go through a notochord stage during their development. Looking 
further into the classification, chordates consist of three subphyla: Cephalochordata, Tunicata 
and Vertebrata (Craniata). It is a superclass Tetrapoda, or tetrapods (four-limbed vertebrates) 
that represent an exceptional model of evolutionary success, as documented by their 
ecological diversity today. The main reason behind this is that the evolution of tetrapods took 
place around the time that the colonisation of dry land started, which was about 360 million 
years ago (Sander, 2012). The first tetrapods were aquatic animals but with a move from the 
sea, through swamps, onto the land habitat about 50 million years later, they had to adapt in 
order to survive. The evolutionary changes in reproduction were essential to drive this 
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survival. Tetrapods include two groups of animals: anamniotes and amniotes. The first 
tetrapods were mainly anamniotes and predominantly aquatic, represented by fishes and 
amphibians. This is a more primitive group that lays eggs in water. Anatomically, the 
anamniotic egg is characterised by the lack of amnion, an innermost membrane of an 
amniotic egg, filled with amniotic fluid during the embryonic development. Physiologically, 
the lack of amnion means that the anamniote embryo is able to develop in an aquatic 
environment through a direct exchange of oxygen, CO2 and waste with the water in which the 
egg is laid.  
However, most tetrapods are amniotes (represented by reptiles, birds and mammals) which 
lay eggs on the land or are carried by the mother who gives birth to the live young. This was 
made possible by the adaptations brought by the development of the amniotic egg and driven 
by the tetrapods’ conquest of the dry land. Amniotes have developed a more complex egg, 
characterised by four extraembryonic membrane structures: yolk sac, amnion, chorion and 
allantois. The amnion is the innermost membrane, enclosing the embryo in amniotic fluid 
which serves a protective purpose, but this environment is also a water replacement because 
now it provides an interface between the embryo and its environment allowing for 
respiratory, excretory and nutritional functions. This evolutionary innovation has permitted 
amniotes to inhabit terrestrial environments much more successfully than anamniotes (Reisz, 
1997). 
Various reproductive solutions as described above have led to the following classification of 
a birth process: 
(1) Oviparity – undeveloped eggs are released. This is a process in which the undeveloped 
fertilised eggs are released and they finish their development externally. All birds, some 
fishes and most reptiles are oviparous. As introduced earlier, mammals are tetrapod amniotes 
and there are three classes of mammals – Prototheria (monotremes), Metatheria (marsupials) 
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and Eutheria. Within mammals, monotremes are oviparous animals, and one example is the 
duckbill platypus as an egg laying mammal.  
(2) Viviparity – a solution in which the mother bears live young and the offspring is born 
without the requirement to finish their development outside the parental body. Viviparity is 
represented by the development of placenta which will allow the nutrient supply from the 
mother. The amniote egg has allowed the move from oviparity to viviparity because it 
increased the capacity of respiration, excretion and nourishment from the mother, without the 
need for surrounding water. Eutherian mammals are viviparous and they have the most 
complex placental development (Moffett & Loke, 2006), especially compared to a much 
simpler marsupial placenta. Viviparity has independently evolved many times within the 
subphylum Vertebrata (Romer, 1967; Blackburn, 1998). Another example of viviparous 
animals are the blue sharks with a yolk sac placenta (Hamlett & Wourms, 1984; Hamlett et 
al., 1985).   
(3) Ovoviviparity – an intermediate solution between oviparity and viviparity, where 
embryos develop inside the mother getting all their nutrients from a yolk sac, until the mother 
either gives birth to live young or lays eggs to hatch. An example is the tiger shark. 
Although viviparity comes with reproductive advantages, it is an immunological conundrum 
that a zygote, created by the fusion of gametes from two genetically distinct individuals, now 
can exist inside of a maternal body for any period of time, remaining unharmed until the end 
of gestation. This defies one the main immunological concepts, allorecognition, which is the 
process of immune cells recognising antigens derived from a genetically distinct individual 
organism of the same species, or in simpler terms, a capability to differentiate between ‘self’ 
and ‘non-self’. Pregnancy, therefore, represents the only phenomenon in mammals in which 
allorecognition occurs physiologically (Moffett-King, 2002). The concept of the developing 
embryo as an allograft was originally introduced by Peter Medawar (Medawar, 1953). This 
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concept led to a dogma in the field of reproductive immunology that maternal tolerance is 
essential for successful pregnancy, because it enables the mother to not reject an implanted 
embryo. However, Moffett and Loke point out that the focus should not be on the interactions 
between the mother and the fetus, because they are not in a direct contact. Rather, the direct 
tissue contact occurs between maternal cells in the uterus and the cells derived from the fetal 
membranes and this is the key to understanding the immunology of placentation (Moffett & 
Loke, 2006). It is this maternal-fetal contact zone that represents the placenta. The placenta is 
essential for the exchange of gases, nutrients and waste products between the mother and the 
growing fetus. 
 
1.1.2 Placental types  
Placental mammals can be further classified into distinct groups according to the type of 
placenta they establish for nourishment of the growing embryo. There are several systems of 
classification, but one feature is common to all types of placentas: a complete separation of 
fetal and maternal circulatory systems. The differences in placental shape, maternal-fetal 
interdigitation and histological organisation will determine the type of the placenta in a 
particular species (Benirschke et al., 2012). In order to understand how placental anatomy is 
tied to functions they perform in each system of classification, it is important to describe the 
formation of individual extraembryonic membranes. A common misconception is that the 
placenta is formed by the mother, but it is fully formed by a developing embryo and an 
implanting embryo is responsible for all downstream tissue remodelling changes that will 
happen in the mother to allow for a successful pregnancy outcome. Therefore, a basic 
understanding of the embryonic development is necessary to understand how and when the 
placenta is established. Human embryonic development will be used as an example here, but 
it is important to note that various stages will occur at different timepoints in different species 
  23 
and the timing of these stages as well as differences will be described in other sections 
(sections 1.1.3 and 1.1.4). 
When the oocyte fuses with the sperm it is called a zygote and this initial event involves the 
fusion of the pronuclei from the two germ cells. The zygote then goes through distinct stages 
during gestation to develop into a healthy baby. Initially, this happens via transition into the 
embryonic stage and in humans this happens over approximately the first three days post-
fertilisation. Not only is this transition a period of general transcriptional silence, but more 
importantly, it is a period of cleavage cell divisions where each cell (now called a 
blastomere) undergoes a series of divisions. During this process, the embryo size remains the 
same but the number of cells increases from 2- via 4- to 8-cell stage and a major burst of 
transcription happens between the 4- and 8- cell stage, known as the embryonic genome 
activation (EGA) (Niakan et al., 2012). Throughout all cleavage divisions up to this point, 
individual blastomeres are reducing in size, acquiring a ratio of cytoplasm to nucleus that 
resembles more the one of adult cells. The first major morphological change in a growing 
embryo is at the stage of morula (approximately 16 blastomeres), when compaction of cells 
takes place via maximising intercellular contacts and a breaking of the radial symmetry. This 
leads to a formation of the blastocyst, which is a highly polarised stage. Inside the blastocyst 
lies a fluid-filled cavity, blastocoel, and inside it the inner cell mass (ICM) can be found lying 
to one side. ICM is surrounded by an outer layer of cells called trophectoderm (TE). TE is 
essential in formation of the placenta because it is this layer that contains extra-embryonic 
cells giving rise to all cells of the trophoblast lineage. Trophoblast cells are in direct contact 
with the maternal cells of the uterine wall and will be the main constituents of what is called 
a maternal-fetal interface. ICM, on the other hand, will differentiate into the epiblast and 
hypoblast (Fig. 1.1).  
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Figure 1.1. First stages during the embryonic development. First several stages during the embryonic 
development are illustrated and explained in text (section 1.1.2). ICM: inner cell mass. 
 
Although ICM exclusively gives rise to all cells of the future embryo, certain components of 
it contain additional extra-embryonic cells (similarly to TE) which will contribute to the 
formation of one of the extraembryonic membranes: the yolk sac, in a manner summarised in 
the following paragraph.  
The epiblast is also called primary ectoderm and the hypoblast is known as primary 
endoderm. Between the two, a third layer, the mesoderm, forms after which cavities will start 
developing: the extraembryonic coelom within mesoderm and the proamniotic cavity within 
epiblast. Hypoblast spreads out underneath the trophoblast and its edges meet to form a yolk 
sac cavity. These three cavities, extraembryonic coelom, proamniotic cavity and a yolk sac 
cavity now grow in size and eventually lead to a formation of a definitive embryo because 
three layers will be organised in a following way: 
(1) Epiblast: amniotic ectoderm and embryonic ectoderm. 
(2) Hypoblast: yolk sac cavity and embryonic endoderm. 
  25 
(3) Mesoderm: extraembryonic mesoderm and embryonic mesoderm. 
Embryonic components of each one of the layers above will fuse, form the embryonic disk, 
which will form the definitive embryo and later a fetus (Fig. 1.2). Everything else forms the 
extraembryonic membranes through the fusion of distinct layers: 
(1) Amnion: amniotic/extraembryonic ectoderm with extraembryonic mesoderm. 
(2) Yolk sac: extraembryonic hypoblast/endoderm (yolk sac cavity) with extraembryonic 
mesoderm. 
(3) Chorion: blastocyst wall derivative, trophoblast, with extraembryonic mesoderm.  
(4) Allantois: in a developing embryo, allantois forms by fusing of a diverticulum of the 
endoderm (allantoic endoderm) on a posterior part of the embryo with the 
surrounding mesoderm (allantoic mesoderm).  
Figure 1.2. Overview of human post-implantation development. Relevant details are explained in text 
(section 1.1.2). Adapted from Tang et al., 2016.  
 
The chorion is a very important layer because in most mammals, being formed by the fusion 
of trophoblast and extraembryonic mesoderm, it represents the main exchange membrane. 
The chorion itself is not vascularized and depending on how this developmental issue is 
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resolved, there are two different types of placentas. Both extraembryonic and embryonic 
mesoderm develop their blood vessels and if the chorionic mesoderm fuses with now 
prominently vascularised mesoderm of the yolk sac, a choriovitelline placenta will form. 
Also called the yolk sac placenta, this is a solution for the eggs of reptiles, birds and the 
duckbill platypus within mammals and it is phylogenetically older. However, in most 
mammals, this yolk sac placenta is never functional because chorioallantoic placenta forms 
instead, by fusion of the chorionic mesoderm with the allantoic mesoderm. Since both of 
these are very well vascularised, this will become the only exchange site. Chorioallantoic 
placenta is a characteristic of higher primates, including humans.    
Another commonly used systems of placental classification is based on the number of tissue 
layers separating fetal blood vessel lumen from the maternal circulation. This histological 
organisation also defines how deeply the blastocyst will invade into the maternal tissue.  
Epitheliochorial placenta contains six layers. It is also termed the ‘attached’ placenta because 
there is no invasion of the blastocyst into the endometrium. This type is seen in pigs, whales 
and horses. On the maternal side, there are three layers: uterine (endometrial) epithelium, 
connective tissue and endothelium of the maternal blood vessels (moving from the site of the 
implanting blastocyst towards the lumen of the uterus). On the fetal side, in same order, there 
are another three layers: trophoblast, connective tissue and fetal endothelium.   
Cats, dogs and bats establish the endotheliochorial placenta in which the uterine epithelium 
and connective tissue are removed through the tightly regulated level of invasion of the 
blastocyst. There is no contact of maternal blood with trophoblast cells, however. Instead, the 
trophoblast is in direct contact with the maternal endothelium. 
Finally, haemochorial placenta is marked by the deepest invasion of trophoblast cells into the 
endometrium to establish the contact with maternal blood, through the erosion of the 
maternal endothelium. It is called haemochorial because the trophoblast cells are bathing in 
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maternal blood directly. Rodents and higher primates, including humans, are examples of 
organisms with a haemochorial placenta. Menarche, menstruation and menopause are some 
of the phenomena taking place only in species with the haemochorial placenta. There are, 
however, examples of other species that menstruate, in addition to human females and old 
world primates, and these are the elephant shrew (van der Horst, 1954) and several species of 
bats (Rasweiler, 1991; Zhang et al., 2007). 
Based on the shape of the placenta and the surface area of contact between fetal and maternal 
tissue, there are four different types of placentas (Fig. 1.3).  
Figure 1.3. Overview of placental types. Illustration of four types of placenta defined by the shape of the 
placenta and the surface area of contact between fetal and maternal tissues. Relevant details are explained in text 
(section 1.1.2). Adapted from Benirschke et al., 2012.  
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Cotyledonary placenta is seen in ruminants, where multiple areas of attachment (cotyledons) 
to the endometrium are observed, usually elliptical in shape. Zonary placenta surrounds the 
fetus completely and can be seen in dogs and cats. Horses and pigs are examples of animals 
with a diffuse placenta where maternal-fetal interdigitations can be observed over the entire 
chorion. Finally, a discoid placenta is discoid in shape and can be observed in primates and 
rodents. Here, the interactions between the mother and the fetus are only limited to one or 
more poles of a spherical chorion (Benirschke et al., 2012). 
 
1.1.3 Mouse reproduction 
Mus musculus (commonly known as the house mouse), a small mammal of the order 
Rodentia (rodents), has been an invaluable model organism for the studies of biological 
processes. Although used much earlier in the history of scientific research, major progress 
was made in 1902 when French geneticist Lucien Cuénot had showed that the Mendelian 
inheritance applies to animals by following the coat colours in mouse crosses (Hedrich & 
Bullock, 2004). At a similar time, the work conducted by Clarence Little in William Castle’s 
laboratory at the Harvard University, in collaboration with Abbie Lathrop, a renowned mouse 
breeder at the time, marked the beginning steps towards making mouse a mammalian model 
organism of choice in today’s biomedical research (MSG Consortium, 2002). Strains of 
laboratory mice are inbred and therefore genetically identical, which enables researchers to 
perform accurate and reproducible experiments among the institutes. More importantly, the 
fully sequenced mouse genome can be manipulated through creation of transgenic animals by 
a pronuclear injection of any gene(s), for example. This allows for the investigation of 
specific genes’ contributions to homeostasis and disease. The most commonly used approach 
of genome manipulation includes deleting genes of interest and generating ‘knockout’ (KO) 
animals by modifying embryonic stem cells and re-injecting them into a blastocyst. These 
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genes can either by systemically deleted or specifically, in a tissue or cell of interest through 
the use of a Cre/loxP approach (conditional KO). Other examples include generation of 
‘reporter’ animals with fluorescent proteins translated together with a gene of interest, 
allowing tracking of cells that express genes of interest through measurements of the 
fluorescence, or ‘knock-in’ animals where one sequence of interest is replaced with a 
transgene (by one-for-one substitution). Additionally, a whole plethora of genes responsible 
for generation of various immune cells can be deleted to create various immunodeficient 
strains. Finally, it is possible to replace mouse genes with human genes in order to generate 
‘humanised’ mouse models that allow adoptive transfer of human cells and a subsequent 
assessment of human immune cell behaviour in vivo. The latter have recently become 
increasingly appreciated as essential preclinical models. Mouse husbandry allows for 
processes of genome manipulation to run smoothly and under strictly controlled conditions. 
Due to their size (adult mice weighing around 20 g), mice do not require as much housing 
space as some other mammalian model organisms, but most importantly, they have a very 
high fecundity. This is not only important for quick generation of novel, genetically 
manipulated, mouse models, but also makes them desirable models in a study of the 
reproductive system.  
The tubular components of the mouse female reproductive tract (FRT) (vagina, cervix, 
uterine body and two horns and the oviducts) are covered in mucosa, similarly to other 
barrier tissues such as the respiratory and intestinal tissues (Zhou et al., 2018). Having a 
tubular anatomy, there are several anatomical axes used to describe the organisation of the 
uterus: longitudinal, vertical and transverse. Out of these, the vertical axis is the most relevant 
when describing the events occurring during gestation and embryonic development. This axis 
is determined by the orientation of the tissue structures to the mesometrium – the mesentery-
like tissue which connects the uterus to the abdominal cavity wall (Tam, 2004) and functions 
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as a uterine suspensory ligament. A structure in the uterus can either lie on the mesometrial 
pole (proximal pole, on the mesometrial side of the uterus) or the anti-mesometrial pole 
(distal pole, on the anti-mesometrial side).   
The female mouse is a polyestrous animal which means that it undergoes the estrous cycle 
and can reproduce multiple times a year. The word estrous is derived from the ancient Greek 
οἶστρος (madness, frenzy) and refers to a phase during the cycle (estrus) when the animal 
displays a sexually receptive behaviour to signal that it is ready for mating. In all mammals, 
the hypothalamus-pituitary-gonadal (HPG) axis drives the progression through the estrous 
cycle. The cycle in mice spans over approximately four (4.3) days through four stages: 
proestrus (approximately lasting for 32.4 h), estrus (20.7 h), metestrus (21.8 h) and diestrus 
(29.3 h) (van Ebbenhorst Tengbergen, 1955). One of the most commonly used methods of 
determining the phase of the estrous cycle is the vaginal cytology method (Byers et al., 
2012). This method assesses the morphology of vaginal epithelial cells as well as their 
numbers in relation to the immune cells obtained from the vaginal smears. During proestrus, 
only small and round, nucleated epithelial cells can be observed with almost no immune cells 
present. In estrus, now squamous epithelial cells appear cornified, without observable nuclei 
and gradually towards the end of this stage, an influx of leukocytes appears in the vaginal 
smears. A female mouse in metestrus is characterised by dominant leukocytes and a very few 
clusters of both nucleated and cornified epithelial cells in the smears, while it is safe to 
assume that a female is in diestrus if the smears show mainly leukocytes and a lack of their 
association with rare epithelial cells (Byers et al., 2012).  
Hormonal fluctuations induced by the HPG axis tightly regulate uterine changes occurring at 
each of these four stages, while also regulating the development of the preovulatory follicles 
in the ovaries and ovulation (not discussed here). Gonadotropin-releasing hormone (GnRH) 
secreted from the GnRH neurons in the hypothalamus stimulates the secretion of the two 
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gonadotropins, follicle-stimulating hormone (FSH) and luteinising hormone (LH) by the 
gonadotropic cells of the anterior pituitary gland (Fig. 1.4). 
 
 
Figure 1.4. Hormonal fluctuations are induced by the hypothalamus-pituitary-gonadal axis. Illustration of 
the hypothalamus-pituitary-gonadal (HPG) axis as explained in text (section 1.1.3). GnRH: gonadotropin-
releasing hormone, FSH: follicle-stimulating hormone, LH: luteinising hormone. 
 
 
  32 
 
Concentrations of FSH and LH increase during the proestrus, which leads to a production of 
estrogens (mainly 17b-estradiol, also known as E2) through the mechanisms occurring in the 
ovaries. E2 induces an LH surge through a positive-feedback mechanism throughout 
proestrus and into estrus, which leads to ovulation at the onset of estrus. During metestrus 
and diestrus, progesterone is the dominant gonadal hormone which also inhibits the secretion 
of LH. However, throughout metestrus and closer to the end of the diestrus, progesterone is 
replaced with a weaker 20a-OH-progesterone which is not as effective in the LH inhibition. 
This allows for the cycle to continue by entering into the proestrus again (Fig. 1.5).  
 
Figure 1.5. The mouse estrous cycle. Illustration of the mouse estrous cycle as explained in text (section 
1.1.3). Dotted grey arrow indicates positive feedback event. Ovulation is indicated by an arrow. FSH: follicle-
stimulating hormone, LH: luteinising hormone. 
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It is important to note that the post-estrus changes in progesterone synthesis will only occur 
as a consequence of the corpus luteum (CL) regression in the absence of mating during 
estrus. If the mating occurs, the CL will not regress and progesterone will not be converted 
into 20a-OH-progesterone through a mechanism involving prolactin secreted from the 
pituitary (Croy et al., 2014).  
On the morphological level, the uterus appears enlarged and thick during proestrus and 
estrus, correlating with E2 levels. During this time, there is an increase in the level of 
proliferation of stromal cells but a decreased level of the proliferation of the uterine glands’ 
epithelium, although they are less apoptotic at this stage. The thickness of the uterus at this 
stage is due to stromal cell proliferation but also the hypertrophy of the uterine glands later in 
proestrus and early in estrus when they are the most active. The uterus is also most 
vascularized during estrus. Progressing into the metestrus and diestrus with an increase in 
progesterone, the uterus becomes elongated and thin. The uterine epithelium undergoes 
vacuolar degeneration, thins out and at the same time, the glands display minimal activity. 
This is when leukocytes can be observed in the stroma, with their numbers peaking during 
the diestrus.   
Mouse gestation spans over 19-21 days (Fig. 1.6). During the embryonic development, the 
TE and ICM are already formed by embryonic day (E) 3.5, and the blastocyst is ready to 
implant around E4.5. This initially happens on the anti-mesometrial side of the uterus (Tam, 
2004). In mice, implantation of the blastocyst is necessary to induce the decidualisation of the 
endometrium and therefore, the decidua will not form in every estrous cycle, but just in the 
one that ends in a successful pregnancy post-estrus. This is an important difference compared 
to higher primates and a reason why none of the commonly used lab mouse strains 
menstruate, as the endometrium is reabsorbed in lack of fertilisation. Interaction of the 
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blastocyst and uterine epithelium during implantation is essential to transduce the signals to 
the endometrial stroma (fibroblasts) around the embryo.  
 
Figure 1.6. Summary of the main events during mouse gestation. Mouse gestation has been summarised and 
illustrated in this figure based on the explanation in the text (section 1.1.3). MLAp: myometrial lymphoid 
aggregate of pregnancy, gd: gestational day, NK: natural killer cell.  
 
This is why decidualisation only occurs at the implantation sites, while the endometrium 
remains intact between distinct implantation sites, without any extracellular matrix (ECM) 
remodelling taking place. The main event characterising the decidualisation induced by 
implantation at gd 4.5 is the transformation of the endometrial stromal cells into the decidual 
stromal cells along with ECM remodelling. This is accompanied by the endometrial blood 
vessel remodelling as well as a marked influx of immune cells (mainly uterine Natural Killer 
cells) which have been shown to regulate these processes (Croy et al., 2006). There is some 
evidence that the ECM remodelling occurs earlier, in the absence of the implantation, during 
the preimplantation period, on gd 2 (Bijovsky et al., 1992). It is changes in the hormone 
fluctuations during the estrous cycle (Fig. 1.5) that are responsible for the preparation of the 
endometrium for the decidualisation: during the first two days of pregnancy high estrogen 
levels induce epithelial proliferation, but progesterone inhibits this process and induces 
proliferation of the endometrial stroma instead on gd 3 and gd 4 of gestation (Tan et al., 
1999). The initial epithelial proliferation is important because, as mentioned previously, 
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epithelial cells transduce signals necessary for fibroblasts’ transformation and a lack of 
epithelial cells results in a decidualisation defect (Lejeune et al., 1981). From E4.5 onwards, 
trophectoderm differentiates into distinct subsets of the trophoblast lineage, including the 
extra-embryonic ectoderm and ectoplacental cone (EPC). Trophoblast cells on the opposite 
end of the ICM undergo DNA endoreduplication and become trophoblast giant cells (TGCs), 
surrounding the EPC (Fig. 1.7). Formation of mesoderm, ectoderm and endoderm through 
gastrulation take place around day E6.5 (Rossant & Cross, 2001).  
 
Figure 1.7. Early development of the mouse placenta. Relevant details are explained in text (section 1.1.3). 
Adapted from Rossant and Cross, 2001. 
 
The allantois, arisen from this mesoderm, starts fusing with chorion arisen from the 
extraembryonic ectoderm at day E8.5 and this is when the labyrinth (a derivative of 
extraembryonic ectoderm) starts forming, as the area of a direct exchange between the fetal 
and maternal blood. At this point, the structural changes will also start occurring on the 
maternal side, in myometrium, a muscular layer surrounding the endometrium. A structure 
called the myometrial lymphoid aggregate of pregnancy (MLAp) develops at each 
implantation site on the mesometrial side within the myometrium. It is hard and white in 
appearance and harbours a large number of immune cells (Fig. 1.6 and Fig. 1.8). 
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Figure 1.8. Comparison of the uterine structures in the non-pregnant and pregnant mouse uterus. 
Illustration of the main differences in the structure of the uterus of (a) a non-pregnant sexually mature mouse 
and (b) a pregnant mouse at mid-gestation (gd 9.5), described in the text (section 1.1.3). MLAp: myometrial 
lymphoid aggregate of pregnancy, gd: gestational day. 
 
Subsequent days will lead to a formation of the definitive chorioallantoic placenta, which in 
mice is also described as a labyrinthine placenta and is mature by around E10.5 and 
completely functional by E12.5. This type of placenta is the one in which all different 
trophoblast cell types are perfused by a network of channels through which the maternal 
blood circulates (Benirschke et al., 2012). At E12.5 (Fig. 1.7), this placenta consists of 
maternal decidua and two trophoblast zones: labyrinthine trophoblast/labyrinth (made up of 
two layers of syncytiotrophoblast) and the junctional zone (originating mainly from the EPC 
and consisting of the spongiotrophoblast, the TGCs and glycogen cells). This is different 
compared to the early, choriovitelline placenta (from E6-11) which consists mainly of the 
trophoblast giant cells and the yolk sac. The maternal component of the placenta, decidua, 
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initially starts developing anti-mesometrially with the implanting blastocyst but then shifts 
mesometrially to become the decidua basalis. Decidua is the dominant tissue at the 
implantation site between gd 4.5 and 8.5 but the anti-mesometrial decidua begins its 
regression at gd 8.5 (this thin layer is also termed a decidua parietalis), while the decidua 
basalis remains.  
TGCs are very important in the process of placentation, because out of all the trophoblast 
cells in mouse, these are the most invasive ones which penetrate into the endometrial stroma 
and lead to the remodelling of the maternal blood vessels, a process essential for the proper 
functioning of the definitive placenta (Charalambous et al., 2012). This happens through a 
breakdown of the smooth muscle cells and displacement of the endothelial cells of the 
maternal spiral arteries (SA) (Woods et al., 2018). A peak of vascular remodelling can be 
observed at gd 12.5. Over the next several days, the placenta and the fetus develop further 
and grow in size, until between gd 19.5 and 20.5, a pregnant female (dam) gives birth to the 
litter. Recently, the first rodent to undergo cyclic endometrial shedding, Acomys cahirinus 
(spiny mouse), was described (Bellofiore et al., 2016). Further work has shown that these 
rodents have a cycle of variable length (8-9 days) with an average 3-day menses (a ratio 
similar to human cycle). Although there are several differences compared to the human 
menstrual cycle, this small, non-primate species remains an attractive model for reproductive 
biology studies and must be explored in future studies (Bellofiore et al., 2018).  
 
1.1.4 Comparison of human and mouse reproduction 
In humans, similarly to what was described for the mouse in previous section, the HPG axis 
is responsible for hormonal changes regulating the menstrual cycle, which can be described 
by both ovarian (changes in the follicles in the ovaries) and uterine (changes in the 
endometrium) cycle. Within the ovarian cycle, there is a follicular and a luteal phase, while 
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the menstrual cycle consists of menstruation, proliferative and secretory phase. It is therefore 
incorrect to refer to the term ‘estrous cycle’ when describing the reproductive physiology of 
higher primates, although they technically still exhibit a less noticeable estrus at the time of 
ovulation, which occurs between the follicular and luteal phase of the ovarian cycle. Each 
uterine cycle begins with the menstruation phase, day 1 represented by the start of the 
menstrual flow and with a length of 4.5-8 days and the entire cycle 24-38 days. This variation 
in the cycle length usually comes from a variability in the follicular phase length between 
women (Reavey et al., 2018). Prior to menstruation, FSH levels increase, and this trend 
continues throughout the follicular phase, to stimulate the maturation of the ovarian follicles 
(Fig. 1.9). Closer to the end of the follicular phase, these levels of FSH induce the 
proliferative phase of the uterine cycle, characterised by the proliferation of endometrial cells 
in response to estradiol produced by the aromatase from follicle cells.  
 
Figure 1.9. Overview of the normal menstrual cycle. Relevant details are explained in text (section 1.1.4). 
Adapted from Moffett and Male, 2009. FSH: follicle-stimulating hormone, LH: luteinising hormone. 
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In a similar manner, LH starts increasing during the follicular phase, surges right in between 
the proliferative and secretory stage of the cycle through a positive feedback mechanism 
similar to the one seen in a rodent estrous cycle and leads to the ovulation. Again, similarly to 
mice, the secretory phase is dominated by progesterone secreted by the CL, which inhibits 
FSH and LH secretion and this eventually leads to the demise of the CL. This reduction in 
local progesterone concentration will lead to the shedding of the endometrium and also 
release the inhibition of FSH and LH allowing the entrance to another cycle. If fertilisation 
occurs, the CL will not regress and menstruation will not take place as the high progesterone 
levels will remain, allowing for the gestation to begin. The main difference between rodents 
and higher primates, including humans, is that in humans there is no need for an implanting 
blastocyst to trigger the decidualisation reaction (Rossant & Tam, 2017). The endometrium 
undergoes transformation spontaneously into a decidua during each cycle in preparation for a 
potential implantation. Human decidua consists of two regions, a decidua basalis which is in 
direct contact with the invasive trophoblast and decidua parietalis which is interacting with 
the chorionic fetal trophoblasts (Tilburgs et al., 2006). 
If fertilisation occurs, the blastocyst will implant into already receptive transformed maternal 
decidual tissue and this happens about 6 days post-conception. In humans, the placenta is of a 
villous type. Whether a placenta is labyrinthine, like previously discussed for rodents, or 
villous, is tightly connected to the placental shapes described in section 1.1.2. A reduced 
surface area of the chorionic sac where the maternal-fetal interdigitations take place in 
formation of the maternal-fetal interface means that these interdigitations have to be 
organised in a way that maximises the output of the surface area available. Villous placenta, 
found in higher primates and ruminants, forms a tree-like branching extensions and folds of 
the chorion (‘villi’), which are directly surrounded by the maternal blood. Therefore, the 
placental villi are analogous to the mouse labyrinth (Woods et al., 2018). Invasion of human 
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trophoblast cells occurs during the first trimester of pregnancy in humans, unlike for mice 
where it takes place during the entire first half of gestation. In both human and mouse, 
trophoblast cells that are in direct contact with the maternal blood are syncytial, but unlike 
mice, humans have only one layer of syncytiotrophoblast (Woods et al., 2018). The cells of 
trophoblast lineage which are analogues of TGCs in mouse are called extravillous trophoblast 
cells (EVTs) and they will erode through the decidual stroma and along the arteries against 
the flow of blood. One important difference between mice and humans is the level of 
trophoblast invasion: trophoblast invades much deeper into the human uterus, reaching into 
the myometrium, while the invasion in a mouse uterus stops in the decidua basalis formed 
from the endometrium (Georgiades et al., 2002; Ratsep et al., 2014).  
In both human and mouse, the remodelling of the maternal blood vessels is as an essential 
event during placentation because this is what ultimately allows the ‘hemotrophic’ nutrition 
through the exchange between the maternal and fetal circulation, which is one of the main 
functions of the placenta. Prior to that, ‘histiotrophic’ nutrition via the uterine glands is 
essential for the human fetal development and represents the main resource for the first 12 
weeks of human gestation (Burton et al., 2002). The differences between mouse and human 
placentation and cycling can be found summarised in Table 1.1. 
Table 1.1. Comparison of the placentation and cycling between humans and mice. 
Feature Mouse Human 
Placentation Haemochorial Haemochorial 
Placenta shape Discoid Discoid 
Maternal-fetal 
interdigitations 
Labyrinthine Villous 
Gestation length 19.5 – 20.5 days 280 days (approximately 40 weeks) 
Cycle type Estrous (around 4 days) Menstrual (24-38 days) 
Decidualisation 
trigger 
Implanting blastocyst, 
post-implantation 
Every cycle (depending on the 
progesterone levels), pre-implantation 
Placenta functional From gd 10.5 From 10 weeks post-conception 
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1.2 Immunology of the maternal-fetal interface 
Various populations of immune cells have been identified in the FRT. Haematopoiesis is the 
process of formation of the blood cells and all blood lineage cells originate from a 
haematopoietic stem cell (HSC), but the microenvironment in which the HSC will develop 
(its haematopoietic niche) changes during the development. For example, in the adult mice, 
the primary site of the haematopoiesis is a bone marrow (BM), which becomes an additional 
haematopoietic niche only at E17.5 when the first functional HSCs are found in the long 
bones, and it is thought that these HSCs generate all haematopoietic lineages in adults. 
However, this is not the first site where HSCs originate during the embryonic development – 
four other compartments are involved in differentiation of the HSCs during the embryonic 
development and these are the yolk sac, aorta-gonad-mesonephros region (AGM), placenta 
and fetal liver (Mikkola, 2006). In the fetal liver, HSCs can be detected at E11.5 and reach 
their highest number around E15.5. Although not considered to be the major site of 
haematopoiesis in the embryo, AGM is the first site of the definitive HSCs at E10.5. A 
relatively low number of HSCs can be found in the AGM region at this point (Cumano et al., 
1996), which could not explain rapid expansion of the HSCs in the fetal liver a few days later 
(Gekas et al., 2005). This led to a discovery that, compared to the AGM, the placenta also 
exhibits HSC activity and to a much larger extent (Ottersbach & Dzierzak, 2005). HSCs are 
suspected to be recruited to the fetal liver from placenta via umbilical veins at a similar time 
when they can first be detected in the fetal liver (E11.5), because HSCs found in placenta 
have a similar surface phenotype to those in the fetal liver, although the first phase of seeding 
of the fetal liver with HSCs is observed around E9.5. At this stage seeding presumably occurs 
from the yolk sac where haematopoiesis originally starts in mouse around E7.0. Since the 
yolk sac cannot support the proliferation and differentiation of the definitive progenitors, 
  42 
these progenitors are carried out via the vitelline veins to the fetal liver (Gekas et al., 2005) 
(Fig. 1.10).  
 
 
Figure 1.10. Sites of haematopoiesis during the embryonic and adult life. Illustration of the main sites of 
haematopoiesis at the fetal stage before the bone marrow takes over and as explained in text (section 1.2). 
Purple cells represent an illustration of the haematopoietic stem cells. AGM: aorta-gonad-mesonephros.  
 
When considering the yolk sac haematopoiesis, it is important to note that despite a high 
level of functional conservation between mice and humans (Cindrova-Davies et al., 2017), 
human secondary yolk sac starts regressing closer to the end of the first trimester, while the 
one in mouse is active throughout the entire pregnancy (Palis & Yoder, 2001). Recent 
evidence, however, has demonstrated that some immune cell lineages, such as certain tissue-
resident mast cells and macrophages, are generated from the yolk sac progenitors and 
gradually replaced by the definitive BM-derived mast cells (Gentek et al,. 2018), challenging 
the current dogma and suggesting a dual developmental origin of distinct tissue-resident 
immune cells (Guilliams & Scott, 2017).  
Regardless of where the differentiation pathway occurs, the multipotent HSC has two 
possible fates: to commit to either a myeloid or a lymphoid lineage, via differentiation 
through either a common myeloid progenitor (CMP) or a common lymphoid progenitor 
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(CLP), respectively. Immune cells of both lineages can be identified in both human and 
mouse maternal-fetal interfaces and contribute to their homeostasis in unique ways.  
While systematic mapping of all the immune cells present at the maternal-fetal interface in 
mouse is lacking at the moment, a vast amount of data has been generated on the immune 
cells at the maternal-fetal interface in the first trimester of human pregnancy. These are 
predominantly natural killer (NK) cells (around 70% of all immune cells), followed by 
macrophages (representing 20%) as well as about 10% T cells. B cells, dendritic cells (DCs) 
and granulocytes were identified in previous studies, but found to be rare (Erlebacher, 2013; 
Trundley & Moffett, 2004; Bulmer et al., 2010). 
 
1.2.1 Myeloid cells at the maternal-fetal interface 
1.2.1.1 Dendritic cells 
Dendritic cells (DCs) belong to a group of myeloid cells also known as the professional 
antigen-presenting cells (APCs). This means that they can engulf antigens through a process 
of phagocytosis, traffic to a relevant lymph node (LN) where they undergo necessary 
maturation steps, and once mature, present an antigenic peptide within major 
histocompatibility complex (MHC) molecules to T cell-receptor (TCR) on a surface of the T 
cell. This is also known as the ‘first signal’, but mature DCs also provide a second, 
costimulatory signal that is required for the T cell to acquire its effector function (McGovern 
et al., 2015; Schuijs et al., 2018; Eisenbarth, 2018). DCs have always intrigued reproductive 
immunologists because of the assumption that fetally-derived trophoblast alloantigens would 
trigger a T cell-response. Moreover, one would expect DCs to be processing these 
alloantigens, similarly to their function in respiratory or intestinal tissues. The first study of 
human decidual DCs showed that although some cells were present in the first trimester 
decidua (just under 2 % of all immune cells), they displayed an immature phenotype, as 
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lineage negative, CD11c+HLA-DR+DC-SIGN-DEC-205+CD40+ cells (Gardner & Moffett, 
2003). Later work performed in mouse offered an explanation for why the decidual DCs were 
immature: decidualisation trapped DCs within the uterus and they were not able to reach the 
draining LNs (Collins et al., 2009). Therefore, a prohibition of DC migration in pregnant 
uterus and a subsequent lack of antigen presentation has been established as a model of how 
pathological T cell activation during pregnancy induced by alloantigens is avoided. 
Alternative roles, such as trophic functions during artery remodelling via crosstalk with NK 
cells, were proposed for DCs despite evidence that alymphoid mice can still have a normal 
decidualisation reaction (Tagliani et al., 2011). Nevertheless, DCs remain a hot topic in light 
of the phenotype exhibited by an inducible DC knockout mouse (CD11c-diphteria toxin 
receptor DTR), characterised by a severe impairment in implantation and embryo resorption 
(Plaks et al., 2008). Recently, one research group used multicolour flow cytometry and 
computational methods to follow the dynamics of various subsets of DCs throughout mouse 
gestation, and while confirming that plasmacytoid DCs are absent from the decidua and 
almost no CD4+ T cells present, they observed a very significant increase in myeloid DCs 
numbers early in pregnancy (Li et al., 2018).  
 
1.2.1.2 Macrophages 
Macrophages are another subset of APCs and represent a typical example of tissue-resident 
cells. They can be influenced by the environment to become functionally ‘polarised’ towards 
distinct functions, and therefore they are commonly described as either M1 or M2 
macrophages (a parallel with Th1/Th2 responses from distinct effector T cells). M1 
macrophages are induced by pro-inflammatory cytokines and develop further the pro-
inflammatory state through the secretion of pro-inflammatory cytokines such as tumour 
necrosis factor (TNF) and other typically Th1 cytokines. On the other hand, M2 polarisation 
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is induced by Th2-type cytokines, such as IL-13, IL-4 and IL-5 and leads to an anti-
inflammatory, suppressive macrophage phenotype (Nagamatsu & Schust, 2010). M2 
macrophages are usually associated with tissue-remodelling properties and high production 
of IL-10 as well as scavengers of apoptotic cells. In the decidua they constitute up to 20 % of 
all CD45+ immune cells. In vitro macrophage differentiation models demonstrated that 
macrophage colony-stimulating factor (M-CSF) and IL-10 may be instrumental in 
polarisation of the decidual macrophages towards M2 (anti-inflammatory) type, as they 
expressed surface markers such as CD206, CD209 and CD163  (Svensson et al., 2011) and 
there is some evidence that DNA methylation patterns are responsible for this, because genes 
responsible for M1 phenotype were hypermethylated and genes encoding the alternative 
activation (M2) hypomethylated (Kim et al., 2012). Another study has clarified that this 
decidual subset is also characterised by a low expression of CD11c and that it is 
predominantly involved in interactions with extracellular matrix (ECM), but also 
demonstrated that there is an additional subset of CD11c-high decidual macrophages which 
had a pro-inflammatory transcriptome and a higher capacity of processing antigens compared 
to CD11c-low. This study highlighted that decidual macrophages cannot conform to 
traditional M1/M2 designations because it showed that both CD11c-low and CD11c-high 
could produce both pro- and anti-inflammatory cytokines (Houser et al., 2011). One of the 
proposed roles of macrophages at the maternal-fetal interface is that, through secretion of 
proteases, angiogenic growth factors and a range of cytokines, they mediate the SA 
remodelling together with the EVT and uterine NK cells, but this study looked at all 
macrophages by staining for CD14+ only and did not differentiate between CD11c-low and 
high subsets (Lash et al., 2016). In mouse, decidual macrophages were shown to localise in 
the vicinity of the trophoblast but also that during the estrous cycle, their numbers and 
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localisation change was dependant on the hormonal status (De & Wood, 1989; Helige et al., 
2013). 
 
1.2.1.3 Granulocytes 
Similarly to majority of other seminal studies in the field of reproductive immunology, 
granulocytes were originally assessed by measurements in the peripheral blood, or in some 
cases, by examining the lower reproductive tract where it was demonstrated that exposure to 
sperm dramatically increases the numbers of neutrophils in the human cervical mucosa, 
representing the major leukocyte subset in this setting (Thompson et al., 1992), something 
that was later shown to be a consequence of a postcoital inflammatory response and exposure 
to the seminal fluid (Sharkey et al., 2012). Only more recent studies have started focusing on 
granulocytes at the maternal-fetal interface and there is recent evidence that CXCL9-
producing neutrophils can be recruited to the mouse decidua during a prenatal infection with 
Listeria monocytogenes, contributing to the fetal demise through recruitment of CXCR3-
expressing CD8+ T cells. Blocking this CXCL9 receptor by using the CXCR3-neutralising 
antibody protected against fetal resorption (Chaturvedi et al., 2015). Second-trimester 
decidual neutrophils were shown to express a higher levels of factors related to blood vessel 
remodelling compared to peripheral blood neutrophils, potentially induced by CXCL8 
(Amsalem et al., 2014) and suggesting a role in the uterine SA remodelling. Another group 
suggested a similar, but indirect role for human neutrophils, as they demonstrated that 
progesterone- and estriol-stimulated neutrophils induced proangiogenic CD4+ T cells, and a 
non-redundant role of these interactions through the use of neutrophil-specific KO mouse 
(Nadkarni et al., 2016). Finally, decidual neutrophils may also be involved in crosstalk with 
another decidual subset in the first trimester, innate lymphoid cells (ILC3s). They localise 
closely together and CXCL8 and granulocyte-macrophage CSF (GM-CSF), produced by 
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ILC3s, induced migration, survival and production of factors by decidual neutrophils 
necessary for neoangiogenesis and blastocyst implantation (Croxatto et al., 2016). 
There is no evidence on the role of other granulocytes, such as eosinophils and basophils, and 
their involvement in the Th2-like immune response at the maternal-fetal interface. However, 
mast cells (MCs) have been characterised in the decidua in recent years, especially in mouse 
models. Combined MC- and NK cell-deficiency was associated with almost complete 
absence of the SA remodelling and severe fetal growth restriction. On the other hand, 
individual knockouts (just MC or NK cells) had only minor impairment of the SA 
remodelling and a higher number of the other cell that has not been knocked out, suggesting 
compensatory mechanisms between the two cell types (Meyer et al. 2017a; Meyer et al., 
2017b). Only one study so far has looked for mast cells in the human uterus and proposed the 
existence of three subsets of MCs in the endometrium, all expressing steroid receptors and 
suggesting dynamic regulation by the microenvironment (De Leo et al., 2017). Most recent 
data coming from a single-cell RNA sequencing of the human maternal-fetal interface in first 
trimester pregnancy samples did not demonstrate presence of any mast cells in the first 
trimester decidua (Vento-Tormo et al., 2018). 
 
1.2.2 Lymphoid cells at the maternal-fetal interface 
1.2.2.1 Adaptive immunity 
There is conflicting evidence on the involvement of B cells in the uterus. This is because the 
majority of the literature on the B cells during pregnancy describes findings based on the 
assessment of human B cells in the peripheral blood (Lima et al., 2016). The studies that 
analysed B cells in the human endometrium or decidua found only a few or no B cells in 
these tissues (Trundley & Moffett, 2004; Moffett & Shreeve, 2015). In contrast to this 
recently it was shown that human decidua contains between 1-2.5 % of B cells in late 
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gestation and that in pre-term labour, these B cells were functionally perturbed, acquiring 
more B-1-like phenotype (Huang et al., 2016). This was in support of earlier work that 
detected B cells of similar phenotype in preeclamptic placentas, while acknowledging that 
there were no B cells in the healthy placentas (Jensen et al., 2012). In addition, cytokine IL-
33 was shown to induce a production of PIBF1 by the decidual B cells, a factor shown to be 
essential in ensuring term labour by the use of B cell-deficient mice, especially in an 
inflammatory setting (Huang et al., 2016).  
 
However, more work has to be done to understand fully whether B cells are indeed important 
for the physiology of the uterus, particularly in mouse, as there is currently no substantial 
evidence on involvement of B cells in mouse pregnancy, although there are reports 
suggesting pregnancy-related changes, for example in the BM, LN, and spleen B cell 
numbers and maturity (Muzzio et al., 2014). EBF1, encoding early B-cell factor 1, is 
involved in the B cell development and there is evidence that variants in EBF1 are 
significantly associated genome-wide with preterm birth (Zhang et al., 2017). In the 
aforementioned single-cell RNA sequencing study of the entire human maternal-fetal 
interface in first trimester of pregnancy the presence of B cells in the human decidua was not 
investigated since CD19+ cells were excluded at the sorting stage based on the previous 
literature (Vento-Tormo et al., 2018) and therefore no conclusions could be drawn. 
On the other hand, uterine T cells have intrigued immunologists ever since Peter Medawar 
had first proposed the immunological paradox of pregnancy as explained in section 1.1.1 
(Medawar, 1953). This led immunologists to often compare the immunology of reproduction 
to the transplantation immunology and to hypothesise that the suppression of the maternal T 
cells (maternal tolerance) is the main reason why a mother does not ‘reject the fetus’ and that 
the T cells are essential regulators of the trophoblast invasion. Because of the anatomy of the 
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maternal-fetal interface this is unlikely to be an important interaction regulating complex 
events leading up to a successful pregnancy. Two types of interactions occur here: (1) 
maternal blood contacts directly the syncytiotrophoblast, which does not express any MHC 
molecules and therefore cannot deliver a conventional T cell stimulus and (2) decidua 
interacts with the EVTs which only express human leukocyte antigens (HLA) HLA-G, HLA-
E and polymorphic HLA-C (all belonging to MHC class I molecules) (Trundley & Moffett, 
2004). 
Out of T cells at the maternal-fetal interface (10-20 % of all CD45+ cells in human), less than 
half are CD4+ T cells, while 45-75% are CD8+ T cells (Erlebacher, 2013). CD8+ T cells are 
also called cytotoxic T cells (CTLs) and as granular cytolytic cells they resemble NK cells 
morphologically and functionally. In addition to the NK cells, they are the only other cells in 
the decidua that can potentially recognise fetally derived MHC class I on the EVTs as 
foreign, leading to them fulfilling their effector functions. This is, however unlikely to be the 
case, because it was shown that (1) direct allorecognition does not occur and (2) indirect 
allorecognition occurs, but CD8+ T cells that can indirectly recognise fetal antigens undergo 
clonal deletion (Erlebacher et al., 2007) because they cannot be primed due to entrapment of 
DCs within the uterus (described in more detail in the section 1.2.1.1, (Collins et al., 2009)). 
Impaired accumulation of CD8+ T cells was in part also explained by the epigenetic silencing 
of T cell chemoattractants produced by the decidual stromal cells (Nancy et al., 2012). 
Within the CD4+ T cells in mouse uterus, the majority of cells belongs to the CD4+CD25+ 
regulatory T cells (Tregs) (Guerin et al., 2011). A pool of these cells was shown to expand 
during gestation in an alloantigen-independent manner, since they increased in percentages in 
both syngeneic and allogeneic pregnancies. Additionally, neutralising CD25+ Tregs led to 
fetal demise (Aluvihare et al., 2004). In human pregnancy, an association was made between 
HLA-C and the Treg pool. HLA-C mismatched pregnancies had a higher percentage of 
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CD25dim activated T cells as well functional CD25bright Tregs, suggesting that HLA-C 
specifically activates decidual T cells and increases Treg proportion (Tilburgs et al., 2009). 
Mouse studies have demonstrated that fetal-specific Tregs were maintained even after 
delivery, preserving tolerance to a fetal antigen they previously encountered and proliferating 
in a subsequent gestation (Rowe et al., 2012). This provides evidence that there might be a 
regulatory memory of the fetal antigen imprinted during pregnancy on the CD4+ Tregs. 
FOXP3 is a transcription factor (TF) essential for the differentiation of Tregs and only in 
allogeneic matings it was shown that the percentage of these FOXP3+ Tregs was significantly 
increased. This suggested that trophoblast-specific Tregs may home to the uterus (Samstein et 
al., 2012).  
Most recent single-cell RNA sequencing study of the maternal-fetal interface of the first 
trimester maternal-fetal interface has shown the expansion of CD8+ T cells in the decidua and 
suggested indirect regulation of trophoblast invasion through interactions of these T cells 
with myeloid, NK and stromal cells, rather than a direct and exclusive interaction with the 
trophoblast (Vento-Tormo et al., 2018). 
 
1.2.2.2 Innate lymphoid cells  
One of the major advances in the field of innate immunity was made in mid-1970s, when the 
NK cells were first described as large granular lymphocytes through observation of high 
background lysis of YAC-1 tumour cells incubated with mouse splenocytes. Today it is well 
established that NK cells are members of a much larger family of innate cells, collectively 
known as innate lymphoid cells (ILCs). ILCs represent innate counterparts of T cells, 
however with several notable differences. None of the ILCs express antigen-specific 
receptors (such as TCRs and BCRs) and therefore do not rely on somatic gene rearrangement 
for their receptor repertoire. ILCs also do not rely on clonal expansion of cells with a specific 
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antigen receptor. Based on the TFs and cytokines essential for their development as well as 
their effector cytokines, ILCs are further classified into subsets (Fig. 1.11). Until recently, 
three major groups of ILCs were recognised.  
 
Figure 1.11. Innate lymphoid cell subsets. Illustration of the main subsets of ILCs as explained in text (section 
1.2.2.2). Adapted from Vivier et al., 2018. 
 
These include ILC1s, which require T-bet for their development and produce IFN-γ as their 
effector cytokine. According to this nomenclature, NK cells belong to the ILC1 group as the 
cytotoxic ILC1s, while all the other ILC1s are designated as helper ILC1s. In mice, these 
subsets have in common expression of natural cytotoxicity receptors (NCRs) NK1.1 and 
NKp46 and the TF T-bet. NK cells and helper ILC1s can be distinguished based on 
expression of TF Eomesodermin (Eomes) and specific surface markers. NK cells express and 
rely on Eomes for their development. Helper ILC1s do not. The second major group, ILC2s, 
require GATA-3 TF and these cells are major producers of IL-4, IL-5 and IL-13. The third 
group, ILC3s, express TFs RORγt and aryl hydrocarbon receptor (AHR) and secrete type 3 
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cytokines, such as IL-17, IL-22 and IL-23. They consist of three subsets, NCR- ILC3s, 
NCR+ILC3s and lymphoid-tissue inducer (LTi) cells. However, with the accumulation of 
data obtained through transcriptome studies and fate-mapping over the last decade, new 
nomenclature which describes 5 ILC subsets was proposed (Vivier et al., 2018) and approved 
by the International Union of Immunological Societies (IUIS). According to this new 
nomenclature, NK cells and LTi cells are sufficiently distant during their development from 
ILC1s and ILC3s, respectively, to be considered distinct lineages, in addition to ILC1, ILC2 
and ILC3s. While ILCs are also described as circulating cells in blood, they constitute a small 
fraction of total blood leukocytes. On the contrary, ILCs are usually described as tissue-
resident immune cells, found in lymphoid and non-lymphoid organs, where they mainly 
populate mucosal surfaces. They are found in both primary lymphoid tissues including bone 
marrow and thymus, as well as in the secondary lymphoid tissues (SLTs); tonsil, spleen, LNs 
and Peyer’s Patches of the intestine. Moreover they have been characterised in the following 
non-lymphoid tissues: skin, liver, intestine, gingival tissue, salivary glands, uterus (Bernink et 
al., 2013; Sojka et al., 2014; Cortez et al., 2016; Kindstedt et al., 2018; Brown et al., 2018). 
Interestingly, they are observed in fluids other than blood, such as in the breast milk, with 
potential implications on neonatal immunity (Baban et al., 2018), as well as in the synovial 
fluid of patients with juvenile idiopathic arthritis (Velasco-Herrera et al., 2018). A timeline of 
main discoveries in the ILC biology, as well as whether they were first identified in humans 
or mice is summarised in Fig. 1.12. Uterine NK cells are also displayed in this figure and the 
reason behind this will be explained in section 1.2.2.9. 
ILCs are involved in a range of functions such as regulating tissue homeostasis, providing 
innate protection against intracellular parasites or involved in responses to chronic 
inflammatory diseases (Tait Wojno & Artis, 2016). 
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Figure 1.12. Timeline of the main discoveries in the ILC biology. Summary of the main events that led to the 
discovery of the various subsets of the innate lymphoid cells, as described in the text (sections 1.2.2.2-1.2.2.7). 
Uterine NK cells are represented in this figure because that was the year they were first observed and to 
illustrate that they were first ILCs to have been identified, although at that time they were not termed NK cells 
(explained in section 1.2.2.9). LTi: lymphoid-tissue inducer, NK: natural killer, ILC: innate lymphoid cell.  
 
1.2.2.3 Innate lymphoid cell-centric view of the evolution: from Proteozoic to discovery 
Precambrian era was marked by the appearance of primitive single cell organisms, and even 
though multicellular organisation did not take place for another 500 hundred million years, it 
was these single cell organisms that eventually led to the evolution of innate immunity. 
Domains Bacteria, Archea and Eukarya evolved so successfully during the Proteozoic that 
they changed the environment, fostering the metazoan development and marking the 
beginning of Paleozoic era through Cambrian Explosion about 550 million years ago. 
Explosion of new metazoan species provided a range of new hosts for pathogenic single cell 
organisms which subsequently led to evolution of the earliest form of defence, innate 
immune mechanisms, which relied on germline-encoded pattern recognition receptors.  
With the evolution of phylum Chordata, two different adaptive immune systems have 
evolved. Around 500 million years ago, with the appearance of subphylum Vertebrata, 
clonally expanded lymphocytes with somatic gene rearrangement appeared, allowing 
response to a specific antigen. Although this is a hallmark feature of jawed vertebrates of the 
infraphylum Gnathostomata, understanding of the immune system evolution was blurred by 
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the discovery of an alternative adaptive immune system that evolved in jawless vertebrates of 
the infraphylum Cyclostomata within vertebrates (hagfish and lamprey). Instead of V(D)J 
gene segment recombination used for assembling of T cell (TCR) and B cell receptors (BCR) 
in Gnathostomata, jawless vertebrates utilise variable leucine-rich repeats (LRR) to assemble 
variable lymphocyte receptors (VLRs) bound by an invariant stalk region to the lymphocyte 
surface (Pancer et al., 2004; Guo et al., 2009; Hirano et al., 2013). These two adaptive 
immune systems are presumed to have evolved separately in two infraphylums, because 
TCR, BCR and Major Histocompatibility Complex (MHC) genes were not identified in 
Cyclostomata and none of the VLR genes were identified in Gnathostomata (Mayer et al., 
2002). Despite the breadth of knowledge on the evolution of the earliest innate immune 
mechanisms, followed by cellular and humoral arms of the immunity, it is still an enigma 
when the earliest Natural Killer cells have entered the evolutionary scene. There is, however, 
much more phylogenetic evidence available for NK cells than any other subset of innate 
lymphoid cells (ILCs). This is complicated further by the fact that NK cells, just like all other 
ILCs, are marked by features of both innate and adaptive immunity. Urochordates are the 
closest subphylum to vertebrates that undergo the transplantation reaction naturally. In a 
study analyzing the gene expression of a commonly used urochordate model (Botryllus 
schlosseri) during an allorecognition experiment, a subset of Botryllus blood cells expressed 
a human CD94/NKR-P1-related receptor, BsCD94-1 (Khalturin et al., 2003). NKR here and 
throughout the rest of the text stands for the Natural Killer cell Receptor. This suggested the 
existence of an ancestral population of NK cells in a non-vertebrate immune system, even 
though other studies have argued that while BsCD94-1 was without a doubt a group V C-type 
lectin, it was not an orthologue of the human CD94 protein (Sato et al., 2003). Within the 
non-mammalian vertebrates, receptors that are structurally related to mammalian killer cell 
immunoglobulin-like receptors (KIRs) and leukocyte immunoglobulin-like receptor (LILR) 
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receptors were identified in Osteyichties (bony fishes), but NK cell-like cytotoxic cells were 
also shown to exist in vertebrate groups: amphibians, reptiles and birds (Yoder & Litman, 
2010). This suggests that there may have been an ancestral population of NK cells in a 
common ancestor of Cyclostomata and Gnathostomata but potentially also in a common 
ancestor in chordate subphylums Tunicata and Vertebrata. However, as illustrated by the 
example of the BsCD94-1 gene, it is still not completely clear when the NK cells appeared in 
the evolutionary history due to a lack of clear orthologue of NK-associated genes and more 
work will have to be done in the future studies to address this. These cells might have even 
evolved before placentation, which would prove important for understanding the 
immunology of reproduction. Identifying other cells of ILC family in other non-mammalian 
vertebrates and possibly urochordates will aid in reconstructing how these cells evolved 
(Vivier et al., 2016). 
 
1.2.2.4 ILC2  
A range of terms was used to describe the innate immune cells that produce type 2 cytokines 
over the years and that we now know under the term ILC2s: nuocytes (Neill et al., 2010), 
natural helper cells  (Moro et al., 2010), innate type 2 helper cells (Price et al., 2010). They 
were an unexpected discovery of a study describing a novel cytokine produced by Th2 cells, 
IL-25. In wild-type mice, IL-25 treatment induced IL-4, IL-5 and IL-13 cytokines, which 
then augmented Th2-associated diseases. This was documented by striking histological 
changes in both lungs and GI tract, eosinophilia and splenomegaly. However, even Rag-/- 
mice (which are depleted of all T and B cells) exhibited the same pathological changes when 
treated with IL-25, demonstrating that there were cells other than T cells inducing the 
disease. At this early stage, they were characterised only as lineage-MHC-II+CD11c- (Fort et 
al., 2001). It was later shown that these IL-25-responding cells indeed are important 
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mediators of airway hyperreactivity and allergic disease via aforementioned induced 
cytokines, but principally, the mechanism of action involves IL-5 and IL-13 (Hurst et al., 
2002). The cells were also named non-B/non-T (NBNT) cells, and shown to assist in worm 
expulsion during helminth infection (Fallon et al., 2006). Later work has phenotypically 
characterised ILC2s in more detail and it was shown that they respond to another type-2-
inducing cytokine, IL-33, which causes rapid proliferation at various sites, including spleen, 
liver, intestines, mesenteric LNs and fat-associated lymphoid clusters –FALCs. These studies 
have described ILC2s as cells highly expressing IL-7 receptor (CD127), c-Kit, Thy1, ST2 
(also known as IL1RL1) – a subunit of IL-33 receptor and Sca-1 (Ly6a) (Moro et al., 2010). 
A study published at the same time showed expression of IL17RB (IL-17 receptor B which is 
also a receptor for IL-25), thus revealing that ILC2s are poised to respond to both IL-33 and 
IL-25 directly. IL-13 was confirmed to be essential for clearance of helminth infection, 
because the adoptive transfer of IL-13-deficient ILC2s was not sufficient to facilitate the 
worm expulsion compared to wild-type ILC2s (Neill et al., 2010). It is important to note that 
all work on ILC2s described so far has been performed using mouse models. It was not until 
2011 that the first report of human ILC2s was published. Mjösberg and colleagues described 
cells in the fetal and adult gut and lung, as well as in adult blood, and defined them as 
CD127+CD161+ cells that also express CRTH2, a chemoattractant receptor commonly 
expressed on Th2 cells, basophils and mast cells (Mjösberg et al., 2011). This work also 
showed that nasal polyps in chronic rhinosinusitis, a disease marked by type 2 inflammatory 
response, were enriched for ILC2s. ILC2s exist in the murine uterus (uILC2), which is not 
surprising considering that original research on ILC2s showed the highest levels of IL-25 
mRNA in the uterus, in addition to the GI tract (Fort et al., 2001). In mouse, they can be 
found deep in the wall of the non-pregnant uterus and in the myometrium of the pregnant 
uterus at mid-gestation, with notable absence in the decidua. They can be identified within 
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CD11b-NK1.1-NKp46-CD90.2+ lineage negative uterine leukocytes as ST2 and GATA-3 
positive cells (Doisne et al., 2015). Small populations of ILC2s are found within CD127low/- 
endometrial and decidual ILCs in humans (Balmas et al., 2018), although, as previously 
stated, they were not identified within the CD127high ILCs in both mouse and human uterus 
(Doisne et al., 2015; Vacca et al., 2015). 
  
1.2.2.5 ILC3 
The first ILC3s to be described were LTi cells, first identified in 1997 as the CD4+CD3- cells 
expressing lymphotoxin-b (LTb). Interestingly, they were scattered throughout the LNs until 
2 days post-birth when they would exhibit a specific spatial organisation in the cortical area 
of the LNs (Mebius et al., 1997), leading to the hypothesis that they might be involved in the 
initiation of lymphoid structures during ontogeny because they were observed in neonatal 
LNs. Additional studies have shown that these cells might also be important for inducing the 
organisation of Peyer’s patches (Yoshida et al., 1999). 
As mentioned earlier, RORγt has an essential role in the development of ILC3s and while this 
will be discussed in greater detail later, it is worth noting here that Rorc gene mouse mutants 
were instrumental in describing ILC3 subsets. Through analysis of Rorc(γt)-EGFP knock-in 
mouse, it became clear that in the fetus only LTi cells express RORγt and that when RORγt is 
deleted, LTi cells do not develop and LNs as well as Peyer’s patches subsequently do not 
form (Eberl & Littman, 2004). 
One of the first studies to define non-LTi ILC3s was performed in humans, unlike the 
majority of other ILC discoveries that were initially made in mouse models. Originally 
observed in human tonsils and Peyer’s patches, they were named NK-22 cells because they 
co-expressed CD56 with the natural cytotoxicity receptor NKp44 and produced IL-22. They 
were also observed within NKp46+NK1.1+ fraction in mouse mucosal-associated lymphoid 
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tissues and lamina propria of the small intestine when bacterial infection was induced. Both 
mouse and human NK-22s were capable of response to IL-23 and expressed the surface 
chemokine receptor CCR6 (Cella et al., 2008). Even though this resembled Th17 responses, 
NK-22 cells were not able to secrete IL-17, were faster to respond to IL-23 and were not 
derived from blood NK cells when incubated with Th17-polarising cytokines, thus 
demonstrating that this was indeed a distinct lineage of cells (Cella et al., 2008).However, 
this and other work has shown that these cells are not capable of producing IFN-g or 
expressing perforin, which are common features of NK cells (Satoh-Takayama et al., 2008; 
Sanos et al., 2008). Within the group 3 ILC, in addition to LTis, there are two clearly distinct 
subsets in mice, based on CCR6 expression: CCR6+ ILC3s and CCR6- ILC3s. Moreover, 
CCR6- ILC3s can be either NKp46+ or negative. In humans, CCR6 is instead expressed on 
the majority of ILC3s. Human ILC3s are therefore distinguished on the basis of NKp44 and 
there are NKp44+ and NKp44- cells (Cupedo et al., 2008). For the vast majority of ILC3s in 
both human and mouse tissues, RORgt was found to be essential for development (Luci et al., 
2008). Over the years, they have been given various names, such as NCR22 (Satoh-
Takayama et al., 2010), before a uniform nomenclature was proposed in 2013 when all these 
cells were collectively named ILC3s (Spits et al., 2013). Just like ILC2s and the third big 
family, ILC1s (which will be explained in more detail in the next section), they populate the 
uterus (uILC3). In mouse, uILC3 can be identified within CD11b-NK1.1-
CD90.2+RORgt+CD127+ lineage negative uterine leukocytes and similarly to ILC2s, in mouse 
they can only be found in the non-pregnant uterus and in myometrium at mid-gestation. 
uILC3s in mouse include two subsets, LTi-like and NCR- uILC3s. NCR+ ILC3s were not 
observed in the mouse uterus. In human uterus, however, ILC3s are present in both 
endometrium and decidua and the majority of cells belong to the NCR+ILC3 subset, even 
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though LTi-like as well as very few NCR-ILC3 cells were observed (Doisne et al., 2015; 
Vacca et al., 2015). 
 
1.2.2.6 ILC1 
ILC1s are the most extensively described group of ILCs. This is because Natural Killer cells, 
until recently included as members of ILC1 family, have been known for over forty years, 
longer than any other subset of ILCs. In this section, both NK cells and ILC1s will be 
described – NK cells as the ‘cytotoxic’ ILC1s and ILC1s as the ‘helper/noncytotoxic’ ILC1s. 
Helper ILC1s were originally discovered in a research study set up to determine whether 
RORgt and NKR expressing NK cells (in this study called NKR-LTi cells) described above 
(ILC3s) belong to the NK or LTi lineages. This work demonstrated the existence of mouse 
RORgt- NKR-LTi cells that were powerful IFNg producers and inducers of innate colitis 
(Vonarbourg et al., 2010). Subsequently, the existence of ILC1s, for the first time termed 
‘ILC1s’, was demonstrated in humans (Bernink et al., 2013), as cells distinct from 
conventional NK cells, that express T-bet, produce IFNg and can be found in inflamed 
mucosal tissues. This work also suggested that ILC1s could develop from RORgt+ ILC3s 
when stimulated with IL-12, adding to a growing body of evidence on plasticity between 
ILC3 and ILC1 subsets, which will be described in more detail in the section on the ILC 
development.   
 
1.2.2.7 NK cells: discovery 
Natural Killer cells were discovered just over forty-three years ago. First identified in mouse, 
they were named after an observation that there are naturally occurring cytotoxic, ‘killer’ 
cells in cell suspensions prepared from spleen, capable of lysing Moloney leukemia target 
cells (Kiessling et al., 1975a; Kiessling et al. 1975b). Kiessling and colleagues reported 
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several observations that laid foundations for future research into the NK cell biology in the 
following decades and that deserve a mention in this study: 
(1) Natural Killer cells could rapidly kill target cells in vitro and in vivo (on average it 
took 4 hours to observe the lysis of target cells). 
(2) Natural Killer cells exhibited differential cytotoxicity against different tumour cell 
lines. 
(3) Natural Killer cells from mice of various origins and different wild-type strains were 
equally efficient at lysing target cells. 
(4) Cytotoxicity may be mediated by the direct cell-cell contact because supernatants 
failed to induce cytotoxic activity. 
(5) Splenic Natural Killer cells were the most efficient in lysis assays compared to other 
tissues cell isolates were prepared from. 
(6) Animal age affected the cytotoxic potential of Natural Killer cells, with cells isolated 
from 3-week to 2-month-old mice showing increased lysis of target cells compared to 
younger (newborn) and older (6-month old) animals. 
(7) Natural Killer cell cytotoxicity was responsible for majority of lysis observed and 
independent of other lymphocytes. Natural Killer cells isolated from spleens 
originating from nude mice, which lack T cells, as well as splenic cell suspensions 
depleted of T cells, B cells and phagocytic cells retained their capability of lysis 
without reduction compared to whole preparations of cells. 
Another study from the same year supported the majority of Kiessling et al. findings with 
several minor exceptions, such as the observation that NK cells isolated from the LNs were 
more cytotoxic than the splenic NK cells, in contrast to what Kiessling et al. had previously 
showed (Herberman et al., 1975). However, both studies speculated that while this 
cytotoxicity was not dependent on antibodies, it may have been dependent on the 
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sensitisation with an antigen, presumably coming from murine leukemia viruses or 
endogenous type C-viruses which are ubiquitously distributed (Herberman et al., 1975). They 
further assumed that these latent infections become active later in the neonatal period, 
explaining in part significant reduction in target cells’ lysis in cells isolated from newborn 
mice, when NK cells still have not been ‘sensitised by viral antigens’. 
 
1.2.2.8 NK cells perform their functions via engagement of surface receptors 
NK cells are still known as the potent killer cells described forty years ago, but now it is 
established that they have a variety of other roles, such as in immunity to bacteria and 
viruses, responses during transplantation, autoimmunity, hypersensitivity and pregnancy   
(Croy et al., 2002; Vivier et al., 2008). They exhibit a wide range of functions by either 
modulating the immune system, e.g. regulating functions of the effector cells of adaptive 
immunity via secretion of cytokines, or by directly secreting cytotoxic proteins granzymes 
and perforin from their large cytotoxic granules which represent one of the most striking 
morphological properties of these killer cells (Krzewski & Strominger, 2008). NK cells do 
not rely on antigen-specific cell receptors for antigen recognition, similarly to other innate 
immune cells. At the same time their developmental origins, morphology and effector 
functions resemble the adaptive immunity, despite the lack of gene rearrangement and clonal 
distribution. NK cells therefore truly bridge the gap between the innate and adaptive 
immunity (Vivier et al., 2011). They do not require immunisation and sensitisation, which 
makes them ‘natural’ killers. Granularity is essential for NK cells and their function, as it is 
their degranulation and a subsequent release of granule contents what determines the level of 
the NK cytotoxicity. However, the other important component regulating NK cell function is 
the receptors expressed on its surface (NKRs) (Long et al., 2013; Chiossone et al., 2018), 
which regulate whether or not the degranulation will occur. NK cells in both humans and 
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mice express a non-polymorphic receptor FcgIII, also termed CD16. The most direct way of 
killing is by utilising CD16 receptor via antibody-dependent cellular cytotoxicity (ADCC). In 
ADCC, NK cells can bind the Fc portion of an antibody through CD16 which allows them to 
detect any cell that is opsonised by the antibodies and they can then kill it. Therefore, 
although NK cells are able to function independently of the adaptive immune system, B cells 
can utilise NK cells as killers if they produce the appropriate antibody that will interact with 
the CD16. Some other receptors that are non-polymorphic include NKp30, NKp44, NKp46 
which are termed Natural Cytotoxicity Receptors (NCRs), NKG2D or receptors of the SLAM 
family such as 2B4 (CD244) (Long et al., 2013). This is far from an exhaustive list of 
receptors. 
However, there is another way of how NK cells can differentiate self vs non-self and this is 
the regulation via array of germline-encoded inhibitory and activating receptors. Examples of 
these receptors are very polymorphic KIR receptors in humans and their analogues in mice, 
Ly49. The fine-tuning of these interactions is made even more complex by the fact that 
ligands for these receptors on NK cells, human leukocyte antigen (HLA/MHC-I) molecules 
and MHC-I molecules in mouse are also extensively polymorphic. Killing by NK cells is 
triggered immediately upon the detection of a pathogen by an APC (DC for example), which 
then will rapidly produce cytokines such as IL-12, IL-15 and IL-18. These cytokines act on 
NK cells in the vicinity and lower their threshold for activation (Long et al., 2013). NK cells 
represent the third major lymphocyte subset in the peripheral blood (PB) in humans, 
accounting for approximately 15% of the lymphocytes (Purdy & Campbell, 2009). In 
addition to these circulating, conventional NK (cNK) cells found in PB and spleen, they have 
been identified in many organs (thymus, liver, skin, salivary glands and uterus) where they 
regulate the physiology and represent main components of tissue-specific immunity. Tissue 
resident NKs (trNK) do not have the same phenotype in all of these tissues and they appear to 
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be dependent on different TFs for their development (Sojka et al., 2014). There are subtle 
differences between tissue resident NK cells which may point to different developmental 
pathways, or to distinct lineages of trNKs present in different organs. Although NK cells can 
recognise a range of antigens, they are utilising mechanisms slightly different compared to 
lymphocytes of the adaptive immune system. The killing machinery of CTLs and NK cells 
are very similar. Key difference is the lack of a TCR, since both CTLs and NKs can express 
KIRs and CD16. However, CTLs need to be engaged via TCR and costimulatory signal, 
while the NK cell needs the right shift in balance between inhibitory and activating receptors 
in its array of receptors. One more important difference is that NK receptors are germline 
encoded, while TCR genes are rearranged. Thus, the capacity to engage different targets 
comes from the fact that there is a range of inhibitory and activating receptors expressed that 
can be engaged without rearranging.  
1.2.2.9 Uterine NK cells 
It is due to the remarkable progress made by histologists that the study of uterine NK cells 
has begun. Uterine NK cells had been observed long before the scientific community became 
aware of the existence of conventional NK cells in 1975 (Fig. 1.7). Back in the 19th century, 
granulated cells were observed in the decidua (Marchand, 1895) and not long after, some 
investigators speculated for the first time that these decidual cells might be of lymphoid 
origin (Weill, 1921). In later years, observations were made about the existence of similar 
cells in the non-pregnant endometrium. One of the first names was the endometrial K-cells 
(short for Körnchenzellen, term originally coined by Hamperl and Hellweg in 1958). Around 
the similar time, Von Numers termed this peculiar type of cell ‘globular leukocytes’ (Von 
Numers, 1953). However, granularity was a prominent feature of these cells and continuously 
triggered the interest of researchers and often led them to compare to a subset of 
granulocytes, neutrophils. Therefore, it is not surprising that in following years, terms such as 
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‘endometrial granular cells’ (Kazzaz, 1972) remained in use. Only with the advent of 
monoclonal antibodies it became possible to look into the phenotype of the uterine granular 
cells in more detail. Gradually, it became clear that these are immune cells, derived from the 
bone marrow, with CD45 on the surface (Bulmer and Sunderland, 1984). Later work has led 
to the conclusion that these CD45+ leukocytes are NK cells after positive expression of CD56 
(King et al., 1989). This is also when the first reports of uterine NK cells in the rodents 
appeared, although in the beginning they were termed ‘granulated metrial gland cells’ (Peel, 
1989).  
Uterine NK (uNK) cells represent a dominant subset of lymphocytes in human and rodent 
uterus (Moffett & Colucci, 2014; Colucci, 2015; Doisne et al., 2015). The mouse is a good 
model system for studying uNKs as it relies on invasive haemochorial placentation to support 
the development of a growing embryo, similarly to higher order primates (Carter, 2012; Mori 
et al., 2016). uNK cells in murine pregnancy reach their maximal number at mid-gestation 
(gestational day (gd) 9.5-10.5). Their numbers dramatically reduce towards end of gestation 
(gd 18.5 and onwards). In humans, the endometrium is shed and regenerated with every 
menstrual cycle, but if the fertilisation has occured a number of histological changes takes 
place, influenced by change in progesterone levels. uNK cells are present in both 
endometrium and decidua, accounting for about 70% of decidual lymphocytes in humans and 
about 20-30% in mice (Moffett & Colucci, 2014). They remain the dominant immune cells in 
the first half of pregnancy. Human uNK cells are CD56superbright and CD16-, unlike PB 
cytotoxic cNKs which are CD56dimCD16+ or CD56brightCD16-  (Koopman et al., 2003; Male 
et al., 2010). In humans, however, there is another subset of PB CD56-negative NKs. Using 
novel approaches of studying the proteome, such as LEGENDplex, it has been established 
that these cells are very similar to CD56dim cytotoxic NK cells, apart from several vesicle 
trafficking- and lytic granule secretion-related downregulated proteins. These features might 
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explain the reduced responsiveness of these cells, which are commonly found in HIV-1 and 
HCV patients (Voigt et al., 2018). As not all NK cells express CD56 in humans, it is very 
important that there are additional markers established for uNKs, such as CD9  (Moffett & 
Colucci, 2014). Although this is not the topic of this thesis, KIR receptors on the human 
uNKs are essential for the recognition of the HLA expressed on the trophoblast. Different 
combinations of KIR-HLA interactions can correlate with extremes of the obstetric dilemma: 
low birth weight correlates with preeclampsia and high birth weight with obstructed labor 
(Hiby et al., 2014; Moffett & Colucci, 2015; Kennedy et al., 2016). 
Mouse uterine NK cells have traditionally been defined staining positive for Dolichus 
biflorus agglutinin (DBA) (Paffaro et al., 2003; Yadi et al., 2008). Only later it was 
discovered that there were two subsets of uNK cells, DBA+ and DBA- with different 
functional capabilities (Chen et al., 2012a). This will be discussed in more detail in Chapter 
3. Alymphoid Rag2-/-Il2rg-/- mice which lack all B cells, T cells, ILCs and NK cells as well as 
IFNg-/- animals were unable to fully perform the modification of the spiral arteries at their 
implantation sites (Ashkar et al., 2000; Björkström et al., 2013), which pointed to an 
involvement of uNK cells in this process. Despite this failure in remodelling their spiral 
arteries, such knockout females were still fertile and had a normal litter size, but low fetal 
weight in each litter (Ashkar et al., 2000; Barber & Pollard, 2003). NK cells in humans and 
mice localise around spiral arteries (Moffett & Loke, 2006; Zhang et al., 2012). 
Recently, trNK cell population has been defined within all murine uNKs and is distinguished 
from cNKs based on the expression of CD49a and DX5 (Doisne et al., 2015; Sojka et al., 
2014). trNKs are the most abundant subset in the uterus of both virgin and pregnant female 
mice and they are CD49a+ and DX5-. In addition to this, trNK seem to be dependent on 
Eomes TF for development, which is a hallmark cNK TF. There are two more subsets 
identified in uterus: CD49a+Eomes- which are designated as uterine ILC1 subset and also 
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CD49a-Eomes+ cNKs. At the moment the lineage relationships between these 3 subsets are 
unknown. Together, they are termed uterine Group 1 ILCs (g1 ILCs). Uterine trNKs are 
similar to hepatic and salivary gland trNKs as they express CD49a and are E4bp4-
independent, but unlike in liver and salivary glands, they are T-bet independent. However, 
they do depend on Eomes for their development, similarly to salivary gland NK cells (Sojka 
et al., 2014). In general, suggested by the currently available data, the main proposed role of 
the uterine NK cells in both humans and mice is regulation of the vascular remodelling of 
spiral arteries (Ashkar et al., 2000; Wilkens et al., 2013) as well as regulation of the 
trophoblast invasion (Hanna et al., 2006; Chakraborty et al., 2011). This is however 
complicated by the identification of new subsets and requires another assessment of each 
individual subset and its associated functions (Doisne et al., 2015). 
 
1.2.2.10 Group 1 ILC development and plasticity 
All ILCs develop from the CLP resident in BM, which can also give rise to B cells and T 
cells. Transcription factor TCF-1 will induce differentiation of an early innate lymphoid 
precursor (EILP) from CLP, and EILPs are able to give rise to both NK cells and ILC1s, 
through distinct developmental pathways (Yang et al., 2015). ILC1s develop from EILPs 
through another developmental intermediate, termed common helper-like innate lymphoid 
precursor (CHILP) in mouse, and characterised by expression of another TF, Id2. Not only 
can CHILP develop into ILC1s, but also the into ILC2s and ILC3s, and importantly, no NK 
cells develop from this precursor (Klose et al., 2014). This was confirmed through the use of 
mouse models that showed the requirement for Id2 in the development of ILCs (Seillet et al., 
2016). Requirement for other TFs for the development of ILC1s has been shown through 
fate-mapping models for example, so although PLZF is not expressed in mature ILC1s, it is 
important in early stage of the development of ILC1s, ILC2s and ILC3s and PLZF+ 
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progenitors are downstream of Id2+ CHILPs (Constantinides et al., 2014; Constantinides et 
al., 2015) (Fig. 1.13). NFIL3 (also known as E4BP4) was initially described as a master 
regulator of the NK cell development (Gascoyne et al., 2009; Male et al., 2014); discussed 
below. Later work however showed that NFIL3 is also involved in the development of all the 
ILC lineages in the lung and gut (Seillet et al., 2014; Geiger et al., 2014), through regulating 
directly the development of Id2+PLZF+ CHILPs (Xu et al. ,2015). Moreover, Nfil3-/- mice 
lack CHILPs, suggesting that NFIL3 is essential for maintaining the earliest ILC progenitors 
(Yu et al., 2014; Cortez & Colonna, 2016). ILC1s in mice are CD127+ and depend on T-bet 
for their development, but not on Eomes. They express CD127, which is IL-7 receptor and 
IL-7 is required for the ILC development. By contrast, intestinal ILC1s are instead dependent 
on IL-15, thus resembling NK cells (Klose et al., 2014).  
 
Figure 1.13. Innate lymphoid cell development. Illustration of the main ILC developmental pathways, as 
explained in text (section 1.2.2.10). Adapted from Vivier et al., 2018. 
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Due to a distinct developmental pathway, NK cells are now considered a separate lineage 
from the ILC1s (Vivier et al., 2018). From the CLP and through the EILP, they develop via 
the NK cell progenitor (NKP). Further differentiation into a particular lineage is a result of a 
fine balance between activation and repression of essential TFs and cytokines (Male & 
Brady, 2014).  
In the murine NK developmental pathway, CLP develops into two NK-committed 
progenitors, pre-NKPs, followed by refined NKPs (rNKPs) (Carotta et al., 2011; Fathman et 
al., 2011). rNKPs acquire NK1.1 which marks transition into immature NK cells (iNK), 
which further develop into mature NKs (mNK) with the acquisition of additional surface 
receptors. It is of importance to note that while NFIL3 was found to be essential for the 
development of NK cells in the BM (Gascoyne et al., 2009; Male et al., 2014), in some 
tissues this was not the case (Sojka et al., 2014). Additionally, NFIL3 is important for early 
stages of NK cell development, at the transition from the pre-NKP to rNKP stage, but it was 
not required for the development of all NK cell subsets. Specifically, Nfil3-/- animals infected 
with MCMV still had functional Ly49H+ NK cells (discussed in more detail in the section 
1.2.2.11) (Firth et al., 2013), but certain subsets persist in the uterus of these animals 
(Boulenouar et al., 2016). More recent work has demonstrated that NFIL3 directly regulated 
Notch1 gene expression, by rescuing the phenotype of NK deficiency in these animals 
through a short exposure to Notch peptide ligands (Kostrzewski et al., 2018).  
It might be that Notch signalling, or possibly another target gene of NFIL3, is responsible for 
the NK cell development in the tissues where NK and ILC1 populations persist despite the 
lack of Nfil3 gene. Notch signalling was shown to regulate intrinsic levels of T-bet and 
Eomes expression using mouse models, by supressing Eomes in both cNK and ILC1, and to a 
higher extent in liver ILC1s compared to other analysed tissues (Chaves et al., 2018; Perchet 
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et al., 2018). This a similar principle to the one in salivary glands, where Eomes is supressed 
by TGF-b signalling, inducing the differentiation of ILC1s (Cortez et al., 2017). 
Human NKPs have been elusive for a long time, but recently have been identified for the first 
time in a range of tissues, including fetal liver and adult tonsil (Renoux et al., 2015). Another 
study (Scoville et al., 2016) identified a RORγt+ progenitor of all human ILCs in the tonsils, a 
stage of the development that was previously dismissed due to mouse fate-mapping studies 
which failed to identify it (Klose et al., 2014).This is in contrast to previous reports showing 
that RORγt+ progenitors are ILC3-committed progenitors (Montaldo et al., 2014). In general, 
current knowledge on the NK development in humans (with the exception of (Renoux et al., 
2015)) comes mainly from the studies on SLTs such as tonsils, where originally a five-stage 
development model was proposed, based on the differential expression of surface markers 
such as CD34, CD94, CD117 and CD16 (Freud et al., 2014). More recently, however, 
expression of a surface receptor NKp80 has allowed increased resolution of the NK 
development in the SLT because now stage 4 could be divided into distinct stages 4a and 4b: 
4a were NKp80- and could give rise to both NKs and ILC3-like cells, while 4b were NKp80+ 
and NK-restricted (giving rise to CD56bright NK cells) (Freud et al., 2016) .This work was 
built upon by a discovery that there were CD34-CD117+CD56+ cells that gave rise to NK 
cells and ILC3s but not ILC2s, further suggesting a distinct developmental pathway for 
ILC2s in humans (Chen et al., 2018), unlike in mouse where CHILP was identified that gave 
rise to all ILCs (Klose et al., 2014). Elegantly executed single-cell culture assays enabled the 
discoveries summarised in this section. Future studies employing techniques such as single-
cell RNA-sequencing (scRNA-seq) should define various progenitors in depth and dissect 
developmental pathways of distinct lineages. 
Finally, there is a considerable plasticity between ILC3 and ILC1 subsets and within all ILC 
subsets altogether (Spits et al., 2016). It has been shown that under certain conditions, a 
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population of RORγt- and AHR-expressing ILC3s, NCR+ILC3s (they express NCRs such as 
NKp44 and NKp46), can downregulate RORγt and upregulate T-bet and also start secreting 
IFN-γ, thus adopting ILC1 characteristics. These cells are termed ‘ex-ILC3-ILC1s’. The 
existence of such a population suggests that the ILC3 lineage may be a transient step in the 
development of some NK cells and ILC1s. One of the mechanisms shown to regulate this 
process is AHR signalling. AHR is a ligand-activated TF which has been shown to regulate 
differentiation of many immune cells, including NCR+ILC3s (Cella et al., 2010; Vonarbourg 
et al., 2010). Although not all endogenous ligands are known, it is well established that 
products of tryptophan metabolism upon exposure to light in vitro include agonist of AHR, 6-
formylindolo[3,2-b]carbazole (FICZ). The same process takes place in skin cells upon 
exposure to UV-light. It has been shown that AHR signalling stimulation of NCR+ILC3s in 
human tonsils ex vivo with FICZ agonist suppressed differentiation into NK cells and 
maintained ILC3 phenotype. Blocking AHR signalling with an antagonist, on the other hand, 
led to differentiation of fully mature NK cells (Hughes et al., 2014). However, other 
conditions, such as exposure to IL-12, were also found to induce production of IFN-γ by 
ILC3s and it was suggested that exposure to microbial flora is one of the reasons this switch 
takes place (Bernink et al., 2013). These cells have been implicated in colitis.  
Cells largely overlapping with NCR+ILC3s have also been identified in human PB and 
uterine mucosa and have been found to express Rorc and produce IL-22 while also giving 
rise to mature uNK cells (Male et al., 2010). There is even evidence for an essential role of 
Notch signalling in an ILC3/cNK progenitor identified in human PB, so only Notch 
signalling in combination with IL-7 led to NCR+ILC3 differentiation in one type of 
progenitor, while it suppressed the IL-15 dependent cNK development in the same cell; 
mouse studies confirmed only the importance of Notch signalling in NCR+ILC3s (Chea et al., 
2016; Kyoizumi et al., 2017) . This makes the study of ILC1 and cNK differentiation more 
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complex but also demonstrates that the microenvironment (available cytokine milieu) might 
be essential in lineage decision-making. Further studies are necessary to investigate whether 
NCR+ILC3s found in human uterus are developmental intermediates of uNK cells or a 
distinct lineage with a specific function in physiology of the uterus.  
 
1.2.2.11 Adaptive/memory-like NK cells 
Immune memory, or recall response, is one of the main features of the adaptive B and T cells. 
After encountering a specific antigen, these cells are able to mount a more powerful and rapid 
response upon secondary exposure to the same antigen and this is due to the engagement of 
their BCRs and TCRs, respectively, which display antigen-specificity. NK cells do not have 
such antigen-specific receptors and yet ‘adaptive’ or ‘memory-like’ NK cells have been 
described in recent years (O’Sullivan et al., 2015). In 2009, it was suggested for the first time 
that there may exist a subset of NK cells that exhibit features commonly associated with 
immune cells capable of developing immunological memory. This was shown in a mouse 
model of mouse cytomegalovirus infection (MCMV), where Ly49H+ NK cells proliferate 
specifically in response to MCMV in spleen and liver, where they are long-lived, self-
renewing cells (Sun et al., 2009). Some of the surface markers of these memory Ly49H+ cells 
were KLRG1, CD43 and Ly6C, which were not expressed by other Ly49H+ (naive) NK cells 
and upon adoptive transfer into naive animals, memory NK cells were protective when these 
animals were challenged by infection (Sun et al., 2009). IL-12 was shown to be indispensable 
for the maintenance of memory NK cells in mouse (Sun et al., 2012). Costimulation through 
other molecules, such as DNAM-1 was also shown to be essential for proliferation of the 
Ly49H+ cells, as DNAM-1 knockout NK cells failed to differentiate into memory cells 
(Nabekura et al., 2014). Using five biologically and chemically distinct antigens, another 
group demonstrated the existence of memory NK cells in the liver. These cells (about 50 % 
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of NK cells in the liver) were characterised by surface expression of a receptor CXCR6 and 
this receptor was essential in retaining the memory NK cells in the liver through engagement 
with its chemokine, CXCL16, in liver sinusoids (Paust et al., 2010). In humans, another NK 
receptor, NKG2C, marks the adaptive NK cells (Gumá et al., 2006) and unlike the mouse 
analogues, they are not dependent on IL-12, but rather on IL-18 costimulation during the 
encounter with target cells in order to produce cytokines. This report also suggests that 
adaptive NK cells as a target cell sensing hub that can then recruit surrounding cells through 
augmented production of pro-inflammatory cytokines (Hammer et al., 2018).  
It is important to note that epigenetic regulation might be essential for the maintenance of 
these ‘memory’ NK cells. A mouse study has demonstrated that MCMV-specific memory 
NK cells exhibited different chromatin accessibility state to other NK cells, but similar to 
MCMV CD8+ T cells (Lau et al., 2018; Dulson et al., 2018).   
 
1.3. In the clinic 
1.3.1 The Great Obstetric Syndromes 
The latest update of the International Statistical Classification of Diseases and Health 
Problems (ICD-11) published by the World Health Organisation (WHO) defines the perinatal 
period as a period of time between 22 completed weeks after fertilisation and 7 days post-
partum. There are no gold standards for identifying conditions behind perinatal mortality and 
morbidity. Instead, clinical syndromes are the best indicators of these complications which 
can also cause maternal mortality. Fetal growth restriction (FGR), premature labor, premature 
rupture of membranes, pregnancy-induced hypertension and congenital anomalies are among 
the major causes of perinatal mortality and morbidity (Romero, 2009). FGR occurs when the 
fetus does not reach its expected size at a given gestational age and one of the best definitions 
of the condition is ‘fetal growth that has failed to reach its genetically determined potential’ 
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(Gaccioli et al., 2018). FGR is a major determinant of perinatal mortality and morbidity and 
yet the screening methods to detect the FGR have been far from sensitive enough to 
successfully diagnose small babies. An example of a proxy commonly used for FGR 
detection is ‘small for gestational age’ (SGA), referring to babies with birthweights below the 
10th percentile for those at the same gestational age. It is important to make a distinction 
between FGR and SGA, because many SGA babies are born small but healthy (Gaccioli et 
al., 2017). FGR on the other hand, has been to shown to lead to chronic diseases later in life 
(Barker & Osmond, 1986; Cooper et al., 1997). Elegant and well executed recent work has 
suggested that applying well established ultrasound methods in FGR detection, in 
combination with placental biomarker measurements in mother’s blood might improve the 
maternal and perinatal outcomes (Gaccioli et al., 2018), but placental biomarkers currently 
have no role in clinical practice.  
Instead, in addition to the initial ultrasound screening, which will identify all babies that are 
SGA, more features are assessed to diagnose FGR. One of them is the middle cerebral artery 
(MCA) pulsatility index (PI), detected by Doppler sonography to identify brain-sparing as a 
consequence of the FGR. Brain-sparing is the phenomenon when the fetus adapts its 
circulation to maximise oxygen and nutrient supply to the brain (Cohen et al., 2015). 
Together with MCA-PI, ductus venosus and umbilical artery Doppler assessments are 
advocated under the current UK guidance (Mone et al., 2014).  
Similarly to FGR, other diseases in obstetrics are defined by the clinical manifestations of the 
mother, rather than on the underlying mechanisms of the diseases (Romero et al., 2006). This 
led to the term Great Obstetric Syndromes (GOS) to be coined in order to better define the 
obstetrical diseases. Characteristics of the GOS are (1) multiple etiologies, (2) fetal 
involvement, (3) clinical symptoms which are adaptive in nature, (4) long preclinical stage 
and (5) potential interactions between the maternal/fetal genes and the environment (Romero 
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et al., 2006; Di Renzo, 2009). Such heterogeneity in the etiologies between various obstetrics 
syndromes showcases that more research is required to be able to predict disease outcomes 
with higher precision, and emphasis has been on identifying additional biomarkers that could 
be tested for in the clinic.  
In conditions such as FGR, coexistence of other clinical syndromes in addition to the SGA, 
such as maternal preeclampsia, are much better indicators of an unhealthy manifestation of 
the SGA (Gaccioli et al., 2017) due to placental dysfunction as has been shown for the 
majority of FGR cases (Mifsud & Sebire, 2014). Defective deep placentation, characterised 
by the incomplete or non-existent transformation of the decidual and myometrial spiral 
arteries’ segments, has been shown to be present in almost every GOS (Brosens et al., 2011). 
Better characterisation of spiral artery remodelling during the early stages of placental 
development therefore might offer an opportunity to identify women who may go on to 
develop GOS (Pijnenborg et al., 2006). While there is some evidence that immune cells at the 
maternal-fetal interface are involved in the regulation of SA remodelling, more research is 
required to identify the exact cellular interactions that support this process. Ultimately, these 
discoveries should guide future clinical practice. 
 
1.3.2 Uterine NK cells: victims of the nomenclature 
Although NK cells were first identified as cytotoxic cells capable of lysing tumour cells, this 
is not the case for uNK cells, as introduced earlier. When incubated with the same cancer cell 
lines as conventional peripheral blood NK (pbNK) cells, uNK cells were poor killers (King et 
al., 1989). Although a large body of evidence in the literature suggests that a certain level of 
activation of uNK cells is essential for appropriate placentation to take place (Moffett & 
Colucci, 2014), it is still a practice of many clinicians to treat women with infertility 
problems and recurrent miscarriage (RM) with therapies aimed at suppressing NK cells. 
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Unfortunately, this misnomer is responsible for many unsubstantiated hypotheses that uNK 
cells are ‘embryo killers’ in cases of reproductive failure, and this has proven to be a 
powerful advertisement for expensive treatments at the IVF clinics (Moffett et al., 2004; 
Moffett & Shreeve, 2015). These therapies are not backed by enough evidence and stem from 
mainly inaccurate interpretations of currently available literature (Moffett et al., 2004). In 
fact, only pooling of published studies looking at pbNK cell numbers between infertile and 
fertile women showed a significantly higher number of NK cells in infertile women. Meta-
analysis of studies looking at the percentages of pbNK and uNK between these two groups of 
women did not show any significant differences. Similarly, live birth rates between women 
with an increase in pbNK cells versus women with a decrease in pbNK cells showed no 
significant difference. In the same report, a meta-analysis of studies looking at pbNKs in RM 
showed that both percentages and numbers are higher in women with RM compared to 
controls, but such significance was not observed for uNK cells in the same setting (Seshadri 
& Sunkara, 2013). Regardless, there are still clinics all over the world which use ‘NK Cell 
Testing and Activity Investigation’ as a reliable indicator of whether NK cells play a 
causative role in infertility/RM (Sacks, 2015). The problem with this approach is that a 
sample of peripheral blood is a main source for testing the number and/or activity of the NK 
cells. Endometrial biopsy to extract uNKs is optional and not always recommended. Test 
results made on the basis of pbNK measurements are often extrapolated and applied to 
uterine NK cells, even though it is well established that these are phenotypically and 
functionally two completely different cell types (Koopman et al., 2003). Most importantly, 
cell numbers should not be correlated with any fertility outcome, because numbers of pbNKs 
can vary greatly (2-20% of lymphocytes), just like is the case for the endometrial uNKs, 
depending on a range of factors (Bisset et al., 2004). However, once high numbers or 
excessive activity of pbNK cells has been ‘diagnosed’ in women with infertility or RM, they 
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are prescribed one of the commonly used therapies and some examples will be discussed 
here.  
Treatment of a woman who had 10 miscarriages with a steroid (prednisolone) led to a 
successful 11th pregnancy and it was speculated that this was due to the inhibition of Th1 
response initiated by NK cells, because prednisolone treatment reduced the number and 
activity of pbNKs (Ogasawara & Aoki, 2000). This dogma that Th1/Th2 balance has to be 
maintained (with Th2 cytokines responsible for a successful pregnancy) was then furthered 
by a study on a larger sample of RM patients where similar treatment led to a significant 
reduction in CD56+ NK cells in the endometrium pre-conception (Quenby et al., 2005). More 
recently, a stronger glucocorticoid with an even higher anti-inflammatory effect than 
prednisolone, dexamethasone, was reported to have a beneficial effect on patients with 
repeated implantantation failure (RIF) because it reduced the number of uNK cells, but with 
mixed results, including some completed pregnancies but also cases of miscarriage and 
failure to get pregnant, demonstrating that suppression of uNK cells is not a universal 
solution (Zhang et al., 2017). This study did, however, mention work shown that 
dexamethasone use in pregnancy can lead to birth defects and that it is not known how 
dexamethasone is metabolised in the uterus, which is a big concern for the majority of 
therapies aimed at uNK/pbNK suppression. None of these therapies target specifically uNK 
cells and the supposedly beneficial effect can be far outweighed by systemic effects of these 
drugs, such as through the HPG axis.  
Other examples of therapies include intravenous immunoglobulin (Ruiz et al., 1996; Moraru 
et al., 2012). Intravenously given Intralipid has shown some success, with around 50% of live 
births post-intralipid treatment in women with RIF history (Lédée et al., 2018). Intralipid, a 
fat emulsion containing soy bean oil, has originally been proposed as an alternative to 
glucocorticoids as some patients were found resistant to them (Lédée et al., 2018). The 
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authors suggested that it had similar anti-inflammatory effect to steroids, presumably through 
the reduction of CD56+ cells and mRNA ratios of IL-18 to tumor necrosis factor-like weak 
inducer of apoptosis (TWEAK) and of IL-14 to (fibroblast growth factor-inducible 14) FN-14 
which they consider biomarkers over-immune activation (Locksley et al., 2001). A range of 
other therapies were suggested over the years, such as granulocyte colony-stimulating factor 
(G-CSF) (Scarpellini & Sbracia, 2009), but also anti-TNF-a (Raghupathy et al., 2000), 
despite the evidence that an immunosuppressive treatment with TNF-a inhibitor, 
prednisolone and Intralipid may lead to severe systemic candidiasis (Akhanoba et al., 2014).  
In summary, it is clear that there is a need for a detailed understanding of the interactions 
occurring between uNK cells and other cells at the maternal-fetal interface. Such interactions 
might be direct cell-to-cell communication or indirect through the maternal-fetal secretome or 
synthetic compounds. Defining why uNK cells are different from their pbNK counterparts 
will lead to precision medicine advances and development of effective and safe medications 
for women with pregnancy complications and infertility problems. 
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1.4. Objectives of this study 
Determining the function of uterine cell types, including ILCs, is challenging due to a very 
dynamic nature of the organ and limited access to human samples. Currently, there is a lack 
of knowledge on gene expression profiles of distinct subsets of mouse uterine g1 ILCs. 
Knowledge of the proteins expressed on the surface of these subsets is not sufficient to 
explain how each one of them contributes to regulating the uterine homeostasis. Proteins can 
have different functions depending on their localisation and phenotype can be highly 
influenced by the microenvironment. Therefore, understanding a molecular profile of g1 
ILCs would aid in constructing a map of their potential interactions with other immune and 
non-immune cells in the uterus. Modern immunology relies on systems biology to dissect cell 
heterogeneity and ascribe functions to discrete subsets in an attempt to define the cellular and 
molecular pathways of tissue physiology and pathology orchestrated by ILCs. The aim of this 
study was to: 
 
1) Resolve the heterogeneity of mouse uterine group 1 innate lymphoid cells and provide 
the first transcriptome atlas of these cells at mid-gestation (Chapter 3). 
 
2) Explore and validate the findings of the RNA-sequencing experiment and 
demonstrate the value of the resource provided in Chapter 3 (Chapter 4). 
 
3) Understand the origin, plasticity and memory-like properties of the group 1 innate 
lymphoid cells in both mouse and human uterus (Chapter 5). 
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2. Materials and Methods  
2.1 Mice 
All mice were maintained in house, unless specified in text. C57BL/6 (B6) wild-type (WT) 
mice were purchased from Charles River UK. Rag2-/-Il2rg-/- mice were generated by 
Francesco Colucci. Eomes-GFP reporter mice were a gift of Thierry Walzer (International 
Centre for Infectiology Research, Lyon, France), Rorc(gt)-CreTG mice from Gérard Eberl 
(Institut Pasteur, Paris, France) and Rosa26R-EYFP (R26R-EYFP) from Ionel Sandovici 
(Department of Obstetrics and Gynaecology, University of Cambridge, UK) and Dr Helle 
Jorgensen (Department of Haematology, University of Cambridge, UK). Tbx21fl/fl crossed 
with Ncr1-iCre were originally used in collaboration with Victoria Male (University College 
London, UK) and Tbx21fl/fl were later purchased from the Jackson Laboratory (strain ID: 
022741) and further bred in-house. Ncr1-iCre strain was obtained from Eric Vivier (Centre 
d’Immunologie de Marseille-Luminy, France) via The European Mutant Mouse Archive 
(EMMA) at the Sanger Institute. All strains were on a C57BL/6 background. Animals were 
used at 8-12 weeks of age and were age-matched for every experiment and all time-matings. 
The morning of the copulation plug discovery was counted as the gestation day (gd) 0.5 for 
timed-matings. Fine details regarding the husbandry during experiments involving second 
gestation are described in the corresponding section of Results. Mice were bred, maintained 
and mated under specified pathogen-free conditions at the University of Cambridge Central 
Biomedical Service in accordance with the University of Cambridge Animal Welfare and 
Ethical Review Body and United Kingdom Home Office Regulations. For the experiments 
performed in collaboration, mice were bred, maintained and mated at the Animal Facility of 
the IRCCS-AOU San Martino-IST (Italy) in accordance with the Italian and European 
Community guidelines. All experiments were carried out in accordance with Home Office 
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Project Licences PPL 70/8222 and 70/7798. Mouse strains used in this study can be found 
summarised in Table 2.1. 
Mouse Strain Source 
C57BL/6 Purchased from Charles River UK 
Rag2-/-Il2rg-/- 
Dr Francesco Colucci (Institut Pasteur, now at the University of 
Cambridge) 
Rorc(gt)-CreTG Courtesy of Dr Gérard Eberl (Institut Pasteur) 
Rosa26R-EYFP Dr Ionel Sandovici, Dr Helle Jorgensen (University of Cambridge) 
Eomes-GFP Courtesy of Dr Thierry Walzer (University of Lyon) 
Tbx21-/- Courtesy of  Dr Victoria Male (University College London) 
Tbx21fl/fl (also B6.129-
Tbx21tm2Srnr/J) 
Courtesy of Dr Victoria Male, then Jackson Laboratory (strain ID 
022741) 
Ncr1-iCre (also B6.Cg-
Ncr1tm1.1(icre)Viv) 
Courtesy of Dr Eric Vivier (via Sanger Institute, strain ID EM:05625) 
 
Table 2.1. Mouse strains used in this study. 
 
2.2 Genotyping 
2.2.1 DNA isolation 
Ear biopsies (2 mm) from genotyped mice were collected and kept at -20 °C until DNA 
isolation. Biopsies were lysed and DNA isolated by placing them into 20 μL of Dilution 
Buffer (Thermo Fisher Scientific) containing 0.5 μL of DNARelease Additive (Thermo 
Fisher Scientific). The samples were incubated for 55 minutes at 55 °C, followed by 3 
minutes at 98 °C. Samples were then centrifuged briefly to pellet debris. Supernatant 
containing DNA was diluted 1 in 5 in nuclease-free water (New England Biolabs) for the 
downstream use. 
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2.2.2 Polymerase Chain Reaction (PCR)  
Three different sets of DNA polymerases and associated buffers were used for 
conventional PCR genotyping of various mouse strains described in this study using the 
DNA obtained as described above: (1) Phire Hot Start II DNA Polymerase with 2x Phire 
Animal Tissue PCR Buffer (Thermo Fisher Scientific) for Tbx21fl/fl, Ncr1-iCre and  
 
Table 2.2. PCR programmes used in to genotype mouse strains used in this study. 
 
PCR 
programme 
Eomes-GFP Rosa26R-EYFP 
Ncr1-iCre, 
Tbx21fl/fl 
Rorc(gt)-CreTG 
Step Length  
Temp 
(°C) 
Length 
Temp 
(°C) 
Length 
Temp 
(°C) 
Length 
Temp 
(°C) 
Initial 
Denaturation 
5 min 94 2 min 94 5 min 98 2 min  94 
Denaturation 30 sec 94 30 sec 94 5 sec 98 1 min 94 
Annealing 30 sec 63 
1 min 30 
sec 
65 and 
55* 
5 sec 63.1 1 min 55 
Elongation 2 min 72 
1 min 30 
sec 
72 20 sec 72 1 min 72 
Cycles  35 
*20 at 65 followed 
by 20 at 55 °C 
40 35 
Final 
Elongation 
5 min 72 5 min 72 1 min 72 5 min  72 
Size 
WT– 359 bp,  
GFP – 374 bp 
WT – 239 bp, 
Mut – 301 bp 
Ncr1wt/wt  – 300 bp , 
Ncr1Cre/wt – 376 bp 
Tbx21wt/wt – 470 bp, 
Tbx21fl/fl – 650 bp 
WT – 250 bp 
TG – 1 kb  
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Rorc(gt)-CreTG strains, (2) REDTaqÒ DNA Polymerase ReadyMixÔ (Sigma-Aldrich) for 
Rosa26R-EYFP strain and (3) 5x FIREPolÒ Master Mix Ready to Load (Solis BioDyne) 
for Eomes-GFP mouse strain. These were used in the combination with primers (as 
described in Table 2.3), DNA template and nuclease-free water (New England Biolabs), 
according to an appropriate programme (as described in Table 2.2). PCR was performed 
using either TProfessional (Analytik Jena) or SureCycler 8800 (Agilent Technologies) 
thermal cycler instruments. Primers used for genotyping the mouse strains can be found in 
Table 2.3. Representative bands required to interpret the genotyping results can be found 
in Figure 2.1. 
 
Figure 2.1. Representative PCR results for genotyping various strains of mice used and described in this 
study. Genotypes of interest for the experiments in this study are highlighted in red. 
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Rosa26-YFP and Ncr1-iCre were the only strains where three primers were used. PCRs for 
these utilised the same forward primer but two different reverse primers: one for the wild-
type locus and the other one for the YFP or Cre locus. For all other PCRs, two primers 
were used to amplify the transgene of interest. Reactions were performed in 96-well plates 
(Thermo Fisher Scientific). 
ID Name Sequence (5’ – 3’) Use 
3 Rorgt Forw CCCCCTGCCCAGAAACACT Rorgt-Cre genotyping 
(conventional PCR) 4B Rorgt Rev GGATGCCCCCATTCACTTACTTCT 
R26 F R26 Forw TGTTATCAGTAAGGGAGCT Rosa26 YFP 
genotyping 
(conventional PCR) 
R26 RM R26 Rev mut AAGACCGCGAAGAGTTTGT 
R26 RW R26 Rev WT CACACCAGGTTAGCCTTTA 
T F Tbx21 FW AGTCCCCCTGGAAGAACACT Tbx21 fl/fl genotyping  
(conventional PCR) T R Tbx21 RV TGAAGGACAGGAATGGGAAC 
N F Ncr1 FW GGAACTGAAGGCAACTCCTG 
Ncr1-iCre genotyping 
(conventional PCR) 
N R W Ncr1 RV wt TTCCCGGCAACATAAAATAAA 
N R M Ncr1 RV knockin GTCCATCCCTGAAATCATGC 
EG F eGFP-F AAGCTGACCCTGAAGTTCATCTGC Eomes GFP genotyping 
(conventional PCR) EG R eGFP-R AAGTTCACCTTGATGCCGTTCTTCT 
EW F Eomes-Ex6-5p1  ACTACCATGGACATCCAGAATGAGC Eomes WT genotyping 
(conventional PCR) EW R Eomes-Ex6-3p2  CAAAGAACACAACAAAACACCACCA 
1F SPP1-F TTCACTCCAATCGTCCCTAC   Spp1 RT-qPCR 
1R SPP1-R TTAGACTCACCGCTCTTCAT  
2F OGN-F TGCTTTGTGGTCACATGGAT   Ogn RT-qPCR 
2R OGN-R GAAGCTGCACACAGCACAAT  
3F PTN-F TGGAGAATGGCAGTGGAGTGT   Ptn RT-qPCR 
3R PTN-R GGCGGTATTGAGGTCACATTC  
4F CXCL16-F CCAGATACCGCAGGGTACTT  Cxcl16 RT-qPCR 
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Table 2.3 Primers used for PCRs and RT-qPCRs used in this study. 
 
2.2.3 Gel electrophoresis 
PCR product was analysed using agarose gel electrophoresis. 1.5% agarose gel was prepared 
by dissolving agarose (Sigma-Aldrich) in 1x BionicÔ buffer (Sigma-Aldrich). For post-
electrophoresis agarose gel staining, 1x GelRedÒ (Biotium) was mixed into the gel pre-
casting.  Quick-LoadÒ 1kb DNA ladder (100-1,517 bp) (New England Biolabs) was run on 
the gel with the PCR products for approximately 45 minutes at 135 V in 1x BionicÔ buffer. 
Stained gel was visualised and analysed via ChemiDocÔ XRS+ imaging system (Bio-Rad). 
 
2.3 Fetal/placental weight 
Uterine horns of pregnant mouse females at gd 18.5 were dissected and placed on a cold 
plate. Fetuses were dissected out of the uterine horns and placentas were separated. Fetuses 
and placentas were cleared of all adjacent tissues. They were then weighed using a balance 
(Mettler Toledo). 
2.4. In vivo experiments 
2.4.1 Adoptive transfer  
Femur and tibia were dissected out of each limb of a C57BL/6 wild-type (WT) mouse. The 
bone marrow was flushed out using 2.5 ml syringe with a 25 g x 16 mm needle (Terumo). 
Cell suspension obtained in this way was filtered through a 100 µm cell strainer (Miltenyi) 
4R CXCL16-R CCAGTTCCACACTCTTTGCG  
5F TGFb-F CTCCCGTGGCTTCTAGTGC  Tgfb1 RT-qPCR 
5R TGFb-R GCCTTAGTTTGGACAGGATCTG  
CF GAP-F  TGCACCACCAACTGCTTAG  Gapdh RT-qPCR 
CR GAP-R GGATGCAGGGATGATGTTC  
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and then counted using the CedexÒ XS automatic cell counter (Roche). The appropriate 
number of cells, according to the antibody manufacturer’s instructions (Miltenyi), was then 
incubated with Fc-block for 10 minutes at RT, followed by incubation with biotinylated 
lineage antibodies (Miltenyi), antibodies can be found in section 2.9) for 10 minutes at 4 °C. 
Suspension was then washed twice with MACS buffer (1x phosphate-buffered saline (PBS), 
2 mM Ethylenediaminetetraacetic acid (EDTA) and 0.5 % Bovine Serum Albumin). Washing 
steps during this protocol were performed by centrifuging at 300 x g for 10 minutes, unless 
stated differently. After this, cells were resuspended in 90 µl of MACS buffer and 10 µl of 
Streptavidin MicroBeads (Miltenyi) were added and incubated with cells for 15 minutes at 4 
°C. Cells were washed again, and then passed through the LS Column (Miltenyi) on the 
MidiMACSä Separator magnet (Miltenyi) with a 30 µm strainer (Miltenyi) placed on top of 
the column. LS Column was prepared by passing through 3 ml of the MACS buffer and then 
the cell suspension was passed through to isolate the lineage negative cells from the bone 
marrow sample. Column was washed 3 times with 3 ml of MACS buffer each time. Cells 
were then counted manually using the Neubauer chamber haemocytometer (Celeromics) and 
stained for the analysis as described in 2.9.1 and 2.9.2 or stained for cell sorting as described 
in 2.9.3. Post-cell sorting cell populations of interest were diluted in sterile 1x PBS and 
injected intravenously into animals via the tail vein. The volume injected did not exceed 200 
µl as per Home Office Project Licence. Control animals were injected with 1x PBS only.  
 
2.4.2 Progesterone injections 
For the experiments involving progesterone injections, 2 mg of ³ 99 % Progesterone (Sigma-
Aldrich) in 100 µl of Sesame seed oil (Sigma-Aldrich) was subcutaneously injected into each 
of the females daily (100 mg/kg), for 3 consecutive days. Sesame seed oil was warmed to 37 
°C prior to resuspending progesterone. Once this emulsion was prepared, it was injected into 
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females via 1 ml Insulin Syringe with 25 g x 16 mm needle (Terumo). Control group of 
females was injected with sesame seed oil only and this represented a vehicle control in 
experiments. 
 
2.5 Human tissue 
Decidual tissue was obtained from donors undergoing elective termination between 7 and 12 
week of pregnancy. Informed written consent was obtained from all donors and protocols 
used were approved by the Cambridge Research Ethics Committee (study Q4/Q0108/23). 
 
2.6 Cell isolation 
2.6.1 Mouse tissue processing 
2.6.1.1 Accutase protocol 
Mouse uterus, liver and spleen were processed using a protocol involving both mechanical 
and enzymatic processing. Two different types of enzymes were used, depending on the 
downstream use of cell suspensions obtained. For the method involving the use of enzyme 
Accutase (Invitrogen), an adaptation of the protocol developed by Arenas-Hernandez and 
colleagues was used for the work presented in this thesis (Arenas-Hernandez et al., 2015). 
Finely minced tissues were placed into 2-ml tubes with 1 ml of Accutase (5 ml for the 
liver) for 35 minutes at 37 °C with gentle orbital agitation of 80 rotations per minute 
(rpm). For virgin mice, no dissection of the uterine tissues was performed, apart from the 
removal of surrounding adipose tissue. For pregnant females processed this way, the only 
dissection of the uterus was to remove the fetus together with trophoblast. Therefore, the 
resulting cell suspensions represented the whole uterine tissue, without the distinction of 
myometrium and decidua. Following digestion, tissues were passed through the cell 
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strainer (100 µm for uterus, 70 µm for liver and 40 µm for spleen; Miltenyi) using a 
syringe plunger to mechanically dissociate the remaining tissues and then washed with 1x 
PBS (Gibco). Washing steps were performed by centrifugation at 1500 rpm, for 10 
minutes at 4 °C, in 1x PBS, unless stated differently. Leukocytes were then separated 
using 80%/40% Percoll gradient (GE Healthcare Life Sciences) and by centrifuging 
without brakes for 20 minutes at 850 x g. After another round of washing, red blood cell 
lysis was performed on the resulting cell pellet using 1x BD Pharm Lyse buffer (BD 
Biosciences) according to manufacturer’s instructions and for 3 minutes. Single cell 
suspensions washed and obtained in this way were passed through a 30 µm filter 
(Miltenyi) and counted manually using the Neubauer chamber haemocytometer 
(Celeromics) for downstream analysis and assays. The Accutase protocol was used to 
obtain single-cell suspensions for all experiments in which cells were analysed 
immediately ex vivo, since a high cell yield was not a requirement. It was a protocol of 
choice whenever possible, because it allowed for a substantial reduction of the number of 
animals used per experiment in this study.  
2.6.1.2 Liberase DH protocol 
For virgin mice, no dissection of the uterine tissues was performed, apart from the removal 
of surrounding adipose tissue. For pregnant mice, after removal of the fetus and associated 
trophoblast, myometrium/mesometrial lymphoid aggregate of pregnancy (MLAp) and 
decidua were dissected by cutting away the mesometrial pole. Therefore, the resulting cell 
suspensions obtained this way allowed for the distinction of myometrium/MLAp and 
decidua. Dissected tissues were then incubated in a hybridisation oven at 37°C in Hank’s 
Balanced Salt Solution (HBSS) (Gibco) supplemented with 10% fetal calf serum (FCS) 
(Gibco), 5 mM EDTA (Gibco) and 15 mM HEPES (Gibco) with gentle orbital agitation. 
Following such pre-digestion, tissue was macerated to 1 mm3 pieces and digested at 37°C 
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for 30 minutes in Roswell Park Memorial Institute medium (RPMI-1640, or RPMI for 
short) supplemented with 2% FCS (Gibco), 1 WU/ml Liberase DH (Sigma) and 30 mg/ml 
DNase I (Roche). In addition, enzymatically digested uteri were mechanically forced with 
a syringe plunger through a 100 µM cell strainer to increase the cell yield and release as 
many cells as possible. Washing steps were performed by centrifugation at 1500 rpm, for 
10 minutes at 4 °C unless stated differently. Leukocytes were isolated from these cell 
suspensions using 80%/40% Percoll gradient (GE Healthcare) and by centrifuging without 
brakes for 20 minutes at 850 x g. Red blood cells were lysed by adding 1 ml of 1X BD 
PharmLyse (BD) buffer for 3 minutes at RT. Single cell suspensions washed and obtained 
in this way were passed through a 30 µm filter (Miltenyi) and counted manually using the 
Neubauer chamber haemocytometer (Celeromics) for downstream analysis and assays. 
The same protocol was followed for isolation of cells from liver and spleen, but 70 and 40 
µM cell strainers were used during the mechanical processing step described above, 
respectively. The Liberase DH protocol was used to obtain single-cell suspensions for all 
experiments in which a high cell yield with a high purity of leukocytes was required, such 
as Fluorescence Activated Cell Sorting (FACS) and/or in vitro culturing of distinct cell 
subsets. 
 
2.6.2 Human tissue processing 
Decidua originating from consented donors was separated from trophoblast and washed in 
RPMI-1640 (Gibco) for 20 minutes. Washed tissue was manually minced and then 
enzymatically digested in RPMI-1640 with 10% FCS (Gibco) and 10 mg/ml collagenase V 
(Sigma) using GentleMACS (Miltenyi) for 4x 20 seconds, followed by a 45-minute 
incubation at 37 °C. Suspension obtained in this way was passed through 100 µm and 40 µm 
cell strainer, after which it was layered onto Lymhoprep (Axis-Shield) to isolate the decidual 
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leukocytes (by centrifuging for 20 minutes, at 700 rpm at room temperature (RT)). Cells from 
the interface were washed in PBS and counted using EVOS XL Core Cell Imaging System 
(Thermo Fisher Scientific) before downstream application. 
 
2.7 Cell culture  
The primary tissue-resident NK cells (trNKs) isolated from the mouse spleen and uterus were 
cultured in a medium as previously described (Gao et al., 2017) and briefly summarised here. 
trNKs were cultured in the 96-well flat-bottom plates in RPMI-1640 with GlutaMax, 
supplemented with: 10% FCS (Gibco), 1% non-essential amino acids (Gibco), 1 mM sodium-
pyruvate (Gibco), 10 mM HEPES buffer (Gibco), 0.1% 2-mercaptoethanol, 100 IU/ml P/S 
(Gibco), 25 ng/ml IL-15 and/or 6.25 ng/ml TGF-b1 (Peprotech). 
 
2.8 In vitro stimulation of lymphocytes 
For in vitro stimulation, cells were incubated in 96-well U-bottom plates in medium 
(RPMI-1640 with pen/strep and FCS in concentrations described previously) containing 
Cell Stimulation Cocktail (phorbol 12-myristate 13-acetate (PMA)/Ionomycin with protein 
transport inhibitors; Invitrogen) and anti-CD107a antibody (conjugated to FITC or BV421 
and used 1 in 100). At the end of a 4-hour assay according to manufacturer’s instructions, 
cells were stained for analysis as described in section 2.9. Protein Transport Inhibitor 
Cocktail (Invitrogen) was added to the medium instead of the Cell Stimulation Cocktail for 
control wells. Negative control for the stimulation assay was (1) a well of stimulated cells 
without added anti-CD107a antibody or (2) a well of non-stimulated cells incubated in the 
medium only.  
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2.9 Flow cytometry 
2.9.1 Surface staining 
After isolation, primary cells were filtered through a 30 µm strainer (Miltenyi). Cells were 
counted and 2x106 cells/well were distributed into wells of V-bottomed 96-well plates in 200 
µl of Fluorescence-Activated Cell Sorting (FACS) Wash (FW) buffer (1x PBS, 0.5 % bovine 
serum albumin (BSA), 0.1 % sodium azide). Number of cells plated was adjusted if fewer 
cells were isolated during the tissue processing steps as described in 2.6. Cells were then 
washed and subsequently incubated with TruStain fcX (anti-mouse CD16/32) for Fc-receptor 
blocking for 10 minutes at RT. They were then stained with selected antibodies against 
surface antigens and incubated for 20 minutes at 4 °C in a volume of 25 µl. After this 
incubation, cells were washed and stained with a Fixable Viability Dye (Invitrogen) to allow 
for live/dead discrimination and, if necessary, with a fluorescently-labelled streptavidin if the 
biotin-labelled antibodies were used in the first step of the staining, for a period of 30 minutes 
at 4 °C. After this, the suspension was resuspended in a volume of approximately 400 µl of 
FW with EDTA for flow cytometry analysis. All washing steps during surface and 
intracellular staining were done by centrifuging at 4 °C and 1500 rpm for 3 minutes unless 
stated differently.  
2.9.2 Intracellular staining and analysis 
For the intracellular staining, cell pellets in V-bottomed 96-well plates (either surface stained 
as described in the section 2.9.1 or freshly stained for intracellular purposes only) were 
resuspended in 25 µl/well of eBiosciences fixation reagent (Invitrogen) and incubated at RT 
for 45 minutes. Following incubation and washing with eBiosciences Permeabilisation Buffer 
(PB) (Invitrogen) diluted 1:10 in Milli-Q Water (EMD Millipore), cells were stained with the 
selected intracellular antibodies diluted in PB for 30 minutes at RT. After two more washes 
with PB, stained cells were resuspended in 200-400 µl of FW for flow cytometry analysis. 
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All antibodies were purchased from Biolegend, eBioscience, BD Biosciences, R&D Systems 
and Miltenyi. For the multicolour flow cytometry analysis, UltraComp eBeads (Invitrogen) 
compensation beads were used to optimise the fluorescence compensation settings. For all 
flow cytometric analyses, unstained and fluorescence minus one (FMO) controls were used to 
ensure proper gating. Raw data were acquired using BD LSRFortessa™ Analyser (BD 
Biosciences) at the Cambridge National Institute for Health Research Cambridge Biomedical 
Research Centre Cell Phenotyping Hub and they were further analysed by FlowJo software, 
version vX (BD Biosciences).  
 
2.9.3 Fluorescence Activated Cell Sorting 
For Fluorescence Activated Cell Sorting (FACS) where the sorted cells were subsequently 
cultured in vitro in the sterile environment, the same steps were undertaken as for the 
regular flow cytometry staining (described in section 2.9.1), with several notable 
exceptions: (1) antibodies used, while same clones used in the analysis, came from a sterile 
stock used only for FACS purposes; (2) instead of FW, buffer used for sorting was sterile 
1x PBS with 0.01 % BSA; (3) sterile polypropylene tubes, rather than polystyrene, were 
used for sorting to minimize the binding of cells to the tubes. Samples were sorted on 
FACSAria III instrument (BD Biosciences) and sorting files were analysed using FlowJo 
vX software (BD Biosciences). All the sorting experiments were performed with the help 
of staff at the Cambridge National Institute for Health Research Cambridge Biomedical 
Research Centre Cell Phenotyping Hub.  
The list of all antibodies used in this study can be found in Table 2.4. 
Antigen Clone Manufacturer 
CD45 30-F11 BD Biosciences 
CD3 17A2 BD Biosciences 
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CD19 1D3 BD Biosciences 
CD11b M1/70 BD Biosciences 
NK1.1 PK136 BD Biosciences 
NKp46 29A1.4 Biolegend 
CD49a Ha31/8 BD Biosciences 
Eomes Dan11mag Invitrogen (eBioscience) 
CD86 GL1 Invitrogen (eBioscience) 
F4/80 BM8 Biolegend 
B220 RA3-6B2 Biolegend 
MerTK REA477 Miltenyi 
CXCR6 SA051D1 Biolegend 
IL-22 1H8PWSR Biolegend 
MHC-II M5/114.15.2 Invitrogen (eBioscence) 
CD16/32 TruStain fcX Biolegend 
Fixable Viability Dye eFluor 506 Invitrogen 
CD107a 1D4B BD Biosciences 
CD115 AFS98 Biolegend 
CD45.1 A20 Biolegend 
CD45.2 104 Biolegend 
CD244 2B4 BD Biosciences 
CD27 LG.3A10 Biolegend 
CD117 2B8 Biolegend 
CD127 A7R34 Biolegend 
CD122 Tm-b1 Biolegend 
human CD34 AC36 Miltenyi 
human CD38 REA671 Miltenyi 
human CD123 AC145 Miltenyi 
human CD45RA REA562 Miltenyi 
human CD7 CD7-6B7 Miltenyi 
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human CD10 97C5 Miltenyi 
human CD127 MB15-18C9 Miltenyi 
 
Table 2.4. Antibodies used in this study. 
 
2.10 RNA isolation 
2.10.1 RNA isolation for RT-qPCR 
The whole uterus was isolated at time-points of interest and collected in RNAlaterÔ  
(Invitrogen) to stabilise the RNA. Fresh tissue was cut to £ 0.5 cm in any dimension and 
immersed in 5 volumes of RNAlaterÔ, according to manufacturer instructions. It was kept 
in this solution at 4 °C for twenty-four hours, before being transferred into -80 °C where it 
was kept until the RNA isolation.  Tissue was weighed to ensure the same amount was 
used for all samples, immersed in 900 µl of QIAzol Lysis Reagent (Qiagen) in the Lysing 
Matrix S homogenisation tubes (MP Biomedicals) and homogenised on a FastPrep-24 5G 
Homogenizer (MP Biomedicals). Programme used to homogenise tissue on a FastPrep-
24Ô 5G was: 20 seconds at 6 m/s followed by 5-minute rest of the tubes on ice. The 
programme was repeated 2-3 times, depending on the size of the tissue, until most of the 
tissue was finely homogenised. Homogenates were centrifuged at maximum speed for 15 
minutes at 4 °C. The supernatants were then treated with gDNA Eliminator Solution 
(Qiagen) and chloroform (Sigma-Aldrich) according to RNeasy Plus Universal Kit 
(Qiagen) instructions. Downstream steps were according to the Kit.  
 
2.10.2 RNA isolation for RNA-sequencing 
Group 1 ILCs from uterus and liver were sorted from Eomes-GFP reporter mice into the TRI 
Reagent (Sigma). RNA extraction was carried out by following TRI Reagent manufacturer’s 
instructions, followed by RNeasy Micro kit (Qiagen). 
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2.11 Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR)  
Quality and integrity check as well as quantification of the RNA isolated as described in 
2.10.1 was performed using RNA 6000 Nano kit (Agilent) on the 2100 Bioanalyzer 
instrument (Agilent). cDNA was amplified using SuperScript VILO cDNA Synthesis kit 
(Invitrogen) and qPCR was performed using PowerUP SYBR Green Master Mix (Applied 
Biosystems), on the Quant Studio 6 Flex Real-Time PCR System (Thermo Fisher – 
Applied Biosystems). Gapdh was used as a reference gene. Data were analysed using the 
DDCt method.  
 
2.12 RNA-sequencing (library preparation) 
Quality and integrity check as well as quantification of the RNA isolated as described in 
2.10.2 was performed using RNA Pico Nano kit (Agilent) on the 2100 Bioanalyzer 
instrument (Agilent). cDNA was amplified from this RNA using Ovation RNA-seq system 
V2 (NuGEN) and DNA libraries were produced using Ovation Ultralow System V2 
(NuGEN) and following manufacturer’s instructions. All mRNA and cDNA quality controls 
and quantifications were performed using RNA 6000 Pico and High Sensitivity DNA kits 
(Agilent) on the 2100 Bioanalyzer instrument (Agilent). Single-end 50 base pair (SE50bp) 
RNA sequencing (RNA-seq) run was performed on Illumina HiSeq4000 instrument at the 
Cancer Research UK Cambridge Institute Genomics Core.  
 
2.13 RNA-sequencing (computational analyses) 
Data were aligned to GRCm38 mouse genome (Ensembl Release 84) with TopHat2 
(v2.1.1, using bowtie2 v2.2.9) with a double map strategy. Alignments and QC were 
processed using custom ClusterFlow (v0.5dev) pipelines and assessed using MultiQC 
(0.9.dev0). Gene quantification was determined with HTSeq-Counts (v0.6.1p1). 
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Additional quality control was performed with feature counts (v 1.5.0-p2), qualimap (v2.2) 
and preseq (v2.0.0). Differential gene expression was performed with DESeq2 package 
(v1.16.1, R v3.4.2) and with the same package read counts were normalised on the 
estimated size factors. Proportions of specific immune cell types from bulk RNA-Seq can 
be estimated using reference data generated from known proportions of the cell types of 
interest. DeconRNASeq was applied to take these tables of known cell proportions, 
defined by gene expression profiles, and used to deconvolute bulk dataset generated in this 
study to estimate cell proportions within each of the sequences samples. Gene Ontology 
(biological process) analysis was performed using PANTHER (Protein ANalysis THrough 
Evolutionary Relationships database http://www.pantherdb.org). Lists of differentially 
expressed genes (adjusted p<0.05 and log2 Fold Change greater than 2) were submitted to 
PANTHER Overrepresentation Test (released 2017-12-05), with Fisher’s exact testing 
utilising a false discovery rate multiple test correction and a Mus Musculus reference list. 
Further details on annotation versions and release dates can be found in the online Tables 
in the attached publication (Filipovic et al., 2018) at the end of this thesis. Lists of 
differentially expressed genes are provided in the Appendix to the thesis. 
 
2.14 Statistical analyses 
Statistical parameters and tests applied are reported in the figure legends. All statistical 
analyses were performed in Prism 7 (GraphPad Software) with a confidence level of 0.95. 
P-values above 0.05 were considered insignificant and are not indicated in the figures. 
Figures were prepared using BioRender and Illustrator CC 2018 (Adobe). 
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2.15 Data and code availability 
RNA-seq data are deposited in ArrayExpress (EMBL-EBI E-MTAB-6812). An open-
source repository (https://github.com/CTR-BFX/2018-Filipovic-Colucci)  has been created 
with access to the code used in this study. 
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3. Establishing a resource for investigating the functions of 
uterine group 1 ILCs 
3.1 Introduction 
Following up on the landmark studies on the uNK cells introduced in the Introduction section 
1.2.2.9, a major driver for future studies in the field of tissue-resident immune cells, including 
uNKs came from Sojka and colleagues. The premise for this work was a distinct absence of 
studies on NK cells in tissues, due to researchers previously focusing on the cytotoxic, 
conventional NK (cNK) in the spleen (Sojka et al., 2014). There were attempts before to 
redefine murine uNK cells, and for a long time, DBA has been used as a standard to define 
DBA+, IL-22 and VEGFA producing uNK cells as well as DBA-, IFN-g producing uNK cells 
(Chen et sl., 2012). However, following the work done in other non-lymphoid tissues (Sojka 
et al., 2014), an even higher level of cell heterogeneity has been discovered in the mouse 
uterus. Termed tissue-resident NK (trNK) cells, these murine uNKs were distinguished from 
now termed conventional NK (cNK) cells based on the expression of CD49a and DX5 
(Doisne et al., 2015; Sojka et al., 2014). trNKs were shown to be the most abundant subset in 
the uterus of both virgin and pregnant female mice and they are CD49a+ and DX5-. In 
addition to this, trNK seem to be dependent on Eomes TF for development, which is also 
required for cNK development, and they both express high levels of it in the uterus. cNK 
cells resembled DBA- uNK cells while trNKs appeared more similar to DBA+ uNKs 
phenotypically (Chen et al., 2016). A third subset, designated as uterine ILC1s of 
CD49a+Eomes- cells was also defined as a distinct subset consistently present in the uterus. 
At the moment the lineage relationships between these three subsets are unknown. Together, 
they are termed uterine Group 1 (g1) ILCs. A very elegant study recently described g1 ILCs 
on the transcriptomic level in mouse spleen, liver and small intestine several years ago 
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(Robinette et al., 2015). These tissues, however, do not undergo such an extensive level of 
tissue remodelling as the uterus. The uterine g1 ILC subsets have only been described on the 
basis of the surface phenotype, using techniques such as flow cytometry and 
immunohistochemistry. The aim of Chapter 3 was to assess whether the composition of g1 
ILCs is dependent on the stage of reproductive life and to establish a similar resource to the 
one in other non-lymphoid tissues (Robinette et al., 2015), with the goal of describing the 
transcriptome of murine uterine g1 ILCs for the first time. 
 
3.2 Results 
3.2.1 Flow cytometry panel for analysis of group 1 ILCs 
In this study, unless otherwise specified, mouse g1 ILCs were isolated from the following 
tissues: spleen, liver and uterus. Full gating strategy used was the same for all the tissues and 
summarised in Figure 3.1 for spleen (Fig 3.1a), liver (Fig 3.1b) and uterus (Fig 3.1c). All 
tissues in the gates shown here originated from pregnant female mice at mid-gestation (gd 
9.5) to illustrate the gating process. The percentages of the cells in each gate, however, were 
variable and dependent on the method of tissue isolation (mechanical vs. enzymatic 
processing and type of the enzyme used) and the experimental setting. For example, 
percentage of the dead cells was always higher, and frequency of CD45+ cells was lower, in 
the uterine samples, regardless of the stage of gestation. A likely reason for this is that the 
uterus in general , and the maternal-fetal interface in particular, displays a much higher cell 
heterogeneity compared to spleen and liver. More abundant non-immune (CD45-) cells in the 
uterus are also more likely to die during the cell preparation, causing the aforementioned 
increased level of cell death.  
The gating strategy for the uterine samples originating from the pregnant animals presented 
here in Figure 3.1 at gd 9.5 represents the entire pregnant uterus (both myometrium and  
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Figure 3.1. Gating strategy of g1 ILCs in different mouse tissues. Gating strategy used for the isolation of g1 
ILCs from different tissues is shown at mid-gestation. The same strategy was employed when analysing the 
cells from the (a) spleen, (b) liver and (c) uterus. In (a-c), cNKs were defined as single, live, CD45+Lin-
NK1.1+NKp46+CD49a-Eomes+ cells, ILC1s as single, live, CD45+Lin-NK1.1+NKp46+CD49a+Eomes- cells and 
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uterine trNKs as single, live, CD45+Lin-NK1.1+NKp46+CD49a+Eomes+ cells. Colour coding employed here will 
be used in Figure 3.2 and Chapters 4 and 5, but not for the rest of Chapter 3 for reasons explained in text. Some 
of the gates (single cells, live cells and CD45+ cells) have been indicated in the plots. Percentages displayed are 
only representative of this sample for the demonstration purposes. All gates were set using appropriate controls, 
such as FMO and isotype controls. Lineage negative cells were defined as CD3-CD19- cells. Colour coding 
shown here will be used in Figures 3.2 and 3.3 (yellow for cNKs, blue for trNKs and red for ILC1s). 
 
decidua), as described previously in (Montaldo et al., 2016). The reason for this is that some 
of the following experiments in Chapter 3 were carried out in collaboration with the 
colleagues who performed the work in (Montaldo et al., 2016), using a mouse model that our 
laboratory had not yet started breeding at the time.  
It is important to note the colour coding (Figure 3.1c bottom right: yellow for cNK cells, red 
for ILC1 cells and blue for trNK cells), which will be used in this chapter in sections 3.2.1 
and 3.2.2 as well as throughout the Chapters 4 and 5. However, for the rest of this chapter 
(sections 3.2.4 - 3.2.7), a different colour coding, explained appropriately, will be used. This 
is because the generic settings for the processing and performing the quality control of the 
RNA-sequencing data in R were not changed. These settings were used only temporarily and 
until the quality control of the data has been fully performed. In conclusion, splenic, liver, 
and uterine cNKs were defined as single, live, CD45+Lin-NK1.1+NKp46+CD49a-Eomes+ 
cells, liver and uterine ILC1s as single, live, CD45+Lin-NK1.1+NKp46+CD49a+Eomes- cells 
and uterine trNKs as single, live, CD45+Lin-NK1.1+NKp46+CD49a+Eomes+ cells. This was 
adapted from a previously published report (Doisne et al., 2015). 
 
3.2.2 Distribution of group 1 ILCs during reproductive life 
As introduced earlier, the uterine tissue undergoes a remarkable tissue remodelling. This 
remodelling is orchestrated by sex hormones at all main stages of the reproductive life, such 
as puberty, implantation, placentation, parturition and lactation. However, less is known 
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about the composition of uterine g1 ILCs throughout the reproductive life of a female. Since 
it is ethically unacceptable to sample the endometrium and decidua from healthy human 
females, the power of mouse models was harnessed in this study to address the question of 
how g1 ILCs fluctuate throughout the reproductive life of a female mouse. Females were 
sacrificed at four different time-points: pre-puberty (neonates at 3 weeks (w) of age), sexual 
maturity (from 4 w of age onwards, when the animals enter puberty and subsequently sexual 
maturity), gestation (4 time points sampled: gd 5.5, gd 9.5, gd 13.5, gd 17.5) as well as the 
post-partum period (days 1, 10 and 18 post-partum). Results of this work are summarised in 
Figure 3.2, where the circles represent a percentage of the subset within its parent population 
(total g1 ILCs: single, live CD45+CD3-CD19-CD11b-NK1.1+NKp46+ cells). The most 
striking trend observed in the uterus in early life was the abundance of distinct CD49a+ 
subsets at different stages of reproductive life. In females before the onset of puberty (3 w-
old neonatal females), Eomes-CD49a+ ILC1s accounted for around 75% of all g1 ILCs. 
Percentage of the ILC1s, however, dramatically decreased with the onset of the sexual 
maturity and this trend was consistent during the later stages of reproductive life (with about 
3-15% of ILC1s at all later time-points), while the other two subsets, Eomes+CD49a+ trNK 
and Eomes+CD49a- cNK were gradually increasing. As indicated in the Figure 3.2, sexually 
mature females were always mated with the males after 8 w of age (and no later than 12 w of 
age). This was consistent throughout this study, unless specified otherwise. trNKs became the 
most abundant g1 ILCs in early pregnancy upon mating, at gd 5.5, with percentages similar 
to what was observed for ILC1s in the neonatal females. At mid-gestation (gd 9.5), trNK and 
cNK cells were found to be present at similar percentages (around 40-50% each), but the 
continuous decrease of ILC1s was still apparent. From gd 13.5 onwards, once the placenta 
has been established, cNK cells were the dominant population among g1 ILCs. This trend 
continued into the post-partum period, at both 1 and 18 days post-partum (pp). However,  
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Figure 3.2. Distribution of uterine g1 ILCs during various stages of reproductive life. Landscape of g1 
ILCs during reproductive life (including first pregnancy) is presented. The circles on the plots indicate the mean 
percentages and the size of the circles is increasing with the increasing percentage of the indicated subset within 
g1 ILC parent population of single, live, CD45+Lin-NK1.1+NKp46+ cells from B6 (C57BL/6 mice). Mating (at 
any point between 8-12 weeks of age) and parturition are indicated in the Figure. Inset shows the same time 
point as the one below it (10 days post-partum), but in non-breastfeeding females and the experimental set-up 
for this time-point can be found illustrated to the left of the inset. cNK (yellow, Eomes+CD49a-), trNK (blue, 
Eomes+CD49a+), ILC1 (Eomes-CD49a+) w: week, gd: gestational day, BF: breastfeeding, nBF: non-
breastfeeding, pp: post-partum. 
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lactation status appeared to affect the distribution of g1 ILCs. While non-breastfeeding 
females at day 10 pp retained high percentages of cNK cells, in the breastfeeding females 
there was a significant increase of trNK cells at the same time-point, similarly to what was 
observed at mid-gestation (experimental set-up and non-breastfeeding data points can be 
found in the inset and above the plot of Figure 3.2).  
Figure 3.3. Variability of uterine and liver g1 ILCs during various stages of reproductive life. Individual 
data points were shown for the percentages of g1 ILCs during reproductive life (including first pregnancy) in 
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uterus and liver within their parent population of single, live, CD45+Lin-NK1.1+NKp46+ cells. (a) Individual 
data points used to generate the summary in Figure 3.2 (b) Individual data points showing the percentages of 
liver g1 ILCs at various stages of the reproductive life. The uterine and liver samples were matched wherever 
possible. Unlike in Figure 3.2, the non-breastfeeding time-point is indicated in the main plot here. w: week, gd: 
gestational day, BF: breastfeeding, nBF: non-breastfeeding, pp: post-partum. 
 
In majority of the experiments throughout this study, liver was used as a reference tissue 
since ILC1s as Eomes-CD49a+ cells were originally described in the liver (see introduction to 
this chapter). Therefore, individual data points for both uterine and liver g1 ILCs throughout 
the reproductive life are shown in Figure 3.3. Figure 3.2 has been derived from data points 
presented in Figure 3.3a, while the data for equivalent time-points was also collected for the 
liver and is shown in Figure 3.3b. A trend that was observed in the liver was that during the 
adult life of the female, cNK cells were always present in higher percentages within total g1 
ILCs, compared to ILC1s.  
 
3.2.3 Eomes-GFP as a mouse model for the study of group 1 ILCs 
Once it was established that the percentages of uterine g1 ILCs subsets fluctuate throughout 
the reproductive life, a possible explanation was that this dynamic distribution of g1 ILCs 
may reflect subset-specific functions. Eomes as a TF has been shown as essential to make the 
phenotypical distinction between g1 ILC subsets  (Sojka et al., 2014; Doisne et al., 2015). In 
order to study the functions of these subsets separately, it was necessary to use a mouse 
model that would allow for FACS-sorting using Eomes without intracellular staining which 
would permeate and kill the cells. Therefore, an Eomes-GFP knockin reporter mouse model 
(Daussy et al., 2014; Montaldo et al., 2016) was used in this study. The mouse model was 
obtained from the original author (Daussy and colleagues) and rederived in the Cambridge 
Biomedical Services Animal housing facility. The objective was to use the Eomes reporter 
mouse to FACS-sort g1 ILCs and investigate their transcriptome by using RNA-seq. Since 
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rederivation took a long time, sorting of the subsets for the RNA-seq experiment was 
performed by the collaborators at the University of Genoa, Italy (details in the Statement of 
collaborative work), who had an ongoing colony of this strain. The subsets were sorted using 
the gating strategy shown in Figure 3.1(b-c) and this will be discussed later in this section. 
As soon as the first litters of the Eomes-GFP reporter mice were weaned in the Cambridge 
facility, their phenotype and reliability as a mouse model were assessed. As expected, there 
was no detectable GFP signal in the WT females (Fig. 3.4a and 3.4b).  
 
Figure 3.4. Genotyping data of Eomes-GFP mouse model is confirmed by the phenotype. Spleens were 
used to test the expression of GFP by flow cytometry and to verify the genotype of Eomes-GFP animals 
rederived in the Cambridge Biomedical Services animal facility. (a) Genotyping data for a litter of Eomes-GFP 
animals. Rectangles indicate animals from which spleens were used to test for the GFP expression by flow 
cytometry (black, lane 3: wild-type allele only, blue, lane 5: GFP homozygous, red, lane 9: GFP heterozygous 
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animal). (b) Flow cytometry plot showing the level of GFP expression in all cells isolated from the spleen of the 
animal in lane 3. (c) Spleen of the animal from lane 5 was FACS-sorted for GFP+ and GFP- cells and the 2 
sorted populations were then analysed for GFP expression. (d) Spleen of the animal from lane 9 was FACS-
sorted for GFP+ and GFP- cells and the 2 sorted populations were then analysed for GFP expression to validate 
the efficiency of sorting. A section of the spleen was analysed pre-sorting as well (first plot on the left). In all 
settings, cells from a C57BL/6 spleen purchased from Charles River (that were never crossed to Eomes-GFP 
animals) were used as a non-GFP expressing control sample to set the gates (data not shown).  
 
To address the reliability of the GFP signal for future experiments, both homozygous and 
heterozygous Eomes-GFP spleens were assessed phenotypically. Briefly, cells were isolated 
from the whole spleens, and cell suspensions were then FACS-sorted for either GFP+ or GFP- 
cells. In both homozygous (EomesGFP/GFP) and heterozygous (Eomes+/GFP) animals, there was 
a lack of GFP+ cells in the GFP- FACS-sorted tubes. In the GFP+ FACS-sorted fractions, 
however, there was a high frequency of GFP+ cells in both EomesGFP/GFP and Eomes+/GFP 
animals.  
Therefore, the genotyping data was confirmed by the phenotype (Fig. 3.4a,c and d). It is 
essential to note that in the future experiment in our laboratory where EomesGFP/GFP and 
Eomes+/GFP females were used, intracellular staining using the eBiosciences Fix/Perm kit 
(used for other strains) was not performed. This was because the GFP signal is susceptible to 
degradation when using formaldehyde-based buffers (data not shown here). Therefore, where 
intracellular staining was necessary in work with these animals, pH value of the buffers was 
adjusted to 8 to preserve the signal (Daussy et al., 2014).  
In total, 15 samples were sorted into the TRI Reagent and shipped by the collaborators. 
These samples originated from uterus (cNK, trNK, ILC1) and liver (ILC1, cNK) at mid-
gestation (gd 9.5). This time-point was chosen because it offers the highest absolute cell 
numbers from the least number of animals. Three biological replicates in total were 
performed. The information on the sorted samples that was of relevance for the downstream 
application can be found summarised in Table 3.1. For this section, it is important to note a 
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variable number of cells obtained from different replicates, as well as the previously 
mentioned different colour coding for the subsets that will be used until the end of Chapter 3. 
Table 3.1. Summary of the sorted samples from animals at mid-gestation for RNA-sequencing. Three 
biological replicates were performed and within each, five cell types were FACS-sorted into TRI reagent for the 
RNA isolation: cNK, trNK and ILC1 from uterus as well as cNK and ILC1 from liver. The table contains a 
summary of the relevant data for all the steps undertaken in sections 3.2.3-3.2.7. Column ‘Number of cells’ 
represent the number of cells obtained from the collaborators, while all the other columns represent the values 
obtained during the library preparation in Cambridge. Samples have been assigned IDs 1-15, as labelled. Colour 
coding of the samples shown here will be used until and including the Figure 3.12 in section 3.2.7. n/a: not 
applicable, ng: nanogram, µl: microliter, RIN: RNA Integrity Number. 
 
3.2.4 RNA isolation: selection of a method 
Each sample within the three experimental replicates was obtained by pooling a variable 
number of pregnant animals at gd 9.5 to ensure that enough cells could be sorted for the 
downstream application. It was therefore essential to optimise the RNA isolation method to 
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ensure the optimal RNA yield prior to commencing with the RNA-seq of the 15 samples of 
variable, and in some cases, low cell numbers (Table 3.1). 
Firstly, the kit for the RNA isolation was selected. The samples were sorted into TRI Reagent 
by the collaborators. This  allows the extraction of the DNA, RNA and proteins from the 
cells. Two different kits available on the market allowed isolation of the total RNA from the 
low number of cells sorted into the TRI-reagent and they were both tested. One kit was Zymo 
Research Direct-zol RNA kit (in further text Zymo) while the other one was Qiagen RNeasy 
Micro Kit (in further text Qiagen). Both kits were used according to the manufacturer 
instructions, with one notable exception. Prior to passing the RNA through the Qiagen 
column, phase separation using chloroform was performed to isolate the aqueous RNA phase 
from the sorted and lysed cells.  
 
Figure 3.5. Qiagen RNeasy Micro Kit is superior over Zymo kit for the isolation of total RNA. K562 
leukemia cell line was used to test the isolation of the RNA with two kits: Zymo Research Direct-zol RNA kit 
and Qiagen RNeasy Micro kit. Two different numbers of cells were tested with each kit: 10,000 (data not 
shown) or 50,000 cells. (a) Summary of the cell numbers used and the integrity and quality of RNA obtained by 
two different isolation methods. (b) Representative Eukaryote Total RNA Pico assay results for the Zymo kit. 
(c) Representative Eukaryote Total RNA Pico assay results for the Qiagen kit. In (b-c), blue histograms 
represent the RNA profile from 50,000 cells, while the red histograms represent 10,000 cells’ RNA profiles. Q: 
Qiagen, Z: Zymo, RIN: RNA Integrity Number, FU: fluorescence units, s: seconds. 
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Cells used in the initial test where only the kit was assessed were K562 cells, a commonly 
used leukemia cell line. For each of the two kits tested, two different cell numbers were used: 
50,000 and 10,000 (the data for this test can be found summarised in the Figure 3.5a, but 
only the data for 50,000 K562 cells was shown). Eukaryote Total RNA Pico assay was used 
on a 2100 Bioanalyzer system (Agilent) to assess the integrity and quantity of the isolated 
RNA. As shown in Figure 3.5, both Zymo (Fig. 3.5b) and Qiagen (Fig 3.5c) protocols 
allowed the isolation of the RNA of the acceptable integrity, as measured by the RNA 
Integrity Number (RIN) value, and quantity, displayed in the ‘Total amount’ column (Fig 
3.5a). However, as both the quantity and integrity of the RNA isolated from 50,000 cells (and 
similarly for 10,000 cells) were slightly better when the Qiagen kit was used, it was decided 
to continue with this kit as some of the FACS-sorted samples to be sequenced had very low 
cell numbers. A very important step of the Qiagen protocol was to incorporate the DNAse 
step to ensure that the obtained total RNA was as clean as possible. 
 
Secondly, another test was carried out to investigate how the yield of the total RNA obtained 
correlated with number of cells isolated. For this, various numbers of splenic cNKs were 
sorted, RNA isolated and then analysed using the Eukaryote Total RNA Pico assay again. As 
shown in Figure 3.6 and as expected, more RNA was isolated from 40,000 cNK cells 
compared to 20,000 cells, but less total RNA was extracted from the 25,000 cNK cells than 
expected, suggesting a certain level of yield variability to be expected in the RNA extraction 
process. 
Finally, total RNA was extracted from all 15 samples in order to amplify cDNA and begin a 
process of the library preparation for the RNA-seq. Total amount in nanograms obtained 
from each of the samples can be found in Table 3.1 (section 3.2.3) and one representative 
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Total RNA Pico assay plot per sample, for each of the 5 subsets (3 from the uterus and 2 
from the liver) is shown in Figure 3.7 (with the same colour coding used in Table 3.1).  
 
Figure 3.6. Variable yield of total RNA from different numbers of test cells. Splenic cNK cells were sorted 
and three different total numbers of cells per sample were tested using previously selected Qiagen RNeasy 
Micro kit. Representative Eukaryote Total RNA Pico profiles are shown. (a) RNA Pico profile of the ladder as a 
quality control of the 2100 Bioanalyzer run. (b) RNA Pico profile of the total RNA isolated from 20,000 cells. 
(c) RNA Pico profile of the total RNA isolated from 25,000 cells. (d) RNA Pico profile of the total RNA 
isolated from 40,000 cells. Details of the run for each sample can be found under each summary 
electropherogram. FU: fluorescence units, s: seconds. 
 
The RIN values (Table 3.1) were variable, but all samples were of a high quality. Table 3.1 
also shows the total amount of RNA in 5 microliters. This was relevant to ensure that there 
was enough material for the first step of the library preparation. The manufacturer’s 
instructions for the Ovation RNA-Seq System V2 protocol were followed, which came with a 
recommendation to start with no less than 500 picograms of total RNA in 5 µl. Table 3.1 
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demonstrates that this was achieved in all of the 15 samples, including the lowest amount of 
515 pg in sample 1.  
 
 
Figure 3.7. Isolated RNA from g1 ILCs was of a high quality. Using Qiagen RNeasy Micro kit, total RNA 
was isolated from the sorted g1 ILCs summarised in Table 3.1 (titles of each electropherogram are colour-coded 
as in Table 3.1). Post-extraction, a quality control of the RNA using Eukaryote Total RNA Pico assay was 
performed and one representative profile per each of the samples (3 from the uterus and 2 from the liver) is 
shown here, including the ladder. Quantification of these results, including the ones not presented here, can be 
found in Table 3.1. FU: fluorescence units, s: seconds.  
 
3.2.5 Library preparation 
The DNA generated in the previous step was used as a template for the Ovation Ultralow 
System V2 kit in order to produce the libraries for the RNA-seq. Using the High Sensitivity 
DNA chips on 2100 Bioanalyzer instrument, it was confirmed that the produced libraries 
were of a very good integrity, without contaminants and of sufficient quantities. Similarly to 
the RNA profiles, one plot per sample (same samples as in Figure 3.7) is shown for the 
produced libraries (Fig. 3.8).  
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Figure 3.8. Produced libraries for RNA-sequencing were of a high quality. Once the libraries were 
produced using amplified cDNA from samples shown in Figure 3.7 and Table 3.2, a quality control of the DNA 
libraries was assessed using High Sensitivity DNA assay. One representative profile per each of the samples (3 
from the uterus and 2 from the liver – same samples as in Figure 3.7) is shown here, including the ladder. FU: 
fluorescence units, bp: base pairs. Titles of each electropherogram are colour-coded as in Table 3.1. 
 
 
In addition, the pooled library containing all 15 samples, submitted to the Cancer Research 
UK Cambridge Institute Genomics Core, was also run on the High Sensitivity DNA chip and 
was of sufficient quality and quantity to be sequenced using Illumina Hiseq 4000 (Fig. 3.9). 
As the aim of this experiment was to analyse genes differentially expressed between samples, 
in consultation with the CRUK Genomics Core it was decided to proceed with the single-read 
50 base pair (bp) sequencing, which yields enough reads per sample. 
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Figure 3.9. Pooled library submitted for RNA-sequencing was of a high quality. 15 produced libraries were 
pooled and a quality control of this pooled library, which was submitted for RNA-seq to the CRUK Genomics 
Core, was assessed using High Sensitivity DNA assay. Electropherograms show (a) ladder as a quality control 
of the assay run and (b) DNA profile of the pooled library. FU: fluorescence units, bp: base pairs. 
 
3.2.6 Quality control of the RNA-sequencing data 
After the sequencing had been completed, it was essential to perform the alignment and 
quality control of the sequenced samples. Each sequencing sample can fail the quality control 
in a range of different ways, which could cause major issues in the interpretation of the data 
and lead a researcher to come to wrong conclusions. Should any anomalies arise, further 
steps may be required to resolve them before proceeding. Bioinformatic analyses of the 
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RNA-seq data in this and following chapters, including the quality control presented in this 
section, were performed with Dr Russell Hamilton at the Centre for Trophoblast Research 
(details in the Statement of collaborative work).  
15 samples that have been submitted for sequencing were assigned the sequencing IDs as 
explained in the Table 3.2. This was summarised for the ease of understanding of the quality 
control summary figures, although each sequencing ID (starting with L2V...) ended in a 
number corresponding to the sample number (01-15).  
Table 3.2. Summary of the sequencing IDs. 15 samples that have been submitted for sequencing were 
assigned the sequencing IDs by the Cancer Research UK Cambridge Institute Genomics Core. The column on 
the left indicates which sequencing sample corresponds to which sample from Table 3.1. 
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Quality control was performed using the MultiQC tool (created by Phil Ewels at the SciLife 
Lab, Sweden), which puts together a summary report of multiple bioinformatic tools 
commonly used to align the RNA-seq reads to a genome of interest (in this case to the mouse 
genome), and subsequently assess their quality. This allows for the timely assessment of the 
possible batch effects and outlier samples (Ewels et al., 2016), prior to continuing with the 
analysis. In summary, the MultiQC tool reported that all 15 samples had passed the quality 
control. This included the post-alignment tools, such as Qualimap (Fig. 3.10a) and 
featureCounts (Fig. 3.10b), which were used to evaluate the alignment quality carried out by 
the alignment tool TopHat (Fig 3.10c).  
Although one of the most basic steps of this process, FastQ Screen was important as it is this 
screening that showed whether there was any contamination present in the sequenced 
samples. This was done through screening 15 fastq library files generated here against the 
preset reference genome sequences, such as E. Coli, bacteriophage PhiX genome also 
commonly used as a control library or another organism (Wingett & Andrews, 2018). Results 
of this analysis are shown in Figure 3.10d, where the proportion of the reads which mapped 
against each individual reference genome is displayed. 
Reassuringly, the majority of reads mapped against the mouse genome (light blue colour: one 
hit/one genome, which means that these reads mapped uniquely to the specified mouse 
genome and did not map to any other genome or any other location in the genome). There 
were no bars that showed unique mapping to any of the other genomes. However, a 
significantly higher proportion of two other types of mapping were observed against the 
human genome, and this was particularly prominent for sample 3, as pointed out with an 
arrow in Figure 3.10d. One of these was the dark red coloured bar (multiple hits/multiple 
genomes) that indicated that a proportion of reads mapped not only to mouse genome but also  
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Figure 3.10. MultiQC report summary. After sequencing files in the fastq format had been received, they had 
to undergo a quality control using a range of bioinformatic tools. MultiQC puts together summary of these 
results, which include steps pre-alignment, during alignment and post-alignment and they are shown here. 
Sequencing IDs in each of the panels (a-d) are summarised in Table 3.2. (a) Genomic origin of the reads. (b) 
Assignment of the reads. (c) Alignment scores. (d) FastQ Screen results, where an arrow is used to indicate 
sample 3 discussed in text. Each report summary in (a-d) is accompanied by a legend described in the Figure.  
 
to the human and at several locations in both. The other type was a dark blue bar (multiple 
hits/one genome), which means that these reads mapped to the specified genome (human), 
but not uniquely, as they mapped to two or more separate locations, suggesting a possibility 
of the contamination. This issue with sample 3 (uILC1, replicate 1, Table 3.2) was taken into 
account for the future analyses.  
Finally, the remaining plots from the FastQC report (created by Simon Andrews from the 
Babraham Institute, UK) demonstrated that all the libraries were of extremely high quality 
  117 
and none of the samples were flagged as poor quality (summarised in Fig. 3.11). A per base 
sequence quality plot showed that the base calls were of a very good quality (the higher the y-
axis value, the higher the quality score) and similarly, per sequence quality scores plot 
showed that not even a subset of reads was of poor quality since they all had a quality score 
of 30+ (Fig. 3.11a and b).  
Figure 3.11. FastQC report summary demonstrated that all sequenced libraries were of a very high 
quality. All plots feature all sequenced samples, unless otherwise specified for a particular panel. (a) Per base 
sequence quality plot. (b) Per sequence quality scores’ plot. (c) Per base sequence heatmap. (d) Per base 
sequence heatmap: individual display for a sample 9 as a representative example from (c). Other samples had a 
similar profile. (e) Per sequence GC content. (f) Per base N content. (g) Sequence length distribution. (h) 
Sequence duplication levels. N: non-identified base call, bp: base pairs. 
 
  118 
Figure 3.11c displays per base sequence content, which demonstrated the proportion of each 
base position where each of the 4 bases (A, T, G, C) was called. Although none of the 
samples failed this step, a lot of them were issued a warning due to the default setting where 
warning comes from a difference greater than 10% between A and T or G and C in any 
position.  
However, FastQC report tutorial explains that nearly all RNA-seq libraries fail this module 
due to a selection bias in the first 12 bp of each run, since there is a biased selection of 
random primers, but this bias does not extend to any of the sequences and therefore was not a 
reason for concern. A representative example for this selection bias is shown in Figure 3.11d 
(using sample 9). Per sequence GC content (Fig. 3.11e), N content (base calls when the 
sequencer was unable to confidently make a base call; Fig. 3.11f), sequence length 
distribution (Fig 3.11g) and sequence duplication levels (Fig. 3.11e) all passed the quality 
control, similarly to other modules within the FastQC report. 
 
3.2.7 The last step of the quality control: initial Principal Component Analysis  
As the final step of the quality control, an initial Principal Component Analysis (PCA) cluster 
plot, with Principal Components (PC) 1 and PC2, taking into account all genes, was created. 
Surprisingly, sample 11, representing uterine cNKs (Table 3.2), clustered with the uterine 
trNKs (Fig. 3.12a) instead of with the other two biological replicates (samples 1 and 6), and 
therefore this sample was removed from the subsequent analyses. Another PCA plot was 
created to demonstrate this initial quality control once these two samples were excluded (Fig. 
3.12b). Although sample 3, representing uterine ILC1s, caused concern due to a potential 
human contamination (as pointed out in section 3.2.6 and in Figure 3.10d), it clustered as 
expected (Fig. 3.12b). However, in order to ensure that the subsequent analyses were of the 
highest standard, it was decided to remove this sample. 
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Figure 3.12. Initial Principal Component Analysis. All genes covered by the RNA-sequencing were used to 
generate the initial PCA cluster plot as final step of the quality control. (a) PCA cluster plot with all 15 
sequenced samples. Black circles indicate samples which misclustered or did not have the highest scores in all 
previous quality control samples. (b) PCA cluster plot where sample 11 was removed, while sample 3 remained. 
However, this sample is circled as it was decided to exclude it in addition to sample 11, as explained in the text. 
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3.3 Summary 
In Chapter 3, it was shown that there were dramatic changes in the distribution of g1 ILCs 
throughout the reproductive life of a female mouse. As shown in the Figure 3.3a, there was a 
great variability in the non-pregnant (virgin) samples, both before and after gestation. This is 
a very important point, because such variability was not observed in the samples acquired 
during gestation. This variability may reflect the dynamic changes that occur over the course 
of the estrous cycle and its accompanying tissue remodelling. None of the methods which 
allow the determination of the estrous cycle were on the Home Office licence (PPL) used for 
this work and therefore it was not possible to take this parameter into account. However, 
several trends became obvious from the data presented in Figures 3.2 and 3.3:  
ILC1s are the most dominant g1 ILCs pre-puberty.  
By the 3 w of age, sex hormones have not started circulating yet, and the most abundant 
immune cells in the uterus at this time may be essential in the protection of the mucosal 
barrier surfaces or even in the development of the uterus, which is still ongoing in the 
neonates (Filant et al., 2012). 
trNKs are the most abundant g1 ILC population early in gestation (gd 5.5). 
One of the essential first steps to establishing the maternal-fetal interface is implantation. In 
mouse, this process starts around the gd 4 and ends by gd 6, when the embryo is fully 
attached to the endometrium. Around gd 5, endometrium begins the process of 
decidualisation. After gd 9, progressive thinning of the decidua is observed until about gd 12. 
Therefore, the sampled pregnant uterus at gd 5.5 was representative of a time mid-
implantation and at the onset of the decidualisation. trNK cells, as the most abundant cells at 
this time-point may be the main drivers of the extensive tissue-remodelling required to 
establish the maternal-fetal interface. trNKs may mediate SA remodelling in pregnancy in 
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cooperation with cNKs, as they cNKs can be found in similar percentages by mid-gestation 
(gd 9.5). More work is required to investigate this hypothesis further. 
cNKs are the most abundant starting from the second half of gestation (gd 13.5). 
Post-partum period is still marked by the domination of cNKs, unless the females are 
breastfeeding. 
It is an established fact that female mice can ovulate immediately post-partum, within the 
first 24h. Fertility is less efficient during this first post-partum estrus, but it is still possible 
for a female to become pregnant. However, once this estrus ends, there will not be any further 
estruses until the end of the lactation period (Bronson et al., 1966). Looking at the days 1, 10 
and 18 post-partum represented attempts to address three events during the post-partum 
period: first post-partum estrus on day 1, mid-lactation period (with either breastfeeding or 
non-breastfeeding females) on day 10 and finally the end of lactation on day 18, just a day 
before the offspring was weaned on the day 19. A finding that requires further investigation 
is the rise in percentage of trNKs in the breastfeeding females. This was not observed at any 
other point during gestation or before and after pregnancy. Overall, g1 ILCs appear to be 
highly sensitive to gonadal hormone fluctuations at every stage of the reproductive life. 
Eomes-GFP was shown to be a reliable reporter mouse model and successfully established 
as a strain for the future studies in Cambridge. 
Three subsets of uterine g1 ILCs (cNK, trNK and ILC1) and two liver subsets (cNK and 
ILC1) were successfully FACS-sorted. Following the optimisation of the RNA isolation 
method, these sorted cells were RNA-sequenced as explained in sections 3.2.3 to 3.2.7. 
Quality control of the sequenced samples showed a very good quality for majority of the 
samples. Two samples, however, were excluded from the future data analyses to ensure high 
quality data interpretation. Sample 3 was excluded from further analyses. due to a non-
identified source of the human contamination. Although sample 11 had passed all the quality 
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control tests, it clustered with trNKs rather than cNKs. These samples were obtained from the 
collaborators’ laboratory and since it was not possible to determine with a high level of 
confidence if this misclustering was indeed due to a previously unappreciated cell 
heterogeneity, sample 11 was dismissed from further analyses, too. 
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4. Exploration of the RNA-sequencing dataset and 
identifying the core gene signatures of uterine group 1 
ILCs 
4.1 Introduction 
The main intention of this dissertation was to provide the first transcriptome atlas of uterine 
group 1 ILCs. As shown in the Chapter 3, the RNA-sequencing dataset of uterine and liver g1 
ILCs at mid-gestation was successfully generated. It also passed all the necessary quality 
controls required during the computational analysis of the RNA-seq data.  
The main aims of the work in this chapter were to explore this RNA-seq dataset. This was 
done through the validation of the dataset in various ways presented in this chapter, together 
with exploration and identification of the core gene signature of uterine g1 ILCs.  
 
4.2 Results 
4.2.1 Distinct gene signatures of CD49a+ and CD49a- group 1 ILCs 
As shown in the previous chapter, the decision was made to remove two samples from further 
analyses: sample 3 (one of the three replicates of uterine CD49a+Eomes- ILC1s) and sample 
11 (one of the three replicates of uterine CD49a-Eomes+ cNKs). This was displayed in the 
Figure 3.12. However, the PCA clustering performed in Figure 3.12 included all genes from 
the obtained RNA-seq dataset, as the aim of such clustering was a quality control of the 
samples, rather than interpretation of variance between the samples.  
In order to explain the variance between all samples, unbiased clustering was performed, 
similarly to the PCA analysis in the previous chapter. It is a common practice to calculate the 
variance in expression between the samples and only select the genes that are highly variable. 
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This is because highly variable genes are more likely to provide information required to 
cluster samples, especially for the PCA which specifically looks to explain the variance 
between samples. Figure 4.1 shows that regardless of how many of these most variable (MV) 
genes are used to produce the PCA plots, the clustering does not change.  
 
Figure 4.1. Unbiased clustering by selecting various numbers of most variable genes does not affect the 
clustering. Variance in expression between the samples was calculated and the most highly variable genes were 
selected to produced PCA plots presented here, showing 250, 500, 1000 or 47,000 most variable genes. The 
legend accompanying each plot describes the data points (yellow: cNKs, red: ILC1s, blue: trNKs, triangle: liver 
and circle: uterine origin). Percentage of each principal component can be found in the brackets along the axis. 
MV: most variable, PCA: principal component analysis, PC1: principal component 1, PC2: principal component 
2. 
 
Thus, it was decided to continue with interpreting the most stringent version of the PCA plot, 
produced by selecting the top 250 MV, which looked very similar to the other PCA plots 
(Fig. 4.2). PCA confirmed the similarity of transcriptional profiles of hepatic and uterine 
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cNK cells, as well as CD49a+ uterine ILC1s and trNKs, as they clustered together. However, 
this unbiased analysis also highlighted unexpected differences between uterine and liver 
CD49a+Eomes- ILC1s, as they have not clustered as closely together as one might have 
anticipated on the basis of their similar surface phenotypes.  
 
Figure 4.2. Final unbiased principal component analysis. The 250 most highly variable genes were selected 
to produce a PCA plot presented here. The legend accompanying the plot describes the data points (yellow: 
cNKs, red: ILC1s, blue: trNKs, triangle: liver and circle: uterine origin). Percentage of each principal 
component can be found in the brackets along the axis. MV: most variable, PCA: principal component analysis. 
 
Hierarchical clustering of the 2 liver subsets and the 3 uterine subsets using only the 
differentially expressed genes with a log2 fold change cut-off  ³ 7.5 and p-value £ 0.01, 
confirmed that liver and uterine CD49a-Eomes+ cNK cells were very similar (Fig. 4.3), while 
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the tissue of origin determined differences among the other subsets. Indeed, CD49a+Eomes- 
ILC1s from liver and uterus clustered apart, suggesting tissue-specific gene signatures even 
in these two cells types that were sorted using the same FACS panel and that are 
phenotypically very similar.  
 
Figure 4.3. Heat map of differentially expressed genes confirms the difference between CD49a+ and 
CD49a- subsets. Only the differentially expressed genes with a log2 fold change cut-off  ³ 7.5 and p-value £ 
0.01 were selected to generate the heat map. These differentially expressed genes originate from pairwise 
comparisons explained later in this chapter, but with more stringent cut-off values. The legend accompanying 
the plot describes the data points (yellow: cNKs, red: ILC1s, blue: trNKs, light grey: liver and dark grey: uterine 
tissue).  
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The heat map presented in Figure 4.3 was made using the differentially expressed gene lists 
described later in this chapter (with a more stringent log2fold change and p-value cut-off) and 
is used here only to confirm the PCA findings (Fig. 4.2), particularly the differences between 
ILC1s from two different tissues as well as similarities between cNKs from these two tissues. 
 
Figure 4.4. Individual gene expression of selected genes validates the FACS-sorting strategy. Expression 
levels of some genes encoding proteins that were used for the sorting of g1 ILCs from uterus and liver at mid-
gestation for the RNA-seq experiments are shown, in addition to some other genes encoding various proteins 
important in development/functions of distinct subsets of g1 ILCs. The colour scale represents log2(FPKM+1) 
transformed normalised reads. FPKM: fragments per kilobase of exon model per million reads mapped. 
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Furthermore, all five subsets were confirmed to express Klrb1c (NK1.1), Ncr1 (NKp46) – 
although this gene was found to be expressed at low levels in uterine ILC1s in a pattern 
similar to Tbx21 (T-bet) and Ifng (IFNg). The subsets were also distinguished according to 
expression of Eomes, Itga1 (Cd49a) and Itga2 (Cd49b) (Fig. 4.4). Validation through 
analysing the expression of individual genes in such manner indicated that the performed 
sorting was reliable.  
 
4.2.2 Principal Component Analysis reveals novel transcripts in group 1 ILCs 
Genes defining the two principal components used for clustering in Figure 4.2 were explored 
in further detail. Principal component 1 (PC1) explained 61% of the variance between the 
subsets (Fig. 4.2 and 4.5a).  
Some of the genes explaining this variance belonged to the C-type lectin domain families, 
such as Clec7a and Clec4a3, encoding DECTIN-1 and DCIR3, respectively, which were both 
significantly upregulated in both CD49a+ ILC1s and trNKs compared to the cNK cells in the 
uterus, with a similar pattern of expression in liver CD49a+Eomes- ILC1s (individual gene 
expression for these genes will not be presented here). It is also worth noting that although 
these genes were found to be upregulated in both CD49a+ subsets in the uterus, they were 
more highly expressed in ILC1s compared to trNKs. Other genes defining PC1 were genes 
encoding surface-expressed TLR1 and intracellular TLR13, Adgre1 encoding F4/80 and 
Mertk encoding MerTK, a member of the Tyro-3/Axl/Mer (TAM) family of receptor tyrosine 
kinases (RTKs). Similarly, these genes were upregulated in CD49a+ subsets in both organs 
and showed a very low overall level of expression in cNK cells. 
Principal component 2 (PC2) explained 18.8% of the variance (Fig.4.2 and 4.5b). Unlike in 
the uterus, genes found in PC2 were significantly upregulated in the liver ILC1s (expression 
of the individual genes will not be shown at this point), with low to almost no expression 
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observed in any of the other subsets, explaining in part why liver ILC1s do not cluster with 
uterine ILC1s. Surprisingly, several of the top genes defining the PC2 were associated with 
the gene signature of B-cells. In addition to genes encoding various domains of the light and 
heavy immunoglobulin chains, CD79a, Blk as well as CD19 appeared to contribute to this 
variance. One of the rare genes upregulated in uterine ILC1s within PC2 was CD200r2, one 
of the receptors for CD200, type-1 immunoglobulin superfamily member (Fig. 4.5b).  
 
Figure 4.5. Principal components 1 and 2 reveal novel transcripts in g1 ILCs. Top genes which explain the 
variance within PC1 and PC2 are shown. (a) Top genes explaining the variance within PC1. (b) Top genes 
explaining the variance within PC2. 
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4.2.3 Exploration of newly identified transcripts in uterine group 1 ILCs  
Flow cytometry experiments were performed to attempt to explore some of the transcripts 
that were identified through the analysis of the PC1 and PC2 on the protein level, as well as 
some other genes of interest. Only a few of numerous targets explored are presented in 
Figure 4.6.  
Figure 4.6. Protein expression confirmed some of the selected highly expressed transcripts. Plots on the 
left show expression levels of selected individual genes in uterine and liver g1 ILCs. Histograms to the right of 
each gene expression plot show the representative flow cytometry validation data of their protein products in the 
uterus at mid-gestation. Fluorescence minus one (FMO) and isotype controls were used to set the gates for the 
flow cytometry experiments as explained in Chapter 2. Data is representative of at least five independent 
experiments. Colour coding for g1 ILCs is the same as in all previous figures in this chapter. The colour scale 
represents log2(FPKM+1) transformed normalised reads. FPKM: fragments per kilobase of exon model per 
million reads mapped. 
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It was confirmed that F4/80, a protein encoded by Adgre1, was indeed expressed by uterine 
group 1 ILCs, as suggested by the RNA-seq data. However, although both ILC1s and trNKs 
had high levels of the transcript, protein was expressed only in trNKs. On the other hand, 
MerTK protein was expressed at similar levels in both ILC1s and trNKs of mid-gestation 
uterus. Some other genes that are characteristic of cells usually expressing MerTK and F4/80 
(APCs) were also examined on the protein level. CD86 (also known as B7-2), for instance, a 
co-stimulatory molecule required to activate T cells by APCs, was found to be expressed on 
trNK cells. Ptprc gene was expressed equally high in all g1 ILCs in the uterus and liver, but 
there was a distinct pattern of its protein (B220) expression in uterine g1 ILCs, with ILC1s 
displaying almost a bimodal pattern of expression, trNKs displaying intermediate levels of it 
on their surface and cNKs not expressing any B220. 
Figure 4.5b showed that Cd19 was one of the top transcripts explaining the variance within 
PC2. Differential Cd19 gene expression between the liver and the uterus (not shown) pointed 
to a higher level of Cd19 transcript in the liver ILC1s compared to CD49a+ subsets in the 
uterus. This was investigated further on the protein level by flow cytometry in the liver and 
uterus at mid-gestation, by excluding CD19 from the initial gating steps to eliminate lineage-
negative cells and then continuing as previously described. However, on the protein level at 
mid-gestation (gd 9.5), there was not a significant difference in the percentage of CD19+ cells 
between ILC1s and trNK and liver ILC1s (Fig. 4.7a and b), although a low percentage of 
CD19+ cells was observed in both tissues at gd 9.5 in the ILC1 gate. Strikingly, CD19+ cells 
were the most abundant early in gestation within ILC1s, at gd 5.5, when between 10-50% of 
ILC1s expressed CD19 (Fig. 4.7a and b). Even though their percentage was variable (Fig. 
4.7b), it was always significantly higher than at gd 9.5. This was an observation highly 
specific to the uterus, since the same trend in liver ILC1s was not observed.  Once it became  
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Figure 4.7.Some ILC1s express CD19 and MHC-II. (a)  Representative flow cytometry plots showing CD19 
expression on the g1 ILCs in the uterus and liver at gd 5.5 and gd 9.5 as indicated in the figure. ILC1s, trNKs, 
cNKs in both liver and uterus were gated as described in all previous figures. Gates were set using FMO and 
isotype controls as mentioned in the Chapter 2 and all other figures. Data is representative of at least 4 
independent experiments. (b) Quantification of the CD19+ subsets within their parent populations during four 
gestation time-points and as gated in (a) in both uterus and liver. Only significant p-values are presented. Two-
way ANOVA with multiple comparisons corrections was used to analyse the data for statistical significance. 
Error bars represent maximum and minimum values. (c) Expression levels of various genes encoding chains of 
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the MHC-II protein in uterine and liver g1 ILCs samples from the RNA-seq data. (d) Expression of CD115 at 
gd 5.5 and MHC-II at gd 5.5 and gd 9.5 on uterine and liver ILC1s, stratified by CD19 expression. CD115 data 
is representative of 2 independent experiments and MHC-II data is representative of at least 10 independent 
experiments. Dashed line: CD19- IL1s, full line: CD19+ ILC1s, grey-shaded histogram: isotype control for 
CD115. Colour coding for g1 ILCs is the same as in all previous figures in this chapter. The colour scale 
represents log2(FPKM+1) transformed normalised reads. FPKM: fragments per kilobase of exon model per 
million reads mapped. 
 
evident that there are CD19+ and CD19- ILC1s, expression of certain proteins of interest was 
further explored on the surface of these two subsets. One of these proteins was MHC-II, since 
it was observed in the RNA-seq dataset that several genes encoding various chains of the 
MHC-II molecule were upregulated in C49a+ subsets in the liver and uterus, particularly H2-
Aa and H2-Ab in both uterus and liver (Fig. 4.7c). While in the liver there was continuously a 
population of MHC-II+CD19+ ILC1s and MHC-II-CD19- ILC1s, this was not the case in the 
uterus. 
Only at gd 9.5 there was a significant shift in the level of expression of MHC-II on  
CD19+ ILC1s compared to a very low expression early in gestation at gd 5.5, suggesting a 
dynamic regulation of the protein expression in the uterine microenvironment (Fig. 4.7d). In 
addition, the gene encoding macrophage-colony stimulating factor receptor (M-CSFR/CSF-
R1/CD115) and mainly known as a receptor for the M-CSF and IL-34, came up as 
upregulated in CD49a+ cells in the uterus and liver. As shown in Fig. 4.7d, CD115 was 
indeed expressed on both CD19+ and CD19- ILC1s in the uterus at gd 5.5, but only on CD19+ 
ILC1 in the liver at the same time-point. CD115 was not validated to be expressed on the 
uterine trNKs. Finally, when the pregnant uterus at gd 9.5 was dissected into two layers: 
decidua and myometrium/MLAp, there was a higher percentage of CD19+ ILC1s identified in 
the decidua, closer to the site of interaction with the embryo, suggesting not only temporal 
but also a spatial organisation of CD19+ ILC1s (Fig.4.8). 
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Figure 4.8. CD19+ cells are more abundant in the decidua compared to the myometrium/MLAp at mid-
gestation. As explained in the Materials and Methods (Chapter 2), decidua was separated from the 
myometrium/MLAp in order to assess the spatial organisation of CD19+ subsets with a better resolution. The 
populations were sorted as single, live, CD45+CD3-NK1.1+NKp46+ and (1) Eomes-CD49a+ for ILC1s, (2) 
Eomes+CD49a+ for trNKs and (3) Eomes+CD49a- for cNKs. These parent populations of distinct g1 ILCs were 
then gated as shown in the plots above for CD19 expression. Top row represents decidua and bottom row 
myometrium/MLAp. Plots are representative of two independent experiments. D: decidua, M: 
myometrium/MLAp. 
 
4.2.4 Identifying the core gene signatures of uterine g1 ILCs 
Ultimately, the goal of this study was to define the core gene signatures of uterine g1 ILCs 
that would represent a valuable resource for the future studies in the field of reproductive 
immunology. After lists of differentially expressed genes (DEGs) between subsets had been 
generated (with Russell Hamilton, see Statement of collaborative work), they were analysed 
using several approaches: (1) UpSet, (2) Gene Ontology (GO) and (3) exploring DEGs for 
the highest-fold change in genes (either up- or down-regulated). 
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UpSet is a computational tool which is superior over Venn diagrams as it allows visualisation 
of many intersections in a considerably less complex manner. Here, UpSet was used to 
summarise some of the findings from the DEG lists and identify genes only differentially 
expressed in a comparison of interest and nowhere else. This is because the input for the 
UpSet are the DEG lists. By data-mining through these lists, UpSet determines which genes 
(from which pairwise comparison, for instance), have not been identified in any of the other 
comparisons. Initially, 11 pairwise comparisons of the DEG lists were performed. However, 
5 comparisons were finally selected for an in-depth analysis based upon primary objectives of 
this study: (a) what the differences between ‘circulating’ (Eomes+CD49a-) and ‘tissue-
resident’ (Eomes+CD49a+ and Eomes-CD49a+) between the two tissues are and (b) how these 
cells are different from each other within the uterus only. 
 
 
Figure 4.9. Summary of the differentially expressed genes in selected comparisons. UpSetR plot displayed 
here represents the summary of the comparisons of interest for the scope of this study. DEG lists were used for 
the UpSetR input and the comparison lists of genes which were used have been labelled in Roman numbers I-V 
and will be referred in such way throughout the text. The dots in the intersections on the plot on the right-hand 
side of the figure show how many unique genes were found in that particular comparison and none of the others. 
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To address the objective (a), two comparisons between DEG lists were made (summarised in 
Fig. 4.9):  
I All uterine (ILC1, trNK, cNK) vs all liver subsets (ILC1, cNK); 
II Uterine CD49a+ (ILC1, trNK) vs liver CD49a+ (ILC1). 
To address the objective (b), 3 comparisons of DEG lists were performed: 
III Uterine CD49a+ (ILC1, trNK) vs uterine CD49a- (cNK); 
IV Uterine Eomes+CD49a+ (trNK) vs uterine Eomes+CD49a- (cNK); 
V Uterine Eomes-CD49a+ (ILC1) vs uterine Eomes+CD49a+ (trNK). 
The number of differentially expressed genes was variable, from about 250 to just over 1,500 
detected genes with the adjusted p-value < 0.05 and log2 fold change two or above (Fig. 4.9). 
Comparison I: Differences between all uterine and all liver g1 ILCs at mid-gestation 
Functional annotation GO analysis of the differentially expressed genes between all uterine 
and all liver g1 ILCs pointed to vascular endothelial growth factor (VEGF) signalling and 
oxygen/gas transport as some of the most highly enriched biological pathways in all uterine 
g1 ILCs (Figure 4.10a) Specific genes involved in these pathways included Kdr, encoding 
VEGF receptor 2 and Pdgfra, alpha receptor for the plateled-derived growth factor (PDGF), 
found in the VEGF signalling pathway, but also haemoglobin chains within the oxygen and 
gas transport pathways (Hbb-Y, Hba-X, Hbb-BH1) (Fig. 4.10a). In total, 265 pathways were 
detected in this comparison. As many genes were involved in multiple pathways, some of 
them overlapped. For example, regulation of cellular response to TGF-b signalling, SMAD 
protein transduction and regulation of pathway-restricted SMAD protein phosphorylation 
(with upregulated Dab2, Fbn1, Tgfb2, Inhba) all pointed to the importance of tightly 
regulated TGF-b signalling in the uterine g1 ILCs. Other significantly enriched uterine 
pathways included response to hypoxia and decreased oxygen levels (Ang, Hif3a, Hlf, Kdr), 
extracellular matrix organisation (Flrt2, Fbln1, Mmp9, Tgfbi), as well as a number of 
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pathways relating to wound healing and the regulation of blood vessel development.  
Figure 4.10. Genes determining the differences between uterine and liver g1 ILCs. Selected genes from the 
comparisons of interest are presented in the heat maps shown on the left (a-b). The genes in heat maps were 
selected from the analyses of Gene Ontology (GO) enriched pathways (shown to the right of each heat map), 
UpSetR data (Fig. 4.9) and DEG gene lists for highest fold change genes. (a) The heatmap and GO analysis for 
comparison I. (b) The heatmap and GO analysis for comparison II. Patterned bar indicates GO pathways 
enriched in liver ILC1s, while all other bars are pathways enriched in uterine subsets. The colour scale 
represents log2(FPKM+1) transformed normalised reads. FPKM: fragments per kilobase of exon model per 
million reads mapped. 
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Overall, the pathways enriched across uterine g1 ILCs relate to uterine physiology at mid-
gestation, such as vascular remodelling. UpSet list of genes exclusively differentially 
expressed between all uterine and all liver subsets suggested Itga3, encoding CD49c, as the 
most highly expressed liver g1 ILC specific gene and Trim2 as the uterine counterpart (Fig. 
4.10a). 
 
Comparison II: Differences between CD49a+ cells in the uterus and liver at mid-gestation 
Similarly to the previous comparison, but excluding cNK cells from the analysis, DEGs 
determining the differences between tissue-resident (CD49a+) subsets in the uterus and liver 
were further analysed. The top enriched pathway (almost 40-fold) was negative regulation of 
antigen processing and presentation of peptide via MHC-II, with H2-Oa and H2-Ob as 
representative genes within this pathway. Both genes encode H2-O protein with a main 
function of inhibiting the H2-DM-mediated antigen-loading process (Walter et al., 2000). 
Both genes were upregulated in liver ILC1s compared to uterine trNK and ILC1s (Fig. 
4.10b). Most highly upregulated genes in the uterine CD49a+ cells were Gzme, Gzmd, Gzmg, 
Gzmf, encoding ‘non-conventional’ mouse granzymes, identified as a part of the highly 
enriched pathway of cytolysis via the GO. Steroid metabolic processes, including 
progesterone metabolism, were found to be almost 20-fold enriched in the uterus with genes 
such as Srd5a1 and Dhrs9. Genes associated with macrophage chemotaxis, but also 
lymphocyte migration were enriched in uterine tissue-resident cells (Ccl2, Ccl12, Ccl7, Ccl8, 
Ccl17), suggesting that they may be involved in a crosstalk with myeloid and lymphoid cells 
and that this may be of more importance in the uterus compared to liver. This is emphasised 
by a high expression of Spp1, encoding ostepontin, which is important for neutrophil 
migration (Koh et al. ,2007) and reflected in about 6-fold enrichment of neutrophil migration 
pathway in CD49a+ g1 ILCs (Fig. 4.10b). While lymphocyte migration in general was 
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characteristic of uterine CD49a+ cells, liver ILC1s seemed to be equipped with the 
transcriptional machinery required to regulate T cell migration, through the upregulated 
genes Cxcr3 and Ccr6. Collagen metabolism was also found to be upregulated in the uterus, 
with Ctsb and Ctss being the most highly expressed genes. Wound healing and ECM 
organisation (Plau, Flrt3, Hmox1, Pdgfa), as well as regulation of epithelial cell proliferation 
(Vegfa, Mmp12) coming up as enriched pathways showed it may be CD49a+ cells rather than 
CD49a- cNK regulating these essential tissue-remodelling processes. Somewhat unexpected 
was the discovery of pathways like import into cell and phagocytosis, usually associated with 
the antigen-presenting cells (APCs). UpSet analysis pointed to Ccr6 to be exclusively 
differentially expressed in liver ILC1s, but also pointed to Slc16a13 as a uterine CD49a+ 
specific gene. Among genes in the list of differentially expressed genes between uterine and 
liver CD49a+ cells, Cd27, Cd69 and Cxcr6 appeared to be upregulated in liver ILC1s (Fig. 
4.10b). 
 
Comparison III: Differences between the tissue-resident and circulating g1 ILCs in the 
uterus at mid-gestation 
As more detailed, individual comparisons were carried out in the following two comparisons, 
for the overall comparison of CD49a+ (ILC1 and trNK) to CD49a- (cNK) g1 ILCs in the 
uterus, GO Slim was used (a cut-down version of the regular GO used elsewhere in this 
work). Main enriched pathway in uterine CD49a+ cells compared to cNKs was the 
unsaturated fatty acid biosynthesis (genes Mgst1, Mgst2, Alox5ap) (Fig. 4.11a). Related to 
this, lipid metabolism came up as enriched in the 2 CD49a+ uterine subsets (genes Apoe, 
Psap).  The next most enriched pathway was the lysosomal transport (genes Rab7b, Lamp2, 
CD68, Lamp1). Response to IFN-g was highly characteristic of these cells (through a very 
high expression of Irf7 for instance). S1pr5, encoding sphingosine-1-phosphate receptor 5 
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and well-known receptor regulating egress of NK cells came up as the main uniquely 
differentially expressed gene between CD49a+ and CD49a- cells, specifically upregulated in 
CD49a- cNK cells.  
Figure 4.11. Genes determining the differences between uterine g1 ILCs. Selected genes from the 
comparisons of interest are presented in the heat maps shown on the left (a-c). The genes in heat maps were 
selected from the analyses of Gene Ontology (GO) enriched pathways (shown to the right of each heat map), 
UpSetR data (Fig. 4.9) and DEG gene lists for highest fold change genes. (a) The heatmap and GO analysis for 
comparison III. (b) The heatmap and GO analysis for comparison IV. (c) The heatmap and GO analysis for 
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comparison V. Patterned bar in (c) indicates GO pathways enriched in uterine ILC1s, while all other bars are 
pathways enriched in uterine trNKs. The colour scale represents log2(FPKM+1) transformed normalised reads. 
FPKM: fragments per kilobase of exon model per million reads mapped. 
 
On the other hand, hypermethylated-in-cancer-2, encoded by Hic2 appeared specific to 
uterine CD49a+ and no other cells. Ccl7 was a gene with the highest fold change in the 
uterus, while it was almost not expressed at all in the liver ILC1s. Ccl2 and Tlr1 were some 
of the other very highly upregulated genes in trNK and ILC1, while cNK cells may be 
important sources of Mucin4 (Muc4) (Fig. 4.11a).  
 
Comparison IV: Differences between the uterine trNK and cNK cells at mid-gestation 
Msr1, encoding macrophage-scavenger receptor 1 and Clec7a, encoding DECTIN-1, 
exhibited the highest fold change in trNK compared to cNK (about 300-500-fold, 
respectively) (Fig 4.11b). One of the genes upregulated almost 40-fold in trNKs was 
Slc40a1, encoding ferroportin (FPN1) (Fig. 4.12). Given that FPN1 is the main exporter of 
iron from the cells, this suggests iron metabolism may be of importance in uterine tissue-
resident NK cells. This dataset showed a high expression of Nfe2l2 (NRF2) and significantly 
upregulated Nfe2l3 (NRF3) in trNKs (Chevillard & Blank, 2011). Both proteins can bind to 
antioxidant response elements and Nfe2l3 locus has been shown to be associated with 
endometriosis through genome-wide association studies, with a p-value of 1.4 x 10-9  (Painter 
et al., 2010). Some other Nrf2-target genes such as Hmox1 were all found to be highly 
upregulated in trNKs.  
About 900 enriched pathways were detected in the trNKs through the GO analysis. Pathways 
relating to the cholesterol storage and homeostasis were among the most highly enriched 
pathways in trNKs with genes such as Pparg, Apob and Lpl. Genes associated with cellular 
response to IL-18 were also upregulated in a way that suggested crosstalk between trNKs and 
cNKs: trNK cells upregulated Il18 and Ifngr2, while cNK cells upregulated Il18r1 and 
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Il18rap as well as Ifng. Thus, cNK cells may be more responsive to IL-18 and a major source 
of IFN-g, and trNK cells may be more important as producers of IL-18 and cells responsive 
to IFN-g. In a similar manner, trNK cells were also found to potentially be involved in IL-1b 
production but to also be responsive to IL-1, through a high expression of genes such as 
Nlrp1b, Nlrp3, Il1b, (IL-1b production) and Il1r1, Ccl1, Ccl17, Ccl8 (cellular response to IL-
1). Interestingly, apoptotic cell clearance was among the enriched pathways, with genes like 
Lrp1, Axl and Mertk highly upregulated compared to cNK cells. As shown here, trNK (but 
also ILC1) may be highly responsive to TGF-b, sensing this cytokine’s fluctuations through 
receptors such as Lrp1, but also Tgfbr1 (Fig. 4.11b). 
 
Figure 4.12. Differences between the uterine trNK and cNK cells at mid-gestation. Selected genes from the 
comparisons of interest are presented in the MA plot. The genes labelled on the plot were selected from the 
analyses of Gene Ontology (GO) enriched pathways and UpSetR data (Fig. 4.9), both derived from the DEG 
gene lists for highest fold change genes. Red lines represent the absolute cut-off value of the log2 fold change of 
2 that was used to generate the DEG lists. Red dots are significantly upregulated genes in trNKs, while blue dots 
represent cNK upregulated genes.  
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 In addition, Tgfbi, introduced in comparison I earlier as a significantly upregulated uterine-
specific transcript, was upregulated in trNKs. UpSet pointed to Slc16a1, encoding MCT1, 
one of well characterized monocarboxylate transporters (lactate exporter) to be unique to 
trNK, suggesting the potential importance of distinct metabolic requirements for uterine 
CD49a+ trNK cells compared to other subsets. Some other unique genes in trNK compared to 
cNK were Tlr9, Tlr1, Bgn as well as various genes involved in the purinergic receptor 
signaling (P2rx4, P2rx7) pathways (Fig. 4.11b and Fig. 4.12).  
 
Comparison V: Differences between the uterine ILC1 and trNK cells at mid-gestation 
While there was a much lower number of DEGs between uterine ILC1 and trNK than in 
some other comparisons, the GO analysis between them uncovered subtle differences 
between these two subsets phenotypically different by Eomes expression. Most highly 
upregulated gene in ILC1s compared to trNK was Aplnr, encoding for APJ or apelin receptor, 
which responds to the adipokine apelin (Fig. 4.11c). Apelin receptor was shown before to be 
very highly expressed in the mouse endometrium by in situ hybridisation histochemistry, 
while no expression was observed in the myometrium (Pope et al., 2012). 
 Some other highly expressed genes in ILC1s included Adgre4, encoding F4/80 receptor as 
well as Ace, encoding angiotensin I-converting enzyme which is a part of the renin-
angiotensin system. Protein heterodimerisation activity was the most highly enriched 
pathway in uterine ILC1s (gene Hes1 for example). Genes H2-Aa, H2-DMb1, H2-Ab1, H2-
Eb1 and CD74 were found to be expressed highly in both ILC1 and trNK, but to a higher 
extent in ILC1, resulting in pathways related to antigen processing and presentation of 
peptide via MHC class II to be among the most highly enriched pathways detected in ILC1s. 
However, most other detected DEGs were downregulated in ILC1s compared to trNKs. 
Sh2d1a, encoding signalling lymphocytic activation molecule (SLAM)-associated protein 
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(SAP) with a role in SLAM signalling, Sh2d1b2, encoding EAT-2B and also a member of 
SAP-family of adapters, as well as CD96 were all upregulated in trNK. Similarly, Crtam, 
commonly recognised as a receptor for Nectin-like molecules (Arase et al., 2005) and Xcl1, 
encoding lymphotactin previously shown to be produced by the human uNK cells (Kennedy 
et al., 2016), both part of leukocyte-mediated cytotoxicity GO pathway, were found to be 
highly expressed in trNKs. In addition, a number of enriched pathways related to the 
lymphocyte activation and in particular differentiation/activation of T-cells was identified. 
Specific genes from these pathways upregulated in trNKs were CD28 and Zap70, for 
instance. Not only was the trNK signature associated with interaction with lymphocytes, but 
it also suggested a potential regulation of myeloid cell differentiation, through genes such as 
Ets1 and Itgb3. The only uniquely differentially upregulated gene in ILC1 as suggested by 
UpSet was Fam49a. trNK cells were marked by significantly upregulated expression of 
Ltbp3 and Tnfrsf9 among other genes (Fig 4.11c). 
 
4.3 Summary 
In this chapter, the RNA-seq dataset was explored in further detail. The overall aim was to 
interpret the findings, attempt to validate some of them and explore further biologically in 
order to demonstrate the usefulness of the dataset as a resource and finally, to identify the 
core gene signatures for the uterine g1 ILCs at mid-gestation. 
Through PCA and hierarchical clustering of all 5 subsets from the uterus and liver, it became 
clear that what is referred to as ‘tissue-residency’, expression of CD49a surface marker, 
affects how the g1 ILC subsets will cluster. Based on the unbiased PCA clustering analysis 
taking into the account the most variable genes, Eomes-CD49a- cNKs from the liver and 
uterus clustered together and were clearly separated from all the other subsets. According to 
the heat map taking into the account only the DEG lists, Eomes-CD49a+ ILC1s and Eomes+ 
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CD49a+ trNKs from the uterus clustered with the liver ILC1s, while cNKs were separated 
from these 3 subsets, confirming that there are gene signatures that are specific to CD49a- or 
CD49a+ subsets through unbiased clustering approaches. One should be careful when 
defining these cells as ‘tissue-resident’ or ‘circulating’. Although these terms were used in 
this dissertation to refer to CD49a+ cells as tissue-resident and CD49a- subsets as 
circulating/conventional/splenic-like cNK cells, this might not be a completely accurate 
interpretation. Original studies using the surgical mouse model of parabiosis showed that 
CD49a+ liver NK cells were indeed tissue-resident because they were found only within the 
host immune compartment rather than in the other parabiont (Peng et al., 2013). This was 
later confirmed for the uterine and skin CD49a+ cells (Sojka et al., 2014). It was, however, 
recently shown that CD49a+ can be induced on human pbNK cells through the stimulation 
with IL-12 and IL-15 (Hydes et al., 2017). Therefore, one should be careful when using only 
one or several markers to describe cells as truly tissue-resident or circulating. It might be that 
these markers are upregulated as a consequence of their recruitment to distinct 
microenvironment. Thus, one should not use such limited information in order to make the 
assumptions about the origin of cells, for instance.  
Looking in detail at the genes within the first two principal components that determined PCA 
clustering revealed several novel transcripts in both uterine and liver g1 ILCs that were 
previously unappreciated for this group of cells. One of these transcripts was Mertk, encoding 
the MerTK from the TAM receptor family of RTKs, shown here to be expressed by both 
trNK and ILC1s in the uterus and liver and this was explored further on the protein level by 
flow cytometry in the uterus at mid-gestation. This might be relevant to the biology of 
reproduction as it was previously shown that TAM-triple knockouts are infertile (Lu et al., 
1999; Lemke, 2013). trNK cells express highly another TAM receptor, Axl. In addition, it 
was shown that one of the MerTK ligands, Gas6 is expressed by the mouse trophoblast 
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(Madeja et al., 2011). In other studies, TAM receptors have been shown to be in transmitting 
signals required for generation of functional and mature NK cells (Caraux et al., 2006), which 
could also be highly relevant to the g1 ILCs in the uterus. Another gene that was one of the 
top genes within the PC2 was CD200r2, one of the receptors for CD200. Interaction between 
CD200 and its receptors has been associated with immunosuppressive signals and CD200-
deficient mice are susceptible to autoimmunity (Taylor et al., 2005). Interestingly, other 
receptors for CD200 were found to be expressed in the uterine subsets in this study, such as 
CD200r1 and CD200r4 (data not shown). It was shown that CD200 can exert different 
functions depending on the receptor it binds and that it is highly expressed in immune-
privileged sites (Carson et al., 2006). With a very recent study that suggested the involvement 
of soluble CD200 in the predisposition and pathology of endometriosis (Clark et al., 2018), it 
might possible this is another candidate gene that deserves a further look into in order to 
define the tissue-specific functions of g1 ILCs. By confirming the expression of proteins such 
as CD86 and F4/80, it appeared that CD49a+ cells in the uterus at mid-gestation display gene 
and protein signatures resembling cells of myeloid origin, and particularly of the antigen-
presenting cells (i.e. macrophages). Although most of these genes were similarly upregulated 
in liver Eomes-CD49a+ ILC1s, there was no protein expression for any of the proteins stained 
for, suggesting a uterine-specific regulation of the gene expression.  
It was also shown in this chapter that some g1 ILCs, predominantly in the uterus, express 
CD19, a typical B cell protein. CD19+ ILC1s cells were present in significantly higher 
numbers at gd 5.5 compared to gd 9.5 and also expressed MHC-II. CD19 was previously 
described on a subset of human pbNK cells from B lymphoblastic leukemia (Soma et al., 
2014). Another report confirmed the existence of a population of CD19+CD56+ NK cells that 
could be detected in a cohort of pediatric patients with various immunodeficiencies and was 
present at similar levels over a number of years (Korol et al., 2015). CD19 therefore, may 
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mark g1 ILCs with the APC-like signature. Along these lines, DECTIN-1 is a receptor for b-
glucans commonly expressed on phagocytes and plays an important role in the antifungal 
response. Recent study has clarified that NK cells recognise b-1,3-glucan in order to 
stimulate the granule convergence and polarisation (Li et al., 2018) and therefore increased 
expression of the gene encoding DECTIN-1 in uterine CD49a+ subsets may affect their 
effector functions, too.  
Analysing the lists of the DEGs through various approaches pointed to previously 
unappreciated enriched pathways and associated genes in distinct subsets of g1 ILCs. While 
the search for genes of interest discussed here is not an exhaustive list, it demonstrates the 
value of the RNA-seq resource generated and offers the opportunity to design novel research 
projects.  
Overall, uterine trNK and ILC1s appeared to be marked by gene signatures that were not only 
characteristic of other ILCs and NK cells, but also all other subsets of immune cells, 
including certain cells of myeloid lineage such as antigen-presenting cells.  
In order to analyse the generated data systematically, inter-tissue (2 uterine vs liver 
comparisons) and intra-tissue (3 uterine comparisons) were performed in this study. 
From the inter-tissue comparisons between the uterus and liver, some of the most commonly 
identified enriched pathways pointed to a potentially essential role of the TGF-ß signalling in 
the function of uterine g1 ILCs. Both trNK and ILC1s in the uterus at mid-gestation were 
found to express a number of upregulated TGF-ß receptor transcripts (Tgbr1, Tgfbr2). They 
even expressed Lrp1, which can bind the TGF-ß in addition to other functions, such as being 
a haemoglobin scavenging receptor and involved in apoptotic cell clearance (Staudt et al., 
2013; Cao et al., 2014). Importantly, one of the most highly upregulated transcripts overall in 
this RNA-seq dataset was the Tgfbi, encoding the TGF-ß induced protein, TGBI (also known 
as BIGH3). TGFBI is a secreted ECM protein. It was originally identified in human 
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adenocarcinoma cell line post-incubation with TGF-ß for 48 hours, thus the name (Skonier et 
al., 1992). It has since been described as a protein secreted in several tissue 
microenvironments, including tumour models, but it is now known that it can be induced by 
factors other than TGF-ß and jointly with other ECM components like fibronectin, as was 
shown for IL-4 in macrophages (Gratchev et al., 2001). For the field of reproductive biology, 
TGF-ß is very important as it had been shown to inhibit trophoblast proliferation and 
invasion, but different studies reported different downstream inhibition pathways (Staun-Ram 
& Shalev, 2005), as well as that the TGF-ß may promote the proliferation of mouse 
trophoblast stem cells (Erlebacher et al., 2004). Other work showed that the TGFBI 
expression was highest at gd 4 in the mouse uterus, coinciding with the most active period of 
trophoblast invasion, but it was found to reduce from gd 7 in the uterus, while increasing in 
the placenta. In a non-pregnant uterus, its expression was at its highest in estrus (Uekita et al., 
2003). It is therefore tempting to speculate that the TGF-ß induces the secretion of TGFBI by 
uterine CD49a+ cells, which then may be regulating some of the essential downstream events 
ensuring a successful placentation. Based on the work of others summarised above, this may 
occur via regulation of the trophoblast invasion or vascular remodelling and should be 
investigated in the future studies. 
The other common theme to uterine-resident subsets compared to liver was enrichment of 
pathways involved in regulation of the migration of various other immune cells. One of these 
was the 6-fold enrichment of neutrophil migration pathway, and Spp1 was one of the 
transcripts specifically upregulated within this pathway, which is supported by previous 
studies (Koh et al., 2007). Recently, it was reported that the protein ostepontin, encoded by 
Spp1, was secreted by the uterine trNKs and influenced fetal growth (Fu et al., 2017).  
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In order to interpret these findings, the alymphoid mouse model Rag2-/-Il2rg-/- was used as 
these animals lack all B cells, T cells, NK cells and other ILCs. In line with the data 
previously described in this chapter, alymphoid mice indeed had a significantly lower 
expression of Spp1 transcript at mid gestation (Fig. 4.13, bottom), presumably due to the lack 
of trNK cells, although there was still a residual level of expression observed. This confirmed 
findings of the aforementioned study at mid-gestation (Fu et al., 2017), although in the non-
pregnant females, there was no significant difference between the immunocompetent (B6) 
and alymphoid (immunocompromised) animals. This is important because there are other 
sources of ostepontin, such as uterine glands (Hempstock et al., 2004) and it is therefore 
essential to not make premature conclusions only on the basis of expression in one cell type. 
The study by Fu and colleagues has shown 2 other growth factors, Ptn (encoding pleiotropin) 
and Ogn (encoding osteoglycin) to be expressed by the uterine trNK cells, but these were not 
validated in the work presented in this dissertation neither through RNA-seq (not shown), nor 
RT-qPCR (Fig. 4.13, top and bottom) and contradicted published findings (Fu et al., 2017). 
Finally, a highly enriched pathway in uterine compared to liver g1 ILCs was the progesterone 
metabolism (Fig. 4.10b). Uterine NK cells do not express various progesterone and oestrogen 
receptors  in humans and mice (King et al., 1996; Henderson et al., 2003), although there is 
evidence that uNK cells are progesterone-dependent cells (Oh & Croy, 2008). To test 
whether progesterone induction would have any effect on the distribution of the g1 ILCs, 
non-pregnant and non-sexually mature animals were injected consecutively for three days 
with progesterone (as explained in the Chapter 2 and previously described in (Tagliani et al., 
2011)). Only first few time-points are presented in Figure 4.14 (3w, 3w with progesterone 
injections and 5w and 8w when the animals reach sexual maturity).  
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Figure 4.13. Gene expression of the growth factors in the uterus. Levels of the mRNA expression of Spp1, 
Ptn and Ogn were analysed by the RT-qPCR in the whole uterus of C57BL/6 (wild-type, B6) and Rag2-/-Il2rg-/- 
females. Top: non-pregnant (virgin) expression of growth factor genes in the whole uterine tissue from 2 
different strains of mice. Bottom: gd 9.5 (one implantation site per sample) expression of growth factor genes in 
the whole uterine tissue from 2 different strains of mice. Pink squares: Rag2-/-Il2rg-/- data points, black dots: WT 
(C57BL/6) data points. Data are representative of 5 independent experiments and 4 technical replicates were 
used in each biological replicate. Two-way ANOVA with multiple comparisons correction was used for 
statistical significance testing. Error bars represent mean±SD.  
 
While there was no effect observed in the liver between the females at 3w of age that were 
progesterone injected and those that were not (Fig. 4.14b), in the uterus there was a marked 
difference. Progesterone injections inverted the ratio of trNKs to cNKs, similarly what was 
observed later at 8w of age when the animals are sexually mature (Fig 4.14a), although the 
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percentages of both trNKs and cNKs remained much lower than at 8w of age due to a still 
high percentage of ILC1s at 3w of age. This data from the neonatal uterus suggested that 
progesterone may have important functions in shaping the landscape of g1 ILCs. Similarly to 
other studies mentioned earlier, none of the progesterone receptors were detected by the 
RNA-seq in this dissertation either, and therefore the progesterone actions would occur 
indirectly, presumably via crosstalk with other cells in the uterus. 
 
Figure 4.14. Progesterone injection alters the distribution of g1 ILCs in the uterus. Individual data points 
showing the percentages of g1 ILCs during reproductive life in the non-pregnant females in uterus and liver 
within their parent population of single, live, CD45+Lin-NK1.1+NKp46+ cells. Three time points were analysed: 
3w, 5w and 8w with an additional time point indicated as 3wp  to mark the progesterone-injected animas. (a) 
Distribution of g1 ILCs in the uterus at 3w, 3w-progesterone-injected, 5w and 8w. (b) Distribution of g1 ILCs in 
the liver at 3w, 3w-progesterone-injected, 5w and 8w. w: week.  
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The intra-tissue comparison of uterine subsets through analysis of DEG lists showed many 
different pathways that suggested that in particular uterine tissue-resident CD49a+ g1 ILCs 
(ILC1s and trNK) are equipped with machinery to adapt quickly and respond to various 
factors originating from the microenvironment. This also suggested the essential function of 
the tight regulation of various subsets’ immunometabolism in order to ensure they carry out 
their roles at the maternal-fetal interface.  
Microsomal glutathione transferases (Mgst1, Mgst2) were here identified within the most 
enriched pathways related to the fatty acid metabolism in the uterine CD49a+ g1 ILCs. These 
are enzymes which commonly detoxify reactive intermediates through glutathione-dependent 
transferase and peroxidase activities. They are usually activated by oxidative stress. In DCs 
fatty acids are essential for the development and function, and inhibition of the fatty-acid 
biosynthesis perturbed development of the DCs and decreased expression of MHC-II and 
costimulatory molecules (Rehman et al., 2013). Similar pathways were shown to be very 
important for reprogramming of the effector T cells and regulating the fate between Tregs 
and T helper cells (Berod et al., 2014). Thus, it would be of interest to investigate how 
alterations of the immunometabolism of g1 ILC through fatty acid modulation might affect 
their fate or function in the uterus. Recent work demonstrated that cytokine-stimulated NK 
cells upregulated SREBP proteins which promote the expression of genes involved in fatty-
acid and cholesterol synthesis; this was essential for the metabolic reprogramming of NK 
cells (Gardiner & Finlay, 2017; Assmann et al., 2017). Although SREBP proteins may not 
have same functions in the uterine NK cells, other genes that might be uterine-specific were 
identified in this dissertation and deserve further analysis. Slc16a13 encodes an orphan 
monocarboxylate transporter, MCT13, with mainly unknown functions (Halestrap, 2013). It 
is a proton-linked transporter of monocarboxylates such as lactate and pyruvate, transporting 
them out of the cell. Glycolysis is important for pbNK cell functions (Gardiner & Finlay, 
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2017) and the data generated in this study suggested that it may be equally essential for the 
uterine tissue-resident NK cells. Although lactate can be used up in many ways, it might be 
the case that uterine trNK and/or ILC1s produce lactate as a signal for the SA remodelling, in 
a manner analogous to angiogenesis, while inducing immunosuppression through acidosis in 
the tumour microenvironment (Romero-Garcia et al., 2016). It was shown that Warburg-like 
glycolysis is important for decidual development (Zuo et al., 2015). Tissue resident NK cells 
and ILC1s may provide lactate for the development of undifferentiated stromal cells in 
addition to other lactate soures which function through other MCTs (MCT4). It remains to be 
determined whether it is trNKs or ILC1s that are the main mediators of it, if such mechanism 
occurs at all. UpSet analysis pointed to Slc16a1, encoding MCT1, one of well characterized 
monocarboxylate transporters (lactate exporter) to be unique to trNKs (Velásquez et al., 
2016). This does not exclude that both trNKs and ILC1s require metabolic fine-tuning for 
their functions, but via different transporters. Similarly, purinergic signalling may be of 
interest for the future studies regarding uterine g1 ILCs, because it was shown that in liver for 
example, nucleotides (i.e., ATP) can inhibit NK cell cytotoxicity. Scavenging of extracellular 
ATP increased NK activity and stimulated liver regeneration (Graubardt et al., 2013). Most 
recently, one of the genes identified in the RNA-seq here to be upregulated in uterine trNKs, 
P2rx7, was shown to be essential for the maintenance of tissue-resident memory T cells and 
most importantly, to regulate the tissue damage (Stark et al., 2018). This could prove to be 
important in the uterus, a tissue that regularly undergoes tissue remodelling. 
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5. The origin, plasticity and memory-like properties of 
uterine group 1 ILCs 
5.1. Introduction 
As described in much greater detail in Chapter 1, NK cells can be identified in a range of 
lymphoid but also non-lymphoid organs, including uterus. However, how NK cells develop 
in each one of these specific tissue niches is less clear and one of the longest standing 
questions in the reproductive immunology is: do uterine NK cells originate from in situ 
present precursors, or do they migrate there from blood? 
Although human NKPs have been elusive for a long time, they have recently been identified 
for the first time in a range of tissues, including fetal liver and adult tonsil (Renoux et al., 
2015). In general, current knowledge on the NK development in humans (with the exception 
of Renoux and colleagues) comes mainly from the studies on SLTs such as tonsils. In 
Chapter 1 it was also discussed in great detail how ILCs exhibit great plasticity and that 
almost all possible conversions can take place. One example that is highly relevant to the 
work in this chapter came from a finding that cells overlapping with NCR+ILC3s and at the 
time called ‘stage 3 immature NK cells’ were identified in human PB and uterus, while 
expressing Rorc and producing IL-22. However, when they were cultured in vitro, they could 
give rise to mature NK cells (Male et al., 2010). Another study at a similar time discovered 
CD34+ progenitors in the decidua that gave rise to functional NK cells, and although majority 
of the cells that developed from these progenitors were CD56brightCD16-, most of them did 
not express any decidual NK-specific KIRs or any other surface markers (Vacca et al., 2011). 
Before these, it was found that the culture of purified CD16+ pbNK cells with TGF-b could 
give rise to CD16-CD9+ decidual NK-like cells, suggesting plasticity dependent on the local 
cues in the microenvironment (Keskin et al., 2007). This makes the study of ILC1 and cNK 
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differentiation much more complex, especially with a tissue that is not easily sampled, such 
as the uterus. The aim of Chapter 5 was to attempt to answer a question of the g1 ILC 
development, plasticity and whether they can adapt to such a dynamic microenvironment 
through developing memory. 
 
5.2. Results 
5.2.1 Identification of uterine NK progenitors in human and mouse uterus 
Uterine g1 ILCs are abundant in human and murine uterus and it is still unknown whether 
these cells arise from peripheral NKPs found in the PB or in situ progenitors. In this study, 
using the same panel of markers for the identification of NKPs in adult tonsil (Renoux et al., 
2015), NKPs were found for the first time in human decidua (Fig. 5.1). They were identified 
as Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127- cells.  
 
Figure 5.1. NKP exists in freshly isolated human decidua from the first trimester. Freshly isolated decidual 
leukocytes were immediately analysed by flow cytometry ex vivo. Gating strategy is presented. Final 
CD10+CD127- gate represents the NKP population. Lineage channel included CD3, CD4, CD11b, CD11c, CD14, 
CD15, CD19, CD33, CD56, CD66b, CD235a. Data are representative of four independent experiments performed 
on samples of different gestational ages (one sample per independent experiment, n=4).  
 
Frequency of NKPs ranged from 0.02-0.05% of CD34+ cells in the decidua, similar to the 
frequency observed in the tonsil (Renoux et al., 2015). The lowest NKP frequency was 
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observed in the 10-week old decidual sample, while the highest frequency was detected in 8-
week old decidua (data not shown). Fresh and frozen cells were compared and frozen 
samples appeared to have preserved the NKP phenotype and could be used in future 
experiments (data not shown). Once this progenitor was identified, the next step was to 
perform the index sorting and investigate whether these are indeed NK progenitors and 
whether they can exclusively give rise to uterine NK cells. However, due to the lack of 
clinical sample supply, it was not possible to perform these experiments. 
Preliminary experiments performed in the group had pointed to the existence of the NKPs in 
the uterus of virgin mice, phenotypically identical to a previously defined mouse BM NKP 
(Rosmaraki et al., 2001) as Lin-CD45+CD11b-CD122+NKG2D-DX5-NK1.1- cell. They had 
also been found as much more frequent in the uterus than in the BM (unpublished 
observations by another group member). Thus, the aim was to design the experiments in 
which the developmental potential of these uterine NKPs would be compared to BM NKPs in 
vivo, by performing an adoptive transfer of NKPs into. Briefly (more details in Chapter 2), 
NKPs were isolated and FACS-sorted from C57BL/6 WT animals (CD45.2, donor) and 
injected via the tail vain in a PBS suspension into the alymphoid Rag2-/-Il2rg-/- females 
(CD45.1, recipient), lacking all B cells, T cells, NK cells and ILCs, as they are double 
knockouts for the Rag2 gene and common cytokine receptor chain gene (Mazurier et al., 
1999). Originally, this experiment had been performed another group member with the BM 
NKPs in order to optimise the conditions. The readout in these optimising experiments was 
primarily the spleen as one would expect to see the donor cells present in the spleen. 
However, no NK cell engraftment had been observed, even in the spleen which should serve 
as a proxy for successful reconstitution, and therefore, this set of experiments had to be 
repeated (no data of the previous group member shown). These experiments were then 
repeated for this study and the number of injected cells was titrated. PBS-only, 300, 600 and 
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900 NKPs were injected into sexually mature (8-12w) Rag2-/-Il2rg-/- females, but the NK cell 
engraftment still had a very low success rate in all the tissues assessed, including spleen (no 
data shown), at both 14 and 21 days post-transfer.  
However, there were advances in the NK development research since the original paper 
describing NKPs used in previous experiments described here (Rosmaraki et al., 2001). In 
particular, the NKP stage has been refined further into an NK-committed progenitor (pre-
NKP), a developmental intermediate between the CLP and the next stage, termed refined 
NKP (rNKP) (Fathman et al., 2011; Carotta et al., 2011). Therefore, it was decided to re-
assess previous work performed and to examine whether these other intermediates were 
present in the mouse uterus. The same panel as used in the two aforementioned studies from 
2011 was applied, and it was shown that indeed some of these progenitors exist in the mouse 
uterus (Fig. 5.2a). Results for the BM from the original studies were confirmed, as all three 
subsets: CLP (Lin-CD27+CD244+c-kit-CD127+Flt3+CD122-), pre-NKP (Lin-CD27+CD244+c-
kit-CD127+Flt3-CD122-) and rNKP (Lin-CD27+CD244+c-kit-CD127+Flt3-CD122+) were 
present in the BM. Uterus however, contained only the rNKP, rather than the first committed 
NK progenitor, pre-NKP (Fig 5.2a). After this was established, the adoptive transfer 
experiments were repeated, again using BM as source of progenitors in order to optimise the 
experiment prior to injecting the uterine progenitors into Rag2-/-Il2rg-/- model system. 
C57BL/6 (WT) mouse was used as a control to confirm the presence of CD45.2 cells in the 
spleen as WT is a CD45.2+ congenic which allows the identification of cells injected into 
CD45.1+ Rag2-/-Il2rg-/- animal (Fig. 5.2b, top row). As expected, in PBS-only injected 
animals (which were used here as another control) there were no CD45.2+ donor cells 
identified in the uterus (Fig 5.2b, second row). Three other progenitor subsets were injected 
into Rag2-/-Il2rg-/- animals: 10,000 lineage negative cells (CD11b-CD19-CD3-CD5-B220-
Ter119-Gr-1-), 1,500 CLPs or 1,000 rNKPs from the BM injected per animal. Samples were 
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analysed 14 days later. Lineage-negative-injected animals had the highest frequency of 
CD45.2+ cells that reached the uterus during this period and gave rise to cells of other 
lineages, as there were CD3+ and CD19+ cells present in the cell suspensions (Fig 5.2b, third 
row). CLPs injection resulted in a similar frequency of CD45.2+ cells, but there were no 
CD3+ cells detected (Fig. 5.2b fourth row).  
 
Finally, rNKP from the BM, which was also shown to be the only NKP in the uterus (Fig. 
5.2a) gave rise to exclusively CD3-CD19- cells and subsequently the highest frequency of 
Eomes+NK1.1+ cells compared to other investigated samples. However, there was a notable 
lack of consistency between replicates in each of the independent experiments, since some 
Rag2-/-Il2rg-/- animals had much lower percentages of CD45.2+ donor cells in their uteri, 
suggesting that the transferred cells were not reaching this organ. Finally, experiments using 
uterine rNKPs were not performed because it was not in line the Home Office Project 
Licence to use such large numbers of animals. Just one independent experiment with three 
biological replicates would have required the use of over 60 animals and given the lack of 
consistency with progenitors from a much more progenitor-rich organ (BM), this was not 
further pursued. In a manner similar to what was described about the human NKP work, 
index sorting and NK development from this newly identified uterine progenitor has not been 
investigated downstream and this work remains to be done.  
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Figure 5.2. rNKP exists in the non-pregnant mouse uterus. (a) Freshly isolated cells from the bone marrow 
were immediately stained and analysed ex vivo for the presence of the NKPs. The gating strategy is presented. 
CLPs, pre-NKPs and rNKPs are indicated in the final plot in the BM and uterus of a non-pregnant female. Data 
is representative of two independent experiments and animals were pooled for each sample in order to obtain 
enough tissue. (b) Adoptive transfer of the cells isolated from the C57BL/6 (B6/CD45.2/donor) and injected 
intravenously into the tail vain of the Rag2-/-Il2rg-/- (CD45.2/recipient). One representative row per each 
condition (number and type of injected progenitors) is shown out of three independent experiments and three 
replicates per experiments. Top row represents C57BL/6 control animal (spleen), while the remaining rows 
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represent Rag2-/-Il2rg-/- injected with PBS only, 10,000 lineage negative cells/animal, 1,500 CLPs/animal or 
1,000 rNKPs/animal. Lineage channel included CD11b, CD19, CD3, CD5, B220, Ter119 and Gr-1. All gates 
were set using appropriate FMO and isotype controls. 
 
5.2.2 Plasticity of uterine group 1 ILCs  
As explained in more detail in Chapter 1 (section 1.2.2.10), it is impossible to investigate the 
development of ILCs, and in particular the development of g1 ILCs, without accounting for a 
considerable level of plasticity between the subsets. Cells largely overlapping with 
NCR+ILC3s have been identified in human PB and uterine mucosa and have been found to 
express Rorc while also giving rise to mature uNK cells (Male et al., 2010). Due to this 
overlap between ILC3s, ILC1s and various stages of NK cell development in both human and 
mice, the next aim was to investigate whether similar plasticity occurs in the mouse uterus. 
To examine the plasticity of ILC3s and g1 ILCs and dissect further the origin of ILC1 cells in 
the murine uterus, a RORγt-Cre fate-mapping mouse model was utilised. Transgenic mice 
expressing Cre-recombinase under the control of Rorc gene were bred with Rosa26R-EYFP 
reporter mice to generate RORγt-Cre/R26R-EYFP females. In R26R-EYFP animals, there is 
a LoxP-flanked stop cassette located upstream of EYFP. Therefore, when Rorc gene is 
expressed, it activates the Cre-recombinase which excises the stop cassette and subsequently 
activates the expression of YFP. Readout in these animals is the YFP expression when cells 
have been expressing Rorc. Every cell that has expressed RORγt at some point is traceable as 
YFP+, even if the surface phenotype has changed and they do not express RORγt anymore 
and is commonly referred to as the ex-ILC3 if it stopped expressing the protein. Analysis of 
the uterus of these animals demonstrated that ex-ILC3s that were described in other tissues 
(Chapter 2, section 1.2.2.10) exist in the mouse uterus, too. All of the g1 ILCs expressed 
some YFP, with trNKs displaying the highest intensity of YFP, ILC1s lower and cNKs the 
lowest although still being YFP+ (Fig. 5.3). 
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Figure 5.3. Fate-mapping of g1 ILCs. The uterus of RORgt-Cre/R26R-EYFP animals was analysed for the 
expression of YFP in each individual subset. All gates were set using appropriate FMO and isotype controls. 
 
Rorc-expressing cells identified in a previous study in the human uterine mucosa which could 
also give rise to mature uNK cells were shown to produce IL-22, as described by Male and 
colleagues and referenced earlier. Therefore, it was investigated whether any of the g1 ILCs 
in the uterus could also produce IL-22.  
trNK and cNK cells from the uterus at mid-gestation, as well as cNK from the spleen as a 
control, were sorted and incubated with either (1) PMA/I and protein transport inhibitors or 
(2) the control medium containing protein transport inhibitors only, but not PMA/I for 
stimulation. This experiment showed that trNK cells from the uterus at mid-gestation can also 
produce IL-22, regardless of stimulation (Fig. 5.4a). Almost 80% of trNK cells produced IL-
22 when stimulated with PMA/I, but even without stimulation it was 60-70% of cells. The 
IL-22 MFI levels were also significantly elevated in the trNK cells compared to other g1 
ILCs in the uterus and compared to the splenic cNK cells which could not produce any IL-22 
(Fig. 5.4b-c). 
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Figure 5.4. Uterine CD49a+Eomes+ trNK cells produce IL-22 at mid-gestation. Uterine trNKs and cNKs 
from pregnant females at gd 9.5 were freshly isolated, FACS-sorted and then stimulated with PMA/Ionomycin 
Cocktail Mix containing protein transport inhibitors or just protein transport inhibitors. (a) Control wells were 
incubated with the medium that contained only the protein transport inhibitors. (b) Quantification of the data 
presented in (a), representing the percentage of IL-22-producing cells within each g1 ILC subset. (c) MFI levels 
of IL-22 expression measured by flow cytometry on g1 ILCs in the uterus and control samples from the spleen. 
All gates were set using appropriate FMO and isotype controls. Statistical significance was evaluated by two-
way ANOVA with multiple comparisons correction. Tables under panels (b) and (c) summarise p-values for 
comparisons discussed in text. Error bars represent mean ± SD. MFI: mean fluorescence intensity 
 
Recent study has identified plasticity between g1 ILC subsets in tumour microenvironment 
(Gao et al., 2017). This group has shown that in a tumour microenvironment, effector NK 
cells (phenotypically corresponding to cNK cells) can become non-cytotoxic ILC1s and that 
this happens via an intermediate that they termed ‘intermediate ILC1s’ but phenotypically 
they corresponded to uterine trNKs described here. Most importantly, this conversion was 
driven by the TGF-b. The model proposed by this study is summarised in Fig 5.5a. Since 
TGF-b signalling pathways were among the most highly enriched pathways in the RNA-seq 
dataset presented in Chapters 3 and 4, it was of interest for this study whether TGF-b would 
similarly influence the plasticity in the uterus. Firstly, an experiment from Gao and 
colleagues was recapitulated, where cNK cells that were FACS-sorted from both spleen (as a 
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control) and non-pregnant uterus were cultured for five days. They were cultured either with 
TGF-b and IL-15 or IL-15 alone. By performing this experiment it was observed that the 
uterine cNK fully converted into trNK cells, while with IL-15 there was minor population of 
CD49a and Eomes double negative population (Fig. 5.5b).  
 
Figure 5.5 cNK cells from the uterus and spleen may display a tissue-specific plasticity. (a) Summary of the 
model proposed by (Gao et al., 2017) (b) Splenic and uterine cNK cells from non-pregnant females were FACS-
sorted and cultured in either TGF-b with IL-15 (top row) or just IL-15 (bottom row). (c) C57BL/6 splenic cNK 
cells were FACS-sorted and adoptively transferred into Rag2-/-Il2rg-/- females. 14 days post-transfer, uterus, 
spleen and liver were analysed by flow cytometry. Each bottom row plot derives from a corresponding top row 
plot. All gates were set using appropriate FMO and isotype controls.  
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Secondly, splenic cNK cells from B6 WT animals were sorted and injected into alymphoid 
Rag2-/-Il2rg-/- females. 14 days post-transfer, uterus, liver and spleen were analysed for the 
presence of g1 ILCs. The highest frequency of ILC1s was observed in the uterus, compared 
to liver and especially spleen (Fig. 5.5c). However, it is important to observe that the lowest 
percentage and number (not shown here) of cNK cells reached the uterus measured by the 
percentage of NK1.1+ cells, while liver and spleen appeared to have fully been reconstituted 
with transferred NK cells.  
 
5.2.3 Second gestation is marked by the expansion of memory-like ILC1s 
Since it has proven infeasible to attempt to dissect the development and plasticity of g1 ILCs 
in both mouse and human samples any further for the reasons described in the previous two 
sections of this chapter, another approach was undertaken in order to understand how g1 
ILCs persist in the uterine microenvironment during and beyond first gestation which has 
been the subject of the study presented in this dissertation so far.  
As discussed in Chapter 4, although Cd19 gene came up as one of the top genes within PC2 
(Fig. 4.5) and appeared upregulated in liver ILC1s compared to uterine ILC1s, on the protein 
level this was not the case. The CD19 protein was expressed on uterine ILC1s, despite a very 
low level of gene expression detected through the RNA-seq. As further explained in the 
analysis of various comparisons of DEG lists in Chapter 4, one of the genes that came up as 
specifically upregulated in liver ILC1s compared to uterine ILC1s and trNKs was Cxcr6 (Fig. 
4.10b and Fig. 5.6a). Since CXCR6 expression on the cell surface is known to mark memory 
NK and T cells in mice (Paust et al., 2010; Tse et al., 2014), levels of the protein were 
assessed on the surface of g1 ILCs. As shown in Figure 5.6b, uterine ILC1s expressed 
CXCR6 at mid-gestation at the levels comparable to liver ILC1s. cNKs did not express any 
CXCR6 in either of the organs, while uterine trNKs had low-to-intermediate levels of 
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CXCR6 expressed on their surface. These results confirmed previous data on liver ILC1s 
(Paust et al., 2010) and indicated that some subsets of uterine g1 ILC might be able to expand 
in response to gestation-specific signals in following pregnancies if CXCR6 is indeed a 
marker of memory-like, adaptive NK cells.  
 
Figure 5.6. Uterine CD49a+Eomes- ILC1s express CXCR6. (a) Individual gene expression of Cxcr6 gene in 
uterine and liver g1 ILCs. Scale represents log2(FPKM+1) normalised reads. (b) Protein expression measured 
by flow cytometry on g1 ILCs in the liver and the uterus. All gates were set using appropriate FMO and isotype 
controls. FPKM: fragments per kilobase of exon model per million reads mapped.  
 
Thus, the distribution of g1 ILCs was compared between first and second gestation. Due to 
the feasibility challenges with setting up timed-pregnancies and ensuring that the data for first 
and second gestation g1 ILCs distribution was obtained in the same independent experiments, 
only two time points during gestation were investigated: gd 5.5 and gd 9.5. There was a 
marked increase in CD49a+Eomes- ILC1s in second gestation (Fig 5.7a). Although the 
percentage of ILC1s in the second gestation already increased by gd 5.5, it was highly 
significant at gd 9.5 (Fig 5.7b).  
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Figure 5.7. Uterine CD49a+Eomes- ILC1s expand in second gestation and express higher levels of CXCR6. 
(a) Representative plots showing the distribution of g1 ILCs in the uterus during the first gestation (top row) and 
second gestation (bottom row) at gd 5.5 and gd 9.5. Data is representative of two or three independent samples 
and three independent experiments. All gates were set using appropriate FMO and isotype controls. (b) 
Percentages of g1 ILC subsets in the first and second gestation at gd 5.5 and gd 9.5 as presented in (a). 
Statistical significance was determined by two-way ANOVA with multiple comparisons correction. Error bars 
represent mean ± SD. (c) MFI of CXCR6 protein on ILC1s in first and second gestation at gd 5.5 and gd 9.5 
Statistical significance was evaluated by two-way ANOVA with multiple comparisons correction. Error bars 
represent mean ± SD. MFI: mean fluorescence intensity 
 
There were no significant changes observed in percentages of trNKs and cNKs between first 
and second gestation (Fig. 5.7b). Not only did the ILC1 percentages increase in second 
gestation, but there was also a significant increase of CXCR6 expression levels on the surface 
of these expanded ILC1s in the second gestation at gd 9.5 (Fig. 5.7c). The trend that was 
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observed with increased percentages of ILC1s in the second gestation was mirrored by the 
investigation of absolute numbers. Only significant difference was in the absolute number of 
ILC1s in second gestation at 9.5 when they appeared highly increased in numbers (Fig. 5.8a). 
trNKs and cNKs did not exhibit any differences in numbers, similar to the percentage data in 
Figure 5.7b (Fig. 5.8b-c). 
 
Figure 5.8. Uterine CD49a+Eomes- ILC1s are increased in absolute numbers in second gestation. The plots 
are showing absolute numbers of the distinct subsets of uterine g1 ILCs during the first gestation and second 
gestation at gd 5.5 and gd 9.5, for (a) ILC1s, (b) trNKs and (c) cNKs. Data is representative of two or three 
independent samples and three independent experiments. Statistical significance was evaluated by two-way 
ANOVA with multiple comparisons correction. Error bars represent mean ± SD. 
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Finally, it was of interest to investigate whether ligands for receptors detected previously in 
this chapter exist in the uterus. For this, the whole uterine tissue was prepared, total RNA 
isolated and then analysed for the expression of genes of interest by RT-qPCR (as explained 
in Chapter 2) 
Although there was a limited number of samples available for this experiment, it appeared 
that Tgfb1 transcript was already upregulated in first gestation at gd 9.5 compared to gd 5.5 
(Fig. 5.9a) However, in the second gestation, its levels at gd 5.5 increased compared to the 
first gestation at the same time, but this increase did not occur at gd 9.5.  
 
Figure 5.9. Tgfb1 and Cxcl16 transcripts appeared to increase at gd 5.5 in second gestation. Levels of the 
mRNA encoding genes of interest through first and second gestation at gd 5.5 and gd 9.5, analysed by the RT-
qPCR in the whole uterus of C57BL/6 (wild-type, B6) females. (a) mRNA expression of Tgfb1 during first and 
second gestation at two different time points. (b) mRNA expression of Cxcl16 during first and second gestation 
at two different time points. Data are representative of two to three biological replicates, three independent 
experiments and 4 technical replicates were used for each biological replicate. 
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On the contrary, Cxcl16, encoding CXCL16, a ligand for CXCR6 was expressed at a very 
low level at all the time points investigated, except for gd 5.5 during second gestation when 
the expression appeared to increase (Fig. 5.9b). It was impossible to perform any statistical 
testing on this data due to a low number of samples and high level of variability particularly 
for Cxcl16 expression.  
 
5.3. Summary 
Despite recent advances, the molecular mechanism of g1 ILC development in the uterus is 
unknown. The main purpose of this chapter was to understand the origins of the three subsets 
of uterine g1 ILCs and attempt to delineate the lineage relationships between them. 
In this chapter, it was shown for the first time that NKPs exist in the first trimester human 
decidua. Frequency of NKPs within CD34+ was found to be between 0.02% - 0.05%, which 
is in line with previously published data (Renoux et al., 2015). However, the NKP frequency 
appeared to decrease as the gestational age increased. Due to a limited number of samples 
available (each one of a different gestational age), a question of whether this frequency 
change was donor-specific or gestational age-specific remains to be answered in future 
studies. In addition to the human pregnant uterus, the NKP was identified in the mouse non-
pregnant uterus here using a refined understanding of the NK cell development (Fathman et 
al., 2011; Carotta et al., 2011). This was an improvement compared to the previous attempts 
in the group using an older phenotypical definition of the NKP (Rosmaraki et al., 2001), 
because for the first time it was possible to find BM-derived cells of donor origin (CD45.2+ 
cells) in the injected Rag2-/-Il2rg-/- females. Interestingly, uterus only contained rNKPs, rather 
than the upstream pre-NKPs and CLPs that exist in the BM. This suggested that rather than 
the earliest committed NK progenitor (pre-NKP), it is perhaps more likely pre-NKPs home to 
the uterus where they finish their tissue-specific developmental pathways. For both human 
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and mouse experiments involving NKPs, there were tremendous challenges such as the lack 
of clinical samples to continue work on the human NKP, as well as an unjustifiable number 
of mice required to obtain a minimum number of progenitors to inject a group of animals that 
would yield statistically significant data. As stated in the results (section 5.2.1), there was a 
lack of consistency particularly in the uterine NK engraftment, suggesting that specifically 
injected rNKPs might not be reaching the uterus through a tail vein IV injection, as there was 
a much higher level of reconstitution consistency when CLPs and lineage-negative cells were 
injected into alymphoid mice. For these reasons, no further experiments were undertaken.  
However, now that the existence of the NKP has been established, future work should 
involve experiments such as index sorting and developmental assays in order to determine 
whether these are fully NK-committed progenitors as was described before (Renoux et al., 
2015) as well as how functional they are. Endometrium should also be examined for the 
presence of NKPs as soon as the tissue sample collections continue in order to compare the 
findings to the data presented here describing NKP in the non-pregnant mouse uterus. 
In context of the development and the fact that ILCs as a family of cells exhibit a high level 
of plasticity, fate-mapping experiments were performed that confirmed that there might be 
plasticity between ‘ex-ILC3s’ and g1 ILCs in the uterus, since most of the g1 ILCs, but 
particular trNKs, expressed RORgt during their development. In line with these findings, it 
was also shown that trNKs are capable of producing IL-22, similarly to what was 
demonstrated in earlier work on ‘stage 3 immature NK cells’ in the uterine mucosa (Male et 
al., 2010).  
TGF-b signalling was another one of the highlights of this chapter as TGF-b-related 
pathways came up in the RNA-seq analysis in the Chapter 4 and previous work described the 
importance of TGF-b in regulating the plasticity of g1 ILCs in other tissues (Gao et al., 
2017). In vitro culturing and adoptive transfer experiments here showed that uterine cNK 
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cells have the capacity to convert into trNK cells (in vitro) and that splenic cNK cells can 
contribute to reconstituting the ILC1 compartment in alymphoid mice (in vivo). However, 
similar to a manner observed in adoptive transfer experiments with the NKPs, cNK injections 
did not result in a detection of many donor cells in the recipients. Different routes of delivery 
of cells to be injected should be considered for the future experiments. In addition, there was 
a discrepancy between the findings of Gao and colleagues and in vitro culture of splenic cNK 
cells shown here in Figure 5.5b. In the study here, no conversion of splenic cNKs into ILC1s 
during a 5-day culture was observed, unlike in the paper from Gao and colleagues. It is 
unclear why this is, since the concentrations of the TGF-b and IL-15 used in the experiment 
here were identical to the one used in the aforementioned study. Gao and colleagues only 
showed the expression of ILC1-specific markers, rather than the representative plots of all 
cultured g1 ILCs harvested after a 5-day culture, as shown here in Figure 5.5b. It is still 
important to titrate the TGF-b concentration used in the future for uterine cNKs. It was 
technically not feasible to do within the scope of this study as the number of animals required 
was too high. In addition, levels of the TGF-b throughout gestation as well as before and 
after should be assessed, similarly to what was done in Figure 5.9a on a limited number of 
samples. 
Finally, both liver and uterine ILC1s expressed high levels of memory-associated marker 
CXCR6 (Paust et al., 2010; Tse et al., 2014). This guided the study further with the aim to 
assess the distribution of g1 ILCs in second gestation in mouse. There was a significant 
expansion of ILC1s which were CXCR6+ in second gestation. None of the other subsets 
expanded. This suggested the idea of pregnancy ‘memory’. Ligand for CXCR6, CXCL16 is 
expressed by trophoblast cells (Huang et al., 2008) so this may be one of the drivers of the 
expansion. Very importantly, cells described as ‘pregnancy-trained decidual NK cells’ have 
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been described recently in humans (Gamliel et al., 2018), posing the question of the memory 
of pregnancy as an important one to address in future studies.    
One elegant way to address the development and plasticity of g1 ILCs in the uterus in the 
future studies may be the Ncr1iCreTbx21fl/fl  mouse model (in further text: T-bet cKO). This 
model was described recently (Cuff & Male, 2017). Since Cre-recombinase is induced in all 
Ncr1 (NKp46)-expressing cells, the original idea was to generate a mouse model in which T-
bet, as a transcription factor important for the development of ILC1s would be knocked out 
of all NKp46+ cells, generating an ILC1-specific conditional KO, while retaining cNKs. The 
study that reported this originally found that this was not an ILC1-specific KO model as there 
was an equivalent reduction in both cNKs and ILC1s in the liver, which was of interest to this 
group (Cuff & Male, 2017). However, a preliminary experiment was carried out in 
collaboration with Dr Victoria Male at the UCL to investigate the uterus of T-bet cKO 
females. Animals were collected from the UCL animal facility and the experiments 
downstream performed as described in all previous experiments carried out at the University 
of Cambridge. When g1 ILC distribution was assessed, liver findings were confirmed to be 
the same as in the original study, with the same ratio of ILC1s:cNK, showing that both 
subsets were similarly affected by the deletion of T-bet (Fig. 5.10a, top row). Slight 
discrepancy was observed in the spleen (Fig. 5.10a, middle row), where the control animal 
(Ncr1WTTbx21fl/fl) appeared to have an abundance of ILC1s, but on the contrary the deletion in 
the T-bet cKO appeared to have been successful, unlike in the original study by Cuff and 
Male referenced earlier. Finally, the virgin uterus at 8-weeks of age was lacking both ILC1s 
and cNKs, suggesting that this might be of interest for the studies addressing uterine g1 ILC 
lineage relationships in the future (Fig. 5.10a, bottom row), as a trNK-only mouse model. It 
was however surprising to observe a much higher percentage of ILC1s in control animals 
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compared to what was observed previously (Chapter 3), but this might be due to the 
differences in animal facilities.  
 
Figure 5.10. T-bet cKO animals have only uterine trNKs and display an increase in fetal weight in first 
gestation. (a) Representative plots showing distribution of g1 ILCs in liver (top row), spleen (middle row) and 
uterus (bottom row) of 8w old non-pregnant females. (b) Quantification of the data shown in (a), where each 
subset displayed as a percentage of within is parent population of g1 ILCs (all NK1.1% cells), (similar to the 
Fig. 3.2). (c) Quantification of the data shown in (a), where each subset displayed as an absolute number of cells 
within the uterus. (d) Fetal and placental weights of conceptuses from T-bet cKO females mated with WT 
males. Error bars represent mean ± SD.  In order to evaluate the statistical significance of the data, two-tailed, 
unpaired t test was used. Only the significant values are displayed on the plot. Data are representative of 6-10 
litters per cross. Means  g: gram, gd: gestational day, w: week, T-bet cKO: Ncr1iCreTbx21fl/fl  genotype, control: : 
Ncr1WTTbx21fl/fl. 
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The data is preliminary and the quantification can be observed in Fig. 5.10b and c, where it is 
obvious that Ncr1iCreTbx21fl/fl  animals have a much higher frequency and absolute numbers 
of trNK cells, respectively. In addition, measurements of the fetal and placental weights in 
crosses with the T-bet cKO female with the WT male showed that the fetal weight of the 
pups from these crosses is significantly higher compared to the control animals, while there 
was no significant differences in their placental weights (Fig 5.10c). However, most 
interesting experiments utilising these animals would involve investigation of second 
pregnancies as these animals lack ILC1s which were shown to expand specifically in second 
gestation earlier in this chapter. 
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6. Final conclusions and future directions 
In conclusion, the data provided in this thesis has shown evidence required for a further 
understanding of the functions and development of the uterine g1 ILCs.   
The data has been provided to demonstrate a dynamic distribution of the g1 ILCs in the 
uterine microenvironment during the key stages of the mouse reproductive life. Main 
observations from this set of experiments were that (1) ILC1 cells are the most abundant g1 
ILCs before puberty, (2) trNK cells are the most abundant g1 ILCs early in gestation and (3) 
cNK cells become dominant later in gestation. These observations supported the ongoing 
hypothesis in the group that each of these uterine subsets developed distinct uterine-specific 
functions required in homeostasis during non-pregnant and pregnant state.   
By using the RNA-seq, core gene signatures of the g1 ILCs in the uterus at mid-gestation 
were identified and together with the aforementioned data on the distribution of g1 ILCs, this 
dataset represents a valuable resource for future studies. Main focus in this thesis was to 
identify signatures that set uterine CD49a+ tissue-resident ILC1 and trNK cells apart from 
CD49a- cNK cells, as well as to determine their tissue-specific signatures in comparison to 
the phenotypically similar cells in the liver. The lists of detected genes and enriched 
pathways are far too long to be summarised here and have in part been summarised in 
Chapter 4. Therefore, only some of the findings will be discussed here in order to justify the 
final conclusions. 
For both uterine CD49a+ subsets, proteolysis-related terms represented a common theme 
within the enriched pathways. This suggested a protein processing activity by these cells 
during the extensive tissue remodelling taking place at mid-gestation in ILC1s and trNKs. 
Strikingly, genes that are not commonly associated with NKs and ILC1s were upregulated in 
CD49a+ cells. Some of these included Adgre1, Cd86 and Mertk, all much more commonly 
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associated with APCs, and all of these were validated on the protein level on the surface of 
trNKs and/or ILC1 at mid-gestation.  
According to this and DEG data, CD49a+Eomes+ trNK cells appear to be the hub of the 
uterine g1 ILCs, as they were equipped with the transcriptome that may enable them to 
interact with the majority of other cells present at the maternal-fetal interface, including 
trophoblast cells, other leukocytes, secreted growth factors, smooth muscle cells, blood 
vessels and even other g1 ILCs. It will be essential in the future studies to address where 
these cells originate from. From the fate-mapping experiments shown in Chapter 5, they 
resembled ex-ILC3 cells, through Rorc expression at some point during development. They 
were also capable of producing IL-22, regardless of stimulation. This puts more emphasis on 
utilising mouse as a model for reproductive immunology research, since these findings were 
in line with what had previously been described in the human uterine mucosa (Male et al., 
2010).  
 
ILC1s, on the other hand, were only highly abundant before puberty and then again in the 
second gestation. During all the other stages, they were present at very low levels. It was still 
possible to gain an insight into what their functions may be through the RNA-sequencing at 
mid-gestation by investigating DEGs identified between ILC1s and trNKs. ILC1s may 
interact with the adipocytes, as they expressed the receptor for the adipocyte-derived factor 
apelin, which is highly expressed in the mouse uterus. One of the essential events during 
gestation is the SA remodelling and the appropriate regulation of blood pressure. ILC1s also 
expressed gene encoding angiotensin I-converting enzyme very highly and uniquely 
compared to all other subsets. Thus, they might be the essential regulators of this process, 
despite being present in very low percentages and numbers throughout all other stages. This 
however, depends on the rate of mRNA translation into a protein in a particular niche and 
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remains to be investigated further. Not only did the ILC1s (and trNKs) display APC-like gene 
signature, but a minor population of ILC1s was found to express CD19 and MHC-II, 
resembling not only APCs in general, but B cells in particular. Such information on ILC1s, 
however, fits the previous data shown in Chapter 4, such as the identification of the antigen-
processing and presentation via MHC-II pathway as another highly upregulated pathway in 
the uterine CD49a+ cells. Therefore, the MHC-II expression might not necessarily indicate 
that there is an active antigen presentation to the T cells by ILCs, as was shown for ILC3s 
(Burg et al., 2014). It may simply reflect the fact that there is an ongoing protein processing 
following a potential engulfment of cells, since they expressed a range of genes associated 
with apoptotic cell clearance in a macrophage-like manner. Interestingly, high levels of 
CD19+CD5+ cells were shown to be indicators of preeclampsia in humans (Jensen et al., 
2012). These cells were not extensively phenotyped so they might represent a minor 
population similar to CD19+ g1 ILCs described in this thesis, rather than the B cells as they 
were termed in that report. A subset of NKp46+ NK cells resembling B cells which were 
CD19+ and produced immunoglobulins (termed NKB cells) was described in one report, 
although their existence was later disputed (Wang et al., 2016; Kerdiles et al., 2017) and 
therefore this is currently a controversial subject. However, more recently, NKB cells 
appeared in the literature again and were shown to be induced in the SIV and HIV infections 
(Manickam et al., 2018). Thus, this minor subset of CD19+MHC-II+ ILC1s should not be 
dismissed and future studies should address what the biological functions of these cells are. 
More markers should be used to phenotype this subset in the future and not only at gd 5.5 and 
gd 9.5 as shown in this thesis but at the other stages before gestation, at all stages of gestation 
and during the post-partum period. One of the most interesting discoveries made in this thesis 
was that ILC1s expanded in both percentages and absolute numbers in second gestations. 
They also expressed higher levels of the memory-associated NK cell marker, CXCR6, 
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suggesting that these cells expand specifically in response to pregnancy-related cues, since 
CXCL16 can be produced by trophoblast (Huang et al., 2008) and Cxcl16 gene expression 
was upregulated in second gestation in the whole uterus as shown in Chapter 5. Expansion of 
CXCR6+ ILC1s was not observed in the matched liver or spleen. CXCR6+ ILC1s were 
present in much higher numbers and percentages at gd 5.5 of the second gestation, but this 
increased significantly by gd 9.5. It is important to note that at gd 5.5 of the second gestation, 
this otherwise rare subset, was extremely abundant and this was very consistent, which will 
allow for easier FACS-sorting and subsequent in vitro manipulation in the future studies. 
That was one of the main challenges in the work presented in this thesis, since any in vitro 
manipulation of ILC1s required a high number of animals to be sacrificed, due to very low 
numbers before and during first gestation. It will also be essential to continue following the 
dynamics of the ILC1s after first gestation in order to determine when their expansion begins. 
This work represents an exciting direction for the future research, since decidual NK cells 
with memory properties and enhanced function have been identified in subsequent human 
gestations (Gamliel et al., 2018). In addition, there is a lower rate of pregnancy complications 
observed in second pregnancies and memory NK cells/ILC1s might be relevant in these cases 
(Hernandez-Diaz et al., 2009). 
 
The third subset, cNK cells, starts increasing from mid-gestation but peaks in late gestation. 
Therefore, not only is it tempting to speculate that cNK cells are essential for a crosstalk with 
trNK cells at mid-gestation, but also that they might be essential for the immune protection of 
the fetus later in gestation after placenta has been established as they displayed more of a 
cytotoxic gene signature rather than the tissue-remodelling signature of the ILC1s and trNKs.  
 
Certain genes identified in the distinct subsets of uterine g1 ILCs in this thesis had been 
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previously associated with disease in humans, by studying their mutations and 
polymorphisms. One example is the identification of Scarb1 gene, highly upregulated in 
tissue-resident g1 ILCs. In humans, the polymorphism in Scarb1 associates with the success 
of the IVF (Yates et al., 2011). Mucin4 polymorphisms (Mucin4 being highly upregulated in 
cNKs) were found to be associated with endometriosis-related infertility (Chang et al., 2011). 
It is also of importance to note that numerous genes in the UpSet lists did not have a 
canonical name and included pseudogenes, long non-coding RNA and antisense transcripts. 
Given the similarities of g1 ILCs in general, these may prove to be essential in cell-specific 
gene targeting as they may be master regulators of the gene expression in a subset of interest.  
 
The prediction model ImmuCC for mouse tissues that allows the deconvolution of 
transcriptome data was used in order to attempt to identify what cell types were present in 
cell preparations for RNA-seq. Briefly, using the expression profiles of normal mouse 
immune cells obtained on Affymetrix Mouse Genome platform, a signature matrix was 
created to identify 25 immune cell types (Chen et al., 2017). By applying this matrix to the 
RNA-seq dataset described here, relative compositions of these immune cell types were 
inferred in the sorted samples. The close similarity of uterine and hepatic cNK cells was 
confirmed as their gene signatures aligned with NK and T cells. However, the CD49a+ 
compartment was heterogeneous. While trNK and liver ILC1s had similar proportions of 
cell types represented (the highest being activated CD8+ T cells, Th1 cells, activated NK 
cells with lower fraction of monocyte, activated DCs and M1 macrophages), uterine ILC1s 
were very different. The gene signatures of uterine ILC1s predicted cells as diverse as M0 
and M1 macrophages, with the highest fraction being monocytes and activated DCs, which 
corroborated the data obtained through analyses in Chapters 4 and 5, suggesting again that 
these cells have a tissue-specific signature which resembles many other immune cell types 
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(Fig. 6.1). This may be a consequence of adaptation to the particular niche they are found in. 
It is worth noting that ImmuCC is in no way a perfect way for the data deconvolution since 
ILCs are not in the 25 immune cell types, but it did confirm the observations of the Chapters 
presented in this thesis.  
 
Figure 6.1. A prediction model suggests unique features in uterine ILC1s and trNKs that the evidence 
was provided for within the scope of this thesis. The data is explained in the text.  
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Although liver and uterine g1 ILC subsets were very similar, phenotypically, on the 
transcriptome level that was not found to be the case according to the evidence presented in 
this thesis. Genes that were validated on the protein level in the uterus were in most 
independent experiments not validated in the matched livers, although cells originating from 
both tissues had equivalent levels of gene expression. This is an essential point, because a 
tendency of researchers when designing flow cytometry panels is to use the same 
fluorophore for the lineage channel in order to maximise the number of channels available 
for markers of interest for cell phenotyping. For example, F4/80 antibody is very commonly 
used in the lineage negative channel to exclude macrophages when NK cells are analysed, or 
to positively select for macrophages. Similarly, CD11c is often used in the lineage negative 
channels to exclude DCs as their conventional marker, although through this work it became 
evident that all g1 ILCs expressed very high levels of the CD11c protein (data not shown). 
However, with the advance in the flow cytometers that allow cell profiling using a much 
higher number of markers, these non-conventional markers should be used with care and 
their expression reassessed in each individual tissue investigated.  
Finally, NK progenitors were identified in both human and mouse uterus, but it was not 
feasible to continue these projects due to the lack of samples and the need for a high number 
of animals, respectively. However, future projects should attempt to delineate the 
developmental trajectories of the uterine g1 ILCs by harnessing the power of much more 
advanced single-cell technologies available today.  
In support of the findings in this thesis, several excellent single-cell resources were published 
recently. These include two reports describing the human maternal-fetal interface during the 
first trimester of pregnancy (Vento-Tormo et al., 2018; Suryawanshi et al., 2018)2. Vento-
Tormo and colleagues described three subsets of decidual NK cells with distinct surface 
receptor profile and immunomodulatory properties and their data largely corroborates the 
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findings presented in this thesis. The resource presented in thesis here should be used 
alongside these novel human datasets when new experiments are designed. Quality of the 
data presented here was also confirmed by a single-cell study in which the Microwell-seq 
technique of single-cell RNA-seq was used to analyse over 400,000 cells from majority of 
mouse tissues, including uterus (Han et al., 2018). Notably, this was the data from a non-
pregnant mouse, but the expression of many genes was similar to what was observed in this 
thesis on the mid-gestation samples. 
Establishment of the novel resources to guide reproductive research will help clarify results 
presented in this thesis even further. For instance, recently established endometrial and 
trophoblast organoids may be instrumental in determining the lineage potential when 
incubated with NKPs from the human uterus (Turco et al., 2017; Turco et al., 2018). Since 
low numbers of NKPs can be obtained from the uterus and organoids have a very long-term 
life, these experiments would yield significant knowledge on how trophoblast or 
endometrium with various factor they produce affect NK cell development and plasticity and 
provide a much more physiological approach of testing. Synthetic biology approaches are 
available now as well, with the development of organs on chips. One example is the  
microfluidic culture model of the reproductive tract which can mimic the 28-day menstrual 
cycle (Xiao et al., 2017). 
Through studying a cohort of patients with severe combined immunodeficiency (SCID), one 
recent study has suggested that ILCs are redundant (Vély et al., 2016), especially when the B 
and  T cell compartment is preserved, with particular focus on the T cells’ effector 
mechanisms that can compensate for the lack of ILCs. Of particular interest for the research 
presented in this thesis is a conclusion of the study that ILCs appear redundant for human 
reproduction, in addition to not being required during the disease, since 2 female Jak3-
deficient patients had normal pregnancies resulting in healthy babies. However, such 
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conclusions cannot be made without analysis of a much larger cohort and taking into account 
all the clinical data, including the data related to the reproduction. As a recent essay 
proposed, immune system is based on equilibrium and constantly in a dynamic state between 
various antagonistic types of response (Eberl, 2016). These responses originate from both the 
internal and external environment and g1 ILCs in this thesis were shown to be equipped with 
the transcriptome to cope with signals of both origins. 
In conclusion, a transcriptome atlas of uterine g1 ILCs is provided in this thesis. There is an 
obvious heterogeneity within the subsets that were sorted and RNA-sequenced, as some 
genes were detected at very low levels but there was a high protein expression and vice versa. 
Future work should focus on looking into distinct stages of reproductive life and single-cell 
analysis in order to capture the dynamic transcriptomic changes within each subset of the 
uterine g1 ILCs. 
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Appendix  
Table A.1. Comparison I. All differentially expressed genes from the comparison I: all uterine (ILC1, trNK, 
cNK) subsets vs all liver (ILC1, cNK) subsets. FC: fold change, padj: adjusted p-value. 
Gene FC pvalue padj Gene FC pvalue padj
Hba-x 6,7928 1,47E-37 2,27E-33 Trim71 2,6348 0,0001096 0,00785754
Hbb-y 6,5059 1,68E-32 1,29E-28 Hif3a 2,6140 9,47E-05 0,00715437
Hbb-bh1 6,4695 1,83E-31 9,40E-28 Lgmn 2,6045 4,80E-12 4,81E-09
H19 6,3382 5,97E-29 2,30E-25 Gpr31b 2,6016 0,0001347 0,00899237
A2m 6,1354 3,35E-28 1,03E-24 Pla1a 2,5849 0,000149 0,00945524
Prl8a2 5,5805 3,71E-20 7,14E-17 Adamts1 2,5768 0,0001078 0,00776386
Peg3 4,8331 8,24E-16 1,41E-12 Ch25h 2,5531 0,0001565 0,0098306
Prap1 4,6175 2,67E-12 2,94E-09 Ms4a6d 2,5500 6,68E-08 1,94E-05
Serpinh1 4,2129 9,26E-11 6,49E-08 A130050O07Rik 2,5220 9,95E-05 0,00737309
Sox11 4,1860 3,70E-10 2,28E-07 Igf2bp3 2,5143 1,99E-05 0,00221501
Fbln1 4,0091 3,32E-09 1,51E-06 Nefm 2,5105 0,0002348 0,01288916
Gzme 3,9693 5,62E-12 5,10E-09 Arhgap29 2,5040 4,38E-05 0,00402072
Tgfb2 3,9322 5,20E-09 2,17E-06 Plb1 2,4968 0,0001704 0,01049337
Flrt3 3,8176 1,07E-09 5,89E-07 Dixdc1 2,4908 4,03E-06 0,00060273
Retnla 3,7668 1,18E-09 6,26E-07 Gzmf 2,4591 4,13E-05 0,00381415
Map1b 3,6736 4,17E-09 1,84E-06 C430049B03Rik 2,4529 0,0002664 0,01408653
Igf2bp1 3,6649 1,41E-11 1,15E-08 Gm37354 2,4472 5,34E-05 0,004655
Dab2 3,6532 1,11E-22 2,45E-19 Gpr176 2,4469 0,0003325 0,01631997
Hebp1 3,5984 6,28E-09 2,48E-06 Clec5a 2,4407 3,23E-06 0,00050228
Ptn 3,5839 3,12E-08 9,83E-06 Gdf15 2,4400 0,0001264 0,00862044
Mrc2 3,5677 1,87E-07 5,34E-05 Fkbp9 2,4342 0,0002297 0,01273602
Pdpn 3,4863 5,44E-08 1,68E-05 Tdrd9 2,4085 0,000447 0,01985914
Flrt2 3,4834 3,39E-07 9,02E-05 Scamp1 2,4035 3,81E-07 9,18E-05
Nrep 3,4778 3,66E-07 9,17E-05 Snx24 2,3967 0,0001927 0,01129558
F7 3,4759 2,68E-08 8,62E-06 Lhfpl2 2,3955 3,87E-05 0,00361305
Nrk 3,4223 7,66E-09 2,88E-06 Lipt2 2,3907 0,0003086 0,01554739
Cryab 3,3339 9,44E-07 0,0001915 Ms4a8a 2,3887 1,30E-05 0,00163271
Gzmd 3,2738 2,59E-08 8,48E-06 Ms4a14 2,3886 0,0002247 0,01259301
Ms4a7 3,2332 1,73E-12 2,05E-09 Clec4d 2,3759 6,36E-05 0,00530259
Lin28b 3,2275 8,89E-07 0,0001852 Sh3pxd2b 2,3683 2,84E-09 1,33E-06
Spsb1 3,2235 1,52E-06 0,000279 Fign 2,3592 0,0004958 0,0214071
Grb10 3,2006 1,03E-06 0,0002072 Tlr5 2,3591 9,72E-05 0,007309
Pf4 3,1673 5,49E-07 0,0001282 6330403L08Rik 2,3428 0,0005811 0,02408362
Igf2 3,1656 6,81E-07 0,0001458 Rai14 2,3323 1,18E-05 0,0015042
Cpe 3,1549 4,42E-06 0,0006549 Tgfbi 2,3265 1,85E-06 0,00032899
Arfgef3 3,1069 1,96E-06 0,0003439 Layn 2,3255 0,00058 0,02408362
Cd109 3,0490 5,55E-06 0,0007991 Fbn1 2,3194 0,0006992 0,0279987
Zcchc3 3,0414 1,25E-06 0,0002467 Gja1 2,3117 0,0007215 0,02852328
Ahnak2 3,0322 1,71E-06 0,0003108 Cdk5r1 2,2873 0,0004971 0,0214071
Pmepa1 3,0024 1,95E-09 9,72E-07 Ankrd66 2,2830 0,0008502 0,03143346
Gzmg 2,9813 6,77E-06 0,0009405 Ang 2,2789 0,0003541 0,01706063
Fcrls 2,9006 2,09E-06 0,0003627 3110043O21Rik 2,2555 0,0004387 0,01954713
Hsd3b6 2,8932 1,15E-05 0,0014838 Piwil4 2,2524 0,001034 0,0360667
Ccl7 2,8841 5,70E-06 0,0008072 Clec4n 2,2503 6,81E-05 0,00556337
Vcan 2,8774 1,95E-10 1,25E-07 Spata9 2,2340 0,0006559 0,02647101
A530064D06Rik 2,8735 2,58E-09 1,24E-06 Gdf3 2,2325 0,0001271 0,0086309
Gm15246 2,8720 2,29E-05 0,0024043 Tbc1d16 2,2322 0,000714 0,02846223
Speg 2,8647 2,64E-05 0,0027166 2210408F21Rik 2,2312 0,0010605 0,03682343
Afap1l1 2,8610 2,26E-05 0,0023852 Zc3h12c 2,2306 0,0004812 0,02113362
Ccl12 2,8550 7,50E-06 0,0010141 Mgl2 2,2283 0,0001155 0,00809156
Inhba 2,8517 2,11E-07 5,91E-05 Gm14049 2,2266 0,00113 0,03787306
Spp1 2,8400 5,82E-08 1,76E-05 E330034L11Rik 2,2230 1,54E-05 0,00185703
Etv1 2,8388 1,23E-08 4,43E-06 Igsf10 2,2176 0,0011998 0,03935459
Gab1 2,8280 2,80E-06 0,0004552 Ptgfrn 2,2157 0,0009944 0,03516093
Uaca 2,8200 2,66E-05 0,0027166 Csf2rb2 2,2095 8,25E-07 0,00017422
Gm13899 2,8101 3,99E-05 0,0037093 Spic 2,2046 1,02E-09 5,84E-07
Scn3b 2,8072 1,60E-05 0,0019072 Adam15 2,2040 0,0001433 0,00928676
Scin 2,8068 9,40E-07 0,0001915 Il1rn 2,1985 1,90E-05 0,002202
Col4a1 2,7768 4,67E-06 0,0006859 Arhgef17 2,1945 0,0013026 0,04149168
Tpm2 2,7710 4,86E-05 0,0043318 Pdgfra 2,1883 0,0010721 0,03714325
Nes 2,7464 2,21E-05 0,0023498 Hmga2 2,1876 0,0002134 0,01229192
Olr1 2,7458 5,81E-07 0,0001338 Prune2 2,1869 3,58E-05 0,00340643
Gap43 2,7349 6,36E-05 0,0053026 Ermap 2,1858 0,001091 0,03745399
9130008F23Rik 2,7202 1,98E-05 0,002215 Ophn1 2,1853 0,0002558 0,0136908
Kank2 2,7150 2,26E-06 0,0003829 Cxcl3 2,1843 0,0002456 0,0133318
Mitf 2,7017 3,04E-06 0,0004778 Peg10 2,1803 0,0001736 0,01053794
Basp1 2,6692 5,57E-09 2,26E-06 Rab3il1 2,1801 0,00029 0,01480228
Slco2b1 2,6558 2,86E-05 0,002861 Lbp 2,1747 0,0003376 0,01641661
Dusp9 2,6476 3,81E-05 0,0035795 Aoc1 2,1733 0,0015028 0,04569851
Tmem119 2,6356 2,91E-05 0,0028761 Ms4a6c 2,1716 2,23E-06 0,00038122
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Gene FC pvalue padj Gene FC pvalue padj
Rhag 2,1697 0,0010125 0,035558937 Tldc1 -2,3572 0,000148199 0,009441866
Ly6c1 2,1622 0,0001045 0,007671589 Cd22 -2,3663 1,49E-06 0,000276384
Gm37747 2,1622 3,18E-05 0,003068783 5830454E08Rik -2,3743 0,000198053 0,011478909
Met 2,1617 0,0003342 0,016319967 Tcrg-C1 -2,3942 0,000270608 0,014094476
Gm26947 2,1589 0,0001074 0,007763858 Gm16602 -2,4173 0,000395274 0,018410697
Pigz 2,1489 0,0016842 0,049647539 Gpr55 -2,4440 2,12E-05 0,002284688
Marcks 2,1385 1,43E-08 5,03E-06 Ighg2c -2,4554 0,0003142 0,015625865
Tnfsf4 2,1298 0,0011855 0,039053844 Rgs12 -2,4675 1,73E-05 0,002032801
C3ar1 2,1244 0,0001259 0,008620436 Msrb2 -2,4747 1,63E-05 0,00193167
Kdr 2,1241 0,000437 0,019529969 2610524H06Rik -2,4938 2,67E-06 0,000442717
Gm10484 2,1219 0,0001934 0,011295578 Sult2b1 -2,4997 0,000118046 0,008197816
Slfn4 2,1210 0,0002254 0,012593006 Nlgn2 -2,5014 0,000160315 0,010006395
Spint1 2,1105 0,0007164 0,028462229 Ift27 -2,5026 3,11E-05 0,003032399
Gm36992 2,1020 0,0008405 0,031301244 Gm26640 -2,5401 0,000139254 0,009166429
AA467197 2,1011 5,31E-06 0,000772124 Prss12 -2,5451 8,21E-06 0,001091661
Gm16267 2,0957 0,001395 0,043184773 Gstt2 -2,5481 1,36E-06 0,00026185
Trim2 2,0903 0,0007152 0,028462229 Rflnb -2,5669 1,19E-08 4,38E-06
Siglec1 2,0851 6,14E-07 0,000139168 Klk8 -2,5755 4,64E-05 0,004157351
Slfn1 2,0693 4,42E-05 0,004022778 Slc25a2 -2,5897 1,86E-06 0,000328991
Plet1 2,0506 0,0007344 0,028883565 Gm26614 -2,6162 0,000123217 0,00851856
Mest 2,0494 0,0011026 0,037531195 1700029I15Rik -2,6286 6,92E-05 0,005581747
Gm10177 2,0381 0,0005553 0,023382863 Gm26802 -2,6330 0,000102382 0,007552254
9430020K01Rik 2,0368 0,0005686 0,023755512 Trgj4 -2,6560 6,97E-05 0,005599001
Ednrb 2,0281 0,0009444 0,033939116 Cd8a -2,6781 7,43E-06 0,001014098
Stab1 2,0165 0,0002547 0,013690799 Cxcr3 -2,7134 1,09E-10 7,29E-08
Fstl1 2,0100 6,39E-11 4,69E-08 Gm20743 -2,7304 4,33E-07 0,000102744
Papss2 2,0047 0,0002288 0,012734675 Aqp9 -2,7362 3,90E-06 0,000589118
Rab3a -2,0232 0,0001434 0,009286762 Sema4f -2,7553 3,32E-05 0,00317561
2810001G20Rik -2,0268 0,0001569 0,009830602 Fga -2,7702 3,78E-05 0,003571802
Itga3 -2,0319 0,0008788 0,032030428 Gpr182 -2,7825 2,00E-05 0,002215011
Gm527 -2,0640 0,0015135 0,045932255 Art2b -2,8197 2,89E-06 0,000463683
Sox6 -2,0817 0,0013347 0,042090539 A1bg -2,8614 2,97E-05 0,002912888
Bcl11b -2,0855 0,0002349 0,012889159 Chad -2,8630 2,01E-05 0,002215011
Cxcr5 -2,0860 0,0012483 0,040472805 Slc27a6 -2,8838 1,26E-06 0,000246716
Gm42870 -2,0934 0,001275 0,041036878 Bcl2l15 -2,9125 5,71E-06 0,000807167
Ltb -2,1283 0,0005969 0,024640322 Jchain -2,9274 3,31E-06 0,000510392
Alad -2,1303 3,13E-05 0,003033872 Pzp -2,9445 1,52E-05 0,001843142
Sult1a1 -2,1343 0,0015658 0,047250645 Apol11b -2,9532 1,45E-05 0,001805009
Trdv4 -2,1419 6,82E-05 0,005563374 Serpina3k -3,0126 1,01E-05 0,001303347
Tg -2,1474 0,0016443 0,048844902 Nat8f1 -3,1210 2,31E-06 0,000386636
Itih4 -2,1478 0,001664 0,049239319 Tcrg-C4 -3,1320 5,05E-11 3,90E-08
Axin2 -2,1515 0,0009063 0,032875609 Ccdc136 -3,1894 3,72E-07 9,17E-05
Dnajc25 -2,1688 4,30E-09 1,84E-06 Paqr9 -3,2128 1,47E-06 0,000276384
Tle2 -2,1694 0,0011414 0,038007383 Bmp7 -3,3393 1,28E-09 6,60E-07
Alas2 -2,1720 0,0002674 0,014086527 Trgv2 -3,3901 3,59E-07 9,17E-05
Il20ra -2,1727 0,001335 0,042090539 Dtx1 -3,4042 6,43E-23 1,65E-19
Cdon -2,1789 0,0003706 0,017472599 Scd1 -3,4317 1,02E-09 5,84E-07
Gm6934 -2,2068 0,0006032 0,024796689 Gm19590 -3,4376 3,68E-07 9,17E-05
Rln3 -2,2119 0,0010928 0,037453994 Nfe2l3 -3,4388 2,25E-08 7,71E-06
Gm44175 -2,2144 0,000785 0,030105421 Hlf -3,5283 6,00E-08 1,78E-05
Plekhf1 -2,2157 6,91E-05 0,005581747 Igha -3,8681 5,00E-12 4,81E-09
Ciart -2,2264 0,000379 0,017813707 Cd79a -4,1643 6,47E-12 5,54E-09
Fabp1 -2,2316 0,0010574 0,036797638 Igkc -4,3942 2,02E-15 2,83E-12
Ngp -2,2392 0,000872 0,031882046 Podnl1 -4,6955 1,06E-15 1,63E-12
Gm44645 -2,2440 0,0009652 0,034444964 Alb -4,8107 2,08E-14 2,67E-11
4930589O11Rik -2,2542 0,0008502 0,031433459
Gm16565 -2,2736 9,17E-05 0,006996908
Ahsg -2,2846 0,0007731 0,029722333
Ambp -2,2997 0,0007491 0,029238599
Hist4h4 -2,3001 2,79E-05 0,002806303
Pck1 -2,3002 0,0004282 0,019191941
Apob -2,3033 0,0002452 0,013331799
Hspa2 -2,3133 2,36E-08 7,90E-06
Bend5 -2,3310 0,0006352 0,025703851
Cbx6 -2,3346 2,92E-07 7,90E-05
Zfp239 -2,3363 0,0001794 0,010719557
Cd7 -2,3431 2,75E-06 0,000450723
Map7 -2,3444 1,95E-05 0,002211937
AI661453 -2,3459 0,0001362 0,009048411
Mmp9 -2,3494 0,0003181 0,0157686
  206 
Table A.2. Comparison II. All differentially expressed genes from the comparison II: uterine CD49a+ (ILC1, 
trNK) subsets vs liver (ILC1) subset. FC: fold change, padj: adjusted p-value. 
Gene FC pval padj Gene FC pval padj
Gzme 8,1801 8,87E-17 2,62E-13 Dusp9 4,5214 0,000107915 0,003597646
Pdpn 7,6743 2,26E-12 1,25E-09 Adamts1 4,4948 1,05E-06 8,86E-05
Gzmd 7,5979 2,06E-13 1,60E-10 Rab15 4,4928 0,000891749 0,017045089
Cd109 7,5240 5,33E-11 2,17E-08 Tmsb15a 4,4884 1,65E-05 0,000823539
Gzmg 7,2735 1,18E-10 4,48E-08 Rps6ka6 4,4767 0,000249207 0,006657134
Plb1 7,1975 1,16E-09 3,05E-07 Gpr176 4,4679 0,000660179 0,013592993
Gzmf 7,1576 1,07E-14 1,07E-11 Eif2s3y 4,4119 0,000726271 0,01463603
Flrt3 6,9055 3,63E-16 6,89E-13 Adam33 4,4004 1,03E-06 8,76E-05
A2m 6,8499 1,22E-09 3,13E-07 Akr1c18 4,3790 0,001216559 0,021353343
Spsb1 6,7024 1,40E-09 3,46E-07 Pard3 4,3687 0,000610698 0,012900986
Arfgef3 6,3856 1,76E-09 4,23E-07 Tnfaip8l3 4,3567 0,000450165 0,010272553
Speg 6,2710 1,06E-07 1,35E-05 Ccdc122 4,3342 0,000134763 0,00422067
Tdrd9 6,1883 2,48E-07 2,72E-05 Mak 4,3143 0,000949112 0,017900982
Dixdc1 6,1206 4,98E-10 1,52E-07 Basp1 4,2978 7,02E-20 1,20E-15
Retnla 6,0417 3,93E-15 5,59E-12 Fcrlb 4,2900 0,000300962 0,007708533
Rhov 6,0136 6,17E-07 5,82E-05 Afp 4,2740 0,000585414 0,012514471
Ahnak2 5,9917 5,64E-10 1,63E-07 Dsp 4,2700 0,000186099 0,005303052
Clip3 5,9262 1,24E-08 2,13E-06 Ptgfrn 4,2562 4,43E-06 0,000285399
Afap1l1 5,8658 3,25E-07 3,34E-05 Coprs 4,2505 0,000143316 0,004391843
Sox11 5,8531 1,32E-06 0,000105996 Emp1 4,2271 2,62E-10 8,75E-08
Lin28b 5,8489 1,07E-08 1,89E-06 Gm20056 4,2264 0,001189695 0,020956565
Ddx3y 5,7947 1,38E-06 0,000110679 Klhl30 4,2214 5,61E-07 5,35E-05
Inhba 5,7800 1,44E-09 3,51E-07 Fbln1 4,2086 0,000970463 0,018102318
Olfml2b 5,7780 3,77E-06 0,000250208 Slco2b1 4,1908 9,94E-09 1,79E-06
Ccl7 5,6874 1,42E-16 3,47E-13 Lhfpl2 4,1643 5,33E-06 0,000333588
Fkbp9 5,5238 1,70E-07 2,01E-05 Prtg 4,1480 0,000209425 0,005793651
Igf2bp1 5,4808 1,76E-11 7,91E-09 Ifnlr1 4,1060 0,000324189 0,00818346
Erv3 5,4461 1,79E-06 0,000138026 Gm15246 4,0918 0,001064285 0,019346413
Ednrb 5,4247 1,10E-17 6,26E-14 6330403L08Rik 4,0769 0,000138864 0,004294213
Hif3a 5,4196 5,19E-06 0,000327996 Bag2 4,0765 0,000515296 0,011408019
Tal1 5,3709 1,06E-06 8,95E-05 Cbr2 4,0526 1,96E-05 0,000944633
Pf4 5,3565 7,70E-13 5,05E-10 Hsd3b6 4,0244 0,000406112 0,009495785
Hemgn 5,3503 2,46E-08 3,78E-06 Mtcl1 4,0146 0,002462816 0,035564973
Scin 5,3343 5,24E-08 7,51E-06 Car6 4,0074 0,00117723 0,02080138
Ankrd66 5,3339 1,73E-06 0,000134243 Gm43717 4,0055 0,000941275 0,01777281
Piwil4 5,3206 1,38E-05 0,000712524 Tsacc 3,9922 0,002677833 0,037619699
Rnase2a 5,2811 3,52E-05 0,001505755 Bace2 3,9848 0,002653818 0,037486783
A630012P03Rik 5,2644 3,64E-05 0,001547128 Peg3 3,9755 0,001888879 0,029552045
Gm44205 5,2024 1,45E-05 0,000739511 Rbfox2 3,9740 0,00226132 0,033593093
Igsf10 5,2023 6,13E-06 0,000372362 Slc39a2 3,9567 0,00185338 0,029132315
Dpysl5 5,1759 3,42E-07 3,46E-05 Tnfsf4 3,9508 0,000585802 0,012514471
Khdc1c 5,1657 4,01E-06 0,000264284 Stmn2 3,9444 0,002094734 0,031682721
Cped1 5,0987 4,38E-05 0,001819225 Vegfa 3,9425 3,58E-15 5,56E-12
Serpinh1 5,0885 2,38E-05 0,001110741 B4galnt2 3,9383 0,0017889 0,028383054
Flrt2 5,0105 0,000165949 0,004831718 Nt5dc2 3,9337 0,001067984 0,019354931
Ch25h 4,9939 1,92E-07 2,20E-05 Gm42632 3,9264 0,00267538 0,037618927
Spp1 4,9801 2,77E-09 5,99E-07 4930533B01Rik 3,9195 0,00032828 0,008192116
Col1a1 4,9722 6,52E-05 0,002434655 Dab2 3,9094 1,27E-07 1,59E-05
Lipg 4,9602 2,78E-05 0,00126333 Anxa9 3,8966 0,000344515 0,008473376
Prap1 4,9592 6,11E-05 0,002347765 Srd5a1 3,8780 0,000976041 0,018148192
Syngr1 4,9303 9,40E-05 0,003246248 Kdr 3,8718 4,01E-10 1,27E-07
Thsd7a 4,9281 9,56E-05 0,003295617 Mgat3 3,8643 0,000654008 0,013522804
Prl8a2 4,8839 4,50E-05 0,001851401 Gm24273 3,8546 0,002675574 0,037618927
Gm14011 4,8737 0,000153859 0,004605843 Gm13899 3,8467 0,001648532 0,026927082
Gpnmb 4,8556 2,67E-12 1,43E-09 Ctsg 3,8293 0,000718249 0,01450863
Rhag 4,8480 2,34E-06 0,000173094 C3ar1 3,8292 6,94E-15 8,27E-12
Klk1b11 4,8378 0,000106764 0,003573239 Des 3,8262 0,001544604 0,025597652
Eya4 4,8350 0,000265891 0,006982292 Nefm 3,8254 0,002015367 0,030963366
Tgfb2 4,8064 0,000145529 0,004439936 Tm4sf19 3,8242 0,003484012 0,045111803
A230028O05Rik 4,7733 8,64E-05 0,003046591 Epb41l1 3,7963 7,42E-06 0,000437019
Fut10 4,7550 0,000281686 0,007329426 Hmcn2 3,7623 0,003262733 0,043398048
Fcrl6 4,6420 1,23E-09 3,13E-07 Ctnnd2 3,7566 1,91E-05 0,00093233
Dsc2 4,6338 1,16E-05 0,000617051 Cacna1b 3,7431 0,000542346 0,011868342
Hebp1 4,6231 4,79E-07 4,62E-05 Fcrls 3,7382 6,46E-05 0,002422468
Kif26b 4,6171 0,000301224 0,007708533 Lyve1 3,7359 2,21E-06 0,000166065
Prokr1 4,6096 0,000214146 0,005905097 Vipr2 3,7194 9,30E-05 0,003230084
Ccl8 4,5794 6,13E-05 0,002352183 Apol9b 3,7043 0,002518003 0,036043928
Tmprss4 4,5411 0,000505623 0,01126694 Uaca 3,6980 0,001852211 0,029132315
Ccl12 4,5409 1,77E-08 2,85E-06 Gm13650 3,6935 0,000327641 0,008188156
Asns 4,5357 1,51E-05 0,000765003 Ebf3 3,6450 0,001815784 0,028751041
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Gene FC pval padj Gene FC pval padj
Arhgap29 3,6339 4,91E-07 4,71E-05 Slc7a5 2,9417 1,84E-12 1,12E-09
Plxna1 3,6227 9,12E-10 2,43E-07 Lgmn 2,9407 1,63E-07 1,96E-05
Peg10 3,6211 4,11E-06 0,000268727 Gab1 2,9303 0,003560911 0,045700147
Htra1 3,6169 0,000898382 0,017106673 Thbs1 2,9286 3,50E-09 7,37E-07
Pnp2 3,6159 0,000612759 0,012912577 Epas1 2,9255 0,000145913 0,004439936
Zcchc3 3,6113 0,000800542 0,01572434 Mboat1 2,9223 0,002608402 0,037009821
Clec4d 3,6011 3,63E-05 0,001543539 Plau 2,8987 4,43E-07 4,30E-05
Fat1 3,5999 0,000558837 0,012095861 Ecm1 2,8925 0,000288356 0,007457485
Nrk 3,5932 0,000351331 0,008579202 Ms4a14 2,8864 0,001098366 0,019797271
Atp6v0d2 3,5719 0,00296806 0,040561902 C5ar1 2,8746 1,90E-08 3,01E-06
Gpr87 3,5617 0,003259058 0,043398048 Gm20712 2,8572 0,000162972 0,004787898
Ly6c1 3,5410 8,24E-07 7,44E-05 Tjp1 2,8565 0,00014835 0,004481755
Gm5345 3,5270 0,003082328 0,041623618 Rab3il1 2,8488 2,71E-05 0,001241566
Gm15635 3,5124 0,001068213 0,019354931 Dnph1 2,8449 0,001393558 0,023597851
Arg2 3,4974 0,000418808 0,009673379 Dhrs9 2,8378 0,000704559 0,014316808
Lrp12 3,4812 0,000118877 0,003821401 Anpep 2,8375 1,94E-05 0,000942206
Cd300lf 3,4672 9,20E-17 2,62E-13 Anxa4 2,8173 1,85E-11 7,91E-09
Piwil2 3,4541 0,002567274 0,036537402 Scamp1 2,8171 3,00E-05 0,001334308
Sapcd2 3,4257 2,67E-05 0,001230291 Mmp12 2,8118 1,98E-08 3,10E-06
Gm43844 3,4206 0,000112347 0,003699937 Ptafr 2,8115 2,05E-07 2,33E-05
Stab1 3,4128 8,35E-07 7,44E-05 Cd63 2,7888 0,000751959 0,01497689
Sh2d1b2 3,4063 5,63E-05 0,002202861 Psrc1 2,7875 3,72E-05 0,001571131
Spry4 3,3875 0,000764618 0,015193562 Kif5c 2,7863 0,003303926 0,043750746
Tubb2b 3,3598 0,000410737 0,009549012 Sh3pxd2b 2,7674 4,97E-05 0,00201355
Dnmt3aos 3,3583 0,002172586 0,032673016 Snx7 2,7670 7,65E-05 0,002790577
Tdo2 3,3569 0,000355797 0,008615606 Rhou 2,7467 0,000471292 0,01059879
Ccl2 3,3491 4,11E-09 8,45E-07 Ccl17 2,7409 0,003995018 0,049766317
Ankrd33b 3,3353 0,000343392 0,00845794 Mmp14 2,7360 9,63E-06 0,000526475
Ninj1 3,3279 6,22E-08 8,71E-06 Cd93 2,7337 4,17E-07 4,07E-05
Gm38345 3,3127 0,00010781 0,003597646 Gpt2 2,7272 0,003763988 0,047661354
Igf2bp3 3,3125 0,000194482 0,005459887 Gm37534 2,7264 0,003424077 0,044512995
Ccr1 3,3052 8,16E-06 0,000460975 Rnase4 2,7014 0,000661032 0,013594161
Nhsl1 3,3045 0,000316049 0,008027734 Fabp5 2,7000 1,72E-05 0,000854705
Gas6 3,2981 4,04E-06 0,000264986 Fam20c 2,6999 9,28E-07 8,10E-05
Olr1 3,2589 9,61E-06 0,000526475 Mfsd12 2,6913 0,000254261 0,006743319
Tmem171 3,2557 2,94E-05 0,001315173 F10 2,6788 4,36E-09 8,85E-07
Clec4n 3,2474 6,38E-06 0,000385721 Klra4 2,6769 0,000129035 0,004101494
Gm38001 3,2456 0,003929212 0,049205955 Gm16353 2,6512 0,000158796 0,00470824
Cdk20 3,2388 0,00336071 0,0441227 Tln2 2,6500 7,76E-06 0,000449221
Col1a2 3,2387 0,003808069 0,048005856 A530064D06Rik 2,6481 0,000114494 0,003750415
Eomes 3,2141 4,98E-05 0,002014764 Bst1 2,6463 8,07E-06 0,000460284
8030453O22Rik 3,2018 0,002512364 0,036042993 Fth1 2,6307 8,25E-11 3,20E-08
Fnip2 3,1929 4,48E-09 9,00E-07 Fcgr1 2,6266 7,43E-07 6,77E-05
Prune2 3,1889 2,34E-07 2,60E-05 Myo10 2,6250 0,002425533 0,035235246
Gm26797 3,1836 0,000378302 0,008989444 Dhrs3 2,6170 5,83E-06 0,000360468
AA467197 3,1779 1,46E-05 0,000739511 Paox 2,6138 0,001120475 0,02004758
Ms4a7 3,1551 2,01E-05 0,000964595 1700084C06Rik 2,6098 0,003821795 0,048072381
Npl 3,1511 1,12E-06 9,32E-05 Ms4a6d 2,6005 0,000158337 0,00470824
Dcn 3,1452 0,001000124 0,018429417 Spon1 2,5881 0,000285926 0,007417133
Mreg 3,1426 0,002090456 0,031661041 Myo1b 2,5833 0,000859652 0,016580121
Gm26781 3,1309 0,001364451 0,023207582 Atp6v0a1 2,5827 1,27E-06 0,000102692
Slc7a2 3,1267 6,60E-06 0,000394984 Slc16a13 2,5748 0,002044277 0,031155145
Kcnn4 3,1184 5,81E-05 0,002238078 Plet1 2,5721 0,003705374 0,047093837
Il1f9 3,1092 2,80E-05 0,001268121 Hpgds 2,5516 6,77E-09 1,28E-06
Gm15531 3,1087 0,003233893 0,04315819 Rgs16 2,5488 0,001452605 0,024452184
Lpl 3,1079 2,03E-12 1,20E-09 Klrg1 2,5448 0,000791162 0,015593924
9130204K15Rik 3,1069 0,002046748 0,031164979 Apbb2 2,5443 0,001721002 0,027721488
Gdf15 3,1018 9,60E-05 0,003295617 Coq7 2,5305 0,001142188 0,020329515
Reps2 3,0954 8,26E-05 0,002954115 Gm37354 2,5295 0,001211657 0,02129945
Slfn4 3,0913 5,68E-05 0,002207158 Clcn5 2,5268 1,35E-10 4,80E-08
Gzmc 3,0871 0,000520822 0,011500529 Mthfr 2,5242 6,19E-05 0,002356516
Snx24 3,0792 0,0020956 0,031682721 9430076C15Rik 2,5143 3,30E-05 0,001427451
Mt2 3,0684 0,000729561 0,014684996 Srxn1 2,5129 9,64E-05 0,003305001
Gdf3 3,0642 8,25E-06 0,000463134 Gpr157 2,5114 8,99E-05 0,003136894
Hmox1 3,0598 3,75E-06 0,000250129 Ophn1 2,5088 0,003799954 0,047938967
Cstb 3,0597 8,90E-16 1,52E-12 Naglu 2,5038 0,000191084 0,005391088
Rai14 3,0065 9,70E-05 0,003318033 Vcam1 2,4956 6,85E-08 9,43E-06
Fsd1l 2,9991 0,00055755 0,012092523 Mfsd11 2,4938 9,22E-06 0,000512685
Tmem119 2,9652 0,002151652 0,032443944 C5ar2 2,4882 1,84E-05 0,000902001
Mgl2 2,9495 0,000131864 0,004152753 Ctsb 2,4547 5,44E-15 7,14E-12
  208 
 
Gene FC pval padj Gene FC pval padj
Ifit3b 2,4435 9,80E-05 0,0033348 Xcr1 -2,0039 0,003499868 0,045257005
Crtap 2,4239 0,002079014 0,031526284 Tspyl3 -2,0166 0,000226636 0,006159945
Lgals3 2,4138 4,59E-06 0,000294815 Plppr3 -2,0238 1,18E-06 9,69E-05
Tlr5 2,4137 0,001628701 0,026782567 Gm44130 -2,0267 0,002449925 0,035438785
Pdgfa 2,4106 0,002640341 0,037376609 Jakmip1 -2,0530 0,00029078 0,007503421
Grn 2,4002 3,77E-07 3,75E-05 Gramd1a -2,0535 8,25E-06 0,000463134
Spic 2,3960 1,35E-08 2,30E-06 Ubash3a -2,0566 0,003076225 0,041595745
Igfbp4 2,3955 1,65E-07 1,97E-05 Gpr18 -2,0639 0,000589283 0,012541732
Slc7a11 2,3952 7,91E-05 0,002868054 Rab6b -2,0646 0,000595559 0,012643766
Ctla2a 2,3938 3,86E-06 0,000255472 Zfp707 -2,0726 0,003876796 0,048672742
Fam129b 2,3929 0,000102753 0,003445767 Ptpn4 -2,0782 1,04E-05 0,000561335
Arg1 2,3873 0,000749721 0,014965823 Phf1 -2,0806 8,48E-07 7,50E-05
Mt1 2,3826 0,000535106 0,011755114 Leng9 -2,0808 0,001183961 0,020894078
Mrc1 2,3603 0,001154949 0,020535237 Klrk1 -2,0831 9,94E-06 0,000539461
Sh2d1a 2,3594 0,002768909 0,038518746 Nxpe3 -2,0842 1,15E-05 0,000613725
Olfml3 2,3590 0,00159214 0,026237542 Cd3d -2,0877 0,000687397 0,014034895
Rgl1 2,3503 7,63E-10 2,14E-07 Klrc3 -2,0878 0,001323712 0,022707972
Tex264 2,3421 0,000271573 0,007086748 Gm36940 -2,0891 4,48E-05 0,0018512
Mertk 2,3240 3,43E-05 0,001471545 Gm19557 -2,0968 9,75E-05 0,00332964
Slc7a8 2,3131 7,50E-06 0,000439975 1700096K18Rik -2,0981 0,003042792 0,041318544
Cndp2 2,3121 1,84E-13 1,49E-10 Dusp10 -2,1039 0,000146948 0,004463078
Dmxl2 2,2896 0,000355586 0,008615606 Atp2a3 -2,1062 0,000142584 0,004385157
Ms4a8a 2,2845 0,002732494 0,038178105 Stat4 -2,1098 1,05E-05 0,000565887
Trim30c 2,2842 0,00173957 0,027959253 Farp1 -2,1217 0,000806993 0,015832835
Gm37795 2,2827 0,002734731 0,038178105 Itgb7 -2,1263 6,11E-07 5,79E-05
Rsad2 2,2799 9,31E-05 0,003230084 Clcf1 -2,1362 0,00068259 0,013970178
Klra8 2,2743 0,003222502 0,043039818 Klrb1f -2,1379 2,07E-06 0,000157622
Osbpl1a 2,2634 0,000588825 0,012541732 Lrrc75a -2,1391 0,000125716 0,004003445
Chst14 2,2620 0,002640822 0,037376609 E430024P14Rik -2,1494 0,000710636 0,014388911
Litaf 2,2608 2,80E-11 1,16E-08 Gm37842 -2,1638 0,003246985 0,043299046
Rab7b 2,2601 0,000130329 0,004127244 Pde7a -2,2077 7,40E-12 3,51E-09
Eps8 2,2497 2,70E-05 0,001241566 Prkce -2,2120 8,33E-05 0,002964203
Fstl1 2,2431 6,87E-05 0,002554734 Klra5 -2,2122 0,003551287 0,045610923
Cdkn1a 2,2402 2,84E-05 0,001282941 Snord104 -2,2182 0,00055125 0,012016971
Gm43775 2,2313 0,001343146 0,022903262 Tox -2,2205 0,000324184 0,00818346
Gas2l3 2,2228 0,000217018 0,005947131 Cyp2e1 -2,2371 0,000590867 0,012559794
Cpd 2,2165 2,48E-07 2,72E-05 Rasgrp2 -2,2473 1,17E-06 9,64E-05
Stra6l 2,2110 0,002037254 0,031123888 Rab3a -2,2546 0,003893424 0,048829426
Osm 2,2077 2,17E-05 0,001032422 Ets1 -2,2579 0,000200822 0,005596243
Clec4a2 2,2053 0,001677873 0,027344256 D130040H23Rik -2,2588 0,000405675 0,009495785
Lmna 2,2048 0,00169611 0,027519876 Gimap8 -2,2610 0,000872846 0,016740006
Tlr2 2,2028 0,002695555 0,037806432 Peg13 -2,2630 3,14E-05 0,00136878
Plxnc1 2,2011 6,77E-06 0,000404012 Rnf122 -2,2969 0,001285767 0,022242433
Gna12 2,1956 1,38E-09 3,45E-07 Cdyl2 -2,3056 4,55E-05 0,001865036
Prdx1 2,1788 4,58E-14 3,91E-11 Klrb1 -2,3121 0,002196381 0,032862192
4930430E12Rik 2,1430 3,10E-05 0,001366951 Grasp -2,3180 0,001321506 0,022707972
Stard8 2,1407 1,32E-05 0,000690915 Gm26189 -2,3196 0,000863513 0,016605805
Ctsl 2,1407 3,18E-07 3,29E-05 Cacna1e -2,3396 3,14E-06 0,000220717
Ly6c2 2,1327 0,00176111 0,028172809 Gem -2,3408 0,000109368 0,003631397
Nckap1 2,1315 0,003046298 0,041333279 Gm38243 -2,3446 0,000861049 0,016588309
Slfn1 2,1290 0,003479548 0,045096743 Tlr12 -2,3569 0,000465702 0,010514634
Ctsz 2,0947 6,22E-05 0,002359301 9430087J23Rik -2,3578 0,000587682 0,012538928
Gdpd1 2,0923 0,002448194 0,035438785 Tnfrsf18 -2,3586 0,000217064 0,005947131
Scimp 2,0824 0,000149675 0,00450582 Cd69 -2,3599 2,76E-07 2,95E-05
Slc37a2 2,0750 0,000651077 0,01348693 Cbx7 -2,3609 0,000990417 0,018320877
Tax1bp3 2,0593 0,00326284 0,043398048 Grap2 -2,3651 1,17E-05 0,000617656
Gusb 2,0553 1,94E-06 0,000148795 Gm7967 -2,3682 0,000329398 0,008208012
Msr1 2,0540 0,000100734 0,003391379 Ugt3a1 -2,3789 0,002186877 0,03277244
Arl11 2,0532 0,000635077 0,013268214 1700023H06Rik -2,3804 0,002200733 0,032893442
Atp6v1c1 2,0494 1,83E-11 7,91E-09 Gimap4 -2,4032 8,94E-05 0,003126262
Fcgr2b 2,0466 0,000307901 0,007855848 Gm37352 -2,4058 8,07E-05 0,002912495
Lxn 2,0425 3,36E-07 3,42E-05 Mgst2 -2,4097 0,000196538 0,005490515
Usp18 2,0421 5,52E-05 0,002165191 Gm37090 -2,4139 0,002735475 0,038178105
Akip1 2,0262 0,001784356 0,028383054 Chrne -2,4169 0,002704134 0,037895624
Ly6a 2,0249 0,003072278 0,041586608 Gm29438 -2,4171 0,002196717 0,032862192
Tspan3 2,0235 0,000834247 0,016227448 Rfx2 -2,4247 0,002022349 0,031042698
Ms4a4c 2,0193 0,001952651 0,030244828 Fosb -2,4304 0,000168662 0,004896074
Wfdc17 2,0096 8,16E-05 0,002930993 Pitpnm2 -2,4629 0,000175233 0,005052446
Lap3 2,0079 0,000365329 0,008782829 Ppp1r15a -2,4695 3,59E-06 0,000243488
Ctss 2,0076 2,87E-06 0,000206876 Ipcef1 -2,4715 6,05E-12 2,95E-09
  209 
 
Gene FC pval padj Gene FC pval padj
Afmid -2,4788 0,003325062 0,043928391 Xlr4a -3,1038 0,000468908 0,010573047
F2rl1 -2,4936 0,001592483 0,026237542 Apol7e -3,1148 2,07E-05 0,000987377
Ifng -2,4959 0,001069289 0,019354931 Lat -3,1197 1,12E-06 9,32E-05
Katnb1 -2,5005 5,20E-05 0,002087221 Tasp1 -3,1357 5,55E-10 1,63E-07
Lrrk2 -2,5024 0,001068672 0,019354931 Arl4d -3,1364 6,75E-07 6,30E-05
Myo6 -2,5060 1,95E-05 0,000944633 2610024D14Rik -3,1438 0,000215309 0,005927602
Ccl4 -2,5126 4,94E-06 0,000314819 Rab11fip4 -3,1455 2,39E-09 5,23E-07
Dennd5b -2,5292 0,000207992 0,005763335 Gm44175 -3,1544 0,003549375 0,045610923
Slc25a53 -2,5342 7,42E-07 6,77E-05 Gm26884 -3,1556 0,000170014 0,00492694
Tspan15 -2,5398 0,001924275 0,029976273 Angptl1 -3,1565 0,001167218 0,02071023
L1cam -2,5467 1,21E-08 2,10E-06 Klri1 -3,1645 1,96E-09 4,59E-07
Ccl5 -2,5521 9,96E-06 0,000539461 Adgrl4 -3,1914 0,000416525 0,009659872
Osgin1 -2,5527 0,001708271 0,027612194 Fgl1 -3,1977 2,15E-05 0,001026739
Gdf11 -2,5647 5,98E-08 8,44E-06 Heatr9 -3,2527 1,23E-06 0,000100191
Plekhf1 -2,5687 0,001753172 0,028124901 Gm4312 -3,2626 6,31E-05 0,002384098
Dgka -2,5741 2,17E-07 2,45E-05 Aim1l -3,2646 1,85E-07 2,16E-05
Gm26724 -2,5795 0,000210107 0,005803113 Gm28053 -3,2747 0,000559768 0,012095861
E430021H15Rik -2,5798 0,001411703 0,023857786 Gm15872 -3,3037 0,000147719 0,004470592
Gm37023 -2,5885 0,003541923 0,045563301 2810468N07Rik -3,3440 0,001789218 0,028383054
Baiap3 -2,5886 0,000179931 0,005153092 Gm24616 -3,3651 0,003674154 0,046769901
Gm36724 -2,5918 8,43E-05 0,002991291 Cd163 -3,3673 3,30E-05 0,001427451
Adrb2 -2,5930 8,29E-07 7,44E-05 Gm21909 -3,3712 4,26E-06 0,000277221
Cnrip1 -2,6021 1,44E-05 0,000736651 Ttn -3,3830 3,75E-07 3,75E-05
Klrb1a -2,6172 1,09E-05 0,000582479 Ddx43 -3,3931 9,16E-08 1,19E-05
Izumo4 -2,6212 0,000544816 0,011907118 Clec1b -3,4041 0,002997837 0,040838049
Akap12 -2,6397 0,000459973 0,010420842 Ebf1 -3,4077 7,60E-05 0,002779528
Rora -2,6513 5,65E-06 0,000350673 Klrc1 -3,4275 1,01E-08 1,80E-06
Zfp831 -2,6533 6,15E-05 0,002353271 Cyp2d22 -3,4286 0,003397921 0,044387004
Aff3 -2,6805 0,001308815 0,022537169 C330011M18Rik -3,4302 1,19E-07 1,49E-05
Serpina3f -2,6833 9,48E-06 0,000521859 Gm6506 -3,4417 0,000136649 0,004256304
Traf3ip2 -2,6834 1,12E-07 1,43E-05 Gm27240 -3,4422 3,17E-06 0,00022156
Gm38126 -2,6892 0,000961075 0,018053138 Gm36028 -3,4791 0,003614194 0,046259644
B130055M24Rik -2,7053 0,000369789 0,008877539 Ms4a1 -3,4820 1,41E-12 8,90E-10
Serpini1 -2,7276 1,75E-05 0,000865434 H2-Oa -3,4878 0,000614804 0,012939701
Cers4 -2,7321 1,54E-07 1,86E-05 Lrrn4 -3,4976 0,001636989 0,026815521
Trbc2 -2,7348 4,49E-05 0,0018512 Pik3c2b -3,5012 2,94E-06 0,000211132
Hdc -2,7402 0,000378744 0,008989444 Adgrl1 -3,5125 5,77E-10 1,64E-07
Acpp -2,7604 1,21E-05 0,000635586 Trac -3,5168 8,05E-06 0,000460284
Cd27 -2,7633 8,10E-05 0,002918646 Cd7 -3,5274 2,11E-09 4,74E-07
Bcl11b -2,7690 0,000508177 0,011279685 Cyp17a1 -3,5431 0,002798272 0,038825857
AI661453 -2,7777 0,002415004 0,035172108 Gm37802 -3,5496 0,000374152 0,008957087
Mir6924 -2,7844 0,003399309 0,044387004 Slc25a2 -3,5503 1,53E-05 0,000771767
Gbp10 -2,7877 0,003363431 0,0441227 Klrc2 -3,5517 4,81E-08 6,96E-06
Gimap3 -2,7899 1,36E-05 0,000706795 Cd160 -3,5537 7,12E-08 9,64E-06
Tob1 -2,7967 9,92E-08 1,28E-05 Xkrx -3,5584 0,00035585 0,008615606
Pdzd2 -2,7996 0,000382269 0,009047498 Cd3e -3,5650 0,001454854 0,024465916
Adgrg5 -2,8049 2,19E-05 0,001040406 Prlr -3,5708 0,000431116 0,009917409
Gm37469 -2,8058 0,001019569 0,01869282 Gm42870 -3,5879 0,000397466 0,009331971
4930532G15Rik -2,8069 0,000175898 0,005063079 Gm37447 -3,6302 0,003301267 0,043749479
Gm37215 -2,8237 0,002034038 0,031123888 Gm22101 -3,6604 0,001825614 0,028879894
Astl -2,8285 0,000526472 0,011595298 Gm10874 -3,6780 0,003631983 0,046368222
A630072L19Rik -2,8550 0,003117214 0,041928861 Sema4f -3,6792 0,00126744 0,022075448
Llgl2 -2,8635 0,000101649 0,00341543 Cd8a -3,6816 0,000187154 0,00532321
Slc10a1 -2,8667 2,22E-05 0,001048739 2010005H15Rik -3,7019 0,003953557 0,049474532
Gm26616 -2,8854 0,003108623 0,041879306 Cpne7 -3,7306 5,77E-05 0,002230973
Gm16845 -2,8869 0,000228577 0,006182538 Gm42684 -3,7348 3,91E-10 1,26E-07
Gm4956 -2,9446 1,91E-05 0,00093233 Gm20743 -3,7392 2,96E-07 3,10E-05
Ltb -2,9555 0,003149916 0,042335371 Gm23442 -3,7609 0,003051671 0,041373297
Cd226 -2,9658 1,11E-06 9,31E-05 Cr2 -3,7812 0,000114694 0,003750415
Gm16575 -2,9687 1,80E-05 0,000886777 Cdh17 -3,7953 0,000115172 0,003758819
Gm11769 -2,9739 0,002659475 0,037486783 Dtx1 -3,8106 1,81E-08 2,88E-06
Gjb2 -3,0002 5,52E-05 0,002165191 Cxcr3 -3,8220 6,39E-09 1,23E-06
Rasgrf1 -3,0006 0,000113708 0,003732469 Ighd -3,8383 1,41E-06 0,0001124
Hspa1b -3,0300 0,00032286 0,00817641 Gm45108 -3,8584 0,001786577 0,028383054
1700019D03Rik -3,0341 0,00073327 0,014729412 Mmp9 -3,8599 5,34E-05 0,002111763
Gm17334 -3,0382 0,001019164 0,01869282 Apol11b -3,8747 0,002568476 0,036537402
Gm15890 -3,0601 0,000994548 0,018372227 Tcrg-C2 -3,8867 0,000298522 0,007673897
Rapgef4 -3,0736 0,001110191 0,019926241 Cxcr5 -3,8917 0,000130649 0,00412972
Gm37176 -3,0745 0,003595832 0,04607902 Pax5 -3,8943 0,001139991 0,020311598
Abi3bp -3,0927 0,001634066 0,026796721 Cyp4b1 -3,9025 0,003154229 0,042359985
  210  
Gene FC pval padj Gene FC pval padj
Fam124b -3,9079 0,001758817 0,028162521 Trgv2 -5,5902 4,33E-06 0,000281065
Ccdc136 -3,9207 0,000144335 0,004415141 Trgj4 -5,5938 8,37E-07 7,44E-05
Art2b -3,9352 4,70E-06 0,000300228 A1bg -5,6016 7,58E-06 0,000442471
G0s2 -3,9753 0,000642159 0,01337887 Adh1 -5,6250 2,71E-05 0,001241566
Gm43081 -3,9763 0,001862811 0,029224558 Igkv12-98 -5,6433 9,36E-06 0,000518598
Gm9694 -3,9904 0,001751474 0,028124095 C6 -5,6663 2,19E-06 0,000165641
Gramd2 -4,0263 0,00353729 0,045563301 Igkv2-109 -5,6690 2,40E-05 0,001115255
Chp2 -4,0298 0,00354224 0,045563301 Igha -5,6870 4,61E-08 6,73E-06
Acsm1 -4,0388 0,003420414 0,044509208 Chad -5,7139 8,94E-07 7,86E-05
Snord43 -4,0401 0,000409951 0,009546313 Ahsg -5,7398 9,45E-06 0,000521859
Ighv1-55 -4,0549 0,003341605 0,04397944 Gm26614 -5,7774 3,70E-06 0,000248503
Kcnh6 -4,0577 0,003207338 0,042938075 Cd200r2 -5,7856 7,03E-08 9,59E-06
P4htm -4,0708 0,000778508 0,015415724 Vsig4 -5,7988 7,39E-06 0,00043627
Gm35339 -4,0869 0,000654393 0,013522804 Tcrg-C1 -5,8053 3,14E-09 6,69E-07
Prrt1 -4,0981 5,65E-09 1,10E-06 Igkc -6,0199 3,83E-08 5,74E-06
Pou2af1 -4,1143 0,000158881 0,00470824 Cd40lg -6,0216 2,84E-06 0,000205703
Nat8f1 -4,1228 0,000422036 0,009734771 Gm6934 -6,1252 5,33E-10 1,60E-07
Btla -4,1256 1,50E-06 0,000117379 Ngp -6,1417 3,84E-09 8,00E-07
Igkv2-112 -4,1306 0,002800084 0,038825857 Hlf -6,2732 3,90E-08 5,79E-06
Cxcr6 -4,1633 1,87E-09 4,44E-07 Itih4 -6,3431 1,62E-08 2,67E-06
Hic1 -4,1761 8,60E-05 0,003039472 Iglc1 -6,5732 1,62E-08 2,67E-06
Igkv8-24 -4,1945 0,002341025 0,034329 Podnl1 -6,5955 3,93E-12 1,97E-09
Pdgfrb -4,2093 0,002249637 0,033477816 Ighg2c -6,6177 2,78E-07 2,95E-05
Gm19590 -4,2234 0,001244167 0,021758897 Ltf -6,8146 2,14E-09 4,74E-07
Scd1 -4,2281 2,94E-05 0,001315173 Atp8a2 -6,8275 1,51E-11 6,95E-09
Btbd11 -4,2460 2,70E-13 2,00E-10 Alb -6,9565 2,11E-09 4,74E-07
Zfp683 -4,2624 9,30E-07 8,10E-05 Jchain -6,9871 9,59E-18 6,26E-14
Ighv3-6 -4,2689 0,001969412 0,030449083 Igkv17-127 -7,1033 2,00E-09 4,62E-07
Fga -4,3144 0,00025442 0,006743319 Cd79a -7,2156 7,27E-15 8,27E-12
Tnfrsf13c -4,3228 4,84E-09 9,60E-07 Cd19 -7,4659 1,73E-16 3,68E-13
Ccr6 -4,4031 0,000990695 0,018320877 St6galnac3 -7,5245 1,04E-14 1,07E-11
Paqr9 -4,4084 0,000291011 0,007503421 Igkv1-135 -7,7226 2,13E-12 1,21E-09
Rln3 -4,4896 0,000766572 0,015214667 Igkv10-96 -7,7543 1,68E-14 1,60E-11
Dmpk -4,5020 6,22E-05 0,002359301 Clec4f -8,0141 1,29E-10 4,68E-08
Apol7b -4,5103 2,74E-05 0,001252267
Fcer2a -4,5331 3,23E-08 4,92E-06
Dysf -4,5357 0,001025559 0,018782468
Glp1r -4,5460 0,00026845 0,007038658
Gm26640 -4,5519 7,69E-05 0,002793744
Gm16602 -4,5954 0,000520363 0,011500529
Zfp93 -4,6288 6,06E-06 0,00036955
Mzb1 -4,7031 0,000347145 0,00851352
Pck1 -4,7128 9,90E-07 8,53E-05
Iglc3 -4,7496 1,36E-05 0,000706795
Gm25106 -4,7701 5,87E-06 0,000360468
Sdpr -4,7960 0,000135339 0,004230948
Blk -4,7995 2,29E-05 0,001070915
Igkv17-121 -4,8072 0,000161505 0,004752973
Pzp -4,8430 0,000202459 0,005628293
Gm10505 -4,8471 0,000118879 0,003821401
H2-Ob -4,8580 5,52E-13 3,77E-10
Ighv10-1 -4,8638 0,000392556 0,009229387
Gm26802 -4,8728 3,99E-05 0,001668406
Ambp -4,8908 0,000161041 0,00474751
Kcna2 -4,9051 7,39E-09 1,39E-06
Serpina3k -4,9807 9,59E-05 0,003295617
Bend5 -4,9916 0,000178079 0,005117213
Ccdc80 -4,9928 2,94E-05 0,001315173
Ighv1-64 -5,0112 0,000216489 0,005947131
Axin2 -5,0227 3,47E-08 5,25E-06
Igkv6-32 -5,0685 0,000139124 0,004294213
Cdc42ep1 -5,1057 1,37E-07 1,70E-05
Igkv3-10 -5,1095 0,000163986 0,004808243
Id3 -5,1440 2,61E-14 2,34E-11
Zmat4 -5,1743 2,15E-06 0,000162886
Tat -5,3073 8,25E-05 0,002954115
Igkv3-2 -5,3089 6,31E-05 0,002384098
Tcrg-C4 -5,3770 3,38E-17 1,44E-13
Igkv8-30 -5,3996 7,40E-05 0,002714931
Ablim2 -5,5393 5,85E-06 0,000360468
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Table A.3. Comparison III. All differentially expressed genes from the comparison III: uterine CD49a+ (ILC1, 
trNK) subsets vs uterine CD49a- (cNK) subset. FC: fold change, padj: adjusted p-value. 
 
Gene FC pval padj Gene FC pval padj
Ccl7 7,6916 1,75E-14 5,91E-11 Rin2 5,9022 5,77E-07 3,97E-05
Pf4 7,3764 2,97E-10 1,07E-07 Nr1h3 5,8917 1,62E-07 1,52E-05
Cd109 7,3175 1,06E-08 1,79E-06 Rhov 5,8875 9,52E-06 0,000326269
C3ar1 7,2746 4,47E-14 9,43E-11 Vcam1 5,8835 2,61E-08 3,76E-06
Kdr 7,2540 8,20E-11 3,64E-08 Wdfy4 5,8801 9,01E-08 9,68E-06
Tlr1 7,0754 5,67E-10 1,77E-07 H2-DMb1 5,8770 2,45E-07 2,14E-05
Ptafr 6,9619 3,06E-10 1,07E-07 Ankrd66 5,8525 4,21E-06 0,000176364
Ccl2 6,9266 2,91E-10 1,07E-07 Ctsh 5,8456 4,06E-07 3,03E-05
Msr1 6,8975 1,13E-09 3,07E-07 Anxa3 5,8445 4,24E-07 3,15E-05
Slco2b1 6,7718 6,31E-08 7,60E-06 Cysltr1 5,8351 4,37E-07 3,20E-05
Flrt3 6,7663 2,96E-12 3,33E-09 Atp6v0a1 5,8336 1,54E-08 2,40E-06
Ctnnd2 6,7396 3,86E-08 5,09E-06 Tlr13 5,8201 8,91E-07 5,32E-05
Adam33 6,7207 9,75E-09 1,66E-06 P2ry13 5,8163 1,60E-06 8,37E-05
Fcgr1 6,6940 3,90E-09 8,23E-07 Gdpd1 5,8063 1,43E-06 7,78E-05
C5ar1 6,6837 5,37E-10 1,71E-07 Axl 5,8024 3,88E-07 2,95E-05
Ccl12 6,6717 3,28E-08 4,49E-06 Zscan12 5,7961 6,54E-07 4,30E-05
Mfsd12 6,6694 3,01E-19 5,08E-15 Zak 5,7731 6,01E-09 1,13E-06
Pltp 6,6538 2,99E-10 1,07E-07 Gdf3 5,7717 1,84E-07 1,69E-05
Fam114a1 6,6314 1,18E-08 1,93E-06 Pld4 5,7479 1,09E-06 6,18E-05
Ch25h 6,6158 1,12E-07 1,13E-05 Acvr1 5,7468 2,65E-06 0,000122576
Lpcat2 6,6151 1,38E-10 5,69E-08 Spi1 5,7410 1,24E-06 6,88E-05
Tmem86a 6,6126 2,05E-09 5,01E-07 Oas2 5,7312 8,91E-07 5,32E-05
Nectin4 6,5694 4,64E-12 4,89E-09 Thbs1 5,7293 1,50E-08 2,38E-06
Fkbp9 6,4991 2,94E-07 2,42E-05 Cd68 5,7258 3,55E-10 1,22E-07
Psd3 6,4966 4,41E-09 8,85E-07 Tdrd9 5,7219 1,41E-05 0,000443537
Stxbp1 6,4908 9,56E-10 2,69E-07 Gzmd 5,7205 2,15E-08 3,21E-06
Tal1 6,4448 3,14E-07 2,51E-05 Fam20c 5,7086 8,61E-07 5,26E-05
Lacc1 6,4392 9,76E-10 2,70E-07 Matn2 5,6992 2,64E-06 0,000122576
Ahnak2 6,4089 4,94E-08 6,32E-06 Gas2l1 5,6962 8,68E-07 5,28E-05
Ass1 6,3975 2,09E-11 1,41E-08 Ddx3y 5,6949 1,68E-05 0,000507713
Rnf144b 6,3899 2,24E-09 5,33E-07 Adap2 5,6931 2,72E-06 0,000124473
Lyve1 6,3693 8,23E-08 9,20E-06 Igsf10 5,6928 1,19E-05 0,000389832
Retnla 6,3666 5,12E-11 2,70E-08 Cd93 5,6917 8,61E-10 2,51E-07
Rab7b 6,3189 5,76E-08 7,14E-06 Eps8 5,6916 3,47E-07 2,70E-05
Ptgfrn 6,3150 5,33E-07 3,70E-05 Arg1 5,6824 2,67E-09 6,09E-07
Pde7b 6,3040 1,36E-08 2,18E-06 Ednrb 5,6743 3,30E-14 8,64E-11
Itga9 6,2488 2,21E-08 3,27E-06 Nrp1 5,6727 9,36E-13 1,43E-09
Plb1 6,2416 6,77E-07 4,39E-05 Dsc2 5,6722 6,85E-06 0,000252388
Rab3il1 6,2179 6,49E-07 4,30E-05 Adgre1 5,6700 1,85E-06 9,19E-05
Cebpa 6,2156 3,83E-08 5,09E-06 Apoe 5,6688 1,32E-07 1,28E-05
Pdpn 6,2077 9,54E-09 1,64E-06 Ltbr 5,6667 5,56E-06 0,000215169
Ecm1 6,1989 2,79E-09 6,27E-07 Tlr7 5,6646 1,90E-07 1,73E-05
Gas6 6,1716 1,31E-07 1,28E-05 Sdc3 5,6556 7,10E-08 8,14E-06
Cxcl16 6,1664 7,72E-11 3,52E-08 Gm44205 5,6452 2,56E-05 0,00070061
Plxna1 6,1507 1,15E-09 3,08E-07 Il7r 5,6418 9,10E-11 3,93E-08
Clec7a 6,1454 2,53E-07 2,17E-05 Olfml2b 5,6357 3,78E-05 0,000953299
Gzmf 6,1420 4,78E-09 9,48E-07 F10 5,6278 9,54E-09 1,64E-06
Fzd7 6,1270 2,70E-08 3,80E-06 Gm43768 5,6171 4,55E-06 0,000187226
Egln3 6,1224 3,02E-07 2,43E-05 Ccl6 5,5985 1,31E-07 1,28E-05
Wfdc17 6,1147 7,08E-08 8,14E-06 Gm13650 5,5918 1,87E-05 0,000552791
Rgs10 6,1105 2,70E-08 3,80E-06 Ifitm1 5,5885 5,37E-06 0,00020972
Trim30c 6,0985 2,51E-08 3,65E-06 Tgm2 5,5843 9,34E-10 2,67E-07
Reps2 6,0816 1,86E-07 1,70E-05 Pfkfb4 5,5706 5,79E-06 0,000220911
Lipg 6,0561 3,51E-06 0,000152327 Slfn4 5,5648 9,40E-07 5,55E-05
Tnip3 6,0530 2,89E-08 4,03E-06 Rnf217 5,5608 5,76E-06 0,000220715
Stra6l 6,0511 8,20E-08 9,20E-06 Cttnbp2nl 5,5582 3,08E-06 0,000138234
Mertk 6,0213 5,98E-07 4,09E-05 Lifr 5,5396 7,74E-07 4,87E-05
Tiam1 6,0203 1,51E-08 2,38E-06 Cd33 5,5339 2,47E-07 2,15E-05
Mafb 6,0189 9,66E-08 1,02E-05 Siglec1 5,5327 1,46E-06 7,89E-05
Plau 6,0116 3,31E-09 7,15E-07 Ly86 5,5300 3,56E-07 2,74E-05
Arl11 6,0075 4,52E-08 5,81E-06 P2ry1 5,5297 1,47E-05 0,000458873
Havcr2 5,9932 9,81E-08 1,02E-05 Gpr84 5,5164 9,90E-06 0,000337399
Mmp14 5,9610 9,17E-08 9,79E-06 Clec4n 5,5121 1,98E-06 9,63E-05
Etv5 5,9499 3,58E-14 8,64E-11 Adamts1 5,5115 2,43E-06 0,000114901
Ier3 5,9475 1,94E-07 1,74E-05 Tlr9 5,5069 4,94E-06 0,000198682
Ninj1 5,9389 5,26E-12 5,22E-09 Cmtm3 5,4899 1,31E-07 1,28E-05
Apbb2 5,9327 4,60E-10 1,51E-07 Csf2rb 5,4884 3,59E-06 0,000155394
C1qb 5,9299 3,19E-07 2,51E-05 Mgat3 5,4871 2,87E-05 0,000767964
Cdkl2 5,9226 4,60E-07 3,32E-05 Mgl2 5,4852 6,29E-07 4,22E-05
Gpnmb 5,9102 1,51E-11 1,16E-08 Sirpa 5,4848 1,70E-06 8,67E-05
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Gene FC pval padj Gene FC pval padj
Ankrd33b 5,4817 2,96E-05 0,000786609 Zfp385a 5,1670 3,90E-05 0,000977737
Clec10a 5,4816 2,35E-05 0,000652462 Igfbp5 5,1649 9,21E-05 0,001937896
Arhgap24 5,4790 2,76E-06 0,000125356 Rnase2a 5,1621 0,000203815 0,003554858
Hmox1 5,4702 3,49E-07 2,70E-05 Cacna1d 5,1604 1,14E-05 0,000375158
Coprs 5,4654 3,96E-05 0,000988275 Cd36 5,1530 4,65E-06 0,000189974
Clec4a1 5,4642 5,65E-06 0,000217539 Ptk2 5,1522 6,68E-05 0,001513232
C1qc 5,4490 2,30E-06 0,000110328 A630012P03Rik 5,1490 0,000208258 0,003608715
Tmem256 5,4352 1,81E-06 9,10E-05 Avil 5,1482 1,56E-06 8,20E-05
Apba1 5,4283 5,92E-06 0,000224731 Mmp19 5,1458 3,99E-05 0,000993102
Ifi207 5,4277 2,62E-06 0,000122289 Lmo2 5,1362 1,63E-05 0,000494791
Gzmg 5,4272 4,36E-07 3,20E-05 Hacd4 5,1302 1,83E-05 0,000544503
Fmn1 5,4202 8,85E-06 0,000308962 Lhfpl2 5,1280 1,09E-05 0,000362876
Cp 5,4168 7,01E-09 1,27E-06 Inhba 5,1259 1,34E-06 7,42E-05
Il1r2 5,4146 1,49E-05 0,000462847 Ifitm3 5,1255 2,03E-05 0,000590897
Plbd1 5,3980 1,67E-06 8,58E-05 Slc7a8 5,1254 1,49E-06 7,93E-05
Pla2g7 5,3925 9,34E-06 0,000322163 Atrnl1 5,1240 4,60E-05 0,001116859
H2-Eb1 5,3905 8,59E-06 0,000303524 Arhgef39 5,1235 2,10E-05 0,000599909
Igf1 5,3892 1,94E-07 1,74E-05 Parp12 5,1225 1,59E-07 1,50E-05
Rab32 5,3838 7,67E-11 3,52E-08 Alox5ap 5,1181 2,86E-05 0,000766311
Tmtc3 5,3824 4,39E-07 3,20E-05 Tlr3 5,1169 5,31E-07 3,70E-05
Adora2b 5,3811 2,04E-05 0,000592181 Tifab 5,1147 3,36E-05 0,000867196
Cdc42bpb 5,3772 5,88E-06 0,000223818 Slc8a1 5,1139 5,73E-05 0,001328196
H2-Ab1 5,3760 5,02E-06 0,000200316 H2-Aa 5,1091 2,12E-05 0,000602302
Tnfrsf11a 5,3711 7,06E-07 4,51E-05 Tmem144 5,1067 7,17E-05 0,001595542
Dcn 5,3708 2,98E-05 0,000790673 Nfix 5,0972 3,79E-05 0,000953299
Aif1 5,3673 9,28E-06 0,000320782 Vdr 5,0963 6,01E-05 0,001380384
Lrp1 5,3663 6,34E-07 4,25E-05 Cryl1 5,0953 3,42E-06 0,000149113
Slc7a7 5,3579 6,00E-08 7,33E-06 Cxcl2 5,0889 2,39E-05 0,000659725
Nt5dc2 5,3578 4,05E-05 0,001006251 Emp1 5,0854 1,08E-11 8,69E-09
Csf1r 5,3557 3,64E-06 0,000156879 Ctss 5,0830 2,65E-08 3,79E-06
Ccr1 5,3531 2,83E-07 2,35E-05 Ly6a 5,0777 2,01E-06 9,78E-05
Slc15a3 5,3527 5,02E-07 3,58E-05 Fcrl5 5,0765 2,08E-05 0,000595236
Plscr3 5,3433 8,78E-06 0,000308439 Pparg 5,0738 6,83E-05 0,001542607
Gm38357 5,3385 4,17E-09 8,47E-07 Aph1c 5,0602 1,51E-06 8,02E-05
Lpl 5,3259 1,17E-09 3,08E-07 3110082I17Rik 5,0595 3,09E-06 0,0001383
Trem2 5,3241 1,14E-05 0,000375158 Aph1b 5,0590 4,95E-05 0,001177371
Afp 5,3140 3,73E-05 0,000944305 Atp6v0d2 5,0558 4,25E-05 0,001044924
Ifi204 5,3084 3,45E-07 2,69E-05 Hgf 5,0554 8,39E-05 0,001798488
Cd74 5,2991 5,00E-06 0,000199739 Stard8 5,0515 1,04E-15 8,76E-12
Mefv 5,2796 1,17E-05 0,000383745 Stau2 5,0457 1,12E-08 1,86E-06
Stom 5,2781 3,34E-11 1,94E-08 Ms4a6d 5,0345 6,57E-06 0,000243988
Hp 5,2774 3,79E-06 0,000161987 Cped1 5,0295 0,0002231 0,0038085
C130050O18Rik 5,2761 1,57E-05 0,000483011 Cttn 5,0284 0,00014693 0,00278128
Pafah2 5,2692 1,10E-05 0,000362876 Cfh 5,0283 7,47E-06 0,000270264
Shtn1 5,2677 6,95E-06 0,000255269 App 5,0129 6,39E-06 0,000238516
Sh2b2 5,2550 2,59E-06 0,000121473 C3 5,0085 1,20E-06 6,77E-05
Anpep 5,2475 1,87E-06 9,23E-05 Wdfy3 5,0042 4,04E-05 0,001004265
Fggy 5,2464 4,24E-05 0,00104479 Plxnb2 5,0001 1,81E-06 9,10E-05
Cd180 5,2421 7,15E-06 0,000260237 Olr1 4,9998 2,04E-05 0,000592181
Csf2ra 5,2418 6,24E-07 4,21E-05 Gm37648 4,9997 5,21E-06 0,000206639
Myof 5,2388 2,31E-06 0,000110434 Dusp4 4,9888 5,68E-05 0,001318758
Ccl8 5,2362 4,86E-05 0,001160286 Adgrg6 4,9885 0,00011066 0,002240564
P2ry6 5,2321 6,46E-06 0,000240686 Ctsg 4,9824 0,000173711 0,003163933
Cebpd 5,2292 3,24E-05 0,000842043 Gsn 4,9810 5,85E-07 4,01E-05
Gm15635 5,2225 7,08E-05 0,001580211 6430548M08Rik 4,9784 6,76E-05 0,001530115
Tbc1d8 5,2208 4,45E-07 3,22E-05 Ago4 4,9784 4,84E-06 0,000195123
Arhgap29 5,2159 9,55E-07 5,55E-05 Il18 4,9767 0,0001121 0,002262648
Acvrl1 5,2070 3,25E-05 0,000844547 Mrm2 4,9736 1,22E-05 0,00039717
Lsr 5,2027 1,21E-05 0,000395264 Ccdc122 4,9637 0,000120413 0,002378079
Rhou 5,2003 1,07E-05 0,000356462 Gm16353 4,9621 8,55E-07 5,24E-05
Dhrs9 5,1956 3,73E-06 0,000159957 Pde8b 4,9443 8,07E-05 0,001747545
A230028O05Rik 5,1935 0,000120065 0,002373984 Sncg1 4,9392 2,80E-05 0,000754044
Vipr2 5,1896 2,87E-05 0,000767989 Pid1 4,9321 2,09E-05 0,000597773
Flt1 5,1889 1,22E-05 0,000395663 Gpr19 4,9309 1,61E-05 0,000491761
Spsb1 5,1887 1,64E-06 8,51E-05 St8sia6 4,9298 0,000124879 0,002454792
4930533B01Rik 5,1767 7,54E-05 0,001657037 Ifngr2 4,9292 3,77E-06 0,000161227
Mtss1 5,1747 3,68E-07 2,82E-05 Il1a 4,9286 7,06E-05 0,001578345
P2rx7 5,1744 8,82E-06 0,000308962 Cd83 4,9252 3,45E-08 4,69E-06
Cds1 5,1717 5,92E-05 0,001362975 2210406H18Rik 4,9249 6,58E-08 7,81E-06
Gdf15 5,1672 4,94E-05 0,001176974 9130204K15Rik 4,9218 0,000126199 0,002458821
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Gene FC pval padj Gene FC pval padj
Ms4a4a 4,9157 9,28E-06 0,000320782 Nlrp3 4,6676 0,000235161 0,003974176
Arfgef3 4,9147 2,94E-06 0,000132519 Gzme 4,6617 2,54E-06 0,00011979
Mreg 4,9044 3,48E-05 0,00089416 Gpt2 4,6616 7,61E-06 0,000274203
Prokr1 4,9009 0,00035651 0,005526557 Siglece 4,6609 0,000182285 0,003288149
Hpgds 4,8988 1,57E-12 2,20E-09 Gm13710 4,6594 0,000566124 0,007705757
Plaur 4,8950 6,38E-06 0,000238516 Gpr35 4,6592 5,68E-05 0,001318758
Kcnk6 4,8940 7,65E-08 8,66E-06 Fut10 4,6560 0,001011918 0,011827451
Gspt2 4,8923 0,000127272 0,002467314 Gm23722 4,6537 0,000171741 0,003134826
Tifa 4,8899 0,000118398 0,002352055 Ctsz 4,6484 1,91E-07 1,73E-05
Copz2 4,8861 1,11E-05 0,000366162 Tgfbi 4,6469 5,63E-05 0,001314161
Kdelc1 4,8857 1,51E-05 0,000467016 Fpr2 4,6457 0,000217257 0,003731421
Clec4a2 4,8830 4,14E-06 0,000174834 Epb41l1 4,6417 1,71E-06 8,67E-05
Tnf 4,8796 2,61E-06 0,00012191 Sestd1 4,6401 5,20E-05 0,00122786
Gstm4 4,8789 7,55E-05 0,001658663 Ifit3b 4,6400 2,59E-06 0,000121491
Grn 4,8756 4,87E-09 9,55E-07 Rnf150 4,6368 5,00E-06 0,000199739
Rubcnl 4,8725 8,04E-05 0,001745428 Tnfaip2 4,6332 0,000242841 0,004079443
Thsd7a 4,8633 0,000406719 0,006075934 Rps4l 4,6325 5,44E-05 0,001273546
Slamf8 4,8629 9,20E-05 0,001937508 Cd300a 4,6306 2,36E-05 0,000654147
Twnk 4,8542 7,97E-07 4,96E-05 Arhgef10l 4,6290 0,000219783 0,003763305
Mpeg1 4,8528 2,12E-05 0,000602302 Alox5 4,6183 0,000126331 0,002458821
Cyp4f18 4,8517 0,000102584 0,002112547 Clec4a3 4,6154 0,000441644 0,006461316
Batf3 4,8371 5,64E-05 0,001315333 Plekho1 4,6142 2,90E-06 0,000131341
Plin2 4,8286 7,78E-12 6,91E-09 Spic 4,6140 1,21E-06 6,78E-05
Aqp9 4,8208 3,31E-05 0,000856972 Tmem221 4,6045 0,00055528 0,007624047
Marcks 4,8200 9,37E-06 0,000322584 Gm42603 4,6038 0,00078623 0,009757588
Rassf4 4,8194 5,08E-06 0,000202243 Gm2a 4,6013 3,41E-06 0,000149113
Sh3bp4 4,8079 0,000103323 0,002117441 E130102H24Rik 4,5999 0,000255077 0,00423855
Gm6377 4,8026 0,000170573 0,003122974 Tbxas1 4,5995 3,19E-06 0,000140699
Vkorc1 4,8020 3,42E-06 0,000149113 Bag2 4,5949 0,000452217 0,006597833
Ppfibp2 4,8000 0,000108756 0,002212648 Pdgfc 4,5944 0,000281235 0,004609632
Tmem26 4,7937 0,000186157 0,00334726 Oasl2 4,5924 5,23E-06 0,000206639
Klk1b11 4,7919 0,000426677 0,006282037 Bex6 4,5908 0,000640693 0,008396211
Lgmn 4,7882 7,88E-07 4,94E-05 Stab1 4,5904 8,52E-07 5,24E-05
Gm14011 4,7878 0,000613773 0,008120285 Mrc1 4,5901 2,30E-05 0,000643208
Fn1 4,7858 3,18E-06 0,000140699 Kcnk13 4,5872 0,000291632 0,004738591
Tmem106a 4,7804 1,47E-07 1,41E-05 Zfyve9 4,5819 0,000155619 0,002903403
I830077J02Rik4,7787 0,000103164 0,002116744 Tlr2 4,5650 5,65E-05 0,001316549
Abcc3 4,7784 0,000101843 0,002099859 Bmpr1a 4,5622 1,94E-05 0,000569917
Tlr6 4,7775 4,40E-07 3,20E-05 Vill 4,5594 0,000175201 0,003180782
Ap1s1 4,7713 5,99E-05 0,001379092 Ifi211 4,5590 1,60E-06 8,37E-05
F11r 4,7711 4,06E-05 0,001006999 Lst1 4,5589 0,000149675 0,002817436
Scamp1 4,7701 2,42E-05 0,000668626 Fap 4,5588 0,000452667 0,006598685
Cd4 4,7667 0,000127145 0,002467314 C1qa 4,5531 0,000193956 0,003445666
Klra2 4,7643 8,76E-05 0,001863234 Lrrc25 4,5389 0,000558607 0,007647293
Ak4 4,7637 0,000241103 0,004054286 Gm26797 4,5363 7,28E-05 0,001615388
Laptm4b 4,7599 6,99E-06 0,000256302 Gm17068 4,5317 0,000461436 0,006697568
Rusc2 4,7568 0,000166793 0,003077819 Zfp467 4,5314 3,18E-07 2,51E-05
Slc6a12 4,7507 0,000197654 0,003490713 Adap2os 4,5289 0,000307398 0,004910586
Clec4d 4,7467 3,41E-05 0,000878602 Ypel2 4,5254 0,000357448 0,005530931
Pla2g15 4,7414 1,36E-06 7,51E-05 2810025M15Rik 4,5229 6,97E-05 0,001565593
Tmem176b 4,7379 9,00E-05 0,001905201 Ctsb 4,5187 1,12E-10 4,71E-08
Lyz2 4,7378 4,54E-05 0,001107102 Spats2 4,5161 0,000682713 0,008796487
Gm45041 4,7369 0,000161013 0,002987513 Pdia5 4,5137 0,000566533 0,007705757
Cybb 4,7272 9,37E-05 0,001960148 Kif26b 4,5135 0,001254069 0,013933555
Mt1 4,7244 5,47E-06 0,00021196 Dab2 4,5134 3,41E-06 0,000149113
Gm5345 4,7124 0,000592093 0,007925592 Ly6i 4,5043 0,000117405 0,002343375
Gm16316 4,7120 7,82E-05 0,001706976 Dmxl2 4,5013 1,39E-05 0,000438033
Upp1 4,7039 0,000572542 0,007768699 Tgm1 4,4963 0,000497691 0,007065705
Sgms1 4,6990 3,20E-05 0,000835145 Gm15531 4,4916 0,00029223 0,004739181
P2ry12 4,6945 4,65E-05 0,001122033 Gm2396 4,4852 0,000606927 0,00806654
Ms4a7 4,6917 1,38E-05 0,000435307 Gm13391 4,4842 0,000937148 0,011107472
Mfsd7a 4,6906 0,000384304 0,005828848 Rtn1 4,4821 0,000557522 0,007644844
Eya4 4,6902 0,001053333 0,012190786 Dynlt1a 4,4819 0,000194325 0,003446351
Ugt1a7c 4,6820 1,85E-06 9,19E-05 Reep6 4,4819 0,000819935 0,01008682
Kif13a 4,6811 2,47E-05 0,000678727 Tns3 4,4793 4,66E-05 0,00112319
Htra3 4,6760 0,000202115 0,003537333 Gm37199 4,4730 0,000819658 0,01008682
Gm20658 4,6756 0,000571947 0,007766868 Apobec1 4,4727 2,82E-07 2,35E-05
Isg15 4,6711 3,18E-06 0,000140699 Tmprss4 4,4724 0,001537236 0,016214528
Slc7a2 4,6709 9,83E-08 1,02E-05 Fat1 4,4643 0,000575258 0,007776338
Rcn3 4,6705 0,000294596 0,004763806 Paox 4,4606 1,88E-06 9,23E-05
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Gene FC pval padj Gene FC pval padj
Akap1 4,4570 0,000757751 0,009516248 Trib1 4,2803 8,69E-05 0,001856672
Cdk5rap1 4,4535 2,18E-06 0,000105114 Pira2 4,2790 0,001251501 0,013914189
Rps6ka2 4,4500 0,000219608 0,003763305 Ift22 4,2775 7,45E-05 0,00163983
Tfec 4,4492 0,001060244 0,012239614 Scin 4,2755 3,53E-05 0,000901854
Sfmbt2 4,4480 0,000289377 0,00471103 Asah1 4,2739 4,07E-08 5,28E-06
Gm26603 4,4456 0,0008872 0,01065777 Bcl2a1d 4,2735 2,94E-05 0,000784548
St6gal1 4,4455 0,000130209 0,002512703 Arhgap23 4,2712 2,83E-07 2,35E-05
Ifi203-ps 4,4421 0,000181539 0,003278202 Ralb 4,2710 6,16E-07 4,17E-05
Zfp608 4,4380 9,83E-07 5,66E-05 Tlr5 4,2699 0,000532778 0,007371486
Rnf180 4,4334 0,001097499 0,012575011 Gm5431 4,2694 8,13E-05 0,001752575
Lgals3 4,4328 7,04E-08 8,14E-06 Plxnd1 4,2688 0,000679321 0,008786373
Dock1 4,4197 0,000626987 0,008248643 Homer3 4,2642 0,001580833 0,016570746
Gria3 4,4103 0,000523939 0,007299273 Amz1 4,2633 0,000371041 0,005668451
Gm15448 4,4103 0,000986175 0,011585157 Cdk20 4,2628 0,000530951 0,007358274
Clec4b1 4,4094 0,000840974 0,010275365 Atf3 4,2599 1,09E-05 0,000362876
Gm33370 4,4065 0,00061386 0,008120285 Cacna1b 4,2595 0,000489961 0,006988924
Siglecf 4,4028 0,001500418 0,015965967 Ptpro 4,2594 0,0005884 0,007894957
Rab13 4,4027 0,000564639 0,007692411 Eid2b 4,2553 0,000113252 0,002279367
Mcemp1 4,4002 0,00025055 0,004179804 Bcl2a1a 4,2441 0,001849849 0,018637722
Ralgds 4,3991 3,58E-08 4,83E-06 Lyz1 4,2440 0,001379042 0,014890473
C5ar2 4,3978 9,49E-07 5,55E-05 6330403L08Rik 4,2438 0,000404633 0,006050121
Neil2 4,3968 0,00074185 0,00938638 Sirpb1b 4,2409 0,000520459 0,007279177
Mmp13 4,3963 0,000555553 0,007624047 Mtus1 4,2292 0,000201945 0,003537333
Tdo2 4,3959 8,39E-05 0,001798488 Agpat9 4,2234 0,000505394 0,007127072
Tmcc2 4,3929 0,000214537 0,003695899 Prss16 4,2229 0,001319204 0,014455322
Gm17034 4,3911 0,000833066 0,010203698 Card9 4,2219 0,001542768 0,016252548
Armc6 4,3881 0,000389348 0,005881434 Akr1c18 4,2203 0,003667442 0,030958496
Kcnj2 4,3866 0,000327814 0,00514796 Sqrdl 4,2198 1,24E-05 0,00040045
Clec12a 4,3858 8,10E-05 0,001750758 Pirb 4,2174 9,69E-05 0,002015982
Gm44981 4,3821 0,001193037 0,01345038 Nuak1 4,2153 0,000296708 0,004784211
Gm15503 4,3763 0,001085897 0,01247598 Rasgrp4 4,2116 0,00040823 0,006093109
Thop1 4,3754 0,000450084 0,006572401 Nlrc4 4,2104 0,000575541 0,007776338
1700071M16Rik 4,3716 0,001103529 0,01261839 Slfn1 4,2074 8,98E-05 0,001902091
Jag1 4,3711 0,000315382 0,0050087 Fnip2 4,1991 1,48E-09 3,73E-07
Kank3 4,3660 0,000646832 0,008456953 Gm20056 4,1955 0,002874301 0,025781491
Hck 4,3655 0,001046124 0,012159837 P2ry2 4,1936 0,002840174 0,025575213
Mfsd7b 4,3646 4,02E-09 8,37E-07 B4galt4 4,1839 0,001996851 0,019718316
Apol9b 4,3641 0,001307066 0,014380287 Abca3 4,1815 3,08E-05 0,000810729
Mctp1 4,3607 0,000754871 0,00950123 Speg 4,1781 0,000275351 0,004530799
Hk2 4,3596 8,72E-07 5,28E-05 Il6 4,1700 0,003387352 0,029167996
Tbc1d32 4,3582 1,60E-05 0,000489401 Grk3 4,1700 0,000899568 0,010760369
Spint1 4,3565 0,000695964 0,008908592 Ptgs2 4,1694 0,000852407 0,010372802
Stmn2 4,3551 0,001856974 0,018676039 Ifit3 4,1669 2,05E-05 0,000593224
Mtap7d3 4,3494 0,000682408 0,008796487 Aldh3b1 4,1633 0,001371207 0,014824854
Il6ra 4,3479 0,000256042 0,0042504 Nme4 4,1600 0,001730833 0,01777846
RP23-292C5.8 4,3459 1,78E-05 0,000531061 Cd300lb 4,1540 0,001041001 0,012116995
Gm16120 4,3432 0,00033667 0,005257656 Slmo1 4,1529 0,001716308 0,017683114
4930512H18Rik 4,3410 0,001866955 0,018754055 Gm44860 4,1519 0,000779306 0,009688265
Rbfox2 4,3401 0,002206511 0,021277884 Ifi30 4,1417 6,25E-06 0,000234639
Klhl13 4,3393 0,001098514 0,012578101 Gpr87 4,1399 0,002871736 0,025776849
Gm24273 4,3389 0,001980107 0,019564436 Kirrel 4,1384 0,0033722 0,029107229
Ppfia4 4,3331 0,000876643 0,010578309 Ceacam1 4,1373 0,000383717 0,005825175
Slc11a1 4,3317 9,13E-05 0,001927428 C4b 4,1336 0,001405858 0,015096937
Pard3 4,3264 0,001765748 0,018049158 Snx24 4,1318 0,001161552 0,013183534
Nlrp1c-ps 4,3254 0,000605599 0,008061592 Il1b 4,1185 0,000715658 0,00912342
Nostrin 4,3214 0,000592073 0,007925592 Pnp2 4,1153 0,000506119 0,007131337
Ehd1 4,3170 3,15E-09 6,90E-07 4933440N22Rik 4,1147 0,000265678 0,004393063
Pmp22 4,3168 0,000659921 0,008596882 Aatk 4,1115 0,001421491 0,015222141
Ifi205 4,3168 0,000107154 0,002185323 2610203C22Rik 4,1109 0,001570754 0,016475335
Nr1d1 4,3153 0,000300857 0,004828111 Gm20548 4,1070 0,000126316 0,002458821
Rab15 4,3131 0,002973208 0,026434437 AA467197 4,1055 4,24E-05 0,001044485
RP23-323L3.1 4,3129 3,00E-05 0,000796878 Syngr1 4,1027 0,002358352 0,022359958
F13a1 4,3100 0,000157781 0,002937234 Cd63 4,1023 0,000106533 0,002177918
Gm15964 4,3099 0,000875366 0,010575879 Adk 4,0998 0,000289683 0,004711475
Hlx 4,3052 0,000198336 0,003494628 Hcar2 4,0987 0,000504662 0,007122708
Gm15987 4,3037 0,000195448 0,003458992 Arhgef11 4,0972 0,000145473 0,002759894
Bace2 4,2963 0,002737961 0,024989552 Ckap4 4,0943 0,00019824 0,003494628
Kctd17 4,2943 0,000422215 0,006252041 Folr2 4,0931 0,001447501 0,015461403
Tmem176a 4,2924 0,000173027 0,003154894 Cxcl10 4,0927 9,29E-05 0,001949714
Flrt2 4,2836 0,00032027 0,005067232 Prune2 4,0859 1,46E-06 7,89E-05
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Gene FC pval padj Gene FC pval padj
Slfn5 4,0820 4,72E-05 0,001131453 Adck1 3,9300 3,68E-06 0,000158524
Fpr1 4,0813 0,001040911 0,012116995 Ms4a14 3,9213 0,0054797 0,041309402
Pdxk 4,0766 9,10E-09 1,60E-06 Trim47 3,9208 0,003817847 0,03190723
1500005C15Rik 4,0764 0,001229411 0,013722858 Abca9 3,9208 0,001777699 0,018116513
Smo 4,0752 0,001745023 0,017858955 BC028528 3,9188 0,000542638 0,007465029
Rnf128 4,0721 0,001346924 0,014627963 Spon1 3,9183 5,46E-06 0,00021196
Rab20 4,0678 8,78E-05 0,001865411 Ncf2 3,9173 5,85E-05 0,001351333
Pilra 4,0662 0,000612474 0,008114679 Asph 3,9144 0,000148211 0,002796108
Dnase1l3 4,0633 0,000441711 0,006461316 Dppa3 3,9135 0,005131919 0,039613247
Ccdc184 4,0622 0,004501011 0,036218539 Hebp1 3,9115 2,35E-05 0,000652462
Eng 4,0615 0,00225985 0,021582463 Slc36a3os 3,9055 0,003800112 0,031806255
Apob 4,0572 0,000901452 0,010775261 Nacc2 3,9038 8,41E-08 9,33E-06
Psrc1 4,0572 6,65E-08 7,84E-06 Cd24a 3,9037 2,15E-08 3,21E-06
Serpinb8 4,0566 0,000276902 0,004551875 Rbm47 3,9025 0,000766253 0,009586451
Olfml3 4,0518 9,47E-07 5,55E-05 P2rx4 3,9016 2,71E-06 0,000124343
Dpep2 4,0453 1,21E-05 0,000395264 Tbc1d4 3,9009 0,000152098 0,002855687
Dgat2 4,0392 0,002941216 0,026212468 Gm21057 3,8995 0,003490964 0,029887616
Gm12454 4,0390 0,000396821 0,005964681 Bst1 3,8984 1,15E-05 0,000378897
Galm 4,0387 0,000626739 0,008248643 Map3k15 3,8965 0,000302282 0,004841674
Gm42934 4,0331 0,002414689 0,022701305 Naaa 3,8962 1,58E-05 0,000486029
Lrrk2 4,0329 0,000524097 0,007299273 Clcn7 3,8953 2,74E-10 1,05E-07
Catsperg1 4,0302 0,002940884 0,026212468 Ifi27l2a 3,8949 0,000239701 0,004034725
Gm15374 4,0301 0,001926724 0,019217106 Gm42793 3,8937 0,002738094 0,024989552
Igf2bp2 4,0258 0,000112254 0,002262648 Gm10693 3,8888 0,004371786 0,035432262
Gm14548 4,0226 0,003436702 0,029512939 Tmem119 3,8882 0,001372439 0,014828671
Ttc30a1 4,0224 0,00149277 0,015894603 Tnfrsf21 3,8846 0,000428703 0,006303835
Gm43775 4,0223 1,03E-06 5,90E-05 Tlr8 3,8837 0,00439491 0,035602572
Asns 4,0205 0,000642339 0,008406985 Car6 3,8831 0,003756932 0,031524581
8430408G22Rik 4,0165 0,003131026 0,027461202 Rgs7bp 3,8827 0,000334232 0,005234127
Gm15922 4,0090 0,003565527 0,030341162 Rai14 3,8770 0,000159827 0,002972043
C78197 4,0085 0,001313552 0,014442217 Klra17 3,8753 0,001643851 0,017072159
Abcc2 4,0076 0,001361035 0,014733774 Il15 3,8750 2,15E-05 0,000608269
Fth1 4,0046 4,46E-11 2,51E-08 Sh3bp5 3,8747 9,49E-06 0,000325823
Pstpip2 4,0042 0,001998188 0,019719979 Adgb 3,8741 0,00306637 0,027063
Gm16094 4,0031 0,000671734 0,008708274 Gm12689 3,8732 0,005307743 0,040525303
Stxbp6 4,0009 0,000906276 0,010809935 Abcd2 3,8728 0,000386014 0,005844272
Gngt2 3,9972 0,000126396 0,002458821 Irf6 3,8723 0,00253436 0,023576675
Themis2 3,9948 2,21E-05 0,00062437 Cd300c2 3,8716 0,004750256 0,037455735
Rgmb 3,9929 0,002451233 0,022968052 Tst 3,8668 0,003307261 0,028664062
Ldhb 3,9890 0,001227732 0,013722695 Mgst1 3,8622 0,003146459 0,027567885
Rnase4 3,9877 0,000109562 0,002224177 Fam198b 3,8615 0,000300617 0,004828111
Gm17359 3,9867 0,003875832 0,032249526 Cacnb1 3,8609 0,002542464 0,023626008
Carmil1 3,9863 0,001849779 0,018637722 Ube2l6 3,8609 5,67E-07 3,92E-05
Cd276 3,9858 0,002731109 0,024958504 Melk 3,8559 8,87E-05 0,001882417
A530064D06Rik 3,9856 0,00014843 0,002797117 D430018E03Rik 3,8557 0,006658025 0,047441592
Lyl1 3,9809 0,002176429 0,021096349 Gm37498 3,8429 0,003726365 0,031328144
Ugt1a6a 3,9804 0,000401092 0,006007832 Gm37347 3,8391 0,003622168 0,030683823
Tcp11l1 3,9781 0,000236738 0,003993358 Gm6264 3,8313 0,000776467 0,009671071
Med29 3,9772 2,12E-05 0,000602837 Mfap3l 3,8281 0,004993495 0,038918805
8030453O22Rik 3,9687 0,0015627 0,016403514 Fcrls 3,8276 0,000495092 0,007035618
Dnmt3aos 3,9679 0,001294315 0,014295953 Myo10 3,8271 0,000484356 0,006923003
Daglb 3,9636 1,41E-07 1,36E-05 Src 3,8262 0,005652339 0,042070766
Mtcl1 3,9595 0,005529874 0,041507279 Tns4 3,8247 0,000522171 0,007290515
Nek4 3,9552 5,47E-05 0,001279227 Cdc42ep2 3,8168 0,00464842 0,036963817
Gda 3,9533 0,000119258 0,002366366 Fuom 3,8159 0,006100604 0,04465833
Cfp 3,9521 4,77E-05 0,001140582 Clec4e 3,8152 0,001049547 0,012182835
Sbf2 3,9518 2,11E-05 0,000602302 Gm37168 3,8152 0,005650665 0,042070766
Gm43068 3,9515 0,004287811 0,034980878 Wfdc18 3,8151 0,006495139 0,046604316
Zfp629 3,9510 2,69E-06 0,000123657 Clec5a 3,8139 0,001325342 0,014483674
Thefg 3,9474 0,001086686 0,012476541 Gm43221 3,8114 0,003954419 0,032757971
Batf2 3,9464 0,004031715 0,033267569 Spp1 3,8067 2,03E-05 0,000590897
Rnf149 3,9451 1,84E-06 9,19E-05 Mmp27 3,8039 0,005271778 0,04032372
Gm15931 3,9440 0,003188798 0,02787427 Npl 3,8014 1,12E-06 6,36E-05
Glrx 3,9419 4,27E-10 1,44E-07 Tnfrsf8 3,7943 0,006323105 0,045852946
Ms4a4c 3,9418 2,04E-05 0,000592181 Cd300e 3,7927 0,004838916 0,037941961
Apip 3,9382 1,01E-05 0,000341917 Hist1h2bc 3,7868 6,18E-05 0,001416317
Slc16a10 3,9359 1,65E-05 0,000500283 Dok3 3,7849 0,004030376 0,033267569
Btbd3 3,9350 0,000494815 0,007035618 Tctex1d2 3,7810 0,001330674 0,014507526
Fabp5 3,9347 1,55E-05 0,000476779 Scpep1 3,7731 2,33E-05 0,000649811
Tsacc 3,9327 0,005971559 0,043907354 Ccl9 3,7688 7,80E-06 0,000279976
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Dck 3,7670 2,44E-12 3,12E-09 Mapt 3,6236 0,006967075 0,049083828
Msrb2 3,7624 0,00019994 0,003509046 Gm15356 3,6233 0,002494478 0,023282716
Igf2bp1 3,7608 6,72E-08 7,87E-06 Smpdl3b 3,6216 0,002076524 0,020350181
Gm19719 3,7606 0,006398152 0,046236853 Tarm1 3,6106 0,0025496 0,023655293
Tnfsf15 3,7603 0,005190269 0,039923553 Zfp503 3,6098 0,005077473 0,039337002
Gm17084 3,7493 0,004778611 0,03759144 Wdr60 3,6088 0,003841287 0,032056977
2010300C02Rik 3,7470 0,001272852 0,014095811 C1rl 3,6069 0,00326467 0,028382434
Tmem67 3,7468 8,92E-07 5,32E-05 Fabp4 3,6020 0,006036795 0,044248845
Gm15551 3,7455 0,005962243 0,043873991 Gm12971 3,5959 0,006939986 0,048954334
Psap 3,7444 1,44E-06 7,83E-05 Cd86 3,5957 0,001720852 0,017719107
Plxdc1 3,7425 0,005158538 0,03972781 Epcam 3,5945 0,006323607 0,045852946
Renbp 3,7415 4,04E-06 0,00017153 Scarb1 3,5938 0,000152215 0,002855687
Acta2 3,7411 0,00656033 0,046943796 Gm37468 3,5872 0,007107171 0,049759047
Pusl1 3,7406 0,000156383 0,002914418 Plxdc2 3,5850 0,003777083 0,031677916
Tnfsf18 3,7387 0,004528707 0,036373381 Adam15 3,5800 0,001935534 0,019236723
Gzmc 3,7346 0,000623843 0,008232966 Rragd 3,5795 0,003451941 0,029598594
Deptor 3,7338 0,000326499 0,005132087 Lrp5 3,5795 0,000439882 0,006445743
5730508B09Rik 3,7331 0,000426744 0,006282037 Sh3pxd2b 3,5773 0,000139744 0,00267224
Gm28404 3,7285 0,002288248 0,021804284 Zeb2os 3,5757 0,000137817 0,002641382
Nucb2 3,7283 0,00214181 0,020844641 Hsf2 3,5738 6,51E-07 4,30E-05
Nfam1 3,7272 0,002235039 0,021467065 Igsf6 3,5738 0,001406219 0,015096937
Ms4a8a 3,7264 0,001892892 0,018969413 Ccrl2 3,5701 4,29E-06 0,000178458
Ppic 3,7237 0,003381501 0,029167996 Rasgrp3 3,5689 0,00069083 0,00886723
Fcrl6 3,7230 3,18E-05 0,000830735 Gas2l3 3,5642 1,14E-08 1,88E-06
Gys1 3,7218 6,22E-05 0,001421497 9430076C15Rik 3,5619 2,23E-05 0,000626615
Gm44079 3,7213 0,00659987 0,047119804 Car9 3,5616 0,004736583 0,037387137
Afap1l1 3,7171 0,000467348 0,006743452 Slc27a1 3,5613 9,99E-05 0,002070944
Ophn1 3,7155 0,000925603 0,011001564 Gm128 3,5487 0,006479307 0,046543199
Bco2 3,7113 0,005436159 0,041164348 Piwil4 3,5470 0,004567011 0,036540425
Gm15530 3,7066 0,006716224 0,047725413 Fblim1 3,5470 0,003321834 0,028760806
Gm42868 3,7010 0,006479511 0,046543199 Hfe 3,5425 0,001179961 0,013347562
Xxylt1 3,6996 0,001616894 0,016864893 Serping1 3,5398 0,006274774 0,045596872
Mir5104 3,6993 0,004447724 0,035978569 Marcksl1 3,5396 0,000739301 0,009361145
Enkd1 3,6968 0,004331438 0,035238111 Zfp704 3,5371 6,42E-08 7,68E-06
Zfp750 3,6959 0,005640808 0,042070766 Gm16464 3,5370 0,000300862 0,004828111
Il1rl2 3,6914 9,45E-07 5,55E-05 Asb2 3,5360 0,001335807 0,014554085
Angptl4 3,6906 0,003294577 0,028583503 Parvb 3,5327 3,87E-05 0,000970732
Zcchc14 3,6893 0,002607792 0,024092116 Gstt3 3,5309 0,005806962 0,042975085
Pilrb1 3,6864 0,001446095 0,015456174 Ryr1 3,5282 0,006398483 0,046236853
Gm13207 3,6857 0,006487395 0,046579997 Dram1 3,5262 0,00021419 0,003693796
Ptrhd1 3,6847 0,000194082 0,003445666 Ptprj 3,5245 8,96E-06 0,000311452
Hpse 3,6842 1,90E-05 0,000560843 6430573P05Rik 3,5201 0,00667969 0,047555344
Fcgr4 3,6841 0,006460402 0,046485129 Chchd4 3,5187 1,93E-05 0,000567353
Gm38156 3,6785 0,004947235 0,03864755 Rab11fip5 3,5133 0,003649959 0,030872725
Gm43149 3,6757 0,003662396 0,030931385 Ampd3 3,5075 0,000562441 0,007671206
Ramp1 3,6735 0,001832347 0,018549433 B830042I05Rik 3,5059 1,60E-05 0,000489401
Cebpb 3,6716 8,37E-07 5,17E-05 Ang 3,5036 0,005261216 0,040297762
Nlrp1a 3,6666 0,00567136 0,042137958 Ifitm2 3,4995 0,003849494 0,032077849
Sdhaf1 3,6645 0,000117882 0,002348247 Cd101 3,4981 0,004872046 0,038130827
Cpq 3,6591 7,09E-06 0,000258782 Scel 3,4943 0,000659419 0,008596882
BC049715 3,6580 0,000875245 0,010575879 Piwil2 3,4930 0,006686395 0,047563365
Snx9 3,6564 2,26E-06 0,000109003 Acsl1 3,4929 6,22E-06 0,000234293
Cd40 3,6563 4,72E-05 0,001131453 Cst3 3,4853 0,00018092 0,003270515
Tnfsf13b 3,6544 0,002894212 0,025895906 Col15a1 3,4850 0,005800766 0,042966936
Nudt12 3,6540 0,005657907 0,04209363 Fcgr2b 3,4809 2,10E-06 0,00010177
Mmp12 3,6520 1,05E-07 1,08E-05 Cisd1 3,4789 1,86E-05 0,000550855
Mx2 3,6491 0,000695229 0,008908592 Lin28b 3,4783 0,000270473 0,004461907
Oas1g 3,6459 0,000683123 0,008796487 Slc27a6 3,4777 0,002294444 0,021850986
Arnt2 3,6456 0,004777475 0,03759144 Dapk1 3,4771 0,00461391 0,036788342
Arrdc4 3,6419 4,64E-10 1,51E-07 Tusc1 3,4751 4,05E-07 3,03E-05
Tspyl4 3,6401 5,31E-06 0,000208622 Anxa5 3,4699 3,70E-13 6,93E-10
Pls3 3,6401 0,005084193 0,039352913 Oas3 3,4637 3,72E-07 2,84E-05
Dna2 3,6387 1,26E-05 0,000404076 Gm44270 3,4562 0,005306202 0,040525303
Fam213b 3,6374 0,00507322 0,039322119 Fmnl2 3,4517 0,001359198 0,014723338
Gm26387 3,6371 0,001338442 0,014573376 Gm37058 3,4498 0,001654782 0,017175111
Lin7a 3,6369 0,006222746 0,045277322 Art2a-ps 3,4462 0,001787374 0,018182054
Ptgr1 3,6280 1,33E-05 0,000424263 Rsad2 3,4450 1,47E-05 0,000458781
Basp1 3,6264 1,27E-14 5,91E-11 Plac8 3,4445 0,001319886 0,014455322
Spdl1 3,6249 8,33E-05 0,001789181 Ethe1 3,4421 0,001684042 0,017406994
Ctsk 3,6246 0,000507795 0,007142214 Plk2 3,4421 4,50E-05 0,001098771
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Fancb 3,4397 0,005803875 0,042971099 Gm9888 3,2081 0,00147885 0,015756334
Bst2 3,4355 1,16E-07 1,16E-05 Gatm 3,2050 0,005253493 0,040256888
Lilrb4a 3,4312 0,000400985 0,006007832 Galc 3,1966 6,00E-06 0,00022749
Gm17705 3,4304 0,00381956 0,03190723 Mvk 3,1962 0,000628087 0,008256678
Cdh1 3,4303 0,002144451 0,020858306 Slc9a6 3,1952 7,98E-05 0,00173427
Lima1 3,4292 0,003331806 0,028832349 Tmem51 3,1762 0,000502309 0,007113298
Slc7a11 3,4220 5,90E-05 0,001361217 Cd2ap 3,1754 0,000463629 0,006712081
Tmem106c 3,4211 0,000189779 0,003394282 Irf7 3,1747 5,04E-05 0,001198048
Acp2 3,4196 4,72E-06 0,000191642 Dnase1l1 3,1685 0,000356952 0,005528335
Cpd 3,4180 6,43E-11 3,19E-08 Snx7 3,1682 6,39E-05 0,001452709
Pgap1 3,4073 0,000726442 0,009239834 Sgcb 3,1677 0,001317587 0,014455322
Gm4951 3,4067 0,006729822 0,04777154 Irak3 3,1575 0,003404606 0,029296979
Dpp7 3,4028 0,000209866 0,003630352 Wdr41 3,1520 8,35E-10 2,51E-07
Kmo 3,3969 0,005399488 0,040947739 B430306N03Rik 3,1489 0,000847251 0,010317495
Slc16a7 3,3932 0,002658655 0,024452787 Stx3 3,1459 2,22E-07 1,96E-05
Nid2 3,3863 0,002026386 0,019951558 6820402A03Rik 3,1448 1,30E-05 0,000414844
Gm42515 3,3847 0,000335253 0,005245243 Gm28727 3,1446 0,007051961 0,049413531
Angptl2 3,3847 0,000636534 0,008348192 Pygl 3,1426 0,00210318 0,020551695
Atp1a3 3,3835 0,00045373 0,006608477 Gins2 3,1348 3,60E-05 0,000915022
Gm44949 3,3741 0,005322286 0,040602982 B4galt6 3,1300 2,48E-05 0,000680155
Sash1 3,3665 0,006682448 0,047555344 Cmpk2 3,1266 6,69E-06 0,000247337
B3gnt3 3,3653 0,002660433 0,024452787 Pdgfa 3,1215 0,001730464 0,01777846
Bcl2a1b 3,3636 0,000520734 0,007279177 Ccdc18 3,1202 0,002276256 0,021714554
Dhx58 3,3625 5,60E-06 0,00021604 Fam46c 3,1122 5,31E-11 2,71E-08
Rasa4 3,3566 0,000116515 0,002331137 Cep170b 3,1104 0,006974015 0,049112208
Rogdi 3,3490 0,004260362 0,034830473 Pars2 3,1068 0,005088485 0,039368072
Dtx4 3,3459 0,005437814 0,041164348 Cxcl3 3,1045 0,005830117 0,043127522
2810002D19Rik 3,3424 1,04E-05 0,000349617 Dock7 3,1009 0,002095662 0,02049011
Cdkn1a 3,3387 1,03E-06 5,90E-05 Tbc1d19 3,0969 0,007140185 0,049845346
Ctif 3,3387 0,001318939 0,014455322 Eepd1 3,0940 0,002209756 0,021297
Hk3 3,3372 0,000136588 0,002626779 Idh1 3,0891 0,00012766 0,002469301
Cln6 3,3307 4,72E-05 0,001131453 Ifit1 3,0861 0,001510653 0,016054613
E230016K23Rik 3,3203 0,000841354 0,010275365 Myo5a 3,0824 0,000349346 0,005430482
Ccnd1 3,3158 0,002385787 0,022504852 Smox 3,0790 8,08E-09 1,45E-06
Tfe3 3,3126 1,31E-09 3,39E-07 Rhbdf2 3,0744 0,000538472 0,00742589
Alas1 3,3113 1,67E-05 0,000505004 Oxnad1 3,0689 0,000228849 0,003894827
2900005J15Rik 3,3083 0,003441405 0,029538292 F630040K05Rik 3,0667 3,92E-05 0,000981982
Evi2a 3,3072 2,70E-05 0,000732559 Fcgr3 3,0644 1,68E-06 8,64E-05
Ftl1 3,3071 6,68E-07 4,37E-05 2310022B05Rik 3,0634 0,002007936 0,019804588
Tbc1d9 3,2949 0,003448706 0,029585896 Cd302 3,0567 0,004972949 0,03879452
Ckb 3,2915 0,005105713 0,039465149 Pros1 3,0544 0,002570449 0,02383353
Msra 3,2900 4,36E-06 0,000181176 Gm42989 3,0527 0,000476739 0,006837307
Pkib 3,2886 9,83E-05 0,002039862 Lpxn 3,0501 0,000127163 0,002467314
Mt2 3,2880 0,00221855 0,021357342 Vcan 3,0458 0,006329844 0,045878447
Ifit2 3,2843 0,000130557 0,002516533 Nxpe5 3,0441 0,000288486 0,004701061
Mfsd11 3,2833 1,98E-07 1,77E-05 Gm42462 3,0404 0,005147972 0,039664551
C920021L13Rik 3,2787 0,005289288 0,040439319 Wrb 3,0380 1,29E-05 0,000411271
Hexa 3,2783 2,23E-07 1,96E-05 Prdx4 3,0378 0,000554509 0,00762212
Bnip3 3,2759 0,000147368 0,002786441 Ncf1 3,0330 0,000119507 0,00236852
5730409E04Rik 3,2736 0,000738647 0,009359893 Cpne2 3,0319 0,000254541 0,004233818
Dnase2a 3,2652 0,000248798 0,004167063 Cstb 3,0179 2,25E-11 1,46E-08
AW209491 3,2568 0,000180088 0,003258983 Hbegf 3,0129 0,000315068 0,005008431
Ctsl 3,2537 1,46E-06 7,89E-05 Coq3 3,0116 0,000831236 0,010188681
Ccl17 3,2483 0,004180421 0,034279241 Rhag 3,0104 0,003559934 0,030308858
Slc35f6 3,2428 2,91E-07 2,41E-05 Gm38236 3,0031 0,002254299 0,021555786
Mx1 3,2422 8,51E-06 0,000301367 Fdps 2,9979 0,001227467 0,013722695
P4ha1 3,2356 7,19E-12 6,74E-09 1700030K09Rik 2,9966 0,001444127 0,015444925
Ppp2r2c 3,2307 0,00173753 0,017825534 Hvcn1 2,9895 3,61E-05 0,00091579
Zfp516 3,2289 0,003360676 0,029037478 Tacc2 2,9860 0,001858168 0,018676909
Fndc3b 3,2270 3,12E-05 0,000820536 5031439G07Rik 2,9820 0,001036222 0,012078037
Nectin3 3,2268 0,000373093 0,005694651 Slc8a3 2,9816 0,007009709 0,049315097
Gpr55 3,2247 0,002991489 0,026554976 Phf11d 2,9793 3,42E-05 0,000880143
Cep85l 3,2238 0,003238537 0,028213411 Tada2a 2,9751 0,000583276 0,007857452
Blnk 3,2208 0,001624948 0,016917511 Lamp1 2,9695 4,63E-11 2,52E-08
Gm44104 3,2188 0,003281763 0,028501656 Adamtsl4 2,9665 0,000284978 0,004661919
Tceal8 3,2182 0,004282093 0,034974232 Arhgap19 2,9617 1,81E-11 1,27E-08
Tmem9 3,2138 5,17E-07 3,65E-05 Mpp1 2,9610 2,83E-09 6,29E-07
Tanc2 3,2112 2,66E-05 0,000723117 Irf5 2,9555 0,001381857 0,014911327
Gm37354 3,2105 0,002794508 0,025353506 4930539J05Rik 2,9508 0,006881953 0,048687508
Tpd52 3,2099 0,000198497 0,003494628 Hsd17b7 2,9492 0,000292798 0,00474383
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Gm15832 2,9472 0,002090617 0,02045487 Alcam 2,7109 0,000142127 0,002711664
Dock4 2,9411 0,005144105 0,039652868 Il1f9 2,7103 0,000878621 0,010578309
Tns1 2,9380 0,002682595 0,02462964 Msrb1 2,7035 0,000800007 0,00987769
Mfsd13a 2,9332 0,002146943 0,020870518 Ifih1 2,7009 0,001537216 0,016214528
Tdrkh 2,9293 0,002254501 0,021555786 Ccdc88a 2,6899 0,00023235 0,003946444
Hdac9 2,9279 0,001832875 0,018549433 Lyrm2 2,6850 8,75E-05 0,001863234
Mob3b 2,9240 0,001236107 0,013770261 Tmem206 2,6841 4,02E-07 3,03E-05
Cd99l2 2,9237 0,000423812 0,006270182 H1f0 2,6812 0,000843172 0,010282677
Coq7 2,9233 0,000991805 0,011624584 Cd22 2,6809 0,002526627 0,023517706
Nudt1 2,9173 0,001053846 0,012190786 Ogfrl1 2,6808 0,004524591 0,036373381
Tgfbr1 2,9166 7,29E-05 0,001615388 Yae1d1 2,6799 1,76E-10 7,07E-08
Wdr11 2,9148 0,000296458 0,004784211 Ell2 2,6793 1,72E-05 0,000516062
Pik3r2 2,9128 0,000467067 0,006743452 Nol4l 2,6779 0,000142363 0,002713099
Gpam 2,9088 0,003727949 0,031328144 Cenpn 2,6729 0,003253384 0,028313509
Tmem50b 2,9063 2,23E-05 0,000627458 Cyth3 2,6715 0,000245839 0,004125692
Cln8 2,9061 0,001065725 0,012286065 Galk1 2,6714 0,004540897 0,036417864
Pik3r6 2,9050 0,002762385 0,025129661 Nrp2 2,6675 0,003342896 0,028913482
Gart 2,9049 2,62E-11 1,64E-08 Lap3 2,6563 2,05E-05 0,000592419
Pgpep1 2,9040 0,000362197 0,005567705 Mcfd2 2,6531 4,97E-06 0,000199492
Stard9 2,8998 0,003167389 0,027736856 Oas1a 2,6427 0,001175007 0,013300454
Slfn3 2,8991 0,004926581 0,038504035 Creg1 2,6409 0,000385754 0,005844272
Aifm2 2,8837 0,001931005 0,019223637 Rasal2 2,6386 0,005649585 0,042070766
H2-DMa 2,8796 0,005370756 0,040821619 Ddx60 2,6303 0,000779496 0,009688265
Hsd17b11 2,8760 1,28E-05 0,000410899 Gusb 2,6260 4,37E-07 3,20E-05
Maf 2,8681 1,67E-06 8,58E-05 Tmem220 2,6169 0,00651563 0,04672305
Cul7 2,8626 0,005325139 0,040602982 Mpv17l2 2,6091 0,000583984 0,00786071
Skap2 2,8606 5,30E-06 0,000208622 Sgk3 2,6078 0,001670187 0,017292436
Trpm2 2,8580 0,002408661 0,02265727 Hexb 2,5992 8,95E-08 9,68E-06
Chst14 2,8521 0,000726981 0,009239834 Bpifc 2,5981 0,004659896 0,037037606
Fos 2,8506 0,000515842 0,007244123 Sult6b1 2,5948 0,00299667 0,026572994
Pwwp2b 2,8504 0,002070723 0,020318756 Xylt1 2,5944 4,39E-06 0,000181766
Nxt2 2,8436 1,04E-05 0,000349577 Mtmr10 2,5889 5,37E-06 0,00020972
Cd300lf 2,8352 8,63E-10 2,51E-07 Gpr146 2,5884 0,000277567 0,004558363
Pnp 2,8351 2,11E-07 1,87E-05 Cacna2d4 2,5876 0,000540634 0,007443536
Npc2 2,8294 2,15E-08 3,21E-06 Selenop 2,5875 3,00E-07 2,43E-05
Lrrtm2 2,8286 0,001182043 0,013362154 Ly6e 2,5812 1,03E-05 0,000347348
Il2ra 2,8261 0,001199843 0,013500031 Zfp839 2,5734 0,000189545 0,003394282
Gm12185 2,8188 0,001733392 0,017793905 Stat2 2,5712 2,56E-05 0,00070061
Mgat4b 2,8131 3,15E-05 0,000828097 Adam9 2,5677 1,06E-05 0,000355946
Tmem156 2,8070 0,000835079 0,01021352 Rbpj 2,5673 0,000389515 0,005881434
1500011B03Rik 2,7944 0,004320124 0,03518262 Nagpa 2,5488 4,26E-06 0,000177845
Sat1 2,7907 0,00028428 0,004655014 Filip1l 2,5420 0,000490211 0,006988924
Ptgs1 2,7890 0,001384116 0,014926151 Atpif1 2,5416 4,53E-06 0,00018673
Peli2 2,7856 0,007006573 0,049315097 Wwc2 2,5410 0,002377799 0,022479793
Soat1 2,7855 3,45E-07 2,69E-05 Ero1l 2,5397 6,97E-07 4,47E-05
Uevld 2,7839 0,000339667 0,005299553 Vwa5a 2,5337 1,19E-07 1,19E-05
Nfxl1 2,7761 1,15E-05 0,000378897 Cyfip1 2,5322 2,67E-06 0,000122922
Loxl3 2,7757 0,005123951 0,039569849 Lamp2 2,5288 6,38E-05 0,001452709
Sh3tc1 2,7704 0,000391311 0,005892725 Dnajc25 2,5268 1,02E-05 0,000345407
St3gal2 2,7615 0,000611623 0,008109776 Plin3 2,5255 0,002381671 0,022491191
Gm7160 2,7556 0,001601029 0,016730458 Mospd2 2,5228 0,001821793 0,01847646
Sap30 2,7515 0,000203097 0,003546001 Dse 2,5227 1,53E-07 1,46E-05
Bri3bp 2,7498 2,72E-05 0,000737003 Trf 2,5185 0,00247409 0,023122939
Trpm4 2,7479 7,39E-05 0,001629842 Ano10 2,5181 0,000807006 0,009949536
Rnf141 2,7424 8,49E-12 7,16E-09 Aldh6a1 2,5158 0,002441847 0,022905557
Gm37780 2,7422 0,002223791 0,021395586 Ctsc 2,5099 3,51E-05 0,000897558
Hint2 2,7398 0,006844523 0,048504087 Pomk 2,5038 0,000688226 0,008840537
Cndp2 2,7389 1,54E-14 5,91E-11 Eef1e1 2,5011 0,00023677 0,003993358
Arhgef12 2,7383 0,005271216 0,04032372 Trip13 2,4977 0,00264219 0,024391447
Anxa4 2,7378 4,07E-08 5,28E-06 Gch1 2,4952 2,30E-05 0,000643208
Gaa 2,7330 4,64E-05 0,001121943 Slc45a4 2,4928 1,46E-05 0,000457855
Nme6 2,7329 0,000830763 0,010188681 Nit2 2,4871 0,005216745 0,040048078
Eef1akmt1 2,7309 0,004664764 0,037057067 Milr1 2,4850 0,002815909 0,025465477
Abhd12 2,7291 5,36E-06 0,00020972 Lipa 2,4813 2,05E-09 5,01E-07
Fads1 2,7271 0,000184844 0,003327191 Atp6ap2 2,4786 9,66E-07 5,58E-05
Ext1 2,7265 0,00695385 0,049031623 Trappc6a 2,4772 0,001809717 0,018376087
Zfp992 2,7242 3,29E-05 0,000853259 Txndc15 2,4751 0,001305716 0,014380287
Lair1 2,7237 0,000122705 0,002417689 Ubac1 2,4693 0,00275587 0,025111023
Mlh3 2,7207 0,007093346 0,049682879 Erbb3 2,4683 0,001204455 0,013542895
Ppargc1b 2,7195 0,003870579 0,032237619 4931406C07Rik 2,4673 0,00484948 0,037989472
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Snx20 2,4575 0,000732005 0,009289694 Heatr5a 2,2561 6,02E-09 1,13E-06
Pfdn1 2,4498 0,002691806 0,024687333 Fgd4 2,2556 0,00660169 0,047119804
Nkiras2 2,4427 0,002125104 0,020717919 Litaf 2,2533 5,62E-08 7,02E-06
Slamf6 2,4350 0,000959143 0,011320442 Ctu1 2,2468 0,001066797 0,01229003
Emilin2 2,4243 0,00052487 0,007300376 Dexi 2,2425 0,006074888 0,044508713
Dram2 2,4195 9,64E-05 0,002008001 Ndrg1 2,2386 0,000222894 0,0038085
Swap70 2,4193 0,000687119 0,008833044 Hspbap1 2,2343 0,00540443 0,040966795
Umps 2,4172 7,03E-06 0,000257333 G6pdx 2,2301 3,50E-05 0,000896275
Gpx1 2,4152 0,007017445 0,049315097 Rell1 2,2273 3,51E-06 0,000152327
Nadk 2,4117 0,000728097 0,009247056 Ssfa2 2,2248 2,21E-05 0,00062454
Sgpl1 2,4086 6,55E-07 4,30E-05 Zfp324 2,2245 0,002374268 0,022459006
Slc25a45 2,3981 8,11E-05 0,001751271 Khk 2,2151 0,002864682 0,025740935
Igfbp4 2,3979 8,35E-06 0,000297022 Bach1 2,2107 0,00098333 0,011565437
Dclre1c 2,3915 3,00E-07 2,43E-05 Abcg3 2,2087 0,006874372 0,048654281
Cep70 2,3862 0,001271345 0,014088374 Fam84b 2,2038 0,000324689 0,005113169
Skp2 2,3807 8,74E-07 5,28E-05 Cables1 2,1990 0,002698136 0,024731932
Map4k3 2,3802 0,000874832 0,010575879 Pgd 2,1978 1,27E-08 2,06E-06
Hs1bp3 2,3792 0,00220648 0,021277884 Treml2 2,1923 0,003973364 0,032882607
Klc4 2,3791 0,001297779 0,014324829 Erlin1 2,1810 0,00545478 0,041237258
Akap7 2,3781 0,006373339 0,046114429 Rab31 2,1795 0,000776966 0,009671071
Ocrl 2,3774 2,74E-05 0,00074046 Smim4 2,1760 0,001792496 0,018212188
Vps26a 2,3770 2,44E-10 9,56E-08 Mtmr4 2,1672 0,000508162 0,007142214
Specc1 2,3737 0,00024642 0,004131335 Cyp4f13 2,1659 0,006411131 0,046288585
Mfsd1 2,3733 2,59E-12 3,12E-09 Svbp 2,1658 0,000397504 0,005964681
Prkcd 2,3686 0,001839548 0,018589464 Nceh1 2,1652 0,000717133 0,009135319
Itgb3 2,3641 0,005385866 0,040918029 Slc25a13 2,1632 0,001875937 0,018821866
Dennd1a 2,3639 2,24E-08 3,28E-06 Akr1a1 2,1624 3,11E-08 4,31E-06
Dnhd1 2,3616 0,001948398 0,019330401 Gm15601 2,1620 0,002391588 0,022546963
Coq4 2,3595 0,001557404 0,016365841 Tmem65 2,1601 8,84E-06 0,000308962
Smim13 2,3571 0,002503926 0,023345065 Brca2 2,1554 0,001845875 0,01863715
Cep76 2,3567 3,21E-05 0,000835924 Erp29 2,1436 0,000205374 0,003574655
Ets2 2,3513 2,06E-05 0,000593405 Cpped1 2,1405 5,69E-06 0,000218582
Slc43a2 2,3458 0,000574403 0,007776338 Tmem104 2,1381 0,001839098 0,018589464
Nampt 2,3455 0,001084833 0,012472249 Rflnb 2,1375 0,005554478 0,041636364
Chml 2,3443 0,003604145 0,030593943 Tor3a 2,1358 0,000877454 0,010578309
Nek6 2,3411 0,000790486 0,009785599 Slc30a1 2,1340 8,01E-07 4,96E-05
Slc31a2 2,3383 0,001224547 0,013713951 Synj2 2,1316 0,006905595 0,048772935
Mthfr 2,3366 0,001535008 0,016214528 Tspan3 2,1274 0,002514628 0,023418949
Dnajc4 2,3364 0,000681516 0,008796487 Lyn 2,1265 0,000755971 0,009507989
Il1rl1 2,3362 0,006897757 0,048742439 Mthfd2 2,1262 0,004666932 0,037057067
Fgd6 2,3323 0,000238996 0,004026888 Sema4b 2,1246 3,09E-11 1,86E-08
Mcmdc2 2,3317 0,006268255 0,045569132 Itpripl2 2,1244 9,54E-05 0,001991913
Serpinb6a 2,3279 0,000102979 0,002115516 Smpdl3a 2,1237 0,003039749 0,026856159
Gla 2,3268 1,20E-07 1,19E-05 Smad1 2,1223 0,003015685 0,026713521
Ifit1bl1 2,3192 0,005355198 0,040758473 Pank1 2,1215 0,000860794 0,010467307
AI413582 2,3187 0,00031798 0,005035724 Il4ra 2,1202 2,65E-05 0,00071982
Pak4 2,3141 0,000170337 0,003122716 D630030B08Rik 2,1191 0,002462773 0,023037786
Blvra 2,3132 0,000634358 0,008328993 Rnh1 2,1184 5,25E-07 3,69E-05
Frmd4b 2,3125 7,39E-06 0,000268046 Tbcc 2,1157 0,005646729 0,042070766
Hic2 2,3123 0,006778633 0,048097781 Cd274 2,1103 0,000454232 0,006610072
Fam151b 2,3117 0,006653062 0,047426265 Qpct 2,1046 0,003429521 0,029481294
Dusp6 2,3066 0,000824796 0,01013922 Dhrs4 2,1001 0,002324651 0,022101221
Tln2 2,3023 0,000286034 0,004670134 Tmem55b 2,0990 0,001631209 0,016961757
Gm17259 2,3022 0,004469109 0,036114743 Rpain 2,0936 0,000414634 0,006164088
Amica1 2,2998 0,001205408 0,013544579 Hilpda 2,0898 0,000669308 0,008696877
Frmd4a 2,2982 0,000254492 0,004233818 Serp1 2,0881 2,07E-05 0,000595236
Prdx1 2,2973 1,62E-11 1,19E-08 Osbpl1a 2,0844 0,005743291 0,04261608
Tep1 2,2939 0,000897494 0,01074318 Agpat5 2,0790 0,001146042 0,013033813
Gm5615 2,2899 0,002115361 0,020646808 Ifi213 2,0767 0,006496309 0,046604316
Smim3 2,2898 8,05E-05 0,001745583 Minpp1 2,0733 6,93E-05 0,001559548
Arl5c 2,2875 0,00217256 0,021070961 Gpr157 2,0696 0,003823049 0,031920569
Naa40 2,2861 0,000987754 0,011585157 Klhl5 2,0681 3,16E-06 0,000140438
Cnpy3 2,2846 0,000520928 0,007279177 Slc11a2 2,0653 9,57E-07 5,55E-05
Abcg1 2,2841 5,52E-08 6,95E-06 Rtp4 2,0651 0,006966008 0,049083828
Aacs 2,2826 0,000594374 0,007942211 Syce2 2,0603 0,0003482 0,005417654
Pofut2 2,2818 3,03E-05 0,000802324 Ctsa 2,0573 0,000170721 0,003122974
Snx2 2,2770 3,90E-07 2,95E-05 Taldo1 2,0539 8,71E-05 0,001857097
Fam129b 2,2742 0,001743601 0,017855238 Fam102b 2,0364 0,000498993 0,007078236
Dstyk 2,2626 0,0022529 0,021555786 Atp6v1c1 2,0350 5,16E-08 6,55E-06
Slc29a3 2,2622 0,001345208 0,014618735 Ctso 2,0338 1,86E-06 9,19E-05
  220 
 
Gene FC pval padj Gene FC pval padj
Abhd4 2,0310 0,001852053 0,018647524 Adamts10 -2,2600 0,000105686 0,002163221
Slc6a6 2,0304 1,85E-06 9,19E-05 Gm15232 -2,2624 0,005271174 0,04032372
Jup 2,0300 2,40E-09 5,55E-07 Fasl -2,2636 0,004488828 0,036137741
Tbl3 2,0295 0,003033777 0,02683151 Smad3 -2,2717 0,000387614 0,005863228
Gpr137b 2,0276 2,77E-05 0,000747297 Vps37b -2,2744 0,00041396 0,006163311
Ahcyl2 2,0231 0,001977096 0,019554664 Spata13 -2,2811 1,83E-05 0,000544781
Tmcc3 2,0229 0,000963224 0,011352713 B130055M24Rik -2,2832 0,006703091 0,047662032
Myadm 2,0180 0,003783688 0,03171754 Sh2d3c -2,2882 9,58E-07 5,55E-05
Atp6v1b2 2,0166 1,72E-06 8,69E-05 Gm26189 -2,2928 0,003387798 0,029167996
Zfp235 -2,0003 0,006446108 0,046441713 Glcci1 -2,2976 0,001255291 0,013937949
Mfsd4a -2,0011 3,35E-09 7,15E-07 Cbarp -2,2998 0,001519498 0,016117162
Znrf3 -2,0017 0,002199136 0,021231039 Phf1 -2,3133 1,76E-06 8,89E-05
Ms4a4b -2,0083 0,002824533 0,025529785 Hcst -2,3144 0,002648696 0,024438137
P2ry10 -2,0188 0,002510536 0,023393761 Rfx3 -2,3178 8,85E-08 9,68E-06
Gse1 -2,0229 0,000224395 0,003822881 Gigyf1 -2,3193 0,000167236 0,003082632
Gm27271 -2,0235 0,001743437 0,017855238 Gm36940 -2,3215 0,000122646 0,002417689
Gm37387 -2,0265 0,005948502 0,043830244 Mag -2,3215 0,004363556 0,035416803
Tsr3 -2,0312 0,000664603 0,008649071 Prkcq -2,3233 0,005065053 0,03927706
Tas1r3 -2,0339 0,004960951 0,038718831 Gabbr1 -2,3322 0,002598835 0,024043859
Tspan32 -2,0447 3,17E-05 0,000830376 Plekhg2 -2,3368 1,22E-06 6,83E-05
Cers4 -2,0462 0,000757756 0,009516248 Polm -2,3405 0,000507426 0,007142214
Chsy1 -2,0539 0,002044601 0,020107432 Gpr174 -2,3420 0,001031483 0,012039441
Snord104 -2,0626 0,004209045 0,034444326 Plppr3 -2,3438 2,39E-06 0,000113776
Orm2 -2,0631 0,00563287 0,042038665 Adora2a -2,3457 0,001709251 0,017631943
Asrgl1 -2,0796 3,84E-05 0,000965562 Abtb2 -2,3459 0,001365625 0,014773976
9430087J23Rik -2,0873 0,007041807 0,049403961 Scml4 -2,3462 0,004764616 0,037527065
Fam122b -2,0917 0,000602248 0,00802965 Arap2 -2,3546 0,000783179 0,009726876
Gm16575 -2,1047 0,007028646 0,049332144 Farp1 -2,3559 0,00139967 0,015056893
Gramd4 -2,1151 0,001783491 0,018153503 Asap2 -2,3566 0,00011685 0,002335053
Gem -2,1203 0,002687946 0,024665341 Dgka -2,3576 4,33E-05 0,001064074
Tmco6 -2,1229 0,005470037 0,041282117 4833403J16Rik -2,3711 0,00687423 0,048654281
Gimap6 -2,1248 0,004731182 0,037375233 Gm38384 -2,3713 0,000293097 0,004744125
Trbc2 -2,1275 0,00594546 0,043830244 Dusp2 -2,3731 2,65E-05 0,00071982
Hmces -2,1293 0,000321695 0,005085009 Serpinb9 -2,3785 0,00353235 0,030184484
Agap2 -2,1299 0,000571046 0,007760892 Gm10125 -2,3818 0,000164387 0,003036741
Epha1 -2,1433 0,000532715 0,007371486 Enpp5 -2,3856 0,003709454 0,031219388
Lsm11 -2,1453 0,00404711 0,033361955 Lax1 -2,3964 0,004671133 0,037057067
Fyn -2,1565 0,000634576 0,008328993 Tmc8 -2,4020 1,83E-05 0,000544781
Chst11 -2,1568 0,00123222 0,013745116 Rasgrp2 -2,4150 1,71E-05 0,000514664
Mctp2 -2,1610 0,002177769 0,021097216 Setbp1 -2,4156 0,000468614 0,006755258
Zscan20 -2,1611 0,001475333 0,015738748 Klri2 -2,4185 0,006898387 0,048742439
Scfd2 -2,1617 0,000333114 0,005221462 B3gnt7 -2,4250 0,000454903 0,006614128
Poc5 -2,1681 0,000674501 0,00873072 Ikzf3 -2,4307 0,000322781 0,005097402
Zdhhc18 -2,1771 3,07E-05 0,000810729 Gm7967 -2,4362 0,001188182 0,013413574
Klhl12 -2,1854 9,01E-08 9,68E-06 Nlrc3 -2,4368 0,000665532 0,008654481
Zfp212 -2,1895 1,57E-07 1,48E-05 Gadd45gip1 -2,4409 0,003891399 0,032363086
Snx33 -2,1918 0,001266156 0,014040094 Apol7e -2,4415 0,005539358 0,041559966
Pdcd4 -2,1934 1,81E-07 1,68E-05 Gm12763 -2,4437 0,002786721 0,025323725
Jakmip1 -2,1967 0,000891701 0,010688999 Cnrip1 -2,4480 0,000358759 0,005537776
Zbtb16 -2,1978 0,005297491 0,040483678 Tob1 -2,4484 4,11E-05 0,001015684
Sp4 -2,2004 8,94E-06 0,000311452 Ndnf -2,4659 0,001070358 0,012314231
Ipcef1 -2,2152 7,67E-07 4,85E-05 Eml2 -2,4703 0,006159931 0,044994972
Gm37912 -2,2166 0,001325399 0,014483674 Hip1r -2,4766 1,95E-05 0,000571167
Bach2 -2,2202 1,27E-06 7,03E-05 Gm37963 -2,4824 0,00551533 0,041443469
Rasal3 -2,2232 5,43E-05 0,001273546 Ccnd3 -2,4842 3,32E-05 0,000857085
Gm44226 -2,2299 0,001588126 0,016626531 Hs3st3b1 -2,4858 0,000350825 0,005448453
Gimap5 -2,2328 0,001724589 0,01774675 Gm28100 -2,4902 0,004471388 0,036114743
Ablim1 -2,2330 0,002197747 0,021231039 Galntl6 -2,4907 0,000843146 0,010282677
Mxd4 -2,2348 1,25E-05 0,000404076 Zhx2 -2,4925 7,85E-05 0,001711561
Tmtc4 -2,2354 2,48E-07 2,15E-05 Atxn7l2 -2,4973 0,000683698 0,008796487
Mmgt2 -2,2388 0,000313716 0,004996345 Cd247 -2,4990 0,006862014 0,048607611
Ccnd2 -2,2395 7,43E-08 8,46E-06 Zdhhc15 -2,5014 0,003433101 0,029497038
Gm14300 -2,2461 0,003574686 0,03039863 Pim2 -2,5067 1,64E-06 8,51E-05
Tulp4 -2,2489 4,16E-06 0,000175466 Gfod1 -2,5085 0,001185594 0,013393321
Gm18988 -2,2513 0,002367376 0,022418956 Cbx7 -2,5108 0,002765813 0,025147281
Card6 -2,2521 4,77E-06 0,000193411 Klre1 -2,5115 0,003575885 0,03039863
Kif21b -2,2541 3,61E-08 4,83E-06 Nxpe3 -2,5139 1,07E-05 0,000358192
1700025G04Rik -2,2542 0,004533457 0,036392806 Ubxn11 -2,5222 0,00152714 0,0161687
Fzd5 -2,2558 0,003219255 0,028088955 Itgb7 -2,5223 2,30E-06 0,000110328
Pde7a -2,2559 4,15E-09 8,47E-07 B930095G15Rik -2,5259 0,001872378 0,018797335
  221  
Gene FC pval padj Gene FC pval padj
Acap1 -2,5372 0,002084618 0,020417633 Amotl1 -2,8176 0,000719775 0,009162063
Pear1 -2,5381 0,004504372 0,036228294 Gm12216 -2,8290 4,10E-06 0,000173651
Zfp420 -2,5476 0,000145134 0,002757286 Mgst2 -2,8322 0,000145172 0,002757286
Lrrc75a -2,5479 0,000292116 0,004739181 Nkg7 -2,8449 0,001215933 0,013626529
Gm43062 -2,5483 0,000670054 0,008699865 Gm14276 -2,8462 0,005029351 0,039143993
Ptpn4 -2,5559 3,28E-06 0,000144303 Adamts14 -2,8502 0,001148735 0,013046842
Slc2a4rg-ps -2,5567 0,000287283 0,004685998 Pias3 -2,8602 0,000167925 0,003091953
Rundc3b -2,5570 0,002256548 0,021563139 Spn -2,8622 1,57E-06 8,26E-05
Zfhx2 -2,5661 5,28E-07 3,70E-05 Klrd1 -2,8640 6,32E-05 0,001442291
S1pr4 -2,5672 0,001620789 0,016895072 Gsta3 -2,8739 0,005794557 0,042939809
Fam184a -2,5690 0,002183981 0,021145248 Klrb1c -2,8860 0,00016848 0,003098779
Rab37 -2,5776 0,00367757 0,031028465 Gm19557 -2,8943 1,48E-06 7,91E-05
Ets1 -2,5802 0,000410616 0,006123295 Gm43753 -2,8962 0,00615743 0,044994972
Spry2 -2,5843 0,001352185 0,014666203 Gpc1 -2,9001 0,000472371 0,006803597
F2rl1 -2,5848 0,004910885 0,038399158 Skap1 -2,9016 0,000902241 0,010777052
Vopp1 -2,5883 3,01E-06 0,000135457 Slc26a10 -2,9186 0,000196287 0,003470199
Gm37034 -2,5927 0,003894873 0,032376008 Gm36931 -2,9218 0,000223725 0,003815316
Fam65b -2,5936 6,14E-06 0,000232376 Bcl9l -2,9279 2,58E-06 0,000121446
Zfp300 -2,5954 0,001853033 0,018647524 Camk2n1 -2,9356 0,000523258 0,007299273
Lpin1 -2,6020 0,000370298 0,005662229 Gm37023 -2,9371 0,002666202 0,02449246
6330409D20Rik -2,6069 0,003235765 0,028203838 Klrk1 -2,9466 6,93E-07 4,46E-05
C030034L19Rik -2,6086 0,004811659 0,037780931 Plcb4 -2,9469 2,76E-06 0,000125356
Atp2a3 -2,6125 0,000140772 0,002688865 Lrrn4cl -2,9482 0,001339478 0,014575246
Tbc1d10c -2,6142 0,002234263 0,021467065 Il12rb2 -2,9508 1,25E-05 0,000404076
Tmem71 -2,6146 0,000190652 0,003406281 Cfap74 -2,9538 0,005773599 0,042803305
Gimap8 -2,6159 0,00100266 0,011727362 Gm38243 -2,9615 0,000112287 0,002262648
Ccdc88c -2,6186 6,79E-05 0,001534207 Srpk3 -2,9651 0,005039564 0,039151212
Izumo4 -2,6205 0,002605005 0,024087726 Elovl7 -2,9716 0,005211121 0,040048078
Zfp275 -2,6211 3,50E-05 0,000896275 Zpbp -2,9719 0,0029269 0,026132925
Dpy19l3 -2,6212 5,88E-08 7,24E-06 D8Ertd82e -2,9775 1,43E-05 0,000449383
Rab11fip4 -2,6245 4,82E-06 0,000195123 A930024E05Rik -2,9824 0,001956796 0,01938651
Gimap4 -2,6334 0,000297826 0,004797641 Sell -2,9841 0,000562628 0,007671206
Gm36932 -2,6461 0,005521014 0,041459224 Gm29237 -2,9843 0,001849222 0,018637722
Sorbs1 -2,6462 0,006315817 0,045835874 Dnah8 -2,9860 0,002252181 0,021555786
Syne3 -2,6479 0,00082999 0,010188681 Aff3 -2,9865 0,002458534 0,023023668
Sorcs2 -2,6504 0,005251116 0,040256888 Rbm46os -2,9882 0,005954369 0,043835177
Hsd11b1 -2,6531 0,002608336 0,024092116 Mir6924 -2,9928 0,00417922 0,034279241
Satb1 -2,6555 0,001904233 0,019037814 Tmtc1 -3,0047 0,000884548 0,010633491
Gm11346 -2,6566 0,001278021 0,014134491 Dab2ip -3,0111 0,000311767 0,004974702
Sbk1 -2,6587 0,003348468 0,028946831 Gm4956 -3,0119 0,000169889 0,003117897
Zfp937 -2,6614 6,47E-07 4,30E-05 F2rl2 -3,0162 9,62E-05 0,002004686
Gm19585 -2,6617 0,00030209 0,004841674 Gm42572 -3,0176 6,78E-06 0,000250175
Gimap3 -2,6746 0,000390633 0,005887775 Thefc -3,0222 0,000143643 0,002734398
Phf21b -2,6818 0,001977959 0,019554664 Gm4759 -3,0256 0,000137749 0,002641382
Gm26762 -2,6828 7,31E-05 0,001618872 A430078G23Rik -3,0299 7,92E-07 4,95E-05
Fcho1 -2,6886 2,82E-05 0,000759875 Zfp473 -3,0306 0,000594748 0,007942211
Amigo1 -2,6931 8,39E-06 0,000297915 4930577N17Rik -3,0377 0,002280394 0,021741733
Gm38224 -2,6959 1,70E-06 8,67E-05 Stat4 -3,0381 2,82E-07 2,35E-05
Slc25a53 -2,6991 9,14E-06 0,000317079 D130040H23Rik -3,0412 4,61E-05 0,001116859
Ddx43 -2,7161 0,00036473 0,005587917 Gm16334 -3,0441 0,000951444 0,011237433
Gm38126 -2,7247 0,003661908 0,030931385 B3gnt5 -3,0484 3,15E-07 2,51E-05
Prkca -2,7294 0,000154584 0,002890476 Zfp831 -3,0497 0,000101749 0,002099859
Borcs7 -2,7472 0,000374248 0,005707109 Gzma -3,0503 0,000918247 0,010929485
Ncr1 -2,7587 0,000581162 0,007841503 Klri1 -3,0534 2,77E-07 2,35E-05
H2-Ob -2,7596 0,005396804 0,040947739 Klra13-ps -3,0556 0,000934387 0,011089226
Gm42822 -2,7621 0,000171547 0,003134685 Gm37469 -3,0667 0,001417246 0,015186327
Zdhhc12 -2,7624 0,00114016 0,012975665 Arhgef18 -3,0762 2,66E-06 0,000122843
Raver2 -2,7726 0,000415135 0,006164088 Chrne -3,0843 0,000746432 0,0094302
Ifng -2,7755 0,002127237 0,020726736 Katnb1 -3,1021 4,59E-05 0,001116311
Klrb1f -2,7787 2,79E-07 2,35E-05 Sytl3 -3,1024 7,38E-05 0,001629842
6030443J06Rik -2,7820 0,00140841 0,015101231 Llgl2 -3,1043 0,000361638 0,005565139
Klra9 -2,7888 0,000280098 0,004595464 Dlg3 -3,1060 1,09E-05 0,000362876
Dyrk2 -2,7973 6,55E-13 1,11E-09 Traip -3,1175 0,005646145 0,042070766
2810039B14Rik -2,8023 0,000586734 0,007878867 Klra14-ps -3,1181 0,005904759 0,043583456
Gm42684 -2,8033 5,11E-05 0,001210684 Theam -3,1228 0,000787575 0,009767088
Rnf157 -2,8039 0,000210426 0,003636325 Itgam -3,1275 0,002418897 0,022728201
Gm37368 -2,8091 0,003544053 0,030246721 Gm17552 -3,1393 0,006441942 0,046431539
Aknaos -2,8117 1,37E-05 0,000433426 Cdk5r1 -3,1566 0,003816682 0,03190723
Cd27 -2,8144 0,000626856 0,008248643 Gm38228 -3,1567 0,004548112 0,036441073
Ryr3 -2,8162 0,005363723 0,040804938 Cuedc1 -3,1581 0,002597091 0,024040906
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Gene FC pval padj Gene FC pval padj
C230085N15Rik -3,1584 0,001060987 0,012239815 Gm16479 -3,8803 3,17E-05 0,000830735
Tpmt -3,1676 0,00554738 0,041601651 Gm43967 -3,8934 0,003541061 0,030239762
Rfx2 -3,1713 0,000753546 0,009491642 St6galnac2 -3,8970 0,002366617 0,022418956
Mcam -3,1889 0,006170168 0,045030744 Cacna2d2 -3,9093 0,000275121 0,004530799
Mirt1 -3,2021 6,82E-07 4,41E-05 Scn11a -3,9104 0,004737123 0,037387137
Klra6 -3,2052 0,000683754 0,008796487 Klrb1a -3,9106 1,18E-06 6,66E-05
Nkd1 -3,2065 0,006000305 0,044038795 A630072L19Rik -3,9410 0,000161778 0,002994523
AI847159 -3,2176 6,09E-07 4,14E-05 2010300F17Rik -3,9508 0,000362465 0,005567705
Zfp174 -3,2265 0,000744464 0,009412393 Gm15854 -3,9771 0,001048014 0,012173417
Kcnj8 -3,2275 0,003421379 0,029426303 Gm25106 -3,9846 0,000585039 0,007864401
Tbx21 -3,2584 0,000482147 0,006897272 Slc5a11 -3,9850 0,003557623 0,030308858
Gm44775 -3,2623 0,007126941 0,04981475 Gm29157 -3,9885 0,000977661 0,011506795
Zfp78 -3,2667 0,001553875 0,016338942 Btbd11 -3,9893 6,12E-09 1,13E-06
Gm13807 -3,3030 0,00029967 0,004822743 Gm43203 -3,9989 0,00069509 0,008908592
Rnf125 -3,3281 0,000390538 0,005887775 Sync -4,0100 0,004640145 0,036950275
Gm16239 -3,3301 0,001327284 0,014489298 Gm22779 -4,0156 0,004021109 0,033212551
Lat -3,3363 8,60E-06 0,000303524 Gm10130 -4,0317 0,000918891 0,010929485
Cdc20b -3,3374 0,006205809 0,045188555 RP24-462O14.2 -4,0429 0,00205206 0,02016902
Gm11212 -3,3486 0,001282945 0,014179649 Gm5395 -4,0483 0,005216538 0,040048078
Scn3b -3,3522 0,002314933 0,022021241 Gm8482 -4,0677 0,005907256 0,043583456
E430014B02Rik -3,3599 2,30E-05 0,000643208 Gm38309 -4,0683 4,38E-05 0,001073343
Gm37520 -3,3623 0,001100118 0,012587915 Kcnc1 -4,0885 0,000216157 0,003716321
Gm26792 -3,3633 0,00303666 0,026842933 Gm44280 -4,1261 0,004528881 0,036373381
Pxylp1 -3,3658 0,000455491 0,006616976 Clnkos -4,1977 0,000987167 0,011585157
Rab6b -3,3677 1,52E-06 8,02E-05 Gm24616 -4,2094 0,000503739 0,007122534
Pde2a -3,3799 0,001124469 0,012817108 Unc5cl -4,2357 0,002839498 0,025575213
Cspg5 -3,3856 0,000874587 0,010575879 Klrc2 -4,2430 6,87E-09 1,26E-06
Gm37766 -3,3884 0,00705047 0,049413531 Prss27 -4,2561 0,002888945 0,025876237
Gm16845 -3,3931 7,64E-05 0,001673521 Gm614 -4,2576 0,000494188 0,007035618
Itga2 -3,4299 0,000790808 0,009785599 Grhl2 -4,2696 0,001846477 0,01863715
Dnase1 -3,4399 0,004323136 0,03519016 Gm43172 -4,2778 0,002503265 0,023345065
Gm29123 -3,4493 5,34E-05 0,001256154 Gm44081 -4,2817 0,003613664 0,030627161
Gm37248 -3,4546 0,000232617 0,003946997 Serpini1 -4,3080 8,82E-08 9,68E-06
Bach2it1 -3,4637 0,000107048 0,002185323 Gm15556 -4,3334 0,002942025 0,026212468
1700007L15Rik -3,4644 0,002198308 0,021231039 Bmp10 -4,3340 0,000377284 0,00574822
Gm43647 -3,4701 0,000575113 0,007776338 Gm37261 -4,3406 0,002790196 0,02532801
1700105P06Rik -3,4732 0,005065078 0,03927706 Cldnd2 -4,3661 0,000175943 0,003190811
Gm38118 -3,4837 8,71E-05 0,001857097 Gm21909 -4,3749 6,17E-08 7,49E-06
Gm24119 -3,4915 0,000878703 0,010578309 Gm37176 -4,3865 7,39E-05 0,001629842
Klf12 -3,5213 0,005460429 0,041261469 4930447F24Rik -4,3972 0,002827389 0,02554191
Mss51 -3,5310 7,73E-05 0,001690112 5430400D12Rik -4,4881 0,002333397 0,022158831
Adgrl4 -3,5421 0,000604742 0,008056541 Sspo -4,5466 0,001163149 0,013186997
Gm37452 -3,5562 0,002249897 0,021555786 Klrb1 -4,5679 8,89E-07 5,32E-05
Gm37266 -3,6046 4,42E-05 0,001081011 Camsap3 -4,5932 0,000250053 0,004175638
Qprt -3,6333 2,50E-07 2,15E-05 Dpf3 -4,6181 0,000610612 0,008107581
Gm38026 -3,6687 7,46E-11 3,52E-08 Gm43913 -4,7193 1,47E-05 0,000458271
Il18rap -3,6876 0,000127667 0,002469301 Gm37593 -4,7815 1,01E-05 0,000343127
Gm27240 -3,6975 8,00E-06 0,000285953 Gm26744 -4,8260 0,000189589 0,003394282
Tshz3 -3,7046 7,63E-07 4,84E-05 Muc4 -4,8310 2,29E-05 0,000641541
Gm10490 -3,7227 0,005951767 0,043835154 Cyp17a1 -4,8839 0,000192745 0,003436411
Gm37856 -3,7237 0,000617795 0,008165929 E230020A03Rik -4,8899 6,86E-05 0,001547413
Il18r1 -3,7249 0,000353624 0,005486868 G0s2 -4,8961 0,000137352 0,002638481
Ccl5 -3,7268 1,96E-06 9,60E-05 Gm45107 -4,9157 0,000702219 0,008972448
Klrc3 -3,7289 6,39E-06 0,000238516 Gm10505 -4,9823 0,000295173 0,004768565
Klrc1 -3,7419 9,63E-08 1,02E-05 2810468N07Rik -5,0317 8,31E-05 0,001788622
Gm43858 -3,7476 0,000100272 0,002075076 Gm25635 -5,0351 7,14E-05 0,001591478
Arl4d -3,7639 3,11E-06 0,000138966 St6galnac3 -5,0677 4,70E-05 0,001131453
Heatr9 -3,7718 2,33E-06 0,000111109 Gm6934 -5,0965 1,47E-06 7,91E-05
Gm29155 -3,7721 0,001520361 0,016117162 Wdr86 -5,2021 5,11E-05 0,001210684
Gm26580 -3,7824 0,000530699 0,007358274 Gm13375 -5,2803 1,94E-05 0,000569297
Slc2a10 -3,7876 0,002854147 0,025673627 Fibcd1 -5,3396 0,000234316 0,00397183
Baiap3 -3,7900 5,23E-06 0,000206639 Cdc42ep1 -5,3751 3,14E-07 2,51E-05
Bmx -3,7967 0,006157123 0,044994972 Fam132b -5,4068 3,03E-05 0,000801185
Gm28277 -3,8091 0,004800377 0,037727473 Gpr63 -5,8914 1,95E-05 0,000571167
Proca1 -3,8112 0,00360793 0,030593943 Fam124b -6,0189 8,22E-06 0,000293271
Ap3s1-ps2 -3,8193 0,00616676 0,04502536 Cym -6,0304 7,67E-06 0,00027591
Rac3 -3,8304 0,00384593 0,032074109 D830036C21Rik -6,4157 4,21E-06 0,000176364
Plekhg5 -3,8433 1,41E-06 7,69E-05 Nap1l5 -6,5811 1,07E-07 1,10E-05
S1pr5 -3,8528 7,08E-05 0,001580211 Tmem74b -6,7548 7,32E-07 4,66E-05
C330011M18Rik -3,8535 2,96E-07 2,42E-05
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Table A.4. Comparison IV. All differentially expressed genes from the comparison IV: uterine Eomes+CD49a+ 
(trNK) subset vs uterine Eomes+CD49a- (cNK) subset. FC: fold change, padj: adjusted p-value. 
Gene FC pval padj Gene FC pval padj
Msr1 8,9447 2,05E-38 8,35E-35 Pdpn 6,7391 6,77E-12 4,55E-10
Tlr1 8,4375 3,27E-25 1,30E-22 Clec4a3 6,7297 2,36E-25 9,87E-23
Clec7a 8,3704 3,17E-32 4,70E-29 Axl 6,7168 5,47E-31 5,95E-28
Ptafr 8,3361 2,78E-31 3,24E-28 Lyz1 6,7109 1,00E-09 4,83E-08
Mertk 8,3072 9,34E-29 6,63E-26 Gzmf 6,7063 1,12E-10 6,21E-09
Tfec 8,2760 8,46E-16 1,05E-13 Plekhg1 6,7060 3,10E-11 1,85E-09
Ccl2 8,1743 1,94E-28 1,32E-25 Fzd7 6,6991 1,15E-12 8,86E-11
Kdr 7,9454 7,78E-17 1,13E-14 Spi1 6,6975 7,44E-14 6,81E-12
Fcgr1 7,8447 8,27E-32 1,04E-28 Atp6v0a1 6,6968 1,48E-21 3,60E-19
Adap2 7,8357 6,39E-29 4,74E-26 Stxbp1 6,6862 1,09E-11 7,07E-10
Fmn1 7,8109 2,34E-24 8,10E-22 H2-Eb1 6,6777 4,87E-33 7,95E-30
Ccl7 7,8036 3,87E-18 6,79E-16 Reps2 6,6472 1,84E-10 9,89E-09
C3ar1 7,7980 1,52E-36 4,96E-33 Tnip3 6,6460 1,18E-12 9,05E-11
Cd109 7,7791 6,31E-11 3,63E-09 Mefv 6,6459 3,45E-13 2,95E-11
Mafb 7,7463 3,38E-53 5,51E-49 Mgat3 6,6338 6,72E-08 2,31E-06
Slco2b1 7,6934 2,31E-12 1,62E-10 Cdkl2 6,6336 1,42E-09 6,62E-08
Rab7b 7,6169 6,46E-19 1,21E-16 P2ry1 6,6296 9,32E-09 3,71E-07
Tlr13 7,5709 3,68E-28 2,31E-25 Cd33 6,6224 1,46E-25 6,27E-23
P2ry13 7,5662 3,06E-22 8,32E-20 Hmox1 6,6153 5,11E-22 1,37E-19
Havcr2 7,5475 1,88E-21 4,49E-19 Thbs1 6,5927 1,37E-27 7,95E-25
Cebpa 7,5472 6,09E-20 1,24E-17 Ecm1 6,5869 1,74E-11 1,09E-09
Itga9 7,5421 1,24E-33 2,88E-30 Gpr84 6,5786 4,72E-11 2,74E-09
Atrnl1 7,4969 2,69E-15 3,09E-13 Anpep 6,5614 4,50E-26 2,10E-23
Slc8a1 7,4545 4,20E-13 3,55E-11 Arl11 6,5585 1,10E-12 8,63E-11
Cd300c2 7,4541 5,07E-19 9,61E-17 P2rx7 6,5476 3,54E-17 5,25E-15
Plb1 7,3793 9,91E-12 6,49E-10 Gzmd 6,5432 3,34E-15 3,78E-13
Hck 7,3716 9,90E-26 4,48E-23 Tifa 6,5418 1,31E-14 1,38E-12
Gdpd1 7,3617 7,02E-14 6,47E-12 Aif1 6,5349 3,21E-20 6,63E-18
Hgf 7,3465 1,05E-12 8,34E-11 Tmem86a 6,5340 1,39E-11 8,95E-10
Wfdc17 7,3462 5,88E-28 3,55E-25 Cd36 6,5309 4,60E-21 1,07E-18
Ifitm1 7,3438 1,60E-12 1,18E-10 Gas6 6,5270 3,23E-10 1,71E-08
C5ar1 7,3242 3,18E-28 2,08E-25 Myof 6,5161 1,22E-25 5,38E-23
Oas2 7,2879 8,77E-34 2,39E-30 C1qc 6,4961 5,63E-23 1,64E-20
Ahnak2 7,2839 1,64E-12 1,21E-10 Fam114a1 6,4934 3,73E-09 1,62E-07
Adgre1 7,2719 1,18E-42 9,64E-39 Cd4 6,4658 3,75E-11 2,21E-09
Wdfy3 7,2473 5,83E-42 3,17E-38 Dock1 6,4638 7,56E-15 8,16E-13
Rab3il1 7,1989 1,83E-11 1,12E-09 Acvrl1 6,4496 3,51E-10 1,83E-08
Lpcat2 7,1984 5,16E-30 4,67E-27 Lrp1 6,4367 9,23E-23 2,64E-20
Lrp12 7,1336 5,52E-09 2,30E-07 Plau 6,4260 1,24E-16 1,76E-14
Plxna1 7,1234 1,39E-23 4,44E-21 Clec4n 6,4218 4,66E-14 4,49E-12
Stra6l 7,1141 5,50E-14 5,18E-12 Gm37199 6,4091 5,16E-08 1,81E-06
C1qb 7,1126 1,81E-33 3,28E-30 Mfsd12 6,4074 2,78E-17 4,16E-15
Ctnnd2 7,1093 8,22E-10 4,03E-08 Gm44205 6,4008 5,02E-07 1,40E-05
Ctsh 7,1003 1,54E-33 3,13E-30 Rgs10 6,3914 2,43E-13 2,11E-11
Zfp385a 7,0836 2,99E-12 2,07E-10 Wdfy4 6,3847 3,73E-16 4,75E-14
Fam20c 7,0804 1,59E-17 2,45E-15 Abcc3 6,3838 1,58E-11 1,01E-09
Rin2 7,0714 1,38E-16 1,94E-14 Ankrd33b 6,3836 1,66E-07 5,19E-06
Flrt3 7,0249 6,59E-14 6,14E-12 Ltbr 6,3799 5,11E-09 2,16E-07
Nlrp3 7,0179 1,41E-15 1,68E-13 Ear2 6,3747 4,83E-13 4,02E-11
Anxa3 7,0171 1,63E-23 5,12E-21 Csf1r 6,3718 4,79E-25 1,86E-22
Lyve1 6,9838 7,55E-11 4,26E-09 Cd180 6,3692 2,17E-22 6,01E-20
Tlr8 6,9575 3,63E-18 6,43E-16 Clec10a 6,3650 6,44E-09 2,66E-07
Pparg 6,9428 1,07E-12 8,47E-11 Cxcl16 6,3536 1,90E-21 4,49E-19
Cttnbp2nl 6,9368 1,32E-20 2,86E-18 Kif26b 6,3276 1,20E-07 3,91E-06
Vcam1 6,9336 1,49E-27 8,38E-25 Alox5ap 6,3269 2,41E-14 2,49E-12
Rnf144b 6,9333 2,49E-13 2,15E-11 Il7r 6,3260 2,58E-17 3,90E-15
Pla2g7 6,9005 2,14E-16 2,86E-14 Fabp4 6,3182 4,25E-10 2,18E-08
Csf2rb 6,8868 2,50E-29 2,15E-26 Retnla 6,3174 2,77E-11 1,67E-09
Fkbp9 6,8677 1,12E-08 4,39E-07 Pde7b 6,3093 1,28E-10 7,05E-09
Lacc1 6,8511 4,86E-21 1,12E-18 Ass1 6,3021 4,04E-14 3,92E-12
Pltp 6,8345 1,67E-13 1,51E-11 F10 6,2986 2,48E-24 8,42E-22
Eps8 6,8243 7,61E-25 2,82E-22 Apoe 6,2968 5,45E-17 8,01E-15
Pld4 6,8175 2,62E-25 1,07E-22 Tlr9 6,2802 3,68E-14 3,64E-12
Mmp14 6,7887 1,44E-16 2,00E-14 Ppfibp2 6,2562 1,76E-12 1,27E-10
Psd3 6,7770 8,37E-12 5,53E-10 Zak 6,2488 8,65E-20 1,72E-17
Pf4 6,7765 1,03E-09 4,94E-08 Tifab 6,2451 1,72E-19 3,35E-17
Acvr1 6,7657 2,07E-10 1,11E-08 Tdrd9 6,2441 8,42E-07 2,23E-05
Sirpa 6,7639 4,57E-32 6,21E-29 Igf1 6,2378 5,73E-15 6,32E-13
Gpnmb 6,7617 3,89E-26 1,86E-23 Ifi207 6,2310 7,16E-21 1,60E-18
Tnfaip2 6,7610 1,22E-15 1,47E-13 Trim30c 6,2142 9,15E-14 8,29E-12
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Gene FC pval padj Gene FC pval padj
Slfn4 6,2103 3,16E-12 2,17E-10 H2-DMb1 5,8322 7,05E-12 4,71E-10
Tnfrsf11a 6,2019 5,96E-25 2,26E-22 Cybb 5,8319 3,58E-23 1,06E-20
Flt1 6,1940 4,90E-14 4,65E-12 Nlrp1b 5,8297 9,65E-12 6,35E-10
Siglec1 6,1929 2,81E-26 1,43E-23 Sgms1 5,8290 2,45E-16 3,22E-14
Cd68 6,1839 3,85E-29 3,14E-26 Zscan12 5,8265 3,20E-07 9,34E-06
Lhfpl2 6,1838 1,59E-11 1,01E-09 Ptgs2 5,8191 3,36E-12 2,30E-10
Plxnd1 6,1780 1,22E-19 2,40E-17 Gm38357 5,8135 9,25E-15 9,92E-13
Tmem26 6,1748 1,76E-09 8,07E-08 1700071M16Rik 5,8064 9,17E-07 2,40E-05
Ccl12 6,1665 2,66E-07 7,85E-06 Adam33 5,8061 4,18E-07 1,19E-05
Tmtc3 6,1461 4,23E-18 7,19E-16 F630028O10Rik 5,8040 2,01E-08 7,56E-07
Epcam 6,1435 3,36E-10 1,76E-08 Ak4 5,8035 1,29E-06 3,27E-05
Tlr7 6,1047 5,68E-18 9,26E-16 Il18 5,7951 3,71E-08 1,34E-06
Mmp13 6,1024 1,11E-10 6,15E-09 Tmem132a 5,7788 8,56E-10 4,17E-08
Nr1h3 6,0857 3,27E-10 1,72E-08 Trem2 5,7689 2,55E-07 7,59E-06
Gm26603 6,0805 4,23E-07 1,20E-05 Thbgf 5,7589 4,15E-18 7,19E-16
Rusc2 6,0788 4,51E-08 1,60E-06 Cds1 5,7435 2,81E-07 8,29E-06
Mmp19 6,0665 2,43E-08 8,98E-07 Mgst1 5,7302 3,18E-07 9,30E-06
Pde8b 6,0652 8,42E-08 2,80E-06 Nrp1 5,7215 1,14E-24 4,12E-22
Adgrg6 6,0544 9,29E-08 3,08E-06 Ier3 5,7199 1,42E-06 3,56E-05
Lmo2 6,0490 5,71E-13 4,68E-11 P2ry6 5,7172 1,25E-17 1,96E-15
Cd300ld 6,0478 1,29E-20 2,84E-18 Gpr141 5,7155 1,41E-11 9,08E-10
Pdgfc 6,0365 7,20E-09 2,92E-07 Olfml2b 5,7091 2,46E-05 0,00043567
Slc15a3 6,0213 1,16E-18 2,13E-16 App 5,7034 2,22E-23 6,83E-21
Tal1 6,0206 1,53E-06 3,78E-05 H2-Aa 5,7017 5,37E-21 1,22E-18
Inhba 6,0174 5,62E-13 4,63E-11 F11r 5,7014 1,84E-16 2,50E-14
Ptgfrn 6,0118 9,09E-07 2,39E-05 Kcnj2 5,7000 2,00E-15 2,34E-13
Cdc42bpb 6,0060 1,10E-08 4,32E-07 Shtn1 5,6879 7,23E-09 2,93E-07
Arg1 6,0007 1,67E-12 1,22E-10 6430548M08Rik 5,6815 2,34E-07 7,11E-06
Adgb 6,0001 6,23E-09 2,58E-07 Matn2 5,6767 1,98E-06 4,75E-05
Clec4a1 5,9973 1,71E-16 2,34E-14 Apba1 5,6755 6,88E-09 2,82E-07
Gm6377 5,9973 7,92E-10 3,94E-08 Scamp1 5,6703 2,53E-16 3,30E-14
Ifitm3 5,9928 9,50E-18 1,52E-15 Tgm2 5,6648 2,05E-27 1,12E-24
Cd300e 5,9889 2,75E-15 3,14E-13 Cd74 5,6446 6,08E-22 1,60E-19
Rhou 5,9841 1,85E-09 8,45E-08 Slamf8 5,6445 3,48E-09 1,52E-07
Tiam1 5,9805 5,20E-10 2,64E-08 Pid1 5,6294 2,66E-14 2,69E-12
Il1rn 5,9796 2,73E-14 2,75E-12 Gdf3 5,6283 6,73E-11 3,87E-09
H2-Ab1 5,9649 2,36E-23 7,13E-21 Ctsg 5,6094 1,24E-05 0,00023843
Apbb2 5,9593 6,43E-10 3,23E-08 Plaur 5,6051 1,75E-12 1,27E-10
Avil 5,9577 1,65E-09 7,59E-08 Mpeg1 5,5992 2,18E-20 4,64E-18
Slc7a8 5,9553 3,01E-26 1,49E-23 Plbd1 5,5952 1,10E-17 1,75E-15
Cxcl9 5,9531 3,89E-10 2,02E-08 Sirpb1c 5,5834 1,43E-07 4,58E-06
Cxcl2 5,9513 2,84E-08 1,04E-06 Ch25h 5,5784 3,17E-06 7,20E-05
Dsc2 5,9495 4,78E-06 0,00010395 Fat1 5,5646 1,42E-06 3,56E-05
Pfkfb4 5,9449 3,81E-08 1,37E-06 Rtn1 5,5605 5,85E-07 1,61E-05
Cyp4f18 5,9365 1,49E-09 6,89E-08 C3 5,5423 1,95E-14 2,02E-12
Ccl6 5,9338 1,14E-15 1,39E-13 Ly86 5,5371 2,43E-15 2,81E-13
Hacd4 5,9232 1,56E-16 2,15E-14 Il1r2 5,5347 1,35E-06 3,40E-05
Lpl 5,9189 3,49E-30 3,56E-27 Lyz2 5,5163 4,32E-18 7,26E-16
Treml4 5,9100 1,03E-11 6,74E-10 Cacna1d 5,5085 1,04E-07 3,40E-06
Nectin4 5,9098 5,35E-10 2,70E-08 Gdf15 5,5058 6,62E-07 1,80E-05
Gzmg 5,8917 6,89E-08 2,35E-06 Rab15 5,4996 8,75E-05 0,00130277
Vipr2 5,8896 4,46E-07 1,27E-05 Mtss1 5,4983 5,01E-10 2,56E-08
Cd93 5,8893 9,89E-19 1,83E-16 Clec4d 5,4913 6,00E-09 2,49E-07
Ptk2 5,8888 4,05E-07 1,16E-05 Nfix 5,4867 3,35E-07 9,76E-06
Siglece 5,8867 2,97E-12 2,07E-10 Gm37347 5,4860 7,27E-08 2,46E-06
Sdc3 5,8855 1,09E-21 2,72E-19 Emp1 5,4802 1,81E-14 1,89E-12
Il1a 5,8804 4,52E-08 1,60E-06 Aqp9 5,4790 3,97E-07 1,13E-05
Csf2ra 5,8725 8,99E-18 1,45E-15 Cmtm3 5,4782 2,98E-11 1,79E-09
Olr1 5,8714 9,32E-13 7,49E-11 Htra3 5,4766 6,45E-07 1,76E-05
Lrrc25 5,8679 1,55E-07 4,89E-06 Gm5150 5,4755 4,42E-09 1,89E-07
Ms4a14 5,8672 5,76E-08 2,01E-06 Thbd 5,4716 1,29E-10 7,06E-09
Nlrp1c-ps 5,8605 2,14E-10 1,14E-08 Rps6ka2 5,4674 5,32E-08 1,87E-06
Ednrb 5,8597 1,14E-14 1,21E-12 Slc7a2 5,4632 2,22E-16 2,95E-14
Mid2 5,8543 6,30E-06 0,00013197 Lifr 5,4577 3,88E-15 4,37E-13
Cttn 5,8525 3,92E-06 8,67E-05 Spats2 5,4556 1,37E-05 0,00025861
Ppfia4 5,8507 5,00E-11 2,89E-09 Apob 5,4547 7,10E-07 1,92E-05
Dusp4 5,8417 7,83E-07 2,10E-05 3110082I17Rik 5,4545 1,58E-11 1,01E-09
Akap1 5,8417 8,69E-07 2,30E-05 Tmem144 5,4537 7,96E-06 0,00016291
Alox5 5,8372 2,51E-09 1,13E-07 Gpr87 5,4490 1,88E-05 0,00034512
Cysltr1 5,8341 1,75E-11 1,09E-09 Cd300lb 5,4476 8,32E-10 4,06E-08
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Pafah2 5,4457 4,47E-06 9,77E-05 Cebpd 5,0853 1,35E-05 0,00025694
Fcrl5 5,4392 7,85E-08 2,64E-06 Stau2 5,0835 2,05E-08 7,69E-07
Ninj1 5,4375 1,77E-10 9,53E-09 Plxnb2 5,0795 1,28E-12 9,64E-11
Gm42934 5,4364 3,02E-06 6,94E-05 Tgfbi 5,0762 7,35E-12 4,89E-10
Aph1b 5,4339 3,92E-06 8,67E-05 Twnk 5,0758 1,49E-07 4,74E-06
Sh2b2 5,4240 2,17E-07 6,65E-06 Pla2g15 5,0676 7,30E-15 7,94E-13
Gzme 5,4205 1,00E-12 7,96E-11 Cfh 5,0631 5,90E-08 2,05E-06
Etv5 5,4092 6,98E-14 6,47E-12 Grn 5,0546 1,80E-17 2,74E-15
Prokr1 5,4042 5,90E-05 0,00093385 Jag1 5,0495 8,85E-06 0,00017826
Dhrs9 5,3847 8,21E-07 2,18E-05 Lyl1 5,0469 4,00E-08 1,43E-06
Hpgd 5,3844 5,77E-13 4,71E-11 Fgd2 5,0448 2,01E-12 1,43E-10
Cd200 5,3834 2,44E-05 0,00043467 Scin 5,0338 1,96E-09 8,91E-08
Ifi204 5,3776 9,11E-14 8,29E-12 Slc7a7 5,0243 1,58E-07 4,97E-06
Slamf9 5,3769 1,28E-06 3,25E-05 Fpr2 5,0217 1,36E-08 5,25E-07
Rnase2a 5,3635 9,50E-05 0,00139894 Plin2 5,0211 2,32E-20 4,85E-18
Arfgef3 5,3460 1,47E-07 4,66E-06 I830077J02Rik 5,0201 4,08E-10 2,11E-08
Mreg 5,3315 4,74E-06 0,00010313 Hpgds 5,0109 1,47E-18 2,67E-16
Grk3 5,3283 1,73E-11 1,09E-09 Gm15531 5,0094 4,05E-05 0,00067337
Ms4a6d 5,3279 7,20E-15 7,88E-13 Il6ra 5,0006 5,34E-13 4,42E-11
Kif13a 5,3270 3,83E-14 3,74E-12 Rnf128 4,9991 3,06E-05 0,00052538
Smo 5,3194 3,19E-07 9,33E-06 Mt1 4,9981 2,61E-08 9,60E-07
Rubcnl 5,3181 3,72E-07 1,07E-05 Ago4 4,9948 5,48E-06 0,00011738
Fn1 5,3174 4,30E-29 3,34E-26 Cd83 4,9937 4,28E-12 2,91E-10
Gm14548 5,3165 2,13E-05 0,00038323 Lgmn 4,9927 1,27E-24 4,50E-22
Gm42632 5,3130 6,77E-05 0,00104416 Adap2os 4,9905 3,10E-06 7,06E-05
Dcn 5,3106 2,90E-05 0,0005024 A230028O05Rik 4,9797 0,00024774 0,00315205
Slc40a1 5,3093 5,43E-08 1,90E-06 Kdelc1 4,9768 1,47E-06 3,66E-05
Adamts1 5,3076 7,21E-06 0,00014854 Gm26813 4,9735 3,07E-05 0,00052612
F13a1 5,3033 3,87E-16 4,89E-14 Carmil1 4,9690 4,56E-06 9,97E-05
Ctss 5,2974 4,47E-24 1,49E-21 Vill 4,9528 1,31E-06 3,32E-05
Pdia5 5,2880 2,42E-05 0,00043082 Tmem176b 4,9506 5,02E-15 5,60E-13
Nostrin 5,2853 4,05E-08 1,44E-06 Arhgef10l 4,9459 6,93E-06 0,00014419
Egln3 5,2782 8,93E-06 0,00017967 Coprs 4,9392 0,0002364 0,00303854
Dmxl2 5,2492 1,24E-12 9,39E-11 Rbm47 4,9317 2,09E-15 2,43E-13
Nxpe4 5,2491 4,73E-10 2,42E-08 Arnt2 4,9316 1,92E-05 0,00035103
Ccr1 5,2479 3,33E-08 1,21E-06 Ctla4 4,9235 1,17E-06 2,98E-05
Bcl2a1a 5,2466 6,16E-06 0,00012947 Neil2 4,9234 7,89E-05 0,00119411
Aph1c 5,2444 3,35E-08 1,21E-06 Ypel2 4,9202 5,83E-05 0,00092639
Adamdec1 5,2311 1,65E-06 4,03E-05 Afp 4,9175 0,00039079 0,00463914
Rab32 5,2279 3,12E-18 5,59E-16 Tcf7l2 4,9154 1,20E-11 7,79E-10
Gm15931 5,2114 1,76E-06 4,28E-05 Gpr19 4,9123 7,53E-06 0,00015449
Pilrb2 5,2111 8,66E-10 4,20E-08 Zfyve9 4,9082 1,22E-06 3,10E-05
Arhgap29 5,2099 3,61E-07 1,05E-05 Il1b 4,9067 1,30E-12 9,69E-11
Parp12 5,2074 1,58E-26 8,33E-24 Dab2 4,9001 2,19E-20 4,64E-18
Tnf 5,2060 2,13E-13 1,89E-11 Mrc1 4,8956 1,57E-09 7,24E-08
Kcnk6 5,1997 2,86E-16 3,71E-14 Arhgap24 4,8896 2,99E-05 0,00051628
Gm2396 5,1995 7,00E-06 0,00014536 Nlrc4 4,8751 7,87E-08 2,64E-06
Stom 5,1992 3,27E-11 1,95E-09 Igf2bp2 4,8640 1,16E-08 4,52E-07
Gpr35 5,1983 2,30E-13 2,01E-11 Ralgds 4,8578 6,61E-16 8,30E-14
Ifngr2 5,1908 2,65E-14 2,69E-12 Tbc1d8 4,8516 4,66E-09 1,98E-07
Atp6v0d2 5,1871 7,68E-05 0,00116806 Snx24 4,8425 6,06E-06 0,00012823
Slc6a12 5,1822 2,01E-05 0,00036563 AA467197 4,8408 1,26E-12 9,53E-11
P2ry12 5,1724 4,94E-12 3,35E-10 Gm13710 4,8403 0,00020689 0,00272363
Tns3 5,1694 2,25E-13 1,98E-11 Rnf180 4,8369 0,0002178 0,00283527
Amz1 5,1665 1,79E-07 5,60E-06 Spic 4,8217 5,66E-24 1,85E-21
Adora2b 5,1615 1,50E-05 0,00028162 Cdc42ep2 4,8208 4,79E-05 0,00078048
Stard8 5,1578 6,55E-22 1,70E-19 Stab1 4,8195 4,17E-09 1,79E-07
Mctp1 5,1534 1,79E-05 0,00033247 Mmp27 4,8177 0,00023098 0,00298063
C1qa 5,1468 1,34E-07 4,34E-06 Ms4a7 4,8142 2,28E-13 2,00E-11
Tlr2 5,1448 1,51E-10 8,16E-09 Bace2 4,8093 0,00062902 0,00688592
Klra2 5,1393 1,92E-16 2,59E-14 Myo10 4,8071 3,13E-09 1,38E-07
Hp 5,1340 6,33E-08 2,18E-06 Mrm2 4,8069 2,10E-05 0,00037952
Ankrd66 5,1193 9,53E-05 0,001401 Col15a1 4,8012 1,57E-08 6,02E-07
Ptpro 5,1101 6,88E-11 3,94E-09 Ctsz 4,7937 2,04E-13 1,82E-11
Mfsd7a 5,1091 3,41E-05 0,0005795 Plscr3 4,7928 6,07E-05 0,00095414
Cd300a 5,1074 9,89E-23 2,78E-20 B4galt4 4,7870 1,05E-05 0,00020773
Rnf217 5,1005 2,65E-05 0,00046436 Gm44860 4,7812 1,40E-08 5,38E-07
Marcks 5,0994 8,45E-22 2,15E-19 Gm43768 4,7799 0,00012272 0,00173752
Gm13650 5,0993 8,24E-05 0,00123817 Pstpip2 4,7795 1,43E-06 3,58E-05
Lilra5 5,0945 1,37E-09 6,41E-08 Ugt1a7c 4,7765 2,33E-06 5,51E-05
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Gas2l1 4,7730 2,76E-05 0,00047958 Tmem256 4,5134 6,43E-05 0,00100269
Rassf4 4,7720 1,00E-15 1,23E-13 Kynu 4,5102 3,57E-06 8,00E-05
Tbxas1 4,7674 1,19E-12 9,08E-11 Ddx3y 4,5083 0,00088457 0,00906294
Dapk1 4,7656 2,49E-11 1,52E-09 Igfbp5 4,5020 0,0008025 0,00836927
Ly6a 4,7545 1,49E-10 8,15E-09 Eya4 4,4968 0,0015564 0,01434261
Arhgef39 4,7486 9,51E-05 0,00139894 Pira2 4,4967 0,00023908 0,00307062
Hcar2 4,7324 3,01E-07 8,87E-06 Ceacam1 4,4960 3,09E-08 1,13E-06
Ifi203-ps 4,7280 2,08E-08 7,78E-07 Fap 4,4913 0,00042483 0,00497439
C130050O18Rik 4,7264 3,55E-05 0,0006015 Dnmt3aos 4,4826 0,00017611 0,00236805
Ldhb 4,7254 2,89E-05 0,0005001 Ms4a8a 4,4704 2,03E-08 7,62E-07
Gpt2 4,7142 1,46E-05 0,00027516 Nuak1 4,4695 3,10E-05 0,00053101
Abca9 4,7114 9,90E-13 7,92E-11 Art3 4,4683 0,00026681 0,00335026
Gm15374 4,7086 0,00017781 0,00238901 Plpp3 4,4655 0,00068757 0,00739287
Soga1 4,7010 9,91E-08 3,28E-06 Card9 4,4653 0,00011276 0,00161199
Ms4a4a 4,6995 1,58E-08 6,05E-07 Eng 4,4638 0,00020898 0,00274233
Slc11a1 4,6990 1,80E-12 1,29E-10 Tcp11l1 4,4610 4,49E-07 1,27E-05
Fcgr4 4,6989 4,61E-09 1,97E-07 Slc27a6 4,4594 1,54E-05 0,00028884
Tlr3 4,6915 9,25E-09 3,69E-07 Gm128 4,4584 0,00040235 0,00474873
Rnf150 4,6876 3,13E-12 2,16E-10 Tbc1d32 4,4572 1,21E-07 3,92E-06
Tmem106a 4,6860 6,21E-10 3,13E-08 Copz2 4,4519 5,25E-05 0,00084594
Gsn 4,6824 1,00E-09 4,83E-08 1500005C15Rik 4,4342 0,00019751 0,0026171
Ctsb 4,6809 4,22E-30 4,05E-27 Ifi211 4,4340 1,03E-14 1,10E-12
P2ry2 4,6783 0,00064913 0,00705396 Aldh3b1 4,4219 0,00016408 0,00223205
Mak 4,6735 0,00053319 0,00601979 9130204K15Rik 4,4172 0,00078345 0,00819686
Tlr6 4,6707 1,12E-09 5,30E-08 Ifit3b 4,4155 2,42E-09 1,09E-07
Cep170b 4,6655 5,28E-18 8,70E-16 Apobec1 4,4058 2,96E-19 5,68E-17
C4b 4,6629 1,28E-05 0,00024469 Flrt2 4,3992 0,00025639 0,00323935
Adgrg1 4,6554 6,08E-05 0,00095414 D330045A20Rik 4,3983 0,00038736 0,00460846
Lgals3 4,6552 1,52E-12 1,12E-10 Gm10693 4,3963 0,00063773 0,00696253
Lst1 4,6539 2,20E-08 8,18E-07 Clec12a 4,3952 2,75E-12 1,92E-10
St6gal1 4,6500 3,54E-06 7,94E-05 Arvcf 4,3924 0,00083288 0,00863646
Igsf10 4,6396 0,00049029 0,00561993 Mcemp1 4,3913 4,25E-05 0,00070259
Oasl2 4,6341 3,31E-16 4,26E-14 Cxcl1 4,3893 0,00082498 0,00855995
Skint3 4,6328 1,99E-05 0,00036329 Fcrl6 4,3795 7,11E-09 2,89E-07
Spint1 4,6317 6,26E-06 0,00013139 Fvt 4,3785 5,98E-06 0,00012685
2810025M15Rik 4,6311 1,97E-05 0,00035889 Serpinb8 4,3780 5,00E-07 1,40E-05
Vkorc1 4,6276 1,13E-05 0,00022136 Gm20548 4,3761 4,26E-06 9,33E-05
Trib1 4,6248 4,16E-11 2,43E-09 Rbfox2 4,3737 0,00193784 0,01725337
Kcnk13 4,6245 0,00019895 0,00263397 Abca3 4,3714 2,36E-08 8,78E-07
Gzmc 4,6234 9,76E-09 3,85E-07 2010300C02Rik 4,3706 8,28E-05 0,00124308
Cd320 4,6231 0,00010452 0,00150998 Asph 4,3662 5,25E-09 2,20E-07
Timd4 4,6197 0,00035884 0,00431643 Gm43068 4,3659 0,00089774 0,00917488
Fut10 4,6181 0,00106682 0,01055241 Trim47 4,3645 0,00063849 0,00696452
Bex6 4,6180 0,00012903 0,00181431 Gm21057 4,3531 0,0005082 0,00579666
Gspt2 4,6151 0,00027991 0,00349317 Cd276 4,3517 0,00032875 0,00400467
Clec4e 4,6037 1,84E-07 5,73E-06 Ppic 4,3491 0,00030029 0,00369792
Gm37648 4,5987 4,43E-05 0,00072769 Ifi205 4,3481 9,91E-09 3,89E-07
Gm37168 4,5948 0,00052933 0,00599162 Ralb 4,3477 6,89E-09 2,82E-07
Nt5dc2 4,5941 0,00035843 0,00431467 Hk2 4,3466 3,18E-10 1,68E-08
Cp 4,5900 2,64E-07 7,82E-06 Arhgap23 4,3434 5,24E-07 1,46E-05
Sirpb1a 4,5864 6,99E-09 2,86E-07 Asns 4,3430 0,00024145 0,00309146
Slpi 4,5822 0,00033701 0,00408701 Laptm4b 4,3415 7,87E-05 0,00119202
Gm15448 4,5748 0,00028696 0,00355179 Ly6i 4,3415 2,33E-07 7,08E-06
Upp1 4,5657 0,0008705 0,00892439 Aatk 4,3375 0,00035107 0,00423232
Mgl2 4,5624 3,18E-08 1,15E-06 Spp1 4,3308 5,47E-08 1,91E-06
Gm45041 4,5619 0,00024146 0,00309146 Cdh1 4,3284 7,13E-08 2,43E-06
Siglecf 4,5596 0,00084398 0,00872938 Cdk20 4,3273 0,00061322 0,00675828
Mtus1 4,5580 7,37E-06 0,00015146 St8sia6 4,3262 0,00013776 0,00191887
Lrrk2 4,5563 4,21E-07 1,20E-05 Ccl24 4,3229 0,00111735 0,01090674
Tnfrsf8 4,5521 0,00085988 0,00885451 Fabp5 4,3189 8,27E-09 3,33E-07
Mtap7d3 4,5519 4,83E-05 0,00078493 Gm16353 4,3160 1,79E-06 4,33E-05
4930533B01Rik 4,5473 0,00067499 0,00728412 Cd14 4,3153 1,37E-06 3,46E-05
Slc6a9 4,5413 0,00108001 0,01063773 Gm11440 4,3074 0,00140736 0,01322668
Sfmbt2 4,5301 8,78E-06 0,00017726 Reep6 4,3055 0,00129129 0,01230181
Cyp26b1 4,5300 0,0010891 0,01070788 Klhl13 4,3054 0,00100974 0,01011658
Fnip2 4,5273 1,30E-12 9,69E-11 Mfsd7b 4,3030 7,98E-10 3,96E-08
Gm20658 4,5272 0,00059972 0,00665448 Ckap4 4,3022 2,04E-05 0,00036934
Cd63 4,5217 3,08E-06 7,03E-05 4933416M07Rik 4,3016 0,00113926 0,01107417
Dok3 4,5186 3,37E-05 0,00057346 Ehd1 4,2974 6,70E-09 2,76E-07
Plxdc1 4,5164 0,00029495 0,00364186 1700047K16Rik 4,2942 0,00032565 0,00397583
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B4galnt2 4,2920 0,0014124 0,01326289 Zfp608 4,1056 1,57E-07 4,93E-06
Hlx 4,2912 0,00025421 0,00321673 Nucb2 4,1054 1,09E-06 2,81E-05
Ceacam19 4,2902 0,00161955 0,01479914 Nr1d1 4,1010 0,00064174 0,00699231
Gm14011 4,2888 0,00239221 0,02040759 Gm15964 4,0990 0,0005579 0,00626283
Spsb1 4,2841 0,00011857 0,00168323 Dusp14 4,0951 0,00375737 0,02906648
Thop1 4,2836 0,00066711 0,00721566 Mmp12 4,0928 2,57E-14 2,64E-12
Bmpr1a 4,2824 6,20E-05 0,0009712 Gm5431 4,0915 3,72E-11 2,20E-09
Gm33370 4,2784 0,00099305 0,00997394 Catsperg1 4,0914 0,00254391 0,02144377
RP23-292C5.8 4,2762 7,17E-05 0,00109799 Nlrp1a 4,0864 0,00020963 0,00274861
Ctsk 4,2738 1,02E-05 0,00020281 Il1r1 4,0852 0,00167579 0,01525323
8430408G22Rik 4,2710 0,00076625 0,00807737 Lrrc18 4,0791 0,00029863 0,00368454
Epb41l1 4,2695 2,97E-05 0,00051334 Gstm4 4,0788 0,00119373 0,0114737
Zfp467 4,2691 3,49E-06 7,86E-05 Fmnl2 4,0766 5,87E-06 0,00012499
Tmprss4 4,2633 0,0026194 0,02190021 Gngt2 4,0725 3,14E-09 1,38E-07
Adgre4 4,2606 4,32E-09 1,85E-07 Gm12454 4,0701 0,00054884 0,00617393
Cdk5rap1 4,2587 1,14E-05 0,00022242 Batf2 4,0688 0,00167766 0,0152617
Elavl4 4,2568 0,00273463 0,02265336 Sh3bp5 4,0563 1,25E-10 6,87E-09
Fth1 4,2559 5,01E-18 8,33E-16 Ly6g5b 4,0514 0,0025506 0,02147155
Gm20633 4,2542 0,00020576 0,00271093 Gm17230 4,0509 0,00261253 0,02186402
Pirb 4,2527 1,79E-12 1,28E-10 Igf2bp1 4,0509 1,11E-08 4,33E-07
Fblim1 4,2525 4,04E-05 0,00067244 Trem1 4,0504 0,00165981 0,01513314
Gm26811 4,2468 0,00279116 0,02300489 Wipi1 4,0492 0,00094793 0,00961544
Acod1 4,2378 5,58E-05 0,00089153 Gm16316 4,0491 0,00065322 0,00708889
Rai14 4,2353 2,64E-07 7,82E-06 S1pr3 4,0431 0,00331754 0,02640917
Clec5a 4,2337 2,97E-08 1,09E-06 Slc7a11 4,0429 3,47E-12 2,37E-10
Rasgrp3 4,2221 3,97E-09 1,71E-07 Hist1h2bc 4,0382 2,83E-05 0,0004923
Syngr1 4,2211 0,00204859 0,01810107 Chchd4 4,0370 2,51E-07 7,50E-06
Gm26797 4,2201 0,00027277 0,00341193 Piwil2 4,0336 0,00103722 0,01033809
Ccl8 4,2174 0,00190533 0,01702897 Sirpb1b 4,0301 2,66E-05 0,00046564
Dnase1l3 4,2163 5,04E-08 1,78E-06 RP23-323L3.1 4,0296 0,00020481 0,00270058
Tlr5 4,2156 4,65E-05 0,00075874 Tnfsf13b 4,0279 9,41E-05 0,00138932
C5ar2 4,2140 6,49E-08 2,23E-06 P2rx4 4,0278 4,22E-18 7,19E-16
Sbf2 4,2074 6,26E-20 1,26E-17 Tmcc2 4,0213 0,00049224 0,0056383
Vdr 4,2063 0,00095777 0,00968887 Ugt1a6a 4,0169 0,00063698 0,00695895
Gm13391 4,2052 0,00212629 0,01856632 Csf1 4,0112 1,32E-06 3,33E-05
Lsr 4,2051 0,00039872 0,00472068 Tnfrsf21 4,0096 7,46E-08 2,52E-06
Scamp5 4,2025 0,00042176 0,00494705 Prune2 4,0029 1,87E-07 5,79E-06
Gm12589 4,1956 0,00154175 0,01427003 Cxcl10 3,9965 1,16E-07 3,80E-06
Eid2b 4,1902 0,00025822 0,00325995 Slc16a10 3,9959 7,95E-07 2,13E-05
Fcrl1 4,1861 0,00085142 0,00878961 BC049715 3,9946 0,00022637 0,00293045
Bst1 4,1775 3,03E-09 1,35E-07 Stxbp6 3,9941 6,61E-05 0,00102361
Vwf 4,1719 2,30E-05 0,00041142 Zfp750 3,9894 0,00243541 0,0207328
Sestd1 4,1718 0,00086161 0,0088667 Gm9733 3,9862 0,00110522 0,01081422
Gm43593 4,1697 0,00076109 0,00804547 Slc27a1 3,9789 3,84E-06 8,55E-05
Speg 4,1695 0,00057305 0,00639335 Spdl1 3,9741 1,58E-05 0,00029576
Lipg 4,1690 0,00335187 0,02663034 Tgm1 3,9727 0,00226308 0,01953074
Clec4a2 4,1690 9,64E-09 3,82E-07 Gm42793 3,9711 0,00250947 0,0212303
Zfp503 4,1644 0,0008224 0,00854402 Olfml3 3,9660 7,70E-06 0,0001577
Atf3 4,1619 3,98E-08 1,42E-06 Tmem119 3,9654 0,00014316 0,00198404
Ccl1 4,1595 0,00076436 0,0080696 Flt4 3,9633 0,00201059 0,01780383
Cacna1b 4,1567 0,00109573 0,01075359 Bcl2a1d 3,9629 6,78E-06 0,00014144
Btbd3 4,1538 2,96E-05 0,00051201 Gm12543 3,9629 0,00167884 0,01526393
Tdo2 4,1519 0,00043318 0,00506131 Cd86 3,9552 7,55E-10 3,77E-08
Melk 4,1509 4,13E-05 0,00068463 Ifi30 3,9533 1,30E-15 1,56E-13
Slfn5 4,1501 7,81E-11 4,38E-09 Nfam1 3,9520 1,53E-06 3,78E-05
Ttc30a1 4,1462 0,00103117 0,01028707 4930599N23Rik 3,9513 0,00494904 0,03590914
Angptl4 4,1462 0,00071075 0,00759702 Gm43800 3,9504 0,00470934 0,03444574
Gm15503 4,1398 0,00109088 0,01071887 Rnf149 3,9492 2,65E-11 1,60E-09
Tarm1 4,1367 3,85E-05 0,00064389 Lima1 3,9449 4,81E-07 1,35E-05
Gm5345 4,1330 0,0029842 0,02426487 Gm15635 3,9434 0,00246626 0,02095164
Mcoln3 4,1321 0,00288566 0,02355754 Zfp629 3,9433 1,22E-05 0,00023491
Gm44861 4,1285 7,25E-07 1,96E-05 Gm17068 3,9399 0,00241218 0,02056724
Cryl1 4,1274 0,00019992 0,00264249 Tspyl4 3,9342 4,90E-07 1,37E-05
Rab20 4,1245 4,05E-05 0,00067337 Mapt 3,9333 0,00348785 0,02746999
Gm15356 4,1234 1,62E-07 5,06E-06 Gys1 3,9304 4,38E-05 0,00072032
Asb2 4,1200 6,06E-08 2,09E-06 Slfn1 3,9297 2,15E-07 6,60E-06
M1ap 4,1135 0,00117167 0,01131507 Asah1 3,9287 7,98E-16 9,94E-14
Homer3 4,1126 0,00222671 0,01927807 Tmem221 3,9277 0,0035025 0,02755875
Plekho1 4,1102 1,42E-07 4,55E-06 Rasd2 3,9239 0,00447071 0,03314625
Sh3pxd2b 4,1076 1,12E-12 8,75E-11 Glrx 3,9212 4,72E-14 4,51E-12
  228 
 
Gene FC pval padj Gene FC pval padj
Ceacam18 3,9205 0,00201416 0,01782577 Nxnl2 3,7541 0,00728139 0,04779347
Gm42603 3,9186 0,00430473 0,0322825 Gm43775 3,7532 2,20E-05 0,00039389
Sqrdl 3,9161 1,26E-07 4,10E-06 Adck1 3,7473 3,32E-05 0,00056585
Fggy 3,9154 0,00253409 0,02139418 Rgmb 3,7438 0,0034233 0,02705301
Pdxk 3,9148 1,09E-09 5,17E-08 Psrc1 3,7393 3,68E-06 8,21E-05
1700095J12Rik 3,9130 0,00407951 0,0309925 Tst 3,7389 0,00516469 0,03712387
Ptgr1 3,9123 2,95E-06 6,80E-05 Tmem106c 3,7349 5,17E-05 0,00083256
Ifit3 3,9066 1,02E-06 2,65E-05 Chdh 3,7345 0,004249 0,03198217
Clcn7 3,9049 1,03E-09 4,95E-08 Gm17705 3,7304 0,00071041 0,00759702
Gm2a 3,8960 8,49E-09 3,41E-07 Tmem67 3,7282 1,74E-06 4,25E-05
Sash1 3,8937 2,52E-05 0,00044558 Pgap1 3,7219 5,39E-06 0,00011559
Mfap3l 3,8893 0,00279006 0,02300489 Nupr1 3,7202 0,00029049 0,00359219
Rgl3 3,8876 0,00645135 0,0437538 Ccdc122 3,7187 0,00579483 0,04051416
Dnah12 3,8789 5,08E-05 0,0008216 Lilrb4a 3,7183 1,70E-12 1,24E-10
4930532G15Rik 3,8777 0,00072172 0,00770421 Rps6ka6 3,7158 0,00403567 0,03076778
Rab11fip5 3,8751 0,00022115 0,00287656 Tmem176a 3,7083 8,31E-08 2,77E-06
Gm37498 3,8738 0,00254246 0,0214426 A530099J19Rik 3,7068 0,00656531 0,04426903
Ap1s1 3,8701 0,00089222 0,00912721 Nacc2 3,7047 2,75E-06 6,40E-05
Pilra 3,8653 2,23E-10 1,18E-08 Gm14023 3,7046 0,00044664 0,00518896
Sh3bp4 3,8639 0,00218014 0,01895537 Rps4l 3,7037 0,00111929 0,01091309
Igsf6 3,8626 4,30E-13 3,62E-11 Gm19719 3,7006 0,00660127 0,044438
Gm5970 3,8548 0,00227843 0,01962164 Fcrls 3,6999 0,00018941 0,00252652
Slc39a2 3,8531 0,00401208 0,03063717 Gm44079 3,6938 0,00446908 0,03314625
Cd24a 3,8482 5,79E-08 2,01E-06 Dnah2 3,6890 0,00050425 0,00576373
Ncf2 3,8478 2,64E-09 1,18E-07 Gbp2b 3,6865 0,00069508 0,00746371
Ampd3 3,8464 6,11E-06 0,00012882 Gm42967 3,6846 0,0053486 0,0380965
4930512H18Rik 3,8464 0,00633023 0,04318378 Gm8378 3,6801 0,00678492 0,04543057
Thsd7a 3,8411 0,00651937 0,04405032 Adk 3,6760 0,00250872 0,0212303
1500009L16Rik 3,8389 0,00679392 0,04545386 Tceal8 3,6747 0,00021148 0,00276845
Mt2 3,8381 6,86E-05 0,00105253 Scpep1 3,6741 4,18E-06 9,21E-05
Cd209a 3,8377 0,00118486 0,01142213 Ebi3 3,6736 0,00299792 0,02433316
2210406H18Rik 3,8373 8,41E-06 0,00017155 Syn1 3,6701 0,00089252 0,00912721
Gm17169 3,8361 0,00118959 0,01145257 Tbc1d4 3,6646 0,00056416 0,00632002
Acta2 3,8356 0,00560992 0,03959475 Ptgir 3,6626 0,00232695 0,01995521
B3galnt1 3,8330 0,00129182 0,01230181 Gm23722 3,6609 0,00311653 0,02520262
Stmn2 3,8310 0,00682225 0,04558691 Parvb 3,6542 1,76E-08 6,67E-07
Irf6 3,8309 0,00287563 0,02349923 Batf3 3,6523 0,00143391 0,01341083
Ctsf 3,8258 0,00344892 0,02720277 Deptor 3,6513 3,55E-07 1,03E-05
Gm37468 3,8238 0,00046641 0,0053916 Basp1 3,6484 3,49E-14 3,47E-12
Apip 3,8222 2,45E-05 0,00043531 Acot1 3,6428 0,00666478 0,04479163
Gas2l3 3,8218 1,29E-09 6,04E-08 Cep290 3,6427 5,01E-06 0,00010846
Gad1-ps 3,8211 0,00219787 0,01907902 Neo1 3,6407 0,00313165 0,02526363
Dppa3 3,8185 0,00395341 0,0302742 Gm9974 3,6352 0,00516653 0,03712387
Zdhhc14 3,8175 0,00342688 0,02705612 Zfp704 3,6338 1,03E-07 3,39E-06
Dtx4 3,8174 2,02E-05 0,00036636 Erg 3,6323 0,00144713 0,01351896
Adcy4 3,8163 0,00069884 0,00748936 Rasgrp4 3,6297 9,42E-06 0,00018836
Plxdc2 3,8161 1,62E-05 0,00030266 Fam196a 3,6290 0,00648533 0,04392948
Rab44 3,8143 0,00554634 0,03929903 Nectin3 3,6285 9,10E-05 0,00134871
Angptl2 3,8087 0,00011101 0,00159256 Hsf2 3,6284 9,24E-07 2,42E-05
Ppp2r2c 3,8072 5,86E-05 0,00092958 Cxcl3 3,6266 8,35E-05 0,00125234
Dpep2 3,8022 1,38E-07 4,45E-06 Cfp 3,6212 8,53E-13 6,89E-11
Nid2 3,8001 0,00015028 0,0020633 Ctnnd1 3,6175 8,61E-06 0,00017454
Pnp2 3,7995 0,00228603 0,01967672 Slc43a1 3,6151 0,00617092 0,04242731
Met 3,7974 1,10E-05 0,00021666 9530085L11Rik 3,6149 0,00519291 0,03723144
Rgs7bp 3,7882 0,00107975 0,01063773 Lilra6 3,6143 0,00021032 0,00275541
Ckb 3,7847 8,15E-10 4,01E-08 2900005J15Rik 3,6119 0,00184874 0,01664947
Renbp 3,7818 2,41E-07 7,29E-06 Dio2 3,6107 0,00702975 0,04660102
Dynlt1a 3,7803 0,00212019 0,01854285 Arrdc4 3,6048 1,81E-08 6,86E-07
Med29 3,7763 0,00016032 0,00218454 Galm 3,6032 0,00367732 0,02861677
Nme4 3,7729 0,00433827 0,03241482 Psap 3,6010 1,08E-09 5,12E-08
Abcd2 3,7722 8,21E-07 2,18E-05 BC028528 3,5976 4,22E-06 9,26E-05
Il1rl2 3,7717 1,75E-06 4,27E-05 2810002D19Rik 3,5966 5,17E-06 0,00011144
Daglb 3,7714 8,16E-07 2,18E-05 Cd5l 3,5940 0,00417361 0,03153115
Arhgef11 3,7707 9,69E-05 0,00141684 Hif3a 3,5939 0,00233782 0,02002278
Msrb2 3,7671 0,00021627 0,00282209 A530064D06Rik 3,5928 5,26E-07 1,46E-05
Ang 3,7629 0,00041735 0,00490801 5730508B09Rik 3,5904 0,00026406 0,00331824
Paox 3,7620 0,00014866 0,00204616 8030453O22Rik 3,5903 0,00639117 0,0434798
Rnase4 3,7618 8,63E-05 0,00128859 Nudt12 3,5902 0,00681642 0,04556667
Afap1l1 3,7595 0,00121002 0,01158254 Gm43221 3,5851 0,00310138 0,02510504
Mgarp 3,7586 0,00362719 0,02828066 Fkbpl 3,5779 0,0075553 0,04912283
  229  
Gene FC pval padj Gene FC pval padj
Mx2 3,5703 2,46E-06 5,81E-05 Mvk 3,3363 0,00077078 0,00811629
Nek4 3,5696 0,00032681 0,00398428 Ethe1 3,3361 0,002762 0,02282217
Gm9888 3,5653 0,00059123 0,00656917 Dixdc1 3,3308 3,53E-05 0,00059932
Ccl9 3,5642 4,74E-07 1,33E-05 Cisd1 3,3285 0,00017247 0,00232686
Gm42515 3,5621 8,46E-05 0,0012664 Hbegf 3,3273 4,65E-05 0,00075874
Abcc2 3,5540 0,0032487 0,02606907 Hvcn1 3,3271 5,08E-06 0,00010997
Gda 3,5504 8,66E-05 0,00129057 Dll1 3,3257 0,00430846 0,03229566
Lrp5 3,5499 7,38E-08 2,50E-06 Clec9a 3,3033 0,00119671 0,01148883
Il17rd 3,5489 0,00521389 0,03733261 Lin28b 3,3026 0,00142249 0,01334229
Ifitm2 3,5484 7,82E-05 0,00118568 Npl 3,3020 8,11E-05 0,00122151
Wdr60 3,5480 0,00581342 0,04062669 Ptprj 3,3009 4,46E-13 3,73E-11
Rcn3 3,5462 0,0068411 0,04566306 Gm28727 3,2989 0,00645465 0,04375801
Acsl1 3,5413 6,25E-07 1,71E-05 Hpse 3,2976 7,09E-07 1,92E-05
Dnase2a 3,5343 1,53E-08 5,89E-07 Eepd1 3,2974 0,00062598 0,0068572
Ghb 3,5330 0,00457478 0,03370337 Gab1 3,2881 0,00058719 0,00653255
Snx7 3,5244 7,05E-06 0,0001462 Dsg2 3,2874 0,00574221 0,04023245
Bmyc 3,5226 0,00639229 0,0434798 Il2ra 3,2757 2,85E-06 6,61E-05
Fam198b 3,5203 0,00077816 0,00816246 Ctsl 3,2726 9,46E-11 5,28E-09
Ctif 3,5197 0,00039911 0,00472068 Dram1 3,2713 2,68E-05 0,00046826
H2-M2 3,5156 0,00370503 0,02877747 Tfe3 3,2694 1,75E-11 1,09E-09
Sdhaf1 3,5107 0,00074306 0,00788038 Gm44949 3,2597 0,00726241 0,04776501
Plk2 3,5080 1,86E-05 0,00034195 Fam46c 3,2567 7,42E-11 4,20E-09
Smpdl3b 3,5059 0,00104484 0,01037964 Gm43499 3,2567 0,00585744 0,04084683
Hebp1 3,5053 0,00026162 0,00329077 Cpq 3,2521 0,00028054 0,00349838
Themis2 3,4986 1,19E-09 5,57E-08 Ftl1 3,2499 2,19E-07 6,69E-06
Cpd 3,4981 3,90E-11 2,29E-09 St3gal5 3,2395 1,84E-05 0,00033888
Myo5a 3,4977 1,26E-08 4,88E-07 Slc35f6 3,2364 3,38E-09 1,48E-07
Blnk 3,4963 6,74E-08 2,31E-06 Naaa 3,2286 1,20E-05 0,00023285
Tada2a 3,4919 3,17E-05 0,00054173 Art2a-ps 3,2177 1,16E-06 2,98E-05
Ltb4r1 3,4908 0,00711833 0,04710226 Oas3 3,2177 7,43E-12 4,93E-10
Bgn 3,4907 0,00412737 0,03129776 Cd40 3,2173 2,62E-07 7,78E-06
Gm43914 3,4845 0,00626837 0,04290531 Armc6 3,2170 0,00769856 0,04979106
Il15 3,4838 3,07E-06 7,02E-05 Ophn1 3,2145 0,00085726 0,00883311
9430076C15Rik 3,4833 9,06E-07 2,39E-05 Hexa 3,2092 4,00E-11 2,34E-09
Tmem9 3,4748 3,05E-07 8,96E-06 Slc16a7 3,2085 0,00054786 0,00616705
Tctex1d2 3,4704 0,00034687 0,0041878 B830042I05Rik 3,2070 3,00E-09 1,34E-07
Gm6264 3,4677 0,00267728 0,02229154 Tacc2 3,2028 0,00106468 0,01053766
Oas1g 3,4614 2,95E-06 6,80E-05 Stx3 3,2013 3,32E-09 1,46E-07
Slc13a3 3,4597 0,00517928 0,0371949 Ifit2 3,2006 1,76E-09 8,09E-08
Gm4951 3,4570 0,00160554 0,01469585 E230029C05Rik 3,2004 4,22E-06 9,26E-05
Ramp1 3,4552 0,00256153 0,02154772 Pak6 3,2003 0,00156274 0,0143848
Anxa5 3,4525 1,33E-17 2,06E-15 Ube2l6 3,1908 2,61E-05 0,0004596
Snx9 3,4517 2,49E-07 7,46E-06 Ccrl2 3,1897 2,67E-06 6,23E-05
Pilrb1 3,4510 2,92E-06 6,75E-05 Ell2 3,1895 4,73E-14 4,51E-12
Hk3 3,4505 5,09E-05 0,00082244 Coq3 3,1812 0,00090924 0,00926329
Adam8 3,4471 2,63E-05 0,00046028 Fam129c 3,1742 0,00208802 0,01833288
Map3k15 3,4436 0,0006313 0,00690616 Gm15832 3,1730 0,00025989 0,00327596
E130102H24Rik 3,4427 0,00722668 0,04764211 Rgs12 3,1727 0,00131615 0,01248851
Fpr1 3,4400 0,00269881 0,02241358 Pkib 3,1702 1,01E-06 2,62E-05
Dck 3,4307 2,38E-11 1,46E-09 Ms4a4c 3,1672 3,91E-06 8,67E-05
Adam15 3,4306 0,00023046 0,00297622 Map7 3,1634 0,00032683 0,00398428
Tanc2 3,4282 1,24E-05 0,00023844 Gpam 3,1599 0,0021392 0,01865911
Chil3 3,4236 0,00399855 0,0305482 Zfp516 3,1598 0,00104063 0,01036244
Pusl1 3,4160 0,00129195 0,01230181 Nol4l 3,1592 3,07E-09 1,36E-07
Nfe2l3 3,4119 0,00250884 0,0212303 Mpo 3,1591 0,0068966 0,04598958
Pip5k1b 3,4079 0,00497897 0,03603017 Fndc3b 3,1566 2,33E-05 0,00041611
Ace 3,4052 2,02E-05 0,00036636 B3gnt3 3,1559 0,00496136 0,03596652
Sult2b1 3,4045 0,00414614 0,03139635 Tfpi 3,1530 3,52E-06 7,90E-05
Dock7 3,3952 1,89E-08 7,15E-07 Arhgap19 3,1529 5,55E-14 5,20E-12
Gm16139 3,3940 0,00438251 0,03264072 Acp2 3,1496 5,19E-09 2,18E-07
4933440N22Rik 3,3888 0,00351716 0,02766074 Scel 3,1468 0,00101369 0,01013752
1810055G02Rik 3,3830 0,00444296 0,03297045 Mfsd11 3,1462 7,20E-06 0,0001485
AW209491 3,3823 0,00025377 0,00321374 Gm42962 3,1449 0,00560571 0,03958764
Gm23731 3,3682 0,00727667 0,04778173 Gcsam 3,1445 0,00362364 0,02828066
Frmd5 3,3637 0,00151657 0,01410309 P4ha1 3,1405 1,16E-09 5,48E-08
Cebpb 3,3604 2,88E-08 1,06E-06 Tns1 3,1348 0,00109747 0,01076417
Rsad2 3,3533 2,12E-06 5,08E-05 E230016K23Rik 3,1335 0,00227246 0,01958062
Tusc1 3,3523 8,61E-06 0,00017454 Wdr41 3,1247 1,66E-08 6,31E-07
Vcan 3,3519 7,16E-11 4,07E-09 Mitf 3,1219 5,03E-05 0,0008149
Tbc1d9 3,3468 0,00063561 0,00694871 Nrp2 3,1213 8,95E-05 0,00133141
  230 
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Fam135a 3,1179 0,00507668 0,0365911 Gm37058 2,8808 0,00109847 0,01076749
Dnase1l1 3,1170 0,00013502 0,00188552 Bst2 2,8788 4,99E-08 1,76E-06
Cstb 3,1165 1,03E-10 5,71E-09 Hfe 2,8780 3,96E-05 0,00066019
Rhag 3,1161 0,00518097 0,0371949 Irak3 2,8726 0,00083878 0,00868383
Nudt1 3,1077 0,00060467 0,00669572 B430306N03Rik 2,8702 1,27E-06 3,22E-05
B4galt6 3,1004 3,99E-06 8,80E-05 Hdac9 2,8665 3,25E-09 1,43E-07
Dpp7 3,0977 0,00090707 0,00924697 Atp1a3 2,8623 0,00021759 0,00283477
Rasal2 3,0873 0,00046988 0,00542029 Lamp1 2,8621 7,13E-11 4,06E-09
Ldlrad3 3,0839 7,90E-05 0,00119411 Ppargc1b 2,8609 0,00063877 0,00696452
Tgfbr1 3,0820 1,23E-12 9,37E-11 Sox11 2,8600 0,00753773 0,04906141
Wwc2 3,0774 5,62E-05 0,00089734 Gart 2,8583 9,84E-09 3,88E-07
Cyp27a1 3,0759 0,0006215 0,00682183 Msra 2,8572 0,00012893 0,00181431
Cul7 3,0680 0,00467711 0,03424069 Mpp1 2,8544 7,98E-08 2,67E-06
Rasa4 3,0630 6,85E-05 0,00105187 Cd2ap 2,8390 5,31E-09 2,22E-07
Bnip3 3,0588 2,56E-05 0,00045223 Ccnd1 2,8366 0,00520285 0,03726995
Sort1 3,0564 0,00212298 0,01855729 Nek6 2,8270 8,63E-09 3,46E-07
Btk 3,0545 0,00361822 0,02826477 Ifi27l2a 2,8232 0,00034214 0,00413687
Ccdc136 3,0451 0,00750388 0,04895451 Rnf141 2,8132 9,27E-17 1,34E-14
Cst3 3,0432 2,67E-06 6,23E-05 Serpinb6a 2,8128 9,14E-09 3,66E-07
Pik3r6 3,0418 9,70E-06 0,00019345 Ptgs1 2,8121 5,78E-05 0,00091989
Pdgfa 3,0367 0,00233396 0,02000487 Senp8 2,8113 0,00594811 0,04135535
Gm42462 3,0331 0,00301778 0,0244769 Fcgr3 2,8080 1,17E-05 0,00022892
Hsd17b7 3,0319 0,00058753 0,00653255 Galk1 2,8069 0,00325191 0,02606907
Gm37967 3,0303 0,00769573 0,04979106 Soat1 2,8053 1,85E-13 1,66E-11
Cdh5 3,0284 0,00017548 0,00236163 Uevld 2,8047 5,96E-05 0,0009396
Gm16094 3,0282 0,00767278 0,0497024 Mx1 2,7912 1,55E-06 3,80E-05
Cd200r1 3,0221 0,00018131 0,00243204 Alpk1 2,7860 0,00159183 0,01459489
Chst14 3,0200 0,0003389 0,00410372 4933423P22Rik 2,7799 0,00443952 0,03295997
Kcnj10 3,0175 0,00098855 0,00993839 Stard9 2,7766 0,0005241 0,00594767
Gm37354 3,0143 0,00247043 0,02097381 Trpm2 2,7749 4,70E-07 1,33E-05
Itgb3 3,0128 5,92E-06 0,00012592 Ptrhd1 2,7661 0,00643329 0,04368788
Zeb2os 3,0107 0,00120824 0,01157224 Pros1 2,7572 0,00110315 0,01080209
Il1f9 3,0064 0,00049566 0,0056695 Gaa 2,7489 0,00013113 0,00183588
Cln6 3,0009 0,00023038 0,00297622 Cpne2 2,7480 0,00047393 0,00546312
Dnajc25 2,9959 1,08E-09 5,12E-08 Ero1l 2,7471 1,52E-07 4,82E-06
Gm16464 2,9929 0,00311602 0,02520262 Mfsd13a 2,7407 0,00703115 0,04660102
Rogdi 2,9907 0,00156559 0,01440291 5031439G07Rik 2,7397 1,24E-05 0,00023887
Bcl2a1b 2,9876 8,41E-06 0,00017155 Wdr11 2,7386 3,44E-06 7,77E-05
Cd22 2,9835 0,00015699 0,00214283 Ift57 2,7360 0,0006431 0,00699774
Alas1 2,9792 0,00024755 0,00315199 Zfp839 2,7327 2,06E-06 4,94E-05
Scarb1 2,9792 8,07E-08 2,70E-06 Oxnad1 2,7276 0,00225759 0,01949364
Homer2 2,9766 0,00601192 0,04166065 Gm7160 2,7158 0,00313182 0,02526363
Dnal1 2,9693 0,00628404 0,04294322 Pik3r2 2,7148 0,00077465 0,00814347
Mgat4b 2,9669 5,69E-05 0,00090647 Espl1 2,7102 0,0004235 0,00496246
Dna2 2,9604 1,20E-05 0,00023294 Gm43844 2,7099 0,00578034 0,04043013
Wrb 2,9589 0,00013097 0,0018353 Npc2 2,7040 5,98E-08 2,07E-06
Cd302 2,9560 0,00066609 0,00720944 Rbpj 2,7003 2,05E-12 1,46E-10
AI661453 2,9544 0,00401874 0,03065931 Pwwp2b 2,6996 0,0073411 0,04805002
Ccl17 2,9481 0,00693733 0,0461856 Idh1 2,6934 8,03E-06 0,00016413
Gins2 2,9429 0,0003722 0,00445083 Matk 2,6930 0,00562071 0,03963659
Bpifc 2,9422 0,00260755 0,02184472 Csf3r 2,6885 0,00095814 0,00968887
Bcar3 2,9414 0,00552057 0,03915042 Vegfb 2,6837 0,00589505 0,04103894
1700030K09Rik 2,9413 0,0031194 0,02521335 Mob3b 2,6805 0,00026167 0,00329077
Lonrf3 2,9383 0,00266323 0,02219718 Swap70 2,6790 1,61E-08 6,13E-07
Marcksl1 2,9319 0,00398369 0,03046321 Fut4 2,6784 0,00602119 0,04166809
Rnase6 2,9308 0,00223183 0,01931212 Lap3 2,6772 5,44E-05 0,00087063
Dock4 2,9281 0,00275396 0,02277867 Mtmr10 2,6722 5,21E-06 0,00011208
Sh2d1b2 2,9259 9,96E-05 0,00144832 Eml6 2,6656 0,00096649 0,00975519
Anxa4 2,9247 1,76E-11 1,09E-09 Xylt1 2,6539 4,46E-10 2,29E-08
Tdrkh 2,9227 0,00502267 0,03626596 Zfp992 2,6429 6,66E-05 0,00102855
Cdkn1a 2,9209 3,97E-06 8,77E-05 Itsn1 2,6362 0,00069725 0,00747723
Sgcb 2,9187 0,00518846 0,03721589 Pygl 2,6323 0,00020849 0,00274233
Cd300lf 2,9151 5,44E-09 2,27E-07 Trip13 2,6301 0,00224455 0,01941123
Arhgef12 2,9126 8,20E-05 0,00123287 Irf5 2,6216 0,00037211 0,00445083
5730409E04Rik 2,8991 0,00238421 0,02034996 Hgh1 2,6201 0,00136431 0,01288399
2310022B05Rik 2,8986 0,00649174 0,04393642 Eef1e1 2,6201 3,73E-05 0,00062711
Ift27 2,8977 0,00487319 0,03545347 Siglecg 2,6189 0,00339936 0,02691603
Rhbdf2 2,8950 2,64E-06 6,18E-05 Abhd12 2,6163 1,45E-07 4,63E-06
Ncf1 2,8858 7,89E-13 6,41E-11 Evi2a 2,6137 6,08E-05 0,00095414
Cenpn 2,8845 0,00280129 0,02306507 Mcfd2 2,6129 1,81E-05 0,00033528
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Smox 2,6120 1,18E-06 3,02E-05 Trpm4 2,4674 0,002052 0,01811158
Zfp111 2,6073 0,00422156 0,03182605 Gm11870 2,4669 0,00652602 0,04407697
Galc 2,6066 6,43E-05 0,00100269 Cep70 2,4626 0,00148766 0,0138579
Lpxn 2,6063 0,00012358 0,00174821 Fnbp1l 2,4556 0,00023306 0,00300038
Pqlc1 2,6023 0,00718682 0,04744002 Yae1d1 2,4539 7,83E-08 2,64E-06
Nme6 2,6020 0,00571436 0,04014078 Aldh6a1 2,4521 0,00474111 0,03464708
Mlh3 2,6013 0,00566533 0,0399167 Ddx60 2,4402 1,24E-05 0,00023844
Best1 2,6011 0,00449385 0,03325734 Vwa5a 2,4371 2,53E-09 1,14E-07
Tmem50b 2,6001 9,43E-05 0,00138939 Ifih1 2,4367 5,72E-06 0,00012212
Bri3bp 2,5992 0,00010176 0,0014767 Pak4 2,4348 8,66E-05 0,00129057
6820402A03Rik 2,5972 0,00040139 0,00474079 Tln2 2,4332 0,00077814 0,00816246
Skap2 2,5922 1,37E-07 4,42E-06 Pnp 2,4291 3,63E-07 1,05E-05
Lrp4 2,5905 0,00751107 0,04895451 Dpp4 2,4290 0,00416095 0,03149311
Plac8 2,5882 0,00053166 0,00600959 Slc45a4 2,4242 0,00011239 0,00160802
Prdx4 2,5879 0,00545714 0,03873656 Rnd3 2,4239 0,00566207 0,039911
Cd81 2,5859 9,91E-05 0,00144146 Lipa 2,4186 7,10E-09 2,89E-07
Creg1 2,5848 0,0001386 0,00192894 Gm42989 2,4179 0,00359199 0,02810634
Nfxl1 2,5837 9,76E-07 2,55E-05 Tmem51 2,4155 0,00464485 0,03405037
Lrrtm2 2,5832 0,001882 0,01685739 Ndrg1 2,4139 0,00014141 0,00196469
Epas1 2,5824 1,19E-05 0,00023155 Osbpl1a 2,4123 0,00174142 0,01578014
Maf 2,5822 1,06E-16 1,51E-14 Pomk 2,4086 0,00261007 0,0218546
Pgpep1 2,5821 0,00399042 0,03050036 Coq4 2,4079 0,00376006 0,02906648
Cndp2 2,5816 1,71E-11 1,08E-09 Irf7 2,4067 7,30E-05 0,0011126
Tpd52 2,5764 9,92E-06 0,00019716 Ak6 2,4039 0,00148953 0,01386746
Sphk1 2,5725 0,00727084 0,04778173 Csf2rb2 2,4017 0,0001512 0,00207422
Map4k3 2,5724 2,63E-06 6,18E-05 Nagpa 2,3901 6,82E-05 0,00104884
Dhx58 2,5639 9,59E-05 0,00140585 Nmnat3 2,3887 0,00314777 0,02537975
Slc25a13 2,5636 0,00014992 0,00206005 Cep76 2,3877 3,27E-05 0,00055834
Spon1 2,5610 0,00019629 0,00260729 Itga1 2,3830 1,22E-05 0,00023613
Ext1 2,5593 9,76E-05 0,00142532 Hspbap1 2,3823 0,00426899 0,03208823
Brca2 2,5569 0,00012929 0,00181635 Gpr157 2,3822 0,00110864 0,01083468
Coq7 2,5548 0,00405236 0,03084373 Hilpda 2,3786 0,00012974 0,0018196
Mcm8 2,5523 0,00640303 0,0435347 Rflnb 2,3774 0,00180186 0,01627358
Nxpe5 2,5500 0,00518383 0,03719906 Ogfrl1 2,3708 3,30E-06 7,47E-05
Slc31a2 2,5482 9,06E-06 0,00018173 Trf 2,3691 0,00014317 0,00198404
Kif20a 2,5461 0,00233851 0,02002278 Ly96 2,3662 0,00558017 0,03948197
F7 2,5416 0,00526024 0,03758206 Fads1 2,3609 0,00185285 0,01666948
Bhlhe41 2,5414 0,00626703 0,04290531 Plin3 2,3608 0,00209844 0,018409
Papss2 2,5410 6,12E-05 0,00095814 Blvra 2,3602 0,00031399 0,0038479
Prg4 2,5371 0,00521822 0,03734723 Gla 2,3582 3,66E-07 1,06E-05
F630040K05Rik 2,5319 9,15E-05 0,00135463 Naglu 2,3543 0,0009359 0,00951122
Cln8 2,5316 0,00037545 0,00447985 1500015A07Rik 2,3536 0,00595778 0,04140488
Cadm1 2,5313 0,0049522 0,03591609 Zfp458 2,3528 0,00567656 0,03996128
Slc17a8 2,5290 0,00077645 0,00815494 Fos 2,3493 0,0008481 0,00876079
Ifit1 2,5285 0,00442211 0,0328906 Lyrm2 2,3473 0,00258049 0,02167376
St3gal2 2,5274 0,00104356 0,01037898 Rnh1 2,3471 2,50E-08 9,21E-07
Sema6d 2,5267 0,00453739 0,03346899 Skp2 2,3417 7,07E-06 0,00014632
C130089K02Rik 2,5227 0,00226602 0,01954573 Filip1l 2,3417 5,97E-12 4,02E-10
Cyth3 2,5218 0,00017095 0,00231204 Igfbp4 2,3415 0,00010524 0,0015178
Mpv17l2 2,5139 0,00315793 0,02544914 Tmem65 2,3383 2,22E-06 5,31E-05
Tmem156 2,5093 0,0027745 0,02291384 Nceh1 2,3354 9,57E-06 0,00019096
Phf11d 2,5078 6,08E-06 0,00012848 Slc16a1 2,3340 0,00285724 0,02340755
Fam129b 2,5073 0,00068346 0,00735835 E330009J07Rik 2,3291 0,00044665 0,00518896
Cyfip1 2,5062 1,72E-11 1,08E-09 Slamf6 2,3291 0,00375127 0,02904784
Gm37780 2,5035 0,00461615 0,03395563 Dse 2,3238 2,10E-08 7,83E-07
Fcgr2b 2,5035 1,46E-06 3,65E-05 Synj2 2,3232 0,00277807 0,02293174
Adam9 2,5034 6,60E-05 0,00102295 Gm15601 2,3225 0,0025318 0,02138587
Ccdc88a 2,5012 2,64E-06 6,18E-05 Ano10 2,3211 0,00154242 0,01427003
Fgd6 2,4984 0,00018922 0,00252652 Adamtsl4 2,3161 0,00089986 0,00918829
Gm17259 2,4982 0,00426853 0,03208823 Gusb 2,3151 8,60E-06 0,00017454
Ubac1 2,4935 0,0027061 0,02242848 Mthfd2 2,3137 0,00259216 0,02174933
Cmpk2 2,4895 0,00024615 0,00313864 Psmg3 2,3134 0,0063855 0,04346989
Nxt2 2,4882 0,00028206 0,00350928 Ccne1 2,3117 0,00586635 0,04089147
Alcam 2,4834 0,00025344 0,00321196 Ets2 2,3114 1,78E-06 4,33E-05
Zfp821 2,4824 0,00279643 0,02303668 Sgpl1 2,3008 1,03E-05 0,00020406
Atg14 2,4814 0,00616239 0,04239735 Hbb-y 2,3002 0,00256799 0,02159096
Gcnt2 2,4798 0,00210948 0,01847388 Cxcr2 2,2984 0,00052684 0,0059676
Erbb3 2,4770 0,00134185 0,01270282 Dnhd1 2,2977 0,0075562 0,04912283
Specc1 2,4763 6,54E-05 0,00101589 Heatr5a 2,2890 5,17E-15 5,74E-13
Atp6ap2 2,4687 4,19E-06 9,22E-05 Vps26a 2,2663 3,37E-10 1,76E-08
  232 
 
Gene FC pval padj Gene FC pval padj
Naa40 2,2653 0,00187405 0,01681386 Tspan3 2,0511 0,00575882 0,0403142
Ocrl 2,2652 3,69E-06 8,24E-05 H1f0 2,0468 6,48E-05 0,00100787
Dclre1c 2,2572 2,27E-12 1,61E-10 Scrn3 2,0464 0,0047799 0,0348569
Litaf 2,2569 3,75E-09 1,62E-07 Itpripl2 2,0460 9,08E-07 2,39E-05
Msrb1 2,2512 0,00039849 0,00472068 Ssfa2 2,0431 1,02E-05 0,00020189
Hs1bp3 2,2497 0,00729184 0,04784281 Jup 2,0404 4,71E-07 1,33E-05
Emilin2 2,2476 4,43E-05 0,00072769 4931406C07Rik 2,0402 0,00711198 0,04707935
Umps 2,2465 0,00011455 0,00163472 Tmem104 2,0374 0,00269305 0,02238856
Kmo 2,2391 0,00335349 0,02663034 Wdr46 2,0353 1,96E-05 0,00035889
Dennd2a 2,2268 0,00061998 0,00681435 Mxi1 2,0341 0,00060565 0,00670198
Slc43a2 2,2261 7,20E-06 0,0001485 Sgk3 2,0313 0,00108079 0,01063895
Hivep3 2,2226 2,29E-07 6,98E-06 Champ1 2,0220 0,00040646 0,00479377
Tmem206 2,2176 1,30E-05 0,00024778 Fam76a 2,0183 0,00156752 0,01441251
Ttc27 2,2173 0,00626748 0,04290531 Ddhd1 2,0102 9,46E-09 3,75E-07
Oas1a 2,2164 0,00038977 0,00463045 Ly6e 2,0074 1,58E-05 0,00029576
Sh3pxd2a 2,2084 0,0069692 0,04632219 Tbc1d24 2,0074 0,00137481 0,01296964
Sema4b 2,2058 4,74E-09 2,01E-07 Cables1 2,0065 0,00744367 0,04860436
Prdx1 2,2031 4,64E-09 1,98E-07 Rdh10 -2,0096 0,00337013 0,02673645
Erlin1 2,2031 0,00016711 0,00227149 Ubxn11 -2,0110 0,00073136 0,00778156
Hexb 2,2026 1,53E-06 3,78E-05 Bach2 -2,0112 1,10E-05 0,00021682
Gch1 2,2023 1,30E-05 0,00024808 A130071D04Rik -2,0176 0,00011791 0,00167675
Ydjc 2,1997 0,00274002 0,02268653 Zhx2 -2,0232 1,11E-05 0,00021791
Aacs 2,1985 0,00327906 0,02623086 Klra3 -2,0243 0,00044288 0,00515617
Mtmr4 2,1985 7,22E-05 0,00110257 Abtb2 -2,0266 0,00471772 0,03449155
Cd274 2,1958 1,83E-06 4,43E-05 Scfd2 -2,0305 0,00098857 0,00993839
Lamp2 2,1926 4,13E-05 0,00068463 Gfod1 -2,0310 5,40E-05 0,00086656
Mfsd1 2,1898 3,58E-11 2,12E-09 Zdhhc15 -2,0315 0,00053367 0,00601979
Gpr146 2,1866 0,00037607 0,004484 1700025G04Rik -2,0329 6,92E-07 1,88E-05
Gclm 2,1844 0,00011388 0,00162656 Dxo -2,0364 0,00132798 0,0125934
Gfra2 2,1820 0,0072238 0,04764211 Lrrc28 -2,0409 0,00598286 0,04154382
Hsd17b11 2,1817 0,00014417 0,00199459 Serpinb9 -2,0421 0,00026128 0,00329077
Slc30a1 2,1732 1,79E-06 4,34E-05 Cd247 -2,0422 0,00068494 0,00736944
Atpif1 2,1704 0,00014718 0,00202928 Rab37 -2,0426 0,0011279 0,01098338
Abcg1 2,1655 1,85E-06 4,47E-05 Arhgef4 -2,0428 0,0067296 0,04517143
Ciita 2,1617 0,00543731 0,03862716 Stk10 -2,0488 2,65E-06 6,19E-05
Pigl 2,1533 0,00058487 0,00651176 Spata13 -2,0532 2,29E-06 5,46E-05
Stat2 2,1526 1,41E-06 3,53E-05 Asap2 -2,0665 9,55E-05 0,00140239
Dennd1a 2,1460 8,28E-08 2,76E-06 Ets1 -2,0697 3,20E-05 0,00054709
Klhl21 2,1458 0,00382863 0,02947084 Fyn -2,0726 2,81E-05 0,00048876
Dnajc4 2,1445 0,00435788 0,03250174 Tas1r3 -2,0733 0,00684383 0,04566306
Frmd4b 2,1444 2,38E-06 5,64E-05 Ndnf -2,0737 0,00036305 0,00436057
Clcn5 2,1433 2,81E-06 6,53E-05 Gigyf1 -2,0748 0,00248731 0,02108654
Lair1 2,1431 0,00024099 0,00309022 Tmtc4 -2,0790 8,76E-07 2,31E-05
Pgd 2,1427 1,42E-07 4,55E-06 Rbm12 -2,0814 5,60E-07 1,54E-05
Evi5 2,1423 0,00014526 0,00200447 Rarg -2,0870 0,00730062 0,04788112
Frmd4a 2,1410 7,23E-06 0,00014878 Kif21b -2,0870 5,29E-10 2,68E-08
Cacna2d4 2,1403 0,0001481 0,00204023 Gnal -2,0899 1,21E-05 0,0002343
D630030B08Rik 2,1399 0,00662868 0,04458574 Rasgrp2 -2,0905 6,46E-05 0,00100713
Sat1 2,1380 4,06E-05 0,00067435 Hip1r -2,0916 2,46E-07 7,41E-06
Atp6v1c1 2,1275 3,53E-09 1,54E-07 Ipcef1 -2,0959 3,87E-06 8,59E-05
Sh3tc1 2,1232 0,00258631 0,02171144 Depdc1b -2,1003 0,0071982 0,04749587
Tep1 2,1212 0,00022249 0,00288937 Slc2a4rg-ps -2,1006 0,00172037 0,01561549
Slc9a6 2,1149 0,00462274 0,03397967 Deb1 -2,1047 0,0013864 0,01306385
Selenop 2,1130 8,17E-10 4,01E-08 Arhgef3 -2,1068 8,04E-10 3,97E-08
Mettl6 2,1038 2,48E-07 7,46E-06 Fbxo32 -2,1070 0,00093052 0,0094707
Pofut2 2,1036 0,00048129 0,00553621 Klra1 -2,1102 0,00752014 0,04898601
Akr1a1 2,1032 7,97E-07 2,13E-05 Tulp4 -2,1169 1,68E-06 4,10E-05
Ndc1 2,0985 0,00032907 0,00400556 Tspan32 -2,1179 6,27E-06 0,00013139
Lxn 2,0880 2,55E-05 0,00045016 Gimap8 -2,1251 0,00326089 0,02609959
Capg 2,0863 1,31E-05 0,00024921 Zfp212 -2,1317 3,56E-05 0,00060229
Smim3 2,0855 0,00061941 0,00681267 Atg4d -2,1346 0,00154606 0,01427957
Rnf215 2,0821 0,00451872 0,03339597 Fam184a -2,1347 0,00186657 0,01676521
Abcc5 2,0807 7,99E-05 0,00120616 Atg4b -2,1388 9,26E-06 0,00018532
Agpat5 2,0788 0,00254606 0,02145084 Vps37b -2,1405 0,00122251 0,0116952
Fam213a 2,0770 0,0028979 0,0236456 Gimap4 -2,1427 0,00042537 0,00497718
Rell1 2,0768 6,24E-05 0,00097629 Gimap3 -2,1490 0,00012654 0,00178695
Qpct 2,0732 0,00677168 0,0453978 S1pr4 -2,1512 3,02E-05 0,00052012
Rgl1 2,0658 1,21E-05 0,00023412 1810034E14Rik -2,1583 0,00461285 0,03395318
Fam84b 2,0653 0,00177301 0,01604546 Ccdc88c -2,1636 1,54E-05 0,00028884
Ssx2ip 2,0525 0,00450695 0,03332405 Smad3 -2,1643 5,86E-07 1,61E-05
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Atp2a3 -2,1778 0,00010735 0,00154407 Ascc1 -2,5088 2,62E-05 0,0004596
Gm7967 -2,1780 0,00338904 0,02686033 Gm43062 -2,5124 0,00248321 0,02106273
Gm38384 -2,1896 0,00299081 0,02430648 Prkca -2,5156 0,00037019 0,00443655
Hsd11b1 -2,1986 0,00177365 0,01604546 Camk2n1 -2,5295 6,33E-06 0,00013246
Zfp235 -2,1989 0,00598768 0,0415596 F2rl2 -2,5372 3,84E-08 1,38E-06
Phf1 -2,2070 8,55E-05 0,00127778 Chrne -2,5385 0,00086633 0,00889839
Rfx3 -2,2137 2,54E-06 5,99E-05 Zfp473 -2,5385 0,00492728 0,0357831
Plppr3 -2,2168 3,31E-05 0,00056405 Klrb1f -2,5464 2,92E-06 6,75E-05
Card6 -2,2208 2,46E-07 7,40E-06 Rbm38 -2,5549 3,69E-05 0,00062317
Ptpn4 -2,2225 2,62E-05 0,0004596 Rtm34 -2,5556 0,00028106 0,00350224
Dgka -2,2234 0,00017367 0,00233912 Gzma -2,5852 0,00011078 0,00159061
Cwf19l1 -2,2245 0,00382487 0,0294558 Dab2ip -2,5920 1,79E-06 4,34E-05
Gm37702 -2,2340 0,00484585 0,03527025 Galntl6 -2,5972 0,00756349 0,04915061
Fcho1 -2,2451 1,59E-05 0,00029765 Fbxl2 -2,5989 0,00360127 0,02814583
Satb1 -2,2486 0,00117809 0,01136359 Sorcs2 -2,6085 0,00095408 0,00965981
Sh2d3c -2,2498 2,26E-07 6,90E-06 Llgl2 -2,6086 0,0025786 0,02166901
Pde7a -2,2551 4,97E-09 2,10E-07 Dnah8 -2,6098 1,55E-05 0,00029022
Ifng -2,2564 0,00483601 0,03521432 Amigo1 -2,6130 0,00012669 0,00178754
Prkag1 -2,2582 0,00051553 0,00586792 Sbk1 -2,6141 0,00453461 0,03346785
Tmc8 -2,2716 1,36E-05 0,00025803 Gm4759 -2,6149 0,00073097 0,00778156
Gm11346 -2,2723 0,00753383 0,04905559 Ddx43 -2,6229 0,00145071 0,01354467
Gm19585 -2,2743 0,00095234 0,00964816 Gm26762 -2,6266 0,00061303 0,00675828
Spry2 -2,2744 0,00027185 0,00340307 Cnrip1 -2,6300 0,00075453 0,00798648
Raver2 -2,2774 0,00211698 0,01852471 Gm36931 -2,6350 0,00067172 0,00725594
Sec22c -2,2810 0,00180442 0,01628773 Gm38126 -2,6394 0,00178873 0,01616989
AA465934 -2,2849 0,00116126 0,01122782 Gm10125 -2,6493 0,00103755 0,01033809
Zfp945 -2,2859 3,72E-05 0,00062605 Atxn7l2 -2,6496 0,0001026 0,0014862
Fam65b -2,2970 1,47E-06 3,65E-05 C230085N15Rik -2,6509 0,00120053 0,01151198
Ccnd2 -2,3039 7,66E-09 3,09E-07 Dpy19l3 -2,6578 5,45E-07 1,51E-05
Pim2 -2,3050 1,34E-05 0,00025562 Stat4 -2,6624 1,38E-07 4,44E-06
Dusp2 -2,3096 4,52E-05 0,00074057 Ankrd13d -2,6670 0,00519648 0,03724067
Nxpe3 -2,3130 0,00018235 0,00244398 Sytl3 -2,6690 7,04E-06 0,00014615
Plekhg2 -2,3167 3,13E-06 7,12E-05 Pias3 -2,6711 0,00030205 0,00371266
Itga4 -2,3224 1,55E-07 4,89E-06 Vopp1 -2,6750 1,50E-10 8,15E-09
Cd27 -2,3259 0,00217045 0,01888894 6030443J06Rik -2,6759 0,00461735 0,03395563
Tob1 -2,3392 0,00010373 0,00150123 Rnf157 -2,7002 6,87E-08 2,35E-06
Ncr1 -2,3447 0,00101776 0,01017194 Gm42684 -2,7065 0,00036637 0,00439401
Hrh2 -2,3527 0,00033777 0,00409317 Zfp831 -2,7068 0,00056931 0,00636029
B930095G15Rik -2,3538 0,00532769 0,03798073 Il12rb2 -2,7221 1,46E-06 3,64E-05
Gm26586 -2,3697 0,00320943 0,02582585 D8Ertd82e -2,7255 4,19E-10 2,16E-08
Ccnd3 -2,3755 5,26E-05 0,00084637 A930006L05Rik -2,7321 0,00452464 0,0334094
Mxd4 -2,3774 1,21E-05 0,00023412 Tmtc1 -2,7438 0,00107443 0,01060514
Gm43747 -2,3819 0,00529496 0,03781355 Gm19557 -2,7477 3,82E-05 0,0006403
Nkg7 -2,3822 3,70E-05 0,00062338 Itgb7 -2,7589 1,15E-07 3,75E-06
Skap1 -2,3856 7,80E-05 0,00118395 Klra6 -2,7644 1,13E-06 2,91E-05
Poc5 -2,3910 0,00056545 0,0063254 Spn -2,7708 2,45E-11 1,50E-09
Mmgt2 -2,3917 6,07E-05 0,00095414 AI847159 -2,7737 1,49E-06 3,70E-05
Amotl1 -2,3930 0,0061575 0,04239735 Gm16334 -2,7928 0,00186012 0,01672571
D430013B06Rik -2,3957 0,00306165 0,02482035 Gm37520 -2,7971 0,00739152 0,0483425
Zfhx2 -2,3971 1,13E-12 8,76E-11 Gjb2 -2,8145 0,00125622 0,0119966
Aknaos -2,4095 0,00010939 0,00157207 Mirt1 -2,8203 8,79E-06 0,00017727
Baiap2 -2,4115 8,64E-06 0,00017489 Klra13-ps -2,8248 4,94E-05 0,00080184
Lpin1 -2,4158 2,99E-09 1,33E-07 Gm42585 -2,8440 0,00099913 0,01002266
Slc26a10 -2,4237 0,00057486 0,00640473 1810024B03Rik -2,8450 0,00669764 0,04497536
Klrb1c -2,4339 2,21E-06 5,28E-05 Lrrn4cl -2,8483 0,00698125 0,04636451
2810039B14Rik -2,4415 0,00078583 0,00821121 Gm37023 -2,8533 0,00329574 0,02633848
Gm38243 -2,4427 0,00433519 0,03240665 Zfp937 -2,8551 3,94E-08 1,41E-06
Gpc1 -2,4430 0,00027106 0,00339571 Klrk1 -2,8703 1,14E-06 2,93E-05
Adamts14 -2,4435 5,59E-06 0,00011961 Zfp420 -2,8770 9,09E-05 0,00134777
Klrd1 -2,4496 0,00011847 0,00168323 Klra14-ps -2,8910 7,68E-05 0,00116806
B3gnt7 -2,4518 0,00050865 0,00579779 Polm -2,8938 1,18E-05 0,00022964
Klra9 -2,4620 0,00026804 0,00336055 Lrrc75a -2,8946 1,79E-05 0,00033142
Syne3 -2,4621 0,00011718 0,00166925 Hs3st3b1 -2,9002 5,79E-06 0,00012338
Zscan20 -2,4736 0,00101107 0,01012377 Bach2it1 -2,9014 0,00036257 0,00435803
Gm26189 -2,4791 0,00723915 0,04766969 Rbp -2,9071 0,00346583 0,02730976
Rap1gap2 -2,4833 3,07E-05 0,00052612 Gm12216 -2,9104 2,54E-05 0,00044892
Rab11fip4 -2,4925 9,40E-05 0,00138932 Gm38224 -2,9110 6,26E-05 0,00097839
Zfp275 -2,4936 0,00017007 0,002304 Gm37979 -2,9116 0,00475156 0,03469233
Slc25a53 -2,4958 0,00010045 0,00145899 Borcs7 -2,9148 2,81E-14 2,81E-12
Gm4956 -2,5068 0,00078314 0,00819686 Rfx2 -2,9191 0,00255115 0,02147155
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Gene FC pval padj Gene FC pval padj
Phactr3 -2,9419 0,00022371 0,00290283 Gm29155 -3,5940 0,00566897 0,03992514
Tbx21 -2,9437 0,00044274 0,00515617 Klrc3 -3,5947 8,72E-06 0,00017628
Arhgef18 -2,9438 8,57E-07 2,27E-05 Klrc1 -3,5987 1,05E-06 2,72E-05
Bcl9l -2,9461 2,59E-11 1,57E-09 Cdk5r1 -3,6102 0,00196839 0,01748714
Adgrl4 -2,9598 0,00571272 0,04014078 Klri1 -3,6206 2,56E-07 7,63E-06
Scn3b -2,9651 0,00449807 0,03327345 Gm26792 -3,6212 0,00208027 0,01830162
Rnf125 -2,9843 0,00046683 0,00539266 Klrb1a -3,6425 1,85E-07 5,73E-06
Zfp941 -2,9857 0,00560649 0,03958764 Slc2a10 -3,6632 0,00075999 0,00803908
Gm37452 -2,9935 0,00587469 0,0409321 Qprt -3,6887 1,08E-07 3,53E-06
Gm37766 -2,9983 0,00715535 0,04727055 Gm29123 -3,7148 1,25E-05 0,0002396
Gm16329 -2,9997 0,00263473 0,02199339 Gm38026 -3,7761 2,23E-07 6,81E-06
B3gnt5 -3,0018 3,36E-06 7,58E-05 St6galnac2 -3,7794 0,0029083 0,02371699
Zfp946 -3,0155 0,00243121 0,02070784 Gm44746 -3,7910 0,00048523 0,00557365
Dyrk2 -3,0267 3,64E-13 3,09E-11 Kcnc1 -3,7956 4,75E-05 0,00077339
Gm37248 -3,0482 0,00077486 0,00814347 Tgfb3 -3,8285 0,0009778 0,00985547
Plcb4 -3,0500 4,95E-06 0,00010737 4930431P19Rik -3,8391 0,00114196 0,01109383
Itgam -3,0524 0,0037958 0,02928725 Gm21909 -3,8436 1,37E-05 0,00025904
A430078G23Rik -3,0529 3,79E-07 1,09E-05 Gm22779 -3,8551 0,00513028 0,03692851
Gm18853 -3,0566 0,00330421 0,02636741 Gm37176 -3,8585 0,00076659 0,00807737
Itga2 -3,0744 0,00012864 0,00181197 Gm10490 -3,8624 0,0062268 0,04272838
Cdc20b -3,0899 0,00585286 0,04083232 Gm38309 -3,8644 0,00043449 0,00507295
Cspg5 -3,0927 0,00416278 0,03149311 Gm38118 -3,8667 2,60E-05 0,00045761
Mcam -3,1123 0,00188089 0,01685739 Heatr9 -3,8988 3,15E-06 7,16E-05
Elovl7 -3,1273 0,000815 0,00847801 Gm11655 -3,9020 0,00560218 0,03958764
Zdhhc12 -3,1381 0,00055676 0,00625432 Gm14125 -3,9135 0,00267399 0,02227547
D130040H23Rik -3,1409 0,00013266 0,00185422 Klrc2 -3,9217 1,01E-07 3,34E-06
Pxylp1 -3,1536 0,00041977 0,00493291 Gm45107 -3,9409 0,00609441 0,04206765
Gm27240 -3,1732 4,17E-05 0,00069041 Cyp17a1 -3,9413 0,00331704 0,02640917
Gm37266 -3,1743 0,00147366 0,01373536 Serpini1 -3,9478 3,88E-07 1,11E-05
Gm26910 -3,1841 0,00167285 0,01523501 Gm16479 -3,9559 0,00041056 0,00483509
Gm42572 -3,2151 1,06E-05 0,00020943 Gm13807 -3,9670 3,55E-05 0,00060133
Prss30 -3,2186 0,00669422 0,04497093 Cldnd2 -4,0546 6,79E-06 0,00014152
Gm42822 -3,2531 2,63E-05 0,00046028 5430400D12Rik -4,0936 0,00385823 0,02967068
Gm43214 -3,2592 0,00694337 0,04619703 Cacna2d2 -4,1292 0,00045298 0,00525501
E430014B02Rik -3,2596 9,79E-06 0,00019501 Gm43172 -4,1322 0,00329762 0,02634058
4930481A15Rik -3,2611 0,00381699 0,02940905 G0s2 -4,1841 0,0019172 0,01709752
Gramd3 -3,2645 0,00010618 0,00152988 Gm25635 -4,2264 0,00191014 0,01705325
Mgst2 -3,2919 2,98E-05 0,00051401 Muc4 -4,2268 0,00051806 0,0058927
C330011M18Rik -3,3009 1,09E-05 0,00021501 Wdr86 -4,2272 0,00163434 0,01490927
Pde2a -3,3107 2,21E-05 0,00039672 Plekhg5 -4,2341 1,63E-15 1,93E-13
Mss51 -3,3193 0,00107422 0,01060514 Gm10522 -4,2690 9,07E-05 0,00134715
Gm29157 -3,3217 0,00624323 0,04282308 Gm43860 -4,2946 0,00191204 0,01706084
Il18rap -3,3274 8,44E-05 0,00126471 Gm10505 -4,3106 0,00188708 0,01689361
Il18r1 -3,3301 0,00268337 0,02231949 Gm37593 -4,3221 9,87E-05 0,00143695
Arl4d -3,3330 6,09E-07 1,67E-05 Gm28277 -4,3612 0,00213293 0,01861435
Katnb1 -3,3364 1,60E-05 0,00029945 Gm37785 -4,3975 0,00064283 0,00699774
A630072L19Rik -3,3509 0,00192544 0,01715469 Gm24724 -4,4004 0,00221467 0,01921464
Baiap3 -3,3577 9,22E-06 0,00018467 Klrb1 -4,4021 1,86E-06 4,48E-05
Gm45235 -3,3758 0,00572678 0,04017612 Sspo -4,4122 0,00114448 0,0111117
Klf12 -3,3865 0,00013166 0,00184172 Rac3 -4,4690 0,0005658 0,0063254
Gm16239 -3,3936 0,00298323 0,02426487 Cdc42ep1 -4,5971 5,12E-05 0,00082644
Tmed1 -3,4016 0,00407576 0,03097847 2810468N07Rik -4,6006 0,00014886 0,00204729
Lat -3,4087 1,90E-05 0,00034852 Gm13375 -4,6475 0,00020898 0,00274233
Tshz3 -3,4182 2,10E-09 9,54E-08 Fam132b -4,7309 0,00026803 0,00336055
Gm26580 -3,4212 0,00019912 0,00263412 Casq1 -4,7581 0,00043618 0,00508905
Ccl5 -3,4222 1,85E-07 5,73E-06 Bmp10 -4,7882 0,00016816 0,00228197
H2-Ob -3,4375 3,03E-06 6,95E-05 Gm43913 -4,8036 5,40E-05 0,00086656
Sell -3,4412 3,06E-08 1,12E-06 A3galt2 -4,8067 0,0003494 0,00421525
Gm43203 -3,4427 0,0033565 0,02664126 Gm6934 -4,8923 2,72E-05 0,00047484
Gm24119 -3,4457 0,00246307 0,02093543 Ablim2 -4,9209 0,0002455 0,00313331
Rab6b -3,4599 2,28E-06 5,43E-05 Camsap3 -4,9434 0,00013767 0,00191887
2010300F17Rik -3,4685 0,00031129 0,00381765 Fam124b -5,0117 0,00024241 0,00309866
Flywch1 -3,4918 0,00677838 0,04542407 Gm27241 -5,0414 5,94E-05 0,00093755
6720464F23Rik -3,4943 0,00159873 0,01464997 St6galnac3 -5,0558 7,38E-07 1,99E-05
Dlg3 -3,5002 8,46E-06 0,00017227 Gm26744 -5,0955 0,00015497 0,00211982
Gm16845 -3,5045 0,00015505 0,00211982 E230020A03Rik -5,0981 4,19E-05 0,0006928
Tmem71 -3,5451 2,14E-10 1,14E-08 Ccdc38 -5,1495 5,99E-05 0,00094458
Btbd11 -3,5482 4,95E-08 1,75E-06 Fibcd1 -5,2128 0,000286 0,00354748
Gm20518 -3,5609 0,00119217 0,01146552 9130008F23Rik -5,3625 2,60E-06 6,12E-05
Gm15854 -3,5822 0,00066483 0,00720059 Gm10130 -5,5650 1,75E-05 0,00032602
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Gene FC pval padj
Anxa8 -5,7120 1,88E-07 5,80E-06
Tmem74b -5,8824 2,03E-05 0,00036754
Sync -6,2754 4,45E-06 9,75E-05
D830036C21Rik -6,3229 6,65E-06 0,0001388
Ccdc146 -6,3407 1,89E-09 8,61E-08
Cym -6,7192 7,19E-08 2,44E-06
Nap1l5 -6,8915 1,34E-08 5,20E-07
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Table A.5. Comparison V. All differentially expressed genes from the comparison V: uterine Eomes-CD49a+ 
(ILC1) subset vs uterine Eomes+CD49a+ (trNK) subset. FC: fold change, padj: adjusted p-value. 
Gene FC pval padj Gene FC pval padj
Aplnr 5,0496 6,26E-05 0,00504772 Ppp3cc -2,1115 2,69E-05 0,00278543
Gm27241 4,4456 0,00041432 0,02159677 Bbs9 -2,1149 0,00092056 0,03700647
Gm15987 3,9392 2,73E-06 0,0004615 Nfatc2ip -2,1248 0,00037076 0,01971823
Gm10522 3,9053 0,0003522 0,01887779 Padi2 -2,1397 1,00E-05 0,00129683
9130008F23Rik 3,7796 0,00097806 0,03852492 Nedd4 -2,1462 2,45E-05 0,00259101
Adgre4 3,6980 4,85E-08 2,55E-05 Gem -2,1464 0,00017611 0,01119578
Ace 3,6852 1,19E-06 0,0002814 Xcl1 -2,1708 0,00119996 0,04531157
Palm 3,6636 0,00061672 0,0280977 Acot7 -2,1832 7,91E-05 0,00591007
Gm37979 3,5102 0,00065058 0,0293859 Camk2n1 -2,1945 0,00027867 0,01548341
C920021L13Rik 3,5077 4,06E-05 0,00363311 Fktn -2,2090 0,00021168 0,0128017
Ccdc102a 3,4482 1,90E-05 0,00209489 Brca1 -2,2259 0,000216 0,01300573
Gm42585 3,2837 0,0001434 0,00951428 Eef2k -2,2294 0,00050603 0,02435356
Gm16121 3,2798 0,0001842 0,01154865 Klrb1c -2,2487 1,45E-05 0,00171952
Treml4 3,2742 5,58E-09 4,49E-06 Arsb -2,2582 1,23E-07 5,08E-05
Hes1 3,2085 0,00085346 0,03525448 Slain1 -2,2698 7,54E-05 0,00569643
Igkc 3,1713 0,0002597 0,01478965 Bspry -2,2733 0,00068256 0,03041489
Kmo 3,1188 1,22E-05 0,00151485 Rhof -2,2772 0,00014069 0,0094262
Scarna3b 3,1146 0,00103707 0,04006996 Lef1 -2,2831 0,00043795 0,02233538
Cd300e 3,1016 6,85E-09 4,68E-06 Slc14a1 -2,2959 3,66E-05 0,0033598
Sirpb1a 3,0948 9,30E-07 0,00022697 Gm20743 -2,2987 0,00065144 0,0293859
Skint3 2,9532 0,00031637 0,01729642 Gm44226 -2,2997 5,65E-05 0,00464868
B4galt4 2,8950 0,00014611 0,00964738 Dab2ip -2,3052 7,39E-05 0,00563961
Ciita 2,8132 0,00022497 0,01342742 Ahdc1 -2,3165 0,00020667 0,01261039
Tmem176b 2,8132 1,33E-07 5,34E-05 Trbc1 -2,3202 0,00052237 0,02479064
Cyp4f16 2,8035 3,43E-06 0,00054469 Ablim1 -2,3322 2,50E-05 0,00262804
Clec9a 2,7758 0,00048389 0,02361934 Xrcc5 -2,3340 0,00057651 0,0266207
Sirpb1c 2,7674 0,00078001 0,03357541 1300002E11Rik -2,3415 0,00018109 0,0114307
Dpp4 2,7476 0,00085634 0,03525448 Pcgf2 -2,3462 0,0007775 0,03357541
Pilrb2 2,6831 1,45E-05 0,00171952 Limk2 -2,3569 1,31E-06 0,00030052
Rasgrp4 2,6741 0,000415 0,02159677 Tnfrsf18 -2,3702 0,0005649 0,02638089
Nxpe4 2,6699 6,49E-06 0,00093431 Gm38346 -2,3745 0,00047077 0,02314551
Klra2 2,6257 4,22E-06 0,00063342 Gfod1 -2,3872 6,29E-06 0,00091954
Gm561 2,5694 0,0013506 0,04819844 Cd96 -2,3986 0,00117238 0,0445114
Tmem176a 2,5533 0,00010935 0,00764432 Samd3 -2,3993 0,00028948 0,01601882
Gm8953 2,5299 1,96E-07 7,23E-05 Chst11 -2,4225 6,80E-08 3,10E-05
H2-Aa 2,5054 2,62E-05 0,00273628 Klri2 -2,4256 0,00031078 0,0170591
I830077J02Rik 2,5020 0,0008274 0,03458395 Tnfrsf26 -2,4287 1,53E-06 0,00031237
Kynu 2,4816 0,00082457 0,03458395 Itgb3 -2,4314 0,00025364 0,014566
Mgl2 2,4457 0,00088375 0,03605712 2900026A02Rik -2,4517 6,89E-05 0,00544638
Pilra 2,4219 3,44E-05 0,00319678 Adamts14 -2,4568 6,79E-06 0,00096455
H2-Ab1 2,3892 5,44E-05 0,00450649 Cd28 -2,4762 0,00020608 0,01261039
Ear2 2,3815 4,17E-05 0,00367408 Katnal1 -2,4863 6,86E-05 0,00544638
Clec4a1 2,3809 0,00039539 0,02078532 Gimap1os -2,4926 0,00139434 0,0493725
H2-Eb1 2,3790 2,46E-06 0,00043184 Capn5 -2,4932 0,00056872 0,02638089
Spon1 2,3696 0,00050507 0,02435356 Gimap7 -2,4961 0,00024688 0,01424265
H2-DMb1 2,3345 0,00037695 0,01996954 Tanc1 -2,5030 0,00098382 0,0385295
Lifr 2,3167 2,04E-05 0,00221665 Zdhhc15 -2,5388 5,72E-05 0,00468462
Cd74 2,3111 7,49E-05 0,00568488 Ets1 -2,5391 4,65E-07 0,00013531
Tax1bp3 2,2193 0,0004434 0,02244572 Bzrap1 -2,5623 0,00052552 0,02485418
Cd300ld 2,1988 1,02E-05 0,00130177 Pitpnm2 -2,5643 0,00012015 0,00825203
Lilra5 2,1943 9,77E-05 0,00703106 Klra14-ps -2,5684 0,0010517 0,04049173
Fgd2 2,1829 3,88E-05 0,00351213 Mctp2 -2,5714 2,64E-07 9,26E-05
1600010M07Rik 2,1385 0,00010962 0,00764432 Klhl8 -2,6086 1,98E-06 0,00036684
Smad1 2,0967 0,00016498 0,01063651 Gimap3 -2,6158 3,55E-06 0,00055755
Tifab 2,0883 0,00042229 0,02176349 Plod2 -2,6199 4,58E-05 0,00395799
Ppfia4 2,0474 0,00022444 0,01342742 Ubxn11 -2,6405 4,68E-05 0,00402194
Clec4a3 2,0303 0,00046176 0,02285796 Fcrl6 -2,6518 0,00033877 0,01837423
Fam49a 2,0290 4,10E-06 0,00062567 Unkl -2,6749 1,43E-05 0,00171952
Pld4 2,0256 0,00014328 0,00951428 Arhgef5 -2,6791 0,00050068 0,02426705
fam49a 2,0140 1,56E-09 1,34E-06 Icos -2,6875 6,28E-05 0,00504772
Ikzf3 -2,0041 7,16E-05 0,00559347 Ctsw -2,6975 3,62E-05 0,00334533
Bcl2 -2,0072 5,72E-08 2,79E-05 Slc17a8 -2,7108 0,00044878 0,02246844
Gimap4 -2,0169 0,00094281 0,03767917 Cst7 -2,7236 0,00010759 0,00758002
Pabpc4 -2,0278 1,91E-06 0,00036684 Sytl2 -2,7288 3,13E-07 0,00010421
Rmdn3 -2,0574 0,00081031 0,03428888 E030018B13Rik -2,7292 0,00134823 0,04819844
Ptch1 -2,0574 0,0001524 0,00999904 Asb1 -2,7304 3,25E-05 0,00308231
Kctd9 -2,0788 4,73E-05 0,00403496 Cd247 -2,7357 1,39E-05 0,00169348
Osbpl5 -2,0846 0,00136174 0,04846924 Nkg7 -2,7417 2,56E-06 0,00044214
Gm43481 -2,0998 0,00052174 0,02479064 Cbwd1 -2,7531 0,0005683 0,02638089
Pole -2,1047 0,00016233 0,01051495 Gzma -2,7555 3,85E-05 0,00350989
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Gene FC pval padj Gene FC pval padj
Slc7a2 -2,7606 1,75E-05 0,00196409 Dennd3 -3,4762 8,71E-06 0,00116685
Ltbp3 -2,7616 3,12E-05 0,00299843 Skap1 -3,4789 5,20E-08 2,63E-05
Il2rb -2,7694 7,43E-07 0,00019532 Itm2a -3,4869 2,43E-05 0,00259101
Gzmc -2,7755 0,00056939 0,02638089 Gm38340 -3,4969 0,00070253 0,03094855
Itk -2,7794 2,92E-05 0,0029161 Gzmg -3,5051 0,00128208 0,0472213
Ppp1r16b -2,7860 1,36E-06 0,00030052 Nhsl1 -3,5591 3,39E-05 0,00317619
B230216N24Rik -2,7864 0,00048491 0,02361934 Gzme -3,5804 2,03E-06 0,00037086
Gm43660 -2,7889 0,0010938 0,04175985 Klrg1 -3,6002 1,69E-08 1,05E-05
Dnah8 -2,7956 1,13E-05 0,00142071 4930590J08Rik -3,6106 0,00095147 0,03791466
Epas1 -2,8122 1,98E-06 0,00036684 Dusp4 -3,6295 0,00086804 0,03552216
F2rl2 -2,8162 4,29E-08 2,35E-05 Inhba -3,6515 9,25E-06 0,00122762
Gpnmb -2,8276 7,36E-06 0,00102671 Adgrg1 -3,6662 0,00101272 0,03946724
Epcam -2,8278 0,00075365 0,03270124 Csf2 -3,6844 0,00041557 0,02159677
C230085N15Rik -2,8290 0,00097108 0,03847173 Gm44205 -3,6938 0,00137074 0,04866296
Trdc -2,8291 0,00078711 0,03361957 Prf1 -3,7493 9,05E-11 1,37E-07
Fsd1l -2,8444 0,00079914 0,03392122 Itgad -3,7563 8,53E-05 0,00630039
Clnk -2,8595 5,09E-06 0,0007557 Gm28988 -3,7688 7,77E-05 0,00583198
F2r -2,8735 1,69E-06 0,00033957 Ift27 -3,7926 0,00046325 0,02285796
Prkcq -2,8741 1,07E-07 4,63E-05 5830454E08Rik -3,8163 0,00140648 0,0495458
Ly75 -2,8869 1,70E-05 0,00193831 Crtam -3,8249 2,83E-07 9,68E-05
E430021H15Rik -2,8944 0,00124566 0,0461495 Gm26584 -3,8503 0,00128867 0,0472213
Zap70 -2,9013 0,00023355 0,01369995 Cd320 -3,8947 0,00091018 0,03669724
Dapk2 -2,9264 3,18E-06 0,00051061 Ptpn13 -3,9082 0,00024696 0,01424265
Klra7 -2,9437 7,73E-06 0,00106704 Frmd5 -3,9288 0,00023791 0,01383706
Tmem163 -2,9453 1,82E-05 0,00202566 Gzmf -3,9652 0,00012953 0,00880773
Phactr3 -2,9677 0,00101354 0,03946724 Gzmd -3,9793 1,40E-06 0,00030052
Chrne -2,9690 0,0005294 0,02495132 Mamdc2 -4,0066 7,29E-05 0,00563961
Car2 -2,9793 1,53E-06 0,00031237 Slc27a6 -4,0190 8,67E-05 0,00636862
Lzts1 -2,9815 0,00082553 0,03458395 Adgrg3 -4,0200 0,00030537 0,0168296
Acap1 -2,9969 1,99E-06 0,00036684 Gm6637 -4,0246 9,11E-07 0,00022697
Cdkl2 -3,0000 0,00060968 0,02788477 Klf12 -4,1351 0,00010568 0,00752272
Ctsk -3,0038 0,00120009 0,04531157 Adgrb2 -4,1380 0,00038724 0,02043542
Chpf -3,0205 0,00067871 0,03041489 Gpr87 -4,1425 0,00090465 0,03658205
Gm14029 -3,0316 2,88E-05 0,00289881 Sh2d1a -4,1806 1,08E-11 2,12E-08
Gimap1 -3,0391 3,46E-07 0,00010951 Klhl30 -4,1825 1,16E-12 3,17E-09
Gm10804 -3,0421 0,00133763 0,04811252 Chst2 -4,2061 5,74E-10 5,66E-07
Gfi1 -3,0512 0,00020392 0,01261039 Cep170b -4,2342 1,51E-15 1,03E-11
Akap17b -3,0562 2,61E-06 0,00044593 Ksr2 -4,2520 0,00013159 0,00890375
Tnfrsf9 -3,0639 6,85E-06 0,00096455 Thy1 -4,2606 2,25E-12 5,13E-09
Wdr6 -3,0729 0,0001529 0,00999904 Dixdc1 -4,2673 1,44E-07 5,47E-05
Sh2d2a -3,0822 9,25E-07 0,00022697 Khdc1b -4,2715 3,01E-05 0,00297674
Kcnk5 -3,0824 4,09E-05 0,00363311 Chl1 -4,2943 1,70E-05 0,00193831
Tmem41a -3,0897 0,00053321 0,02504432 Wdr95 -4,3011 0,00041795 0,02163852
Ptprcap -3,0904 6,96E-07 0,00018761 Plb1 -4,3450 5,73E-07 0,00016329
Zfp507 -3,0953 0,00083937 0,03497703 Kcnq5 -4,3802 1,09E-08 7,11E-06
Tcf7 -3,1132 3,10E-05 0,00299843 Oit3 -4,4719 0,00115536 0,0439874
Emid1 -3,1167 6,33E-08 2,98E-05 Eomes -4,4825 4,39E-16 6,00E-12
Scin -3,1628 9,27E-05 0,00674007 Atp1b1 -4,4852 6,87E-15 3,13E-11
Gm37691 -3,1800 9,43E-06 0,00123867 Cdon -4,5783 3,13E-06 0,0005092
Rnf43 -3,1894 4,43E-07 0,00013451 Map7 -4,5991 1,77E-06 0,00034886
Gzmb -3,2254 4,56E-07 0,00013531 Eya2 -4,6272 1,51E-10 2,06E-07
Cd2 -3,2307 2,45E-06 0,00043184 Zfp566 -4,6984 8,31E-06 0,00113529
Armcx4 -3,2354 0,0001285 0,0087817 Fhl2 -4,9263 2,93E-11 5,01E-08
Ifitm10 -3,2356 1,72E-05 0,00193903 Ctla4 -4,9362 1,37E-06 0,00030052
Sh2d1b2 -3,2452 1,69E-05 0,00193831 Nefh -4,9729 1,05E-05 0,00133148
Zfpm1 -3,2865 2,80E-06 0,00046622 Ppm1j -5,0447 1,79E-06 0,00034886
Rab37 -3,2874 9,59E-07 0,00022987 Zfp239 -5,0459 1,61E-05 0,00188647
Kif14 -3,2876 2,16E-05 0,00232404 Ptpn3 -5,0781 5,80E-10 5,66E-07
Avil -3,2889 0,00046119 0,02285796 Mrvi1 -5,1902 3,04E-05 0,00297674
Acsbg1 -3,3033 0,00124592 0,0461495 Epdr1 -5,3080 3,05E-05 0,00297674
Myo10 -3,3088 4,08E-05 0,00363311 Kcnip3 -5,3250 3,74E-13 1,28E-09
Txk -3,3236 6,69E-09 4,68E-06 Spry4 -5,3252 2,20E-08 1,25E-05
Itih5 -3,3355 3,39E-07 0,00010951 Reck -5,4889 2,52E-10 2,86E-07
Klra6 -3,3494 2,25E-06 0,00040417 Slc35f2 -5,5301 7,00E-07 0,00018761
Itga1 -3,3578 1,08E-09 9,86E-07 Mid2 -5,7496 1,01E-05 0,00129683
Vwf -3,3783 0,00050995 0,02445599 Kif26b -6,9672 1,96E-08 1,16E-05
Plscr4 -3,4160 0,0008655 0,03552216
Tnik -3,4198 6,79E-09 4,68E-06
Cd55 -3,4335 2,13E-07 7,67E-05
Sla2 -3,4605 2,84E-05 0,0028731
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Determining the function of uterine lymphocytes is challenging because of the dynamic
changes in response to sex hormones and, during pregnancy, to the invading foetal tro-
phoblast cells. Here we provide a genome-wide transcriptome atlas of mouse uterine group 1
innate lymphoid cells (ILCs) at mid-gestation. Tissue-resident Eomes+CD49a+ NK cells
(trNK), which resemble human uterine NK cells, are most abundant during early pregnancy,
and have gene signatures associated with TGF-β responses and interactions with trophoblast,
epithelial, endothelial, smooth muscle cells, leucocytes and extracellular matrix. Conventional
NK cells expand late in gestation and may engage in crosstalk with trNK cells involving IL-18
and IFN-γ. Eomes−CD49a+ ILC1s dominate before puberty, and speciﬁcally expand in second
pregnancies when the expression of the memory cell marker CXCR6 is upregulated. These
results identify trNK cells as the cellular hub of uterine group 1 ILCs, and mark CXCR6+ ILC1s
as potential memory cells of pregnancy.
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Most innate lymphoid cells (ILCs) reside in tissues, wherethey integrate the local environment and its physiology.While group 2 and 3 ILCs are well characterised across
tissues in humans and mice1, the deﬁnition of group 1 (g1) ILCs
is the most difﬁcult due to their heterogeneity2, as illustrated by
human and murine liver g1 ILCs3. G1 ILCs include cytotoxic,
conventional NK (cNK) cells and tissue-resident ILCs in liver,
uterus, spleen, gut, salivary glands and thymus, which share with
cNK cells expression of surface markers, transcription factor T-
bet and production of IFN-γ. Little is known, however, about the
physiological role of tissue g1 ILCs, whereas tissue ILC2s and
ILC3s contribute to barrier integrity in lung and intestinal
mucosa, promote tolerance of gut bacteria and regenerate lung
epithelium upon viral infection4. G1 ILCs participate in early
responses to infection through production of IFN-γ5,6, however
conversion of cNK cells into ILC1s under the inﬂuence of TGF-β
undermines their anti-viral and anti-tumour responses7,8. Evi-
dence also suggests g1 ILCs are involved in chronic inﬂammation
in lung or intestine, where environmental cues drive ILC3s to
convert into IFN-γ-producing ILC1s, which exacerbate pathol-
ogy9,10. Thus, more information is available about tissue g1 ILCs
in pathology than physiology6.
Uterine ILCs contribute to optimal pregnancy outcome in
mice11–13 and g1 ILCs are the most abundant in both human and
mouse uterus14,15. Among g1 ILCs, human uterine NK (uNK)
cells maintain the integrity of endometrial arteries16 and, during
pregnancy, mediate key developmental processes and actively
regulate placentation17 and reviewed in ref. 18. For example, they
modulate trophoblast invasion, reshape uterine vasculature and
promote foetal growth17,19–21. Genetic epidemiology studies have
shown associations of pregnancy disorders with genetic variants
of Killer-cell Immunoglobulin-like Receptors (KIRs) expressed on
NK and some T cells and their variable HLA-C ligands22,23.
Other functions have been suggested for uterine lymphocytes,
including immunological tolerance24, defence against patho-
gens25,26, and roles in pregnancy complications such as mis-
carriage, although the evidence for this is controversial (reviewed
in ref. 27). Uterine ILC3s may also contribute to tissue physiology
through production of IL-22, which maintains epithelial integ-
rity28. A population of immature NK cells phenotypically over-
laps with ILC3s, suggesting potential plasticity between uterine g1
ILCs and ILC3s29. Mouse uNK cells regulate uterine vascular
adaptions to pregnancy30 as well as foetal growth31, but uterine
g1 ILCs are heterogeneous32 and could contribute to both phy-
siology and pathology of reproduction30,33.
Functional heterogeneity of uterine g1 ILCs may reﬂect divi-
sion of labour, or result from the conversion of a subset into
another under certain conditions determined by the stage of
reproductive life orchestrated by sex hormones. Puberty, blas-
tocyst implantation, placentation, parturition, and lactation are
accompanied by remarkable tissue remodelling, which likely
impacts on and is inﬂuenced by tissue lymphocytes. Additionally,
ILC composition and function may be also marked by innate
memory of pregnancy, which could contribute to the well-known
better outcome of second pregnancies and their less frequent
complications34.
Determining the function of uterine cell types is challenging
because of the changing nature of the organ and the limited
access to human samples. Moreover, lack of knowledge on gene
expression proﬁles of mouse uterine g1 ILC subsets precludes
cell type-speciﬁc gene targeting approaches in mice. Modern
immunology relies on systems biology to decode cell hetero-
geneity and ascribe functions to discrete subsets. Here we
set out to begin to resolve the heterogeneity of g1 ILCs and
provide a whole-genome transcriptome atlas of mouse uterine
g1 ILCs.
We have previously characterised three uterine g1 ILCs14,
including Eomes+CD49a+ tissue-resident (tr)NK cells, which
resemble human uNK cells, Eomes−CD49a+ ILC1s, which may
be analogous to human uterine ILC1s;13,15 and Eomes+CD49a−
cNK cells, which are presumably circulating cells in both species.
Here we determine their whole-genome transcriptional proﬁle.
The results show that trNK cells express genes that make them
interact with most other cell types in the pregnant uterus and
therefore, akin to human uNK cells, emerge as the central g1 ILC
subset. cNK cells in the uterus may support the function of trNK
cells by producing IFN-γ and responding to IL-18. ILC1s are
most abundant before puberty, and CXCR6+ ILC1s speciﬁcally
expand in the uterus, not in the liver, in second pregnancies,
appearing as attractive candidates for memory cells. Determining
the molecular identity and function of mouse uterine g1 ILCs
may guide further work with human cells and generate oppor-
tunities for new treatments of patients with pregnancy
complications.
Results
Dynamic distribution of uterine g1 ILCs. We have previously
deﬁned three uterine g1 ILC subsets13,14. These subsets are all
CD45+CD3−CD19−CD11blow/- NK1.1+ NKp46+ and their
surface phenotype in comparison with that of liver subsets is
shown in Fig. 1a. Here we set out to determine their distribution
during key stages of mouse reproductive life. These were: just
before puberty (3 weeks of age), during attainment of sexual
maturity (5- and 8-week old), early in gestation (gd 5.5), at mid-
gestation (gd 9.5), after placentation (gd13.5), late in gestation
(gd17.5) and post-partum (days 1, 10 and 18). The relative
abundance of different subsets at different stages was striking
(Fig. 1b and Supplementary Fig. 1). Before the onset of puberty
and exposure to sex hormones, Eomes−CD49a+ ILC1s are the
most abundant. During sexual maturation, ILC1s decrease, while
Eomes+CD49a+ trNKs increase. Upon mating, trNK cells are the
most abundant in early pregnancy, on gd 5.5. Once the placenta
has been established, at gd 13.5, trNKs decrease, while Eomes
+CD49a− cNK cells become the most abundant. A similar
landscape with cNK cells being the most abundant is observed
both at days 1 and 18 post-partum, which mark respectively the
beginning and the end stage of breast-feeding. Fertility is lower
during lactation but not at the beginning or the end35. We
observed marked differences in the distribution of g1 ILCs in the
uterus of breastfeeding and non-breastfeeding females at 10 days
post-partum, with breastfeeding females having increased trNK
cells, similar to the distribution observed at mid-gestation (gd
9.5). These results show a dynamic g1 ILC subset distribution
during reproductive lifes that likely reﬂects subset-speciﬁc
functions.
Genome-wide transcriptomes of uterine g1 ILCs. Genome-wide
transcriptional proﬁles of the three uterine g1 ILC subsets sorted
from Eomes-GFP reporter mice at mid-gestation were analysed in
multiple comparisons with the two, well-established liver g1 ILCs
subsets. RNA was extracted from uterine and hepatic lineage
negative CD45+CD11blow/-NK1.1+NKp46+ cells sorted based on
Eomes and CD49a expression as in Fig. 1a. This two-dimensional
discrimination deﬁnes uterine and hepatic Eomes+CD49a− cNK
cells, uterine and hepatic Eomes−CD49a+ ILC1s and, unique to
the uterus, Eomes+CD49a+ trNK cells. Expression of CD49a
therefore marks resident cells in both tissues36. Unbiased prin-
cipal component analysis (PCA) showed shared transcriptional
proﬁles between uterine ILC1s and trNK cells but highlighted
unexpected differences between uterine and hepatic ILC1s. The
PCA also conﬁrmed similarities between uterine and hepatic cNK
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cells (Fig. 2a). Hierarchical clustering using the differentially
expressed genes with a log2 fold change cutoff of 7.5 and p-value
<0.01 conﬁrmed that uterine and hepatic ILC1s cluster apart
(Fig. 2b), despite phenotypic similarities (ref. 14 and Fig. 1a). The
expression of Tbx21 (T-bet), Eomes, Ifng, Itga1 (CD49a), Itga2
(CD49b), Klrb1c (NK1.1), and Ncr1 (NKp46) is consistent with
the sorting strategy, though expression of Tbx21, Ifng and Ncr1 is
low in uterine ILC1s (Fig. 2c).
Surprisingly, genes associated with myeloid cells appeared
among those deﬁning the principal component 1 (PC1), which
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explained 61% of the variance. These included Clec7a and
Clec4a3, encoding Dectin-1 and DCIR3, respectively, Adgre1
encoding F4/80, and Mertk encoding MERTK, a member of the
Tyro-3/Axl/Mer (TAM) family of receptor tyrosine kinases
(Supplementary Fig. 2A), highly expressed in CD49a+ subsets
compared to CD49a− cNK cells in both uterus and liver, thus
deﬁning transcriptomic differences between resident and circu-
lating cells in both tissues. Flow cytometry on uterine subsets
showed expression of F4/80 and CD86 on trNK cells, MERTK on
both trNK and ILC1s and B220 on ILC1s, with trNK expressing
intermediate B220 levels (Fig. 2d). The principal component 2
(PC2) explained 18.8% of the variance, with most genes
signiﬁcantly upregulated in liver ILC1s, with almost no expres-
sion in any of the other subsets, explaining in part why hepatic
ILC1s do not cluster with uterine ILC1s (Supplementary Fig. 2B).
These results mark the uterine resident CD49a+ trNK and ILC1s
as unique subsets.
Core gene signatures of uterine g1 ILCs. To compare g1 ILC
transcriptomes between and among tissues, we ran 5 compar-
isons, the results of which are summarised in the UpSet plot,
which also selects differentially expressed genes exclusively in the
chosen comparison (Fig. 3a). The ﬁrst comparison was between
all liver g1 ILCs (ILC1+ cNK) versus all uterine g1 ILCs (cNK+
trNK+ ILC1). This comparison identiﬁed 265 differentially
expressed genes (Fig. 3b). Gene Ontology (GO) analysis of this
comparison for classiﬁcation by biological process showed that
the most highly enriched biological pathways in uterine cells
relate to vascular endothelial growth factor (VEGF) signalling,
including Kdr, encoding VEGF receptor 2 and Pdgfra, the alpha
receptor for the platelet-derived growth factor (PDGF), but also
oxygen/gas transport, including haemoglobin chains (Hbb-Y, Hba
−X, Hbb-BH1) (Supplementary Fig. 3A and Fig. 3b). Other sig-
niﬁcantly enriched uterine pathways included response to
hypoxia and decreased oxygen levels (Ang, Hif3a), extracellular
matrix organisation (Flrt2, Fbln1, Mmp9, Tgfbi), as well as several
pathways relating to wound healing and the regulation of blood
vessel development. TGF-β signalling genes also distinguished
uterine cells, with upregulated Dab2, Tgfb2 and Inhba (Supple-
mentary Fig. 3A and Fig. 3b). Supplementary Data 1 includes all
differentially expressed genes and pathways highlighted by the 5
comparisons. Trim2 is one of the genes differentially upregulated
only in the uterus and Itga3 encoding CD49c in the liver (Fig. 3b).
The second comparison was between liver CD49a+ ILC1s and
uterine CD49a+ trNK and ILC1s, thus excluding cNK cells, and
informing on tissue-speciﬁc proﬁles of CD49a+ resident cells
(Fig. 3c). The most highly upregulated genes in uterine CD49a+
cells are Gzmd, Gzme, Gzmf, Gzmg encoding non-cytotoxic
granzymes, likely involved in tissue remodelling. Indeed, other
highly expressed genes regulate extracellular matrix organisation
(Flrt2), collagen homeostasis (Ctsb, Ctss), wound healing (Hmox1,
Pdgfa, Plau), and proliferation of epithelial cells (Mmp12, Vegfa)
(Fig. 3c and Supplementary Fig. 3B). Upregulated in uterine
CD49a+ cells are also genes involved in metabolic regulation of
steroids (mainly progesterone metabolism—Dhrs9 and Srd5a1),
ketones (Slc37a2) and amines (Paox). Encoding the orphan
monocarboxylate transporter MCT1337, Slc16a13 may be speci-
ﬁcally upregulated in uterine CD49a+ cells (Fig. 3c). Other
upregulated genes in CD49a+ uterine cells are genes regulating
migration of both myeloid cells (Ccl2, Ccl12, Spp1) and
lymphocytes (Ccl7, Ccl8, Ccl17). Osteopontin-encoding Spp1
was reported to be upregulated in uterine NK cells38 and we
ﬁnd that alymphoid Rag2−/−Il2rg−/− dams express less Spp1
transcripts (Supplementary Fig. 3G). Two other growth-
promoting factors, Pleiotropin-encoding Ptn, and Osteoglycin-
encoded Ogn have also been implicated in NK-cell mediated
foetal growth39, however other cells produce these growth-
promoting factors40 and we found no signiﬁcant difference in
expression between wild-type and alymphoid uterus, thus
excluding Ptn and Ogn as NK-cell and lymphocyte-speciﬁc
factors driving foetal growth (Supplementary Fig. 3G). Expressing
Arg1, Arg2, Ecm1, and Tnfsf4, uterine CD49a+ cells may regulate
type-2 immunity. Unexpected was the discovery of pathways
regulating cellular import and phagocytosis, usually associated
with antigen-presenting cells. The top enriched pathway in
CD49a+ liver cells relative to CD49a+ uterine cells was negative
regulation of antigen processing and presentation of peptide via
MHC class II (Supplementary Fig. 3B). H2-Oa and H2-Ob (also
identiﬁed previously in splenic CD127+ ILC1s2) encode H2-O, an
inhibitor of MHC class II (H2-DM)-mediated antigen-loading
process. Moreover, liver CD49a+ cells may regulate T-cell
migration, with upregulated Cxcr3 and Ccr6. Indeed, Ccr6 may
be exclusively expressed in liver ILC1s. Upregulated in liver cells
are also Cd27, Cd69 and Cxcr6, which encodes a CXCL16
receptor associated with ‘memory’ liver NK cells41 (Fig. 3c).
The third comparison between the two CD49a+ uterine subsets
versus CD49a− uterine cNK cells informs on characteristics
speciﬁc to uterine resident cells (Fig. 3d). Tissue resident cells
highly express genes involved in induction of cell death (Fasl,
Hvcn1, Tnf), response to both type I interferons and IFN-γ
(including Ccl7 and very highly, Irf7) and proteolysis, with nearly
all cathepsins signiﬁcantly upregulated, alongside C3, Plau and
Cpq (Supplementary Fig. 3C). This suggests that uterine resident
cells are involved in protein processing during tissue remodelling.
Enriched pathways are chieﬂy unsaturated fatty acid biosynthesis
(Mgst1) and lipid metabolism (Apoe, Psap) (Fig. 3d and
Supplementary Fig. 3C). When analysed by ﬂow cytometry,
uterine Eomes+ CD49a+ trNK cells are highly granular14, like
their human counterpart. Consistent with this, the lysosomal
transport (CD68, Rab7b, Lamp1 and Lamp2) is enriched in tissue
resident cells. The most upregulated genes in resident CD49a+
cells are Ccl7, Ccl2 and Tlr1 (Fig. 3d). RT-PCR analysis conﬁrmed
higher expression of Ccl2, Ccl7, and Ccl12 by uterine trNK (4.9,
9.7 and 25 folds, respectively) and ILC1s (1.4, 3 and 8.3 folds,
respectively), compared to cNK cells. Tissue resident cells
Fig. 1 Dynamic distribution of uterine group 1 innate lymphoid cells (g1 ILCs) during reproductive life. a Gating strategy for analysis and sorting by ﬂow
cytometry, with all freshly isolated g1 ILCs at mid-gestation (gd 9.5) gated on scatter and then deﬁned as single live CD45+CD3−CD19−CD11blow/-NK1.1
+NKp46+; ILC1 cells deﬁned as CD49a+Eomes−; tissue-resident NK (trNK) cells deﬁned as CD49a+Eomes+ and conventional NK (cNK) cells deﬁned as
CD49a−Eomes+. Each panel is representative of at least a hundred independent samples. b Landscape of uterine g1 ILCs during reproductive life; numbers
in plot indicate mean percentage of each individual subset of g1 ILCs as gated within live CD45+CD3−CD19−CD11blow/-NK1.1+NKp46+ parent population.
The size of the mean data points (ﬁlled circles) is proportional to the increasing percentage of the indicated subset. Inset shows the same time-point as the
dashed rectangle below but in non-breastfeeding females. Data are representative of ﬁfteen independent experiments with three individual animals for
each time-point analysed. Mating for experiments (just after animals turn 8-weeks old) and partum (gd 19.5–21.5) time-points are indicated by the arrows
on the plot. w week, d day, gd gestation day, pp post-partum, BF breastfeeding, nBF non-breastfeeding
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speciﬁcally upregulate the transcriptional repressor Hic2, as well
as Il6, Hint2 and Clec4b1. Highly upregulated exclusively in
uterine cNK cells, as reported previously for splenic cNK cells2, is
S1pr5 encoding sphingosine-1-phosphate receptor 5, which
regulates NK-cell egress. One of the highest fold-change
upregulated genes in uterine cNK cells is Muc4 encoding Mucin4,
involved in epithelial cell integrity and homoeostasis.
The fourth comparison was between uterine trNK cell and cNK
cells. The mutually exclusive expression of CD49a (Itga1) in trNK
cells and CD49b (Itga2) in cNK cells reﬂected the cell-sorting
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strategy (Fig. 3e). About 900 pathways were detected in this
comparison (Supplementary Fig. 3D), including those involved in
responses to IFN-γ and IL-18. Upregulated in trNK cells are Il18
and Ifngr2, while Ifng, Il18r1 and Il18rap are upregulated in cNK
cells. This suggests that trNK cells respond to IFN-γ and produce
IL-18, while cNK cells respond to IL-18 and produce IFN-γ,
(Fig. 3e). trNK cells may also respond to and produce IL-1β,
through highly expressed Il1r1, Ccl17, Ccl8 (cellular response to
IL-1) and Il1b, Nlrp1b, Nlrp3 (IL-1β production). Among the
most highly enriched pathways in trNK cells were those related to
cholesterol storage and homoeostasis, with genes such as Apob,
Lpl and Pparg upregulated in trNK cells (Fig. 3e and
Supplementary Fig. 3D). Interestingly, apoptotic cell clearance
was among the enriched pathways, with Lrp1, Axl and Mertk
highly upregulated in trNK compared to cNK cells. Lrp1 encodes
CD91, a receptor of many ligands and functions. In addition to
roles in apoptosis, and more widely being a haemoglobin
scavenger receptor, it also binds growth factors, including TGF-
β. Therefore, uterine trNK and ILC1s may be highly responsive to
TGF-β, through receptors such as CD91, Tgfbr1 and Tgfbr2. In
addition, Tgfbi, encoding transforming growth factor-beta
induced protein (TGFBIp, BIGH3), is also upregulated in trNK
cells. UpSet pointed to Slc16a1, encoding the cell exporter of
lactate MCT1, to be uniquely upregulated in trNK cells,
emphasising the potential importance of anaerobic glycolysis
for fuelling uterine CD49a+ cells42. Biglycan, encoded by Bgn, is a
CD44 ligand that may be involved in the recruitment of
circulating CD16− NK cells into human endometrium43 and is
upregulated in trNK cells (Supplementary Fig. 3F). Regulators of
cellular extravasation such as Adam8, Ccl2 and Ptafr are
upregulated in trNK, while Itga4 and Fam65b are upregulated
in cNK, suggesting migratory behaviour in both subsets, albeit
through potentially different mechanisms (Supplementary
Fig. 3F). Ly86, Ly96, CD180, Sash1 are all signiﬁcantly
upregulated in trNK and part of highly enriched
lipopolysaccharide-mediated signalling pathway. MyD88-
dependent toll-like receptor (TLR) signalling is also speciﬁc to
trNK cells, with Tlr1, Tlr2, Tlr8, and Tlr9 highly upregulated
(Supplementary Fig. 3F). Lysosome organisation pathway is
enriched in trNK, just like complement and haemostasis
regulation with C3, F7, F10 and Ptrpj. Also, C3ar1 and C5ar1,
involved in complement receptor signalling are upregulated in
trNK cells. Some of the most highly upregulated genes in trNK
cells include P2ry1 and P2rx4, suggesting that purinergic receptor
signalling pathway is highly enriched. Plau, Pdgfa, Sema6D,
Bmpr1a, Plxna1, Itgb3 are all part of smooth muscle cell
migration pathway and upregulated in trNK cells (Supplementary
Fig. 3F). Other pathways enriched in trNK cells include hormone
and sphingolipid catabolism, prostaglandin synthesis, detection of
external biotic stimulus, regulation of nitric oxide biosynthesis,
regulation of TGF-β production and tissue remodelling. Msr1,
encoding macrophage-scavenger receptor 1 and Clec7a, encoding
Dectin-1 exhibited the highest fold change in trNK compared to
cNK (about 300-500-fold, respectively). One of the genes
upregulated almost 40-fold in trNKs is Slc40a1, encoding
ferroportin (FPN1), which is the main exporter of iron from
cells, suggesting that iron metabolism may be of importance in
uterine trNK cells. Our dataset shows high expression of Nfe2l2
(NRF2) and signiﬁcantly upregulated Nfe2l3 (NRF3) in trNK
cells44. Both can bind to antioxidant stress response elements and
Nfe2l3 locus has been shown to be associated with endometriosis
through genome-wide association studies45 (Supplementary
Fig. 3F).
The ﬁfth comparison between uterine ILC1s and trNK cells
highlights transcriptome proﬁles speciﬁc to uterine resident cells
(Fig. 3f). The most highly upregulated gene in uterine ILC1s
compared to trNK is Aplnr, encoding for the adipokine apelin
receptor, which is highly expressed in mouse endometrium46.
Other highly expressed genes in ILC1s include Adgre4, encoding
the macrophage-speciﬁc F4/80 receptor, as well as Ace, encoding
angiotensin I-converting enzyme of the renin-angiotensin system.
The most highly enriched pathway in ILC1s is regulation of
protein heterodimerisation activity, including Hes1, which
interacts with the Notch pathway that is key for ILC develop-
ment. Among the most highly enriched pathways detected in
ILC1s is antigen processing and presentation of peptide via MHC
class II, with H2-Aa, H2-DMb1, H2-Ab1, H2-Eb1 and CD74
highly expressed, albeit they are also expressed in trNK cells.
Enriched in trNK cells and downregulated in ILC1s are Gzmc,
Gzmd, Gzme, Gzmf and Gzmg, assigning tissue-remodelling
properties to trNK cells. Most of these granzymes were previously
shown to peak in mid- to late gestation47. Interestingly, Xcl1
encoding lymphotactin is highly expressed by trNK cells (Fig. 3f).
XCL1 is also produced by human uNK cells and regulates
trophoblast invasion48. trNK cells highly express Cd96 encoding
for the nectin-binding receptor Tactile, and Crtam, encoding a
receptor for Nectin-like molecules, Sh2d1a, encoding SAP, as well
as Sh2d1b2, encoding EAT-2B, also a member of SAP-family of
adapters. In addition, several T-cell differentiation and activation
pathways are enriched in trNK cells, including CD28, Zap70, and
Itk. (Fig. 3f). The trNK signature suggests also regulation of
myeloid cell differentiation, through Ets1 and Itgb3. Other genes
highly expressed in trNK cells regulate protein localisation to
plasma membrane, such as Rab37, Sytl2, Ptch1, Kcnip3, Skap1,
Map7.
Uterine g1 ILCs express CXCR6, IL22 and some are ex-ILC3s.
Although our genome-wide transcriptome analysis showed sig-
niﬁcant upregulation of Cxcr6 in liver ILC1s (Fig. 3c), both liver
and uterine ILC1s express higher CXCR6 protein levels than
trNK cells (Fig. 4a). Because there is some overlapping between
immature NK cells, ILC1s and ILC3s in other tissues2, we
investigated the lineage relationship among the uterine g1 ILCs
using fate mapping reporter mice in which all cells that have
expressed, or actively express the RORγt-encoding Rorc gene are
marked by YFP. Figure 4b shows presence of YFP+ cells among
uterine g1 ILCs, which are aligned with ‘ex-ILC3s’ described in
other tissues. The human equivalent cells reported previously as
stage 3 precursor NK cells29 or NKp44+ ILC3s15 produce IL-22.
We found that trNK in the mouse uterus at mid-gestation also
Fig. 2 Genome-wide transcriptomes of uterine g1 ILCs at mid-gestation. a Unbiased principal component analysis (PCA)-based clustering of uterine ILC1s,
trNK and cNK cells and of liver ILC1s and cNK cells. The 250 most variable genes and the two principal components were used for clustering and to
describe the variance between the subsets. b Heat map of all signiﬁcant differentially expressed genes with a log2fold change >7.5, selected from
comparisons described in the text and presented in Fig. 3a. c Individual gene expression plots of genes encoding proteins used for sorting g1 ILCs and
additional genes used for validation of the ILC and NK-lineages. Scale represents log2(FPKM+ 1) transformed normalised reads. d Individual gene
expression plots of genes encoding F4/80, MERTK, CD86 and B220 in uterine and liver g1 ILCs and ﬂow cytometry validation of their protein products.
Histograms show protein expression on three uterine g1 ILCs gated as gated in Fig. 1a (red line-ILC1s, blue line-trNK, orange line-cNK). FPKM fragments per
kilobase of exon model per million reads mapped
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produce IL-22, regardless of the stimulation and, to a lesser extent
so can ILC1s (Fig. 4c–e). Although Cd27 and Cd69 are both
upregulated in liver CD49a+ cells (Fig. 3c), CD27 and CD69
proteins are present at similar levels in both uterine and hepatic
cells (Fig. 4f). Both transcripts and Ly49 protein expression levels
are slightly higher in trNK cells than in ILC1s and cNK cells
within the uterus (Fig. 4f). Despite variable levels of mRNA, all
three subsets in the uterus have similar protein levels of NKG2D
(Fig. 4f). Bimodal distribution of NKG2A/C/E expression was
observed for trNK cells as well. CD62L-encoding Sell and CD62L
are both upregulated in uterine cNK, similarly to what was
reported previously for splenic cNK cells2. CD103 is expressed by
trNK cells and, to a lower level, by uterine ILC1s, but not by
hepatic ILC1s. However, transcripts levels of CD103-encoding
Itgae are very low in all ﬁve subsets, suggesting high mRNA
turnover and potential importance of CD103 in maintaining
tissue-residency of g1 ILCs (Fig. 4f). trNK cells were also more
proliferative at gd 9.5, as measured by the Ki67 stain (Fig. 4f). A
prediction model conﬁrmed unique features of uterine g1 ILCs
(Supplementary Fig. 4)
CXCR6 marks candidate memory uterine g1 ILCs of preg-
nancy. Adaptive, or memory NK cells have been described in
humans and mice and CXCR6 is associated with memory NK and
T cells in mice49,50. It is conceivable that subsets of g1 ILCs
expand in response to pregnancy-speciﬁc cues in second preg-
nancies and possibly contribute to the lower rate of complications
in second pregnancies. We therefore compared the distribution of
group 1 ILCs between ﬁrst and second gestations and found no
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signiﬁcant differences in trNK or cNK cells composition (Fig. 5a,
b). In sharp contrast, both the frequency and absolute numbers of
ILC1s at mid-gestation raise 4–5 fold in second pregnancies
(Fig. 5a, b and Supplementary Fig. 5) and ILC1s in second
pregnancies upregulate CXCR6 (Fig. 5c), suggesting these cells
respond to pregnancy-speciﬁc cues and expand in second preg-
nancies. These results mark uterine CXCR6+ ILC1s as potential
memory cells of pregnancy.
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Disscussion
We show differences in subset composition at different key stages
of mouse reproductive life. ILC1s are dominant before puberty,
whereas trNKs in early gestation, peaking at gd 5.5 and cNK cells
abund in late gestation. The dynamic composition of g1 ILCs, and
the whole-genome transcriptome atlas we provide here suggests
that g1 ILCs are attuned to uterine remodelling and may have
speciﬁc functions. The picture emerging is one of trNK cells being
the hub of uterine g1 ILCs (Fig. 6), as they interact with the
important cell types and factors in the pregnant uterus, including
TGF-β, blood vessels, smooth muscle cells, glandular epithelial
cells, trophoblast, and leucocytes, including cNK cells. In a cross
talk similar to that of macrophages with peripheral NK cells,
trNK cells may make IL-18 and stimulate cNK cells in the uterus,
which in turn produce IFN-γ and stimulate trNK cells, which
unexpectedly also both respond to and produce IL-1. IL-1 and IL-
18 are part of the same family of cytokines, which also include the
alarmin IL-33, and these are emerging as important factors in
reproductive biology and pregnancy complications12,51. IFN-γ is
the key cytokine required for the reshaping of decidual vascu-
lature in mice that leads to the formation of the placenta. As
shown before using histological criteria for subset deﬁnitions,
cNK cells are the main source of IFN-γ, while other NK-cell
subsets produce angiogenic factors52. Our data conﬁrm this
division of labour among g1 ILCs, with cNK cells supporting
trNK cells to engage with vasculature and other components of
the pregnant uterus. Because cNK cells expand after the estab-
lishment of the placenta, it is tempting to speculate that they
specialise in immune function defending the uteroplacental unit
against pathogens.
The core signatures of uterine resident trNK cells and ILC1s
are marked by genes involved in tissue homoeostasis, metabolism,
genes associated with myeloid cells, cell death, interferon signal-
ling, protein processing and fatty acid biosynthesis. The intra-
tissue comparison between uterine trNK cells and cNK cells
highlighted genes involved in cholesterol storage, apoptotic cell
clearance, aerobic glycolysis, TLR signalling, iron transport, TGF-
β signalling as well as Axl and Mertk of the Tyro-3/Axl/Mer
(TAM) family of receptor tyrosine kinases. Gas6, a ligand for
Mertk is expressed by trophoblast53. TGF-β signalling drives the
transdifferentiation of cNK cells into ILC1s, through an inter-
mediate state that is the phenocopy of uterine trNK cells7. TGF-β
may drive a similar plasticity programme in the uterus whereby
cNK and trNK cells convert into ILC1s in second pregnancies,
thus partly contributing to generation of candidate memory cells.
In our fate mapping experiments plasticity between ex-ILC3s and
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g1 ILCs was evident. Moreover, IL-22 production by mouse trNK
cells aligns them with the previously described human stage 3
uterine NK cells29, also described as NKp44+ ILC3s15.
The comparison between uterine trNK and ILC1s revealed that
trNK cells contribute to tissue remodelling through non-cytotoxic
granzymes, cell–cell interactions through nectin receptors CD96
and CRTAM, as well as the chemokine XCL-1 and the trans-
forming growth factor-beta induced protein TGFBIp, also known
as BIGH3. XCL-1 is expressed by uNK cells, and its receptors by
both uterine myeloid cells and invading trophoblast in humans48.
Therefore XCL-1 emerges as a key molecule in the interactions
between maternal lymphocytes and foetal cells, joining other
molecular interactions, which include MHC class I receptors
NKG2A, human KIR and LILRB, and murine Ly49 (reviewed in
ref. 54). BIGH3 appears as another good candidate for the
molecular interactions between resident uterine g1 ILCs and
maternal endothelial, smooth muscle cells, as well as foetal tro-
phoblast cells. With trNK and uILC1s expressing various TGF-β
receptors TGF-βr1, -βr2 and CD91, it is tempting to speculate
that TGF-β induces the secretion of BIGH3 by these cells, which
in turn regulates downstream events essential for successful
placentation, such as invasion of trophoblast, vascular remodel-
ling, and angiogenesis. Indeed, previous studies show peak
expression of uterine BIGH3 at day 4 of gestation, when tro-
phoblast invasion starts55.
A number of unexpected genes and pathways were highlighted
in trNK cells and ILC1s. Uterine ILC1s may be involved in cross
talk to adipocytes through the expression of the receptor for
apelin. They also express the angiotensin I-converting enzyme,
suggesting a potential role in regulating blood pressure, which is
of paramount importance during gestation. Genes involved in
complement, IL-1-induced plasminogen activation, as well as
haemostasis appear upregulated in trNK cells, which may be
involved in inﬂammation, its accompanying vascular response
and the ensuing tissue remodelling. Upregulated in trNK cells are
Fth1 and Ftl1 encoding ferritin heavy and light chains, with Fth1
20-fold upregulated in trNK compared to cNK, and also one of
the genes with the highest number of reads. It is therefore possible
that trNKs store and export iron or, alternatively, trNK cells
respond to oxidative stress induced by iron. Consistently with this
possibility, Hmox1, which prevents inﬂammatory tissue injury, is
upregulated in trNK cells. Along these lines, genes activated by
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Fig. 6 Suggested g1 ILC functions in the pregnant mouse uterus. Eomes−CD49a+ ILC1s are dominant before puberty and speciﬁcally expand in second
pregnancies, when the expression of CXCR6 is upregulated, marking them as potential memory cells. Eomes+CD49a+ NK cells (trNK) are most abundant
during early pregnancy and may well be the cellular hub of uterine g1 at mid-gestation. They indeed showcase gene signatures of responsiveness to TGF-β,
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in anaerobic glycolysis, lipid metabolism, iron transport and protein ubiquitination. Conventional NK cells expand late in gestation and may engage in
crosstalk with trNK cells involving IL-18 and IFN-γ
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oxidative stress and encoding enzymes that detoxify reactive
intermediates through glutathione-dependent transferase and
peroxidase activities, such asMgst1,2 are also upregulated in trNK
cells. These pathways are important in the biology of DC and
T cells56,57 and future work will establish if uterine g1 ILCs
require these pathways and whether their differentiation is
modulated by metabolism. In a recent study, Srebp proteins and
genes involved in fatty-acid and cholesterol synthesis appeared
essential for the metabolic reprogramming of NK cells in
response to cytokine stimulation58,59. Interestingly, our analysis
reveals that uterine, not liver resident g1 ILCs upregulate
Slc16a13, which encodes lactate and pyruvate cell exporter
MCT1337. Warburg-like glycolysis is indeed important for
decidual development60 and trNKs and ILC1s may provide lac-
tate for the development of undifferentiated stromal cells in
addition to other sources which function through other MCTs
(MCT4). Also, uterine resident g1 ILCs may produce lactate as a
signal for arterial remodelling, similar to the tumour micro-
environment61. The membrane receptor for the high-density
lipoprotein cholesterol Scarb1 is also upregulated in trNK cells, as
well as pathways involved in low-density lipoprotein particle
remodelling (Abcg1, Pla2g7, Mpo) and lipid storage (Apoe, Soat1,
Hexb, Plin2, Gm2a, Ehd1), suggesting that lipid metabolism may
be important for trNK cells. Interestingly, human SCARB1
polymorphism associates with the outcome of in vitro fertilisa-
tion62. Upregulated in g1 ILCs is also Dectin-1, an important
glucan receptor for anti-fungal immunity on macrophages.
Recently, peripheral NK cells were shown to recognise beta 1,3
glucan through NKp3063, suggesting macrophage-like recogni-
tion patterns in NK cells too. Consistently with this notion, we
detected a number of upregulated genes involved in pathways of
microbial molecular pattern recognition. Genes associated with
B-cells, or for protein turnover, antigen processing and pre-
sentation, as well as the macrophage-associated F4/80 marker are
upregulated in ILC1s. The role of these B-cell and myeloid
markers on uterine ILC1s is unknown, and a recently described
subset of NKB cells is controversial64,65, but might be induced in
SIV and HIV infection66. The deconvolution model we have
applied here conﬁrms that uterine g1 ILCs have expression pro-
ﬁles aligned with those of cell types other than NK cells and
including myeloid cells. A clear limitation of the model is that
there are no available ILCs deﬁned in the dataset. Therefore, our
results provide new data speciﬁc to uterine g1 ILCs at mid-
gestation as a new resource for building predictive phenotype
models.
Both liver and uterine ILC1s express higher levels of ‘memory’
marker CXCR6, which prompted us to look for potential changes
in the subset composition in ﬁrst and second pregnancies, with
the idea that CXCR6+ ILC1s may be more abundant in second
pregnancies. This was indeed the case and we suggest these cells
may be associated with memory of pregnancy in the mouse and
expand speciﬁcally in response to local cues. One possibility is
that the CXCR6 ligand CXCL16, expressed also by trophoblast
cells, drives ILC1 expansion during pregnancy. Interestingly,
pregnancy-trained decidual NK cells have recently been described
in humans67, which may contribute to the lower rate of com-
plications that accompany second pregnancies34.
In conclusion, we provide a transcriptome atlas of uterine g1
ILCs. Many genes in the UpSet lists are annotated genes that do
not have a canonical name yet and include pseudogenes, long
non-coding RNA and antisense transcripts. These genes may
discriminate cell types and prove instrumental in cell-speciﬁc
gene targeting. Clearly, there may be heterogeneity even within
the subsets we have analysed in the uterus and some of the genes
may be speciﬁc of smaller populations within the parent popu-
lation. Future work should capture the dynamic transcriptomic
changes within cell types and stages to reveal the biology of
uterine ILCs.
Methods
Mice. C57BL/6 (B6) WT mice were purchased from Charles River UK and Rag2
−/−Il2rg−/− mice maintained in house. Eomes-GFP reporter mice were a gift of
Thierry Walzer68, Rorc(γt)-CreTG/R26R mice from Gérard Eberl69 and Rosa26R-
EYFP from Ionel Sandovici. All strains were on B6 background. All animals were
used at 8–12 weeks of age and were age-matched for every experiment and all time-
matings. The morning of the copulation plug discovery was counted as the
gestation day (gd) 0.5 for time-matings. Mice were bred, maintained and mated
under pathogen-free conditions at the University of Cambridge Central Biomedical
Service in accordance with the University of Cambridge Animal Welfare and
Ethical Review Body and United Kingdom Home Ofﬁce Regulations, as well as at
the Animal Facility of the IRCCS-AOU San Martino-IST in accordance with the
Italian and European Community guidelines.
Cell isolation and functional assays. Mouse uterus, liver and spleen were pro-
cessed using a protocol involving both mechanical and enzymatic processing.
Finely minced tissues were digested in Accutase (Invitrogen) for 35 min at 37°C
with gentle orbital agitation (80 rpm)70 or in Liberase DH (Roche) as described
previously14 for functional assays. Following digestion, tissues were passed through
the cell strainer (100 μm for uterus, 70 μm for liver and 40 μm for spleen) using a
plunger to mechanically dissociate remaining tissues. Leucocytes were then isolated
using 80%/40% Percoll gradient (GE Healthcare Life Sciences) and red blood cell
lysis was performed on the resulting cell pellet using BD Pharm Lyse buffer (BD
Biosciences) according to manufacturer’s instructions. Single cell suspensions
obtained in this way were used for downstream analysis and assays. For in vitro
stimulation, cells were incubated in a complete medium containing Cell Stimula-
tion Cocktail (plus protein transport inhibitors) during a 4-hour assay, alongside
Protein Transport Inhibitor Cocktail for control (both from Invitrogen).
Flow cytometry. Following biotin- or ﬂuorochrome-conjugated antibodies speciﬁc
for the following antigens were used, with the dilutions in the brackets, after the
clone: CD45 (clone 30-F11, 100), CD3 (17A2, 50), CD19 (1D3, 100), CD11b (M1/
70, 100), NK1.1 (PK136, 100), NKp46 (29A1.4, 50), CD49a (Ha31/8, 300), Eomes
(Dan11mag, 100), CD86 (GL1, 50), F4/80 (BM8, 100), B220 (RA3-6B2, 100),
MerTK (REA477, 200), CXCR6 (SA051D1, 100), IL-22 (1H8PWSR, 100), NKG2D
(CX5), NKG2A/C/E (20d5, 100), CD69 (H1.2F3, 50), CD27 (LG.3A10, 50), CD62L
(MEL-14, 100), CD103 (2E7, 25), Ly49H (3D10, 100), Ly49G2 (4D11, 100), Ly49I
(YLI-90, 100), Ly49A (YE1/48.10.6, 50), Ly49D (4E5, 50), Ly49E/F (CM4, 100),
MHC-II (M5/114.15.2, 400), TruStain fcX (anti-mouse CD16/32, 100) for Fc-
receptor blocking and Fixable Viability Dye eFluor 506 (dilution: 1000) for live/
dead discrimination. All antibodies were purchased from Biolegend, Invitrogen
(eBioscience) or BD Biosciences. For intracellular and intranuclear staining, Foxp3/
Transcription Factor Staining Buffer Set (Invitrogen) was used according to
manufacturer’s instructions. Uterine and liver ILC1 were sorted from Eomes-GFP
reporter mice and analysed as live CD45+CD3−CD19−CD11blow/-NK1.1+NKp46
+CD49a+Eomes−, uterine trNK as live CD45+CD3−CD19−CD11blow/-NK1.1
+NKp46+CD49a+Eomes+ and uterine and liver cNK as live CD45+CD3−CD19
−CD11blow/-NK1.1+NKp46+CD49a−Eomes+. Samples were acquired on a LSR
Fortessa (BD Biosciences), sorted on FACSAria III instrument (BD Biosciences)
and analysed using FlowJo vX software (BD Biosciences).
RNA-sequencing and analysis. Group 1 ILCs from uterus and liver were sorted
from Eomes-GFP reporter mice into the TRI Reagent (Sigma). RNA extraction was
carried out by following TRI Reagent manufacturer’s instructions, followed by
RNeasy Micro kit (Qiagen). cDNA was ampliﬁed using Ovation RNA-seq system
V2 (NuGEN) and DNA libraries were produced using Ovation Ultralow System V2
(NuGEN) and following manufacturer’s instructions. All mRNA and cDNA quality
controls and quantiﬁcations were performed using RNA 6000 Pico and High
Sensitivity DNA kits (Agilent) on the 2100 Bioanalyzer instrument (Agilent). RNA
sequencing was performed on Illumina Hiseq4000 at the Cancer Research UK
Cambridge Institute Genomics Core. Data were aligned to GRCm38 mouse gen-
ome (Ensembl Release 84) with TopHat2 (v2.1.1, using bowtie2 v2.2.9) with a
double map strategy. Alignments and QC were processed using custom Cluster-
Flow (v0.5dev) pipelines and assessed using MultiQC (0.9.dev0). Gene quantiﬁ-
cation was determined with HTSeq-Counts (v0.6.1p1). Additional quality control
was performed with feature counts (v 1.5.0-p2), qualimap (v2.2) and preseq
(v2.0.0). Differential gene expression was performed with DESeq2 package (v1.16.1,
R v3.4.2) and with the same package read counts were normalised on the estimated
size factors. Proportions of speciﬁc immune cell types from bulk RNA-Seq can be
estimated using reference data generated from known proportions of the cell types
of interest71. DeconRNASeq72 was applied to take these tables of known cell
proportions, deﬁned by gene expression proﬁles, and used to deconvolute bulk
dataset generated in this study to estimate cell proportions within each of the
sequence’s samples. Gene Ontology (biological process) analysis was performed
using PANTHER (Protein ANalysis THrough Evolutionary Relationships database
http://www.pantherdb.org). Lists of differentially expressed genes (adjusted p < 0.05
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and log2 fold change two or above) were submitted to PANTHER Over-
representation Test (released 2017-12-05), with Fisher’s exact testing utilising a
false discovery rate multiple test correction and a Mus Musculus reference list.
Further details on annotation versions and release dates can be found in the
Supplementary Data 1.
RT-qPCR. Whole uterus was isolated at time-points of interest, collected in
RNAlater (Invitrogen) to stabilise the RNA and kept at 4 °C overnight. Tissue was
homogenised in the Lysing Matrix S homogenisation tubes (MP Biomedicals) on a
FastPrep-24 5G Homogenizer (MP Biomedicals) using RNeasy Plus Universal Kit
(Qiagen) according to manufacturer’s instruction. Isolated RNA quality control
and quantiﬁcation was performed using RNA 6000 Nano kit (Agilent) on the 2100
Bioanalyzer instrument (Agilent). cDNA was ampliﬁed using SuperScript VILO
cDNA Synthesis kit (Invitrogen) and qPCR was performed using PowerUP SYBR
Green Master Mix (Applied Biosystems), on the Quant Studio 6 Flex Real-Time
PCR System (Thermo Fisher – Applied Biosystems). Gapdh was used as a reference
gene. Data were analysed using the ΔΔCt method. Primers were as follows: Spp1,
5′-TTCACTCCAATCGTCCCTAC-3′ (forward) and 5′-TTAGACTCACCGCTCT
TCAT-3′ (reverse); Ogn, 5′-TGCTTTGTGGTCACATGGAT-3′ (forward) and 5′-
GAAGCTGCACACAGCACAAT-3′ (reverse); Ptn, 5′-TGGAGAATGGCAGTGG
AGTGT-3′ (forward) and 5′-GGCGGTATTGAGGTCACATTC-3′ (reverse) and
Gapdh, 5′-TGCACCACCAACTGCTTAG-3′ (forward) and 5′-GGATGCAGGGA
TGATGTTC-3′ (reverse). Ccl2, Ccl7 and Ccl12 were assayed using Thermo Fisher
TaqMan (Assays IDs Mm00441242_m1, Mm00443113_m1, Mm01617100_m1)
with Gapdh as a reference gene (Assay ID Mm99999915_g1).
Statistical analysis and ﬁgure preparation. Statistical parameters and tests
applied are reported in the ﬁgure legends. All statistical analyses were performed in
Prism 7 (GraphPad Software) with a conﬁdence level of 0.95. p-values above 0.05
were considered insigniﬁcant and are not indicated in the ﬁgures. Figures were
prepared using BioRender and Illustrator CC 2018 (Adobe).
Data availability
All relevant data are available from the corresponding author upon reasonable
request. RNA-sequencing data have been deposited in ArrayExpress database at
EMBL-EBI under accession number E-MTAB-6812 (https://www.ebi.ac.uk/
arrayexpress/experiments/E-MTAB-6812). An open-source repository (https://
github.com/CTR-BFX/2018-Filipovic-Colucci) has been created with access to the
code used in this study.
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